WorldWideScience

Sample records for antipsychotic-induced sexual dysfunction

  1. Sexual Dysfunction and Infertility

    Science.gov (United States)

    ... Sexual dysfunction is a problem in a person’s sexual desire, arousal, or orgasm. Sexual dysfunction is common. It ... find they have times when they have less sexual desire and satisfaction because of emotional distress or the ...

  2. Sexual Dysfunction in Women

    Science.gov (United States)

    ... also cause sexual dysfunction. You may have less sexual desire during pregnancy, right after childbirth or when you are breastfeeding. After menopause many women feel less sexual desire, have vaginal dryness or have pain during sex ...

  3. Biology of Sexual Dysfunction

    OpenAIRE

    MN, Anil Kumar; Pai, NB; Rao, S.; Rao, TSS; Goyal, N.

    2009-01-01

    Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the endocrine system, the vascular system and a variety of structures that are instrumental in sexual excitement, intercourse and satisfaction. Sexual function has three components i.e., desire, arousal and orgasm. Many sexual dysfunctions can be categorized according to the phase of sexual response that is affected. In actual clinical practice however, sexual desire, arousal and orgasmic di...

  4. Biology of Sexual Dysfunction

    Directory of Open Access Journals (Sweden)

    Anil Kumar Mysore Nagaraj

    2009-05-01

    Full Text Available Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the endocrine system, the vascular system and a variety of structures that are instrumental in sexual excitement, intercourse and satisfaction. Sexual function has three components i.e., desire, arousal and orgasm. Many sexual dysfunctions can be categorized according to the phase of sexual response that is affected. In actual clinical practice however, sexual desire, arousal and orgasmic difficulties more often than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a wide variety of psychological and physiological causes including derangements in the levels of sex hormones and neurotrensmitters. This review deals with the biology of different phases of sexual function as well as implications of hormones and neurotransmitters in sexual dysfunction

  5. Antipsychotic-induced Hyperprolactinemia

    Directory of Open Access Journals (Sweden)

    Suheyla Dogan Bulut

    2015-06-01

    Full Text Available Prolactin provides the growth of the mammary gland during pregnancy and synthesis and preparation of breast milk for lactation. Antipsychotics and antidepressants that are frequently used in psychiatry, cause hyperprolactinemia. The prevalent opinion is that especially typical antipsychotics increase prolactin levels primarily by blocking D2 receptors in the anterior pituitary. The effects of atypical antipsychotics on hyperprolactinemia vary. Hyperprolactinemia causes galactorrhea, gynecomastia, sexual dysfunction, infertility, acne, hirsutism in women, weight gain, obesity and mood changes in addition to menstrual irregularities such as oligomenorrhea, polymenorrhea and amenorrhea. In the long term, hyperprolactinemia may cause reduction in bone density and osteoporosis. Hyperprolactinemia as a side effect of antipsychotics drugs and its treatment will be reviewed in this article. [Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 2015; 7(2: 109-124

  6. Sexual dysfunctions, depression and antidepressants

    OpenAIRE

    DOĞAN, SULTAN

    2011-01-01

    Normal sexual function is a biopsychosocial process; sexual problems almost always has organic and psychological components and requires multidisciplinary evaluation and treatment. Factors such as relationship conflicts, stresfull events, poor sexual education, aging, declining testosterone levels, medical illness, certain medications, and depressive disorder can contribute to sexual dysfunctions. Depression is one of the most prevalent medical disorders and has been recognised as a distinct ...

  7. Sexual dysfunctions and psychoanalysis.

    Science.gov (United States)

    Levine, E M; Ross, N

    1977-06-01

    The authors examine the major factors involved in recent changes in the social standards and attitudes related to homosexuality. The principal influences investigated include the misconstrued emphasis given to the humanist ideology, which properly stresses the dignity of the individual; the social sciences' relativization of the cultural norms defining homosexuality; the influence of the mass media in disseminating these perspectives and thereby tending to create an acceptable image of homosexuality, and the tendency of all these changes to result in a substantial increase in public acceptance and tolerance of homosexuality. The authors suggest that this trend in public opinion has begun to isolate psychoanalytic knowledge, to reduce its status and acceptability among the public, and to replace it with popular views concerning the meaning of sexual dysfunctions. PMID:869030

  8. Antipsychotics and Sexual Dysfunction: Sexual Dysfunction - Part III

    Directory of Open Access Journals (Sweden)

    Anil Kumar Mysore Nagaraj

    2009-11-01

    Full Text Available Satisfying sexual experience is an essential part of a healthy and enjoyable life for most people. Antipsychotic drugs are among the various factors that affect optimal sexual functioning. Both conventional and novel antipsychotics are associated with significant sexual side effects. This review has presented various studies comparing different antipsychotic drugs. Dopamine antagonism, increased serum prolactin, serotonergic, adrenergic and cholinergic mechanisms are all proposed to be the mechanisms for sexual dysfunction. Drug treatment for this has not given satisfactory long-term results. Knowledge of the receptor pharmacology of an individual antipsychotic will help to determine whether it is more or less likely to cause sexual side effects and its management.

  9. Sexual dysfunctions in psoriatic patients

    Directory of Open Access Journals (Sweden)

    Maria Isabela Sarbu

    2015-04-01

    Full Text Available Psoriasis is a chronic, immune-mediated disorder with a worldwide occurrence characterized by well-defined infiltrated erythematous papules and plaques, covered by silvery white or yellowish scales. It is a physically, socially and emotionally invalidating disorder that affects 1-2% of the population. Sexual health is an important part of general health and sexual dysfunctions can negatively affect self-esteem, confidence, interpersonal relationships and the quality of life. Dermatology Life Quality Index (DLQI, Psoriasis Disability Index (PDI and the Impact of Psoriasis on Quality of Life (IPSO questionnaire are all questionnaires used to assess the quality of life of patients with psoriasis and each has one question regarding sexual dysfunction. Several scales were also designed to particularly assess sexual satisfaction in men and women. The aim of this paper is to perform an overview of the existing studies on sexual dysfunction in psoriatic patients.

  10. Psychiatric disorders and sexual dysfunction.

    Science.gov (United States)

    Waldinger, Marcel D

    2015-01-01

    Sexual problems are highly prevalent among patients with psychiatric disorders. They may be caused by the psychopathology of the psychiatric disorder but also by its pharmacotherapy. Both positive symptoms (e.g., psychosis, hallucinations) as well as negative symptoms (e.g., anhedonia) of schizophrenia may negatively interfere with interpersonal and sexual relationships. Atypical antipsychotics have fewer sexual side-effects than the classic antipsychotics. Mood disorders may affect libido, sexual arousal, orgasm, and erectile function. With the exception of bupropion, agomelatine, mirtazapine, vortioxetine, amineptine, and moclobemide, all antidepressants cause sexual side-effects. Selective serotonin reuptake inhibitors (SSRIs) may particularly delay ejaculation and female orgasm, but also can cause decreased libido and erectile difficulties. SSRI-induced sexual side-effects are dose-dependent and reversible. Very rarely, their sexual side-effects persist after SSRI discontinuation. This is often preceded by genital anesthesia. Some personality characteristics are a risk factor for sexual dysfunction. Also patients with eating disorders may suffer from sexual difficulties. So far, research into psychotropic-induced sexual side-effects suffers from substantial methodologic limitations. Patients tend not to talk with their clinician about their sexual life. Psychiatrists and other doctors need to take the initiative to talk about the patient's sexual life in order to become informed about potential medication-induced sexual difficulties. PMID:26003261

  11. SUBSTANCE USE AND SEXUAL DYSFUNCTION

    Directory of Open Access Journals (Sweden)

    Vijay

    2013-10-01

    Full Text Available ABSTRACT: Substance use disorders form a major part of global disease burden. With increasing trend of use of psychoactive substance, the deleterious effects associated with it also increases. These effects may be biological, social or legal. Among the biological consequences of substance use, little is known of its effect on sexual functioning. In common parlance it is said that many substances increase the sexual desire and hence act as an aphrodisiac. To what extent this is true remains a question of debate. The purpose of thi s article is to review and summarize the available literature on the impact of psychoactive substances like alcohol, tobacco, cannabis and others on sexual functioning. Almost all of them are associated with one or other form of sexual dysfunction. The mec hanism by which they exert such deleterious effect also varies. Further, the sexual dysfunction resulting from substance use can itself have bearing on treatment aspects of substance use. The relationship between sexual dysfunction and substance is attribu ted not only to pharmacological effects, but also to psychological and social factors stemming from substance use. This information of sexual consequence of substance will be of interest and may serve as a powerful tool to healthcare providers

  12. Sexual dysfunctions in psoriatic patients

    OpenAIRE

    Maria Isabela Sarbu; Mircea Tampa; Alexandra Elena Sarbu; Simona Roxana Georgescu

    2015-01-01

    Psoriasis is a chronic, immune-mediated disorder with a worldwide occurrence characterized by well-defined infiltrated erythematous papules and plaques, covered by silvery white or yellowish scales. It is a physically, socially and emotionally invalidating disorder that affects 1-2% of the population. Sexual health is an important part of general health and sexual dysfunctions can negatively affect self-esteem, confidence, interpersonal relationships and the quality of life. Dermatology Life...

  13. Hypnotic metaphor and sexual dysfunction.

    Science.gov (United States)

    Gilmore, L G

    1987-01-01

    Although hypnosis can be very effective in alleviating sexual problems, few sex therapists use hypnotic methods. This paper seeks to encourage a greater use of hypnosis among clinicians by presenting: a description of the new hypnosis exemplified in the work of Milton H. Erickson; an explanation of one of Erickson's most important and innovative methods, the use of multiple embedded metaphors; and case histories illustrating the application of hypnotic approaches to sexual dysfunction.

  14. [Sexual dysfunction among patients with psychiatric disorders].

    Science.gov (United States)

    Soldati, Lorenzo

    2016-03-16

    Scientific literature shows that sexual dysfunction is more common in patients suffering from psychiatric illness as opposed to the general population. It also shows that the prevalence of sexual dysfunction is underestimated by professionals, partly because patients rarely talk spontaneously about their dysfunctions. However, sexual dysfunction has an impact on patients' mental health. Furthermore, some psychotropic medication, antidepressants and antipsychotics in particular, can hinder sexual functioning and induce sexual dysfunction. These harmful effects can, in turn, reduce patients' compliance with their medical treatments. It is therefore important that practitioners take into account their patients' sexual experience. PMID:27149715

  15. Sexual dysfunction in Obsessive-Compulsive disorder

    Directory of Open Access Journals (Sweden)

    Firoozeh Raisi

    2015-05-01

    Conclusion: High prevalence of sexual dysfunction in OCD women and significant correlation between male sexual dysfunction and OCD (r= -481.0 between total score of OCI-R with erectile dysfunction and r= -458.0 between total score of OCI-R and sexual satisfaction could confirm a relation between OCD and sexual disorders. So, evaluation of sexual function in all patients with OCD is recommended.

  16. [Female sexual dysfunction: Drug treatment options].

    Science.gov (United States)

    Alcántara Montero, A; Sánchez Carnerero, C I

    2016-01-01

    Many women will likely experience a sexual problem in their lifetime. Female sexual dysfunction is a broad term used to describe 3 categories of disorders of a multifactorial nature. Effective, but limited pharmacotherapeutic options exist to address female sexual dysfunction. The FDA recently approved the first agent for treatment of hypoactive sexual desire disorder in pre-menopausal women. Off-label use of hormonal therapies, particularly oestrogen and testosterone, are the most widely employed for female sexual dysfunction, particularly in post-menopausal women. Other drugs currently under investigation include phosphodiesterase inhibitors and agents that modulate dopamine or melanocortin receptors. PMID:27041639

  17. Multiple sclerosis and sexual dysfunction

    Institute of Scientific and Technical Information of China (English)

    Zhen-Ni Guo; Si-Yuan He; Hong-Liang Zhang; Jiang Wu; Yi Yang

    2012-01-01

    Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system characterized by episodic and progressive neurologic dysfunction resulting from inflammatory and autoimmune reactions.The underlying pathogenesis of MS remains largely unclear.However,it is currently accepted as a T cell-mediated autoimmune disease.Among other clinical manifestations,sexual dysfunction (SD) is a painful but still underreported and underdiagnosed symptom of the disorder.SD in MS patients may result from a complex set of conditions and may be associated with multiple anatomic,physiologic,biologic,medical and psychological factors.SD arises primarily from lesions affecting the neural pathways involved in physiologic function.In addition,psychological factors,the side effects of medications and physical symptoms such as fatigue,muscular weakness,menstrual changes,pain and concerns about bladder and bowel incontinence may also be involved.Since MS primarily affects young people,SD secondary to MS may have a great impact on quality of life.Thus,maintaining a healthy sexual life with MS is an important priority.The treatment of SD requires multidisciplinary teamwork and cooperation among specialists,individual patients,partners and the society.

  18. Sexual dysfunction within an adult developmental perspective.

    Science.gov (United States)

    Fagan, P J; Meyer, J K; Schmidt, C W

    1986-01-01

    The focus of this paper is on the adult who has adequately mastered the oedipal stage of psychosexual development and who presents with a sexual dysfunction. Drawing on the developmental sequence of Erik Erikson, the authors suggest that failure to address adequately an adult psychosocial crisis may result in sexual dysfunction. There may be both adult developmental deficits and regression to adolescent and adult stages previously negotiated. Both may be symptomatically represented by sexual dysfunction. The authors urge that the sexual and marital problems be evaluated within an adult developmental framework and that the therapy address the psychosocial issues which are appropriate to the developmental stage of the patient. PMID:3820320

  19. Etiology and Management of Sexual Dysfunction

    Directory of Open Access Journals (Sweden)

    Narendra Kumar Muthugaduru Shivarudrappa

    2009-09-01

    Full Text Available Sexual dysfunction is the impairment or disruption of any of the three phases of normal sexual functioning, including loss of libido, impairment of physiological arousal and loss, delay or alteration of orgasm. Each one of these can be affected by an orchestra of factors like senility, medical and surgical illnesses, medications and drugs of abuse. Non-pharmacological therapy is the main stay in the treatment of sexual dysfunction and drugs are used as adjuncts for a quicker and better result. Management in many of the cases depends on the primary cause. Here is a review of the major etiological factors of sexual dysfunction and its management

  20. Diabetes and sexual dysfunction: current perspectives

    Directory of Open Access Journals (Sweden)

    Maiorino MI

    2014-03-01

    Full Text Available Maria Ida Maiorino,1 Giuseppe Bellastella,1 Katherine Esposito2 1Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Second University of Naples, Naples, Italy; 2Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy Abstract: Diabetes mellitus is one of the most common chronic diseases in nearly all countries. It has been associated with sexual dysfunction, both in males and in females. Diabetes is an established risk factor for sexual dysfunction in men, as a threefold increased risk of erectile dysfunction was documented in diabetic men, as compared with nondiabetic men. Among women, evidence regarding the association between diabetes and sexual dysfunction are less conclusive, although most studies have reported a higher prevalence of female sexual dysfunction in diabetic women as compared with nondiabetic women. Female sexual function appears to be more related to social and psychological components than to the physiological consequence of diabetes. Hyperglycemia, which is a main determinant of vascular and microvascular diabetic complications, may participate in the pathogenetic mechanisms of sexual dysfunction in diabetes. Moreover, diabetic people may present several clinical conditions, including hypertension, overweight and obesity, metabolic syndrome, cigarette smoking, and atherogenic dyslipidemia, which are themselves risk factors for sexual dysfunction, both in men and in women. The adoption of healthy lifestyles may reduce insulin resistance, endothelial dysfunction, and oxidative stress – all of which are desirable achievements in diabetic patients. Improved well-being may further contribute to reduce and prevent sexual dysfunction in both sexes. Keywords: diabetes mellitus, diabetes complications, erectile dysfunction, female sexual dysfunction, lifestyle changes

  1. Antidepressant-Induced Female Sexual Dysfunction.

    Science.gov (United States)

    Lorenz, Tierney; Rullo, Jordan; Faubion, Stephanie

    2016-09-01

    Because 1 in 6 women in the United States takes antidepressants and a substantial proportion of patients report some disturbance of sexual function while taking these medications, it is a near certainty that the practicing clinician will need to know how to assess and manage antidepressant-related female sexual dysfunction. Adverse sexual effects can be complex because there are several potentially overlapping etiologies, including sexual dysfunction associated with the underlying mood disorder. As such, careful assessment of sexual function at the premedication visit followed by monitoring at subsequent visits is critical. Treatment of adverse sexual effects can be pharmacological (dose reduction, drug discontinuation or switching, augmentation, or using medications with lower adverse effect profiles), behavioral (exercising before sexual activity, scheduling sexual activity, vibratory stimulation, psychotherapy), complementary and integrative (acupuncture, nutraceuticals), or some combination of these modalities. PMID:27594188

  2. Sexual Dysfunction Due to Psychotropic Medications.

    Science.gov (United States)

    Clayton, Anita H; Alkis, Andrew R; Parikh, Nishant B; Votta, Jennifer G

    2016-09-01

    Sexual functioning is important to assess in patients with psychiatric illness as both the condition and associated treatment may contribute to sexual dysfunction (SD). Antidepressant medications, mood stabilizers, antipsychotics, and antianxiety agents may be associated with SD related to drug mechanism of action. Sexual adverse effects may be related to genetic risk factors, impact on neurotransmitters and hormones, and psychological elements. Effective strategies to manage medication-induced sexual dysfunction are initial choice of a drug unlikely to cause SD, switching to a different medication, and adding an antidote to reverse SD. Appropriate interventions should be determined on a clinical case-by-case basis. PMID:27514298

  3. Questionnaires for assessment of female sexual dysfunction

    DEFF Research Database (Denmark)

    Giraldi, Annamaria; Rellini, Alessandra; Pfaus, James G;

    2011-01-01

    There are many methods to evaluate female sexual function and dysfunction (FSD) in clinical and research settings, including questionnaires, structured interviews, and detailed case histories. Of these, questionnaires have become an easy first choice to screen individuals into different categories...

  4. Male Pseudoheterosexuality and Minimal Sexual Dysfunction

    Science.gov (United States)

    Gutstadt, Joseph P.

    1976-01-01

    There is often a correlation between "pseudoheterosexuality" and minor sexual dysfunction. Insight alone is not sufficient to provide relief, but when the patient can be helped to a comfortable acceptance of his homosexual feelings as a normal and healthy facet of his personality, very often the dysfunction is relieved. (Author)

  5. AB028. New drugs for sexual dysfunction complementary medicine for sexual dysfunction in Australia

    Science.gov (United States)

    Earle, Carolyn

    2015-01-01

    Objective In Australia both oriental and western products are available as complementary medicines. Our aim was to review the current available over-the-counter (OTC) medications for sexual dysfunction and report on this market. Methods Following an earlier published review in 2010, 37 products were reviewed that were listed on the Australian Register of Therapeutic Goods (ARTG) and registered with the Therapeutic Goods Administration (TGA). These products were manufactured in Australia and laid claim to provide treatment for sexual dysfunction. A review of these products and newer products was undertaken to establish the extent of complementary medicines in Australia for sexual dysfunction and the reported clinical experience. Results As at July 2015 there were 31 Australian manufactured OTC products registered with the TGA on the ARTG for sexual dysfunction. Twenty-four were for male sexual dysfunction, 3 for female sexual dysfunction and 4 for unisex sexual dysfunction. The main herbs used in sexual health products in Australia are tribulus terrestris, panax ginseng and horny goat weed. However, complementary medicine practitioners also promote the use of gingko Bilbo, avena sativa and damiana. Many of the ingredients found in men’s products are also in the women’s products. Although review articles for complementary medicine, sexual dysfunction and libido have been written in Australia, as far as can be investigated there are no published randomized clinical trials in the area of complementary medicine and sexual function. Conclusions Complementary medicine has reached a high degree of development in Australia. But, due to the lack of properly conducted placebo-controlled clinical trials there is not a body of supporting evidence of efficacy, certification of purity, guarantee of safety, or well-documented side effects. Even though most OTC medications for sexual health have mild side effects and some also promote general health, the lack of such evidence

  6. Trichotillomania In A Patient With Sexual Dysfunction

    Directory of Open Access Journals (Sweden)

    Aswathi Krishna

    2016-10-01

    Full Text Available Trichotillomania is a chronic psychiatric disorder characterized by pulling out one's own hair, which results in an obvious loss of hair. Hair pulling was first described in Henri Allopeau in 1889. The term "trichotillomania" comes from the Greek words "thrix" - hair, "tillein" - to pull and "Mania" madness or frenzy. 30 year old man presented with complaints of hairpulling behavior and associated erectile dysfunction. His hairpulling behavior improved on treating his sexual dysfunction.

  7. Sexual Dysfunction before and after Cardiac Rehabilitation

    Directory of Open Access Journals (Sweden)

    Jörg Schumann

    2010-01-01

    variables. Methods. Analysis of patients participating in a 12-week exercise-based outpatient cardiac rehabilitation program (OCR between April 1999 and December 2007. Exercise capacity (ExC and quality of life including sexual function were assessed before and after OCR. Results. Complete data were available in 896 male patients. No sexual activity at all was indicated by 23.1% at baseline and 21.8% after OCR, no problems with sexual activity by 40.8% at baseline and 38.6% after OCR. Patients showed an increase in specific problems (erectile dysfunction and lack of orgasm from 18% to 23% (<.0001 during OCR. We found the following independent positive and negative predictors of sexual problems after OCR: hyperlipidemia, age, CABG, baseline ExC and improvement of ExC, subjective physical and mental capacity, and sense of affiliation. Conclusions. Sexual dysfunction is present in over half of the patients undergoing OCR with no overall improvement during OCR. Age, CABG, low exercise capacity are independent predictors of sexual dysfunction after OCR.

  8. AB271. Sexual dysfunction in chronic prostatitis

    Science.gov (United States)

    Cho, In-Rae

    2016-01-01

    Chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS), or NIH category III prostatitis, is a clinical syndrome characterized by genital/ pelvic pain and lower urinary tract symptoms in the absence of urinary tract infection. CPPS is the most common prostatic disease in men younger than 50 years of age and the third most common in men older than 50 years of age. CP/CPPS is a complex entity with unclear etiology. Many articles reported that the high percentage of patients with CP/CPPS had sexual dysfunction. The most common symptoms of sexual dysfunction in chronic prostatitis patients are erectile dysfunction (ED), painful ejaculation and premature ejaculation. So we will discuss about ED and ejaculation problems in CP/CPPS patients.

  9. [How Does Lower Urinary Tract Dysfunction Affekt Female Sexuality?].

    Science.gov (United States)

    Anding, R; Kirschner-Hermanns, R; Rantell, A; Wiedemann, A

    2016-08-01

    With increasing age many women suffer from lower urinary tract dysfunction (LUTD) and female sexual dysfunction. An increasing body of evidence supports an association between the 2 conditions. Especially women with urodynamically proved detrusor hyperactivity suffer from sexual dysfunction and there is some evidence that in patients with stress incontinence sexual health improves after successful surgery. PMID:27328304

  10. Pelvic radiotherapy and sexual dysfunction in women

    DEFF Research Database (Denmark)

    Jensen, Pernille Tine; Froeding, Ligita Paskeviciute

    2015-01-01

    BACKGROUND: During the past decade there has been considerable progress in developing new radiation methods for cancer treatment. Pelvic radiotherapy constitutes the primary or (neo) adjuvant treatment of many pelvic cancers e.g., locally advanced cervical and rectal cancer. There is an increasing...... of life (QOL) issues; sexual functioning has proved to be one of the most important aspects of concern in long-term survivors. METHODS: An updated literature search in PubMed was performed on pelvic radiotherapy and female sexual functioning/dysfunction. Studies on gynaecological, urological...... and gastrointestinal cancers were included. The focus was on the period from 2010 to 2014, on studies using PROs, on potential randomized controlled trials (RCTs) where female sexual dysfunction (FSD) at least constituted a secondary outcome, and on studies reporting from modern radiotherapy modalities. RESULTS...

  11. The Role of Sexual Assault and Sexual Dysfunction in Alcohol and Other Drug Use Disorders

    OpenAIRE

    Sanjuan, Pilar M.; Langenbucher, James W.; Labouvie, Erich

    2006-01-01

    Many women with sexual assault histories receive care in alcohol and other drug treatment programs. Affected women frequently suffer from sexual dysfunction, leading investigators to suggest self-medication may be one path to alcohol and other drug use disorders and relapse. This preliminary study examined sexual dysfunction and sexual assault in 71 women receiving treatment for addiction. Women with prior sexual assault scored higher than non-assaulted women on sexual dysfunction overall, a ...

  12. Antidepressants-Associated Sexual Dysfunction: Impact, Effects and Treatment

    OpenAIRE

    HIGGINS, AGNES; LYNCH, AILEEN MARIA; Nash, Michael

    2010-01-01

    PUBLISHED Sexual dysfunction is a common side effect of antidepressants and can have significant impact on the person?s quality of life, relationships, mental health, and recovery. The reported incidence of sexual dysfunction associated with antidepressant medication varies considerably between studies, making it difficult to estimate the exact incidence or prevalence. The sexual problems reported range from decreased sexual desire, decreased sexual excitement, diminished or...

  13. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark

    DEFF Research Database (Denmark)

    Christensen, Birgitte S; Grønbaek, Morten; Pedersen, Bo V;

    2011-01-01

    Studies have linked obesity, a sedentary lifestyle, and tobacco smoking to erectile dysfunction, but the evidence linking unhealthy lifestyle factors to other sexual dysfunctions or to sexual inactivity is conflicting....

  14. Associations between physical and mental health problems and sexual dysfunctions in sexually active Danes

    DEFF Research Database (Denmark)

    Christensen, Birgitte Schütt; Grønbaek, Morten; Osler, Merete;

    2011-01-01

    Studies have shown a high prevalence of sexual dysfunctions among individuals with a variety of health problems.......Studies have shown a high prevalence of sexual dysfunctions among individuals with a variety of health problems....

  15. Sexual dysfunctions in men treated for testicular cancer

    DEFF Research Database (Denmark)

    Rosendal, Susanne; Kristensen, Ellids; Giraldi, Annamaria G E

    2008-01-01

    Patients treated for testicular cancer have increased risk of ejaculatory, orgasmic and erectile dysfunction compared with healthy men. The underlying relations are unclear. This review describes sexual dysfunctions that are associated with various treatment modalities. One meta-analysis and 11...... original works were examined. About one third of the patients experience one or more sexual problems in relation to the treatment. Only retroperitoneal surgery can cause a specific sexual dysfunction, namely loss of ejaculation ability or ejaculatory functioning. Psychosexual causes are important...... for understanding sexual dysfunctions in patients with testicular cancer....

  16. Factors influencing fluoxetine-induced sexual dysfunction in female rats

    OpenAIRE

    Adams, Sarah; Heckard, Danyeal; Hassell, James; Uphouse, Lynda

    2012-01-01

    Treatment with selective serotonin reuptake inhibitors, such as fluoxetine, produces sexual side effects with low sexual desire being the most prevalent effect in females. In few studies have preclinical models for such antidepressant-induced sexual dysfunction been fruitful. In the current manuscript, the effects of fluoxetine on multiple measures of female sexual motivation and sexual receptivity were examined. Ovariectomized, Fischer rats were primed with 10 μg estradiol benzoate and 500 μ...

  17. Male sexual dysfunction and infertility associated with neurological disorders

    OpenAIRE

    Fode, Mikkel; Krogh-Jespersen, Sheila; Brackett, Nancy L.; Ohl, Dana A; Lynne, Charles M; Sønksen, Jens

    2011-01-01

    Normal sexual and reproductive functions depend largely on neurological mechanisms. Neurological defects in men can cause infertility through erectile dysfunction, ejaculatory dysfunction and semen abnormalities. Among the major conditions contributing to these symptoms are pelvic and retroperitoneal surgery, diabetes, congenital spinal abnormalities, multiple sclerosis and spinal cord injury. Erectile dysfunction can be managed by an increasingly invasive range of treatments including medica...

  18. Sexual Dysfunction and Sexual Behaviors in a Sample of Brazilian Male Substance Misusers.

    Science.gov (United States)

    Diehl, Alessandra; Pillon, Sandra Cristina; Dos Santos, Manoel Antônio; Rassool, G Hussein; Laranjeira, Ronaldo

    2016-09-01

    The aim of this study was to evaluate the potential relationship between self-reported sexual dysfunction, sexual behavior, and severity of addiction of drug users. A cross-sectional design study was conducted at an inpatient addiction treatment unit in Sao Paulo, Brazil, with a sample of 508 male drug users. Sociodemographic data, sexual behavior, and severity of dependence were evaluated.The prevalence of sexual dysfunction was 37.2% and premature ejaculation was 63.8%. Men with sexual dysfunction presented from moderate to severe level of alcohol, tobacco, and other drugs of dependence. The findings from this study are particularly relevant identifying those sociodemographic factors, severity of drug use, and sexual behavior are related to men who experience sexual dysfunction. Health promotion and motivational interventions on sexual health targeted to male drug users can contribute in reducing these at-risk behaviors. More interdisciplinary research is desirable in future in considering men's sexual health. PMID:25643586

  19. Survey of the prevalence of sexual dysfunctions in Kurdish women.

    Science.gov (United States)

    Arasteh, Modabber; Shams Alizadeh, Narges; Ghaderi, Ebrahim; Farhadifar, Fariba; Nabati, Ronak; Gharibi, Fardin

    2014-01-01

    This study evaluates the prevalence of female sexual dysfunctions among Kurdish women. Participants in the study were 196 women between 15 and 55 years of age who attended the gynecological clinic of Be'sat Hospital in Sanandaj Province, Iran. The authors collected relevant data using the Female Sexual Function Index. The mean score was 22.71 (SD = 5). Using a cutoff score of 26.55, the authors found that 151 women (77%) had some sexual dysfunction. Scores declined as patients' age increased; further, an older age at marriage was associated with a higher score. This study, the first about sexual dysfunctions in Kurdish society, shows that sexual dysfunctions are prevalent among women of this ethnicity. Clinicians should complete further studies to assess the factors contributing to this phenomenon. PMID:24228699

  20. SEXUAL DYSFUNCTION IN AN ADULT FEMALE WITH OBSESSIVE SEXUAL THOUGHTS: A CASE REPORT

    OpenAIRE

    Awana, Sunil; Jena, Shivananda

    2002-01-01

    We report a case of an adult married Muslim female from an orthodox background having sexual obsessions about males other than her husband and her 7 year-old son. She developed diminished sexual desire to have sex with her husband as a result of her obsessions. The role of sexual obsessions in sexual dysfunction in females is discussed.

  1. Female sexual dysfunction in female genital mutilation.

    Science.gov (United States)

    Elneil, Sohier

    2016-01-01

    Female genital mutilation (FGM), otherwise known as female genital cutting (FGC), is currently very topical and has become a significant global political issue. The impact of FGM on the lives of women and girls is enormous, as it often affects both their psychology and physical being. Among the complications that are often under-reported and not always acknowledged is female sexual dysfunction (FSD). FSD presents with a complex of symptoms including lack of libido, arousability and orgasm. This often occurs in tandem with chronic urogenital pain and anatomical disruption due to perineal scarring.To treat FSD in FGM each woman needs specifically directed holistic care, geared to her individual case. This may include psychological support, physiotherapy and, on occasion, reconstructive surgery. In many cases the situation is complicated by symptoms of chronic pelvic pain, which can make treatment increasingly difficult as this issue needs a defined multidisciplinary approach for its effective management in its own right. The problems suffered by women with FGM are wholly preventable, as the practice need not happen. The current global momentum to address the social, cultural, economic and medical issues of FGM is being supported by communities, governments, non-governmental agencies (NGOs) and healthcare providers. It is only by working together that the practice can be abolished and women and girls may be free from this practice and its associated consequences.

  2. Female sexual dysfunction in female genital mutilation.

    Science.gov (United States)

    Elneil, Sohier

    2016-01-01

    Female genital mutilation (FGM), otherwise known as female genital cutting (FGC), is currently very topical and has become a significant global political issue. The impact of FGM on the lives of women and girls is enormous, as it often affects both their psychology and physical being. Among the complications that are often under-reported and not always acknowledged is female sexual dysfunction (FSD). FSD presents with a complex of symptoms including lack of libido, arousability and orgasm. This often occurs in tandem with chronic urogenital pain and anatomical disruption due to perineal scarring.To treat FSD in FGM each woman needs specifically directed holistic care, geared to her individual case. This may include psychological support, physiotherapy and, on occasion, reconstructive surgery. In many cases the situation is complicated by symptoms of chronic pelvic pain, which can make treatment increasingly difficult as this issue needs a defined multidisciplinary approach for its effective management in its own right. The problems suffered by women with FGM are wholly preventable, as the practice need not happen. The current global momentum to address the social, cultural, economic and medical issues of FGM is being supported by communities, governments, non-governmental agencies (NGOs) and healthcare providers. It is only by working together that the practice can be abolished and women and girls may be free from this practice and its associated consequences. PMID:26759415

  3. Women's sexual dysfunction: revised and expanded definitions

    OpenAIRE

    Basson, Rosemary

    2005-01-01

    ACCEPTANCE OF AN EVIDENCE-BASED CONCEPTUALIZATION OF WOMEN'S SEXUAL RESPONSE combining interpersonal, contextual, personal psychological and biological factors has led to recently published recommendations for revision of definitions of women's sexual disorders found in the American Psychiatric Association's Diagnostic and Statistical Manual (DSM–IV-TR). DSM-IV definitions have focused on absence of sexual fantasies and sexual desire prior to sexual activity and arousal, even though the frequ...

  4. Sexual dysfunctions and sexology: social constructions, personal meanings and medicalization of sexuality

    OpenAIRE

    Alarcão, Violeta Sabina Niego Perestrelo de

    2015-01-01

    Doutoramento em Sociologia In contemporary constructions of sexuality, the discourses and practices of medicine and clinical psychology occupy a primary role. They contribute to the origin of new normative approaches to sexuality, focused on the issue of good sexual functioning. However, despite the growing attention that sexuality is receiving, the study of the social construction of sexual dysfunction remains incipient, especially in a national context. Overall, the result...

  5. Pharmacological therapy for female sexual dysfunction - Has progress been made?

    NARCIS (Netherlands)

    Davis, Susan R.; Nijland, Esme A.

    2008-01-01

    The investigation of female sexual dysfunction (FSD) is an evolving area in which definitions and models for female sexual functioning are being continually reviewed and revised. The lack of consensus amongst experts in the field and regulating authorities regarding appropriate inclusion and exclusi

  6. USE OF TRANSDERMAL GEL OF SILDENAFIL CITRATE IN SEXUAL DYSFUNCTION

    OpenAIRE

    Harshid Patel , Amit Maniyar and Hiren Patel*

    2012-01-01

    Premature Ejaculation (PE) is one of the most common forms of Sexual Dysfunction and is thought to affect up to 30 % of men. This is the most frequently encountered sexual complaint of men and couples. The physical problem associated with premature ejaculation can be simply described as “over-sensitivity” of the penis. Psychological causes of PE are often associated with “performance anxiety” – anxiety relating to sexual intercourse. The most common treatment today is the oral treatment wi...

  7. Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence

    Directory of Open Access Journals (Sweden)

    Elisabete Rodrigues Nascimento

    2013-11-01

    Full Text Available The aim of this study was to conduct a systematic review of the literature regarding the prevalence of sexual dysfunction in patients with cardiovascular diseases. An article search of the ISI Web of Science and PubMed databases using the search terms "sexual dysfunction”, “cardiovascular diseases”, “coronary artery disease", “myocardial infarct" and “prevalence” was performed. In total, 893 references were found. Non-English-language and repeated references were excluded. After an abstract analysis, 91 references were included for full-text reading, and 24 articles that evaluated sexual function using validated instruments were selected for this review. This research was conducted in October 2012, and no time restrictions were placed on any of the database searches. Reviews and theoretical articles were excluded; only clinical trials and epidemiological studies were selected for this review. The studies were mostly cross-sectional, observational and case-control in nature; other studies used prospective cohort or randomized clinical designs. In women, all domains of sexual function (desire, arousal, vaginal lubrication, orgasm, sexual dissatisfaction and pain were affected. The domains prevalent in men included erectile dysfunction and premature ejaculation and orgasm. Sexual dysfunction was related to the severity of cardiovascular disease. When they resumed sexual activity, patients with heart disease reported significant difficulty, including a lack of interest in sex, sexual dissatisfaction and a decrease in the frequency of sexual activity.

  8. The Relationship between Childhood Sexual Abuse and Sexual Dysfunction in Jamaican Adults

    Science.gov (United States)

    Swaby, Antoneal N.; Morgan, Kai A. D.

    2009-01-01

    This study examined the associations between early traumatic sexualization and later sexual dysfunction in a sample of 100 Jamaican adults while identifying the linkages between age, frequency of abuse, and gender on sexual functioning. Participants were selected via purposive and convenience sampling and divided equally into comparison and…

  9. Sexual dysfunction after radiotherapy for cancer of the cervix uteri

    Energy Technology Data Exchange (ETDEWEB)

    Ohkawa, R.; Takamizawa, H. (Chiba Univ. (Japan). School of Medicine); Arai, T.; Morita, S.

    1981-03-01

    Investigations of sexual consciousness and sexual dysfunction after radiotherapy for cancer of the cervix uteri were performed on patients of middle and old ages by questionnaires and questioning by doctors, and the following results were obtained. 1. Before radiotherapy, sexual activity was most prominent in their twenties and thirties. However, patients who were in fifties when this study was performed had most active sexual lives during the ages from 35 to 50 years. 2. Frequencies of sexual intercourse decreased markedly just before radiotherapy, and many patients received radiotherapy when sexual activity fell. 3. 32% of the patients have not experienced sexual intercourse after radiotherapy. 4. Decreases in the sex urge, sexuality, vaginal discharge, and frequency of sexual intercourse after radiotherapy were recognized in 77%, 77%, 70%, and 93% respectively. 5. Patients who became unwilling to maintain sexual lives after radiotherapy because of fear about recurrence or aggravation of cancer were 38% by questionaires and 49% by questioning by doctors. 6. Pains on sexual intercourse were found in 69% by questionaires and 49% by questionning by doctors. Most pains occurred at penis insertion and was thought to be due to atrophy and inflammation of vagina and external genitalia in most cases. 7. Both vaginal damage and sexual dysfunction in patients with radiotherapy following surgery for cancer of the cervix uteri, in patients with radiotherapy alone for cancer of the cervix uteri, and in patients with radiotherapy following surgery for cancer of the ovary and corpus uteri were marked, modest and mild, respectively. 8. Vaginal damage score was higher in patients treated more than 5 years before than those less than 2 years ago, but there were no differences in sexual dysfunction score between both groups.

  10. Sexual Dysfunction before and after Cardiac Rehabilitation

    OpenAIRE

    Jörg Schumann; Zellweger, Michael J.; Marcello Di Valentino; Simone Piazzalonga; Andreas Hoffmann

    2010-01-01

    Background. The aim of this study was to assess sexual function before and after cardiac rehabilitation in relation to medical variables. Methods. Analysis of patients participating in a 12-week exercise-based outpatient cardiac rehabilitation program (OCR) between April 1999 and December 2007. Exercise capacity (ExC) and quality of life including sexual function were assessed before and after OCR. Results. Complete data were available in 896 male patients. No sexual activity at all was indic...

  11. Sexual Dysfunction in Women with Diabetic Kidney

    Directory of Open Access Journals (Sweden)

    Ersilia Satta

    2014-01-01

    Full Text Available Few studies address alteration of sexual function in women with diabetes and chronic kidney disease (CKD. Quality of life surveys suggest that discussion of sexual function and other reproductive issues are of psychosocial assessment and that education on sexual function in the setting of chronic diseases such as diabetes and CKD is widely needed. Pharmacologic therapy with estrogen/progesterone and androgens along with glycemic control, correction of anemia, ensuring adequate dialysis delivery, and treatment of underlying depression are important. Changes in lifestyle such as smoking cessation, strength training, and aerobic exercises may decrease depression, enhance body image, and have positive impacts on sexuality. Many hormonal abnormalities which occur in women with diabetes and CKD who suffer from chronic anovulation and lack of progesterone secretion may be treated with oral progesterone at the end of each menstrual cycle to restore menstrual cycles. Hypoactive sexual desire disorder (HSDD is the most common sexual problem reported by women with diabetes and CKD. Sexual function can be assessed in women, using the 9-item Female Sexual Function Index, questionnaire, or 19 items. It is important for nephrologists and physicians to incorporate assessment of sexual function into the routine evaluation protocols.

  12. Prevalence and determinants of male sexual dysfunctions during first intercourse.

    Science.gov (United States)

    Santtila, Pekka; Sandnabba, N Kenneth; Jern, Patrick

    2009-01-01

    We explored the balance of genetic and environmental factors on sexual dysfunctions during first intercourse experience in young men. Gender role conflict theory predicts that young males should show high levels of such dysfunctions coupled with mixed affective reactions. Three thousand one hundred eighty six male twins and their siblings (M = 26.17 years, SD = 4.77) completed items on erectile dysfunction (ED), premature ejaculation (PE), contextual factors, and affective reactions during first intercourse, as well as parental attitudes towards nudity and sexuality. Twin modeling revealed a significant genetic effects for PE, but not for ED. Experiences of sexual dysfunction and both negative and positive affects during first intercourse were common among the participants. More positive parental attitudes were associated with less dysfunction and more positive affect during first intercourse. Having the first sexual intercourse with an unknown partner and while strongly intoxicated were, together with group pressure and reluctance to engage in intercourse, related to more negative and less positive affects. Erectile dysfunction during the first intercourse was related to more negative and less positive affects. PMID:19266379

  13. Sexual Dysfunction in Women with Type 2 Diabetes Mellitus

    Directory of Open Access Journals (Sweden)

    Forouzan Elyasi

    2015-05-01

    Full Text Available Background: Sexual dysfunction (SD is one of the important problems in diabetic patients. The present study aimed to determine the prevalence of sexual problems in Iranian women with type 2 diabetes mellitus. Methods: A cross-sectional study was conducted among type 2 diabetic women who visited two outpatient endocrine clinics, namely Imam Hospital and Tuba clinic (Sari, Iran in 2012. Patients were asked to complete two validated questionnaires: Female Sexual Function Index (FSFI and The Hospital Anxiety and Depression Scale (HADS as well as a demographic questionnaire. Analysis was performed using descriptive and analytical tests. P<0.05 was considered to be significant. Results: One hundred and fifty women with type 2 diabetes were investigated. Most of the cases aged 40-44 years old. The mean of the total score of the FSFI questionnaire was 22. The prevalence of sexual dysfunction was 78.7% (CI: 71.4-84.4; among these, 58% (CI: 50.0-65.6 reported problems in lubrication, 50% (CI: 42.1-57.9 complained of decreased sexual desire, 50% (CI: 42.1-57.9 had problems with arousal, 47.3% (CI: 39.5-55.3 had dyspareunia, 32.7% (CI: 25.7-40.5 complained of orgasmic dysfunction and 42.7% (CI: 35.0-50.7 reported problems in sexual satisfaction. With regard to the results of the HADS questionnaire, 58.7% (CI: 50.7-66.2 of the patients had depression and 96.7% (CI: 92.4-98.6 had anxiety. Conclusion: This study showed the high prevalence of sexual dysfunction in diabetic women, especially among those complaining of depression. Health care professionals dealing with diabetic patients should be aware of possible presence of sexual dysfunction in female patients.

  14. Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.

    Science.gov (United States)

    Bo, Qi-Jing; Wang, Zhi-Min; Li, Xian-Bin; Ma, Xin; Wang, Chuan-Yue; de Leon, Jose

    2016-03-30

    This systematic review examines adjunctive metformin therapy for the treatment of antipsychotic-induced hyperprolactinemia. A computerized search of databases in Chinese and the international databases in English provided three trials with a total of 325 patients including one randomized clinical trial (RCT) and two observational studies (single-group, before-after design). A meta-analysis could not be conducted. The quality of evidence ranged from "very low" to "moderate". Metformin patients had a significant decrease in serum prolactin level with a mean of 54.6μg/l in the three trials. In the RCT, menstruation restarted in 67% of those with menstrual disturbances versus 5% in placebo. In one observational study, 91% of patients no longer had signs or symptoms of galactorrhea. In the RCT, adverse drug reactions (ADRs) occurred at similar incidence rates among metformin and placebo patients, except that no significant increases in nausea, insomnia and agitation occurred which were not associated with discontinuations. Our systematic review indicated that adjunctive metformin significantly lowered prolactin level and relieved prolactin-related symptoms in patients with antipsychotic-induced hyperprolactinemia. Future higher quality RCTs need to verify the currently available limited evidence based on three trials which suggest that adjunctive metformin may be used effectively and safely for antipsychotic-induced hyperprolactinemia. PMID:26822064

  15. Heart Rate Variability: A Risk Factor for Female Sexual Dysfunction.

    Science.gov (United States)

    Stanton, Amelia M; Lorenz, Tierney A; Pulverman, Carey S; Meston, Cindy M

    2015-09-01

    Heart rate variability (HRV) is a measure of autonomic nervous system activity, which reflects an individual's ability to adapt to physiological and environmental changes. Low resting HRV has been linked to several mental health conditions, including depression, anxiety, and alcohol dependence (Kemp et al. in Biological Psychiatry 67(11):1067-1074, 2010. doi:10.1016/j.biopsych.2009.12.012; Kemp et al. in PloS One, 7(2):e30777, 2012; Quintana et al. in Drug and Alcohol Dependence, 132(1-2):395-398, 2013. doi:10.1016/j.drugalcdep.2013.02.025). HRV has also been used as a method for indexing the relative balance of sympathetic nervous system (SNS) activity to parasympathetic nervous system activity. This balance--in particular, moderately dominant SNS activity--has been shown to play a significant role in women's genital sexual arousal in the laboratory; however, the role of SNS activity in clinically relevant sexual arousal function is unknown. The present study assessed the feasibility of using HRV as an index of women's self-reported sexual arousal function outside the laboratory. Sexual arousal function, overall sexual function, and resting HRV were assessed in 72 women, aged 18-39. Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p < .001) and overall sexual dysfunction (p < .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. PMID:26081002

  16. Breast cancer treatment and sexual dysfunction: Moroccan women's perception

    Directory of Open Access Journals (Sweden)

    Ismaili Nabil

    2011-06-01

    Full Text Available Abstract Background This exploratory prospective study evaluated women's responses to questions that asked them to describe how their body image and sexual functioning had changed since their breast cancer diagnosis to treatment. Methods A questionnaire concerning body image scale and various sexual problems experienced after diagnosis and treatment was anonymously completed by 120 women in the outpatient clinic of our hospital's Division of medical Oncology. To be eligible, subjects had to be sexually active and had histology proven breast cancer. They also had to have received treatment for breast cancer. Results 100% of participants have never spoken with their doctor about this subject. 84% of the participants continued sexual activity after treatment, but there was an increase in the incidence of sexual functioning problems which resulted in a slight reduction in the quality of their sex lives. 65% of the women experienced dyspareunia followed by lubrication difficulties (54% and the absence or reduction of sexual desire (48% and 64%, respectively while, 37% had lack of satisfaction (37%. Female orgasmic disorder and brief intercourse and arousal were reported respectively by 40% and 38% of the subjects. The sexual dysfunctions were absent before diagnosis and management of breast cancer in 91.5% subjects and of these 100% subjects complained of a deterioration of the symptomatology after the various treatments. 90% of the dysfunctions were observed after chemotherapy, 9% after surgery and 3% after radiotherapy; none of the subjects indicated the onset of dysfunctions to have been associated with hormonotherapy. 100% expressed not having received sufficient information about how the disease and treatment (including surgery might affect their sexual life. Conclusion Breast cancer and its treatment may result in significant difficulties with sexual functioning and sexual life. Addressing these problems is essential to improve the quality of

  17. Obesity and sexual dysfunction in younger Danish men

    DEFF Research Database (Denmark)

    Andersen, Ingelise; Heitman, B. L.; Wagner, Gorm

    2008-01-01

    : To examine a possible association between sexual disorders (erectile dysfunction, ejaculatory disorders, and sexual desire disorders) and obesity among younger men born and living in Denmark. METHODS: A community-based cross-sectional study of sexual health among Danish younger men. Questionnaires were...... to height, weight, smoking status, and alcohol consumption. Erectile dysfunction (ED) was more prevalent among these younger and older men with higher BMI, but only significant among men 20-45 years old, with an odds ratio of 2.74 (95% confidence interval 1.1-6.8). The prevalence of ED was higher among...... the younger obese nonsmokers than obese smokers. Premature ejaculation, retarded ejaculation, and sexual desire disorders were all unrelated to overweight or obesity. CONCLUSION: Obesity (BMI > or = 30 kg/m(2)) seems associated with ED among younger men aged 20-45 years. Health programs directed toward...

  18. Persistent sexual dysfunction after early exposure to SSRIs

    DEFF Research Database (Denmark)

    Simonsen, Anders Lykkemark; Danborg, Pia Brandt; Gøtzsche, Peter Christian

    2016-01-01

    dysfunction. METHODS: Systematic review of animal studies measuring sexual behaviour after end of treatment with SSRIs or serotonin norepinephrine reuptake inhibitors. DATA SOURCES: We searched PubMed and EMBASE. RESULTS: We included 14 studies. The general quality of the studies was poor. Only four studies...

  19. Sexual dysfunction and infertility as late effects of cancer treatment.

    Science.gov (United States)

    Schover, Leslie R; van der Kaaij, Marleen; van Dorst, Eleonora; Creutzberg, Carien; Huyghe, Eric; Kiserud, Cecilie E

    2014-06-01

    Sexual dysfunction is a common consequence of cancer treatment, affecting at least half of men and women treated for pelvic malignancies and over a quarter of people with other types of cancer. Problems are usually linked to damage to nerves, blood vessels, and hormones that underlie normal sexual function. Sexual dysfunction also may be associated with depression, anxiety, relationship conflict, and loss of self-esteem. Innovations in cancer treatment such as robotic surgery or more targeted radiation therapy have not had the anticipated result of reducing sexual dysfunction. Some new and effective cancer treatments, including aromatase inhibitors for breast cancer or chemoradiation for anal cancer also have very severe sexual morbidity. Cancer-related infertility is an issue for younger patients, who comprise a much smaller percentage of total cancer survivors. However, the long-term emotional impact of being unable to have a child after cancer can be extremely distressing. Advances in knowledge about how cancer treatments may damage fertility, as well as newer techniques to preserve fertility, offer hope to patients who have not completed their childbearing at cancer diagnosis. Unfortunately, surveys in industrialised nations confirm that many cancer patients are still not informed about potential changes to their sexual function or fertility, and all modalities of fertility preservation remain underutilised. After cancer treatment, many patients continue to have unmet needs for information about restoring sexual function or becoming a parent. Although more research is needed on optimal clinical practice, current studies suggest a multidisciplinary approach, including both medical and psychosocial treatment options. PMID:26217165

  20. Sexual dysfunction among married couples living in Kumasi metropolis, Ghana

    Directory of Open Access Journals (Sweden)

    Woode Eric

    2011-03-01

    Full Text Available Abstract Background Sexuality and its manifestation constitute some of the most complex of human behaviour and its disorders are encountered in community. Sexual dysfunction is more prevalent in women than in men. While studies examining sexual dysfunction among males and females in Ghana exist, there are no studies relating sexual problems in males and females as dyadic units. This study therefore investigated the prevalence and type of sexual disorders among married couples. Method The study participants consisted of married couples between the ages of 19 and 66 living in the province of Kumasi, Ghana. Socio-demographic information and Golombok-Rust Inventory of Sexual Satisfaction (GRISS questionnaires were administered to 200 couples who consented to take part in the study. All 28 questions of the GRISS are answered on a five-point (Likert type scale from "always", through "usually', "sometimes", and "hardly ever", to "never". Responses are summed up to give a total raw score ranging from 28-140. The total score and subscale scores are transformed using a standard nine point scale, with high scores indicating greater problems. Scores of five or more are considered to indicate SD. The study was conducted between July and September 2010. Results Out of a total of 200 married couples, 179 completed their questionnaires resulting in a response rate of 89.5%. The mean age of the participating couples as well as the mean duration of marriage was 34.8 ± 8.6 years and 7.8 ± 7.6 years respectively. The husbands (37.1 ± 8.6 were significantly older (p Conclusion The prevalence of sexual dysfunction in married couples is comparable to prevalence rates in the general male and female population and is further worsened by duration of marriage. This could impact significantly on a couple's self-esteem and overall quality of life.

  1. Executive Dysfunction Predicts Delinquency But Not Characteristics of Sexual Aggression Among Adolescent Sexual Offenders.

    Science.gov (United States)

    Burton, David; Demuynck, Sophia; Yoder, Jamie R

    2014-11-25

    Our aim in this study was to evaluate executive function and its relationship to delinquency and sexual crime in adolescents incarcerated for sexual crimes. Based on self-report data, 196 male adolescent sexual offenders from a Midwest state reported high rates of executive dysfunction. Although such deficits did not relate to the number of victims of sexual abuse, severity, or degree of force used in commission of the sexual crimes, poor executive function was significantly predictive of both general delinquency and felony theft. In both measures of delinquent conduct, behavioral regulation dysfunction was predictive of the frequency of commission of the crimes, whereas metacognition was not. Research and treatment implications are offered. PMID:25428928

  2. Preclinical effects of melanocortins in male sexual dysfunction.

    Science.gov (United States)

    Shadiack, A M; Althof, S

    2008-07-01

    The neurobiology of sexual behavior involves the interrelationships between sex steroids and neurotransmitters that result in both central nervous system (CNS) effects and effects in the genitalia. Tools such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) scanning can help determine what areas of the brain are activated under sexual stimulation. Our understanding of the role of various neurotransmitters, neurosteroids and other CNS-acting compounds is improving. The role of CNS-acting compounds such as dopamine agonists in the treatment of male sexual dysfunction is under active investigation. Melanocortins have CNS and peripheral roles in a wide variety of bodily functions. The melanocortin agonist bremelanotide appears to act in the CNS to promote erections in preclinical models, and may also stimulate behaviors that facilitate sexual activity beyond their erectogenic effects. PMID:18552829

  3. Sexuality in eating disorders patients: etiological factors, sexual dysfunction and identity issues. A systematic review.

    Science.gov (United States)

    Castellini, Giovanni; Lelli, Lorenzo; Ricca, Valdo; Maggi, Mario

    2016-02-01

    The scientific community appears to be less interested in sexuality of eating disorders (EDs) as compared to other psychiatric or medical comorbidities. However, a clear association between sexual problems and ED psychopathology was reported from different perspectives. The overarching goal of this systematic review was to evaluate the general approach of the scientific literature toward the topic of sexuality and EDs. In particular, four different categories of research have been individuated, encompassing the role of puberty, and sexual abuse in the pathogenesis of the disorders, sexual dysfunctions, and the association between sexual orientation and EDs psychopathology. Timing of puberty with its hormonal consequences and the changes in the way persons perceive their own body represent a crucial period of life for the onset of the disorder. Sexual abuse, and especially childhood sexual abuse are well-recognized risk factors for the development of ED, determining a worse long-term outcome. Recent research overcome the approach that considers sexual activity of EDs patients, in terms of hypersexuality and dangerous sexual behaviors, considering the sexuality of EDs persons in terms of sexual desire, satisfaction, orgasm and pain. Results from this line of research are promising, and describe a clear relationship between sexual dysfunction and the core psychopathological features of EDs, such as body image disturbances. Finally, the analysis of the literature showed an association between sexual orientation and gender dysphoria with EDs psychopathology and pathological eating behaviors, confirming the validity of research developing new models of maintaining factors of EDs related to the topic of self-identity. PMID:26812878

  4. Sexuality in eating disorders patients: etiological factors, sexual dysfunction and identity issues. A systematic review.

    Science.gov (United States)

    Castellini, Giovanni; Lelli, Lorenzo; Ricca, Valdo; Maggi, Mario

    2016-02-01

    The scientific community appears to be less interested in sexuality of eating disorders (EDs) as compared to other psychiatric or medical comorbidities. However, a clear association between sexual problems and ED psychopathology was reported from different perspectives. The overarching goal of this systematic review was to evaluate the general approach of the scientific literature toward the topic of sexuality and EDs. In particular, four different categories of research have been individuated, encompassing the role of puberty, and sexual abuse in the pathogenesis of the disorders, sexual dysfunctions, and the association between sexual orientation and EDs psychopathology. Timing of puberty with its hormonal consequences and the changes in the way persons perceive their own body represent a crucial period of life for the onset of the disorder. Sexual abuse, and especially childhood sexual abuse are well-recognized risk factors for the development of ED, determining a worse long-term outcome. Recent research overcome the approach that considers sexual activity of EDs patients, in terms of hypersexuality and dangerous sexual behaviors, considering the sexuality of EDs persons in terms of sexual desire, satisfaction, orgasm and pain. Results from this line of research are promising, and describe a clear relationship between sexual dysfunction and the core psychopathological features of EDs, such as body image disturbances. Finally, the analysis of the literature showed an association between sexual orientation and gender dysphoria with EDs psychopathology and pathological eating behaviors, confirming the validity of research developing new models of maintaining factors of EDs related to the topic of self-identity.

  5. Incidence of sexual dysfunction: a prospective survey in Ghanaian females

    Directory of Open Access Journals (Sweden)

    Amidu Nafiu

    2010-09-01

    Full Text Available Abstract Background Sexuality is a complex phenomenon that is being influenced by psychological as well as physiological factors. Its dysfunction includes desire, arousal, orgasmic and sex pain disorders. The present study aimed to assess the incidence of sexual dysfunction (SD and related risk factors in a cohort of Ghanaian women. Method The Golombok Rust Inventory of Sexual Satisfaction (GRISS was administered to 400 healthy women between 18 and 58 years old (mean +/- SD: 30.1 +/- 7.9 domiciled in the Kumasi metropolis. Results The response rate was 75.3% after 99 were excluded. Of the remaining 301 women, 50% were engaged in exercise, 26.7% indulge in alcoholic beverages and only 2% were smokers. A total of 62.1% of the women had attained high education, whilst, 28.9% were married. After logistic regression analysis, alcohol emerged (OR: 2.0; CI: 1.0 - 3.8; p = 0.04 as the main risk factor for SD. The overall prevalence of SD in these subjects was 72.8%. Severe difficulties with sexual function were identified in 3.3% of the studied population. The most prevalent areas of difficulty were anorgasmia (72.4%, sexual infrequency (71.4%, dissatisfaction (77.7%, vaginismus (68.1%, avoidance of sexual intercourse (62.5%, non-sensuality (61.5% and non-communication (54.2%. Whereas 8% had severe difficulties with anorgasmia, only 6% had severe difficulties with vaginismus. Conclusion SD affects more than 70% of Ghanaian women who are sexually active. Alcohol significantly influences sexual activity.

  6. Sexual dysfunctions in schizophrenia: Professionals and patients perspectives

    OpenAIRE

    Tharoor, Hema; Kaliappan, Anandhalakshmi; Gopal, Subhashini

    2015-01-01

    Background: Sexual dysfunction (SD) is not commonly reported by persons with schizophrenia unless an enquiry is made by a doctor or staff during routine clinical visits. Materials and Methods: A cross-sectional study was carried out to determine reporting of drug-induced sexual side-effects and the attitude of the treating team in clarifying or detecting this issue. Results: A vast majority of professionals (73.2%) did not enquire about SDs in routine clinical setting and admitted that they l...

  7. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men

    DEFF Research Database (Denmark)

    Gluud, C; Wantzin, P; Eriksen, J

    1988-01-01

    The prevalence and course of sexual dysfunction was evaluated in 221 alcoholic cirrhotic men participating in a double-blind, placebo-controlled study on the effect of oral testosterone treatment on liver disease. At entry, 67% (95% confidence limits, 61%-74%) complained of sexual dysfunction....... In conclusion, oral testosterone treatment does not significantly influence the type or course of sexual dysfunction in alcoholic cirrhotic men. However, sexual function improved after reduction of ethanol consumption in these patients....

  8. Female sexual dysfunction in patients with substance-related disorders

    OpenAIRE

    Diehl, Alessandra; da Silva, Rosiane Lopes; Laranjeira, Ronaldo

    2013-01-01

    OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence...

  9. Vajikarana: Treatment of sexual dysfunctions based on Indian concepts.

    Science.gov (United States)

    Dalal, P K; Tripathi, Adarsh; Gupta, S K

    2013-01-01

    Vajikarana or Vrishya chikitsa is a one of eight major specialty of the Ashtanga Ayurveda. This subject is concerned with aphrodisiacs, virility and improving health of progeny. As per Charak Samhita, by proper use of these formulations, one becomes endowed with good physique, potency, strength, and complexion and sexually exhilarated and sexually potent. This in turn is helpful in many common sexual dysfunctions, including Infertility, Premature Ejaculation and Erectile dysfunction. The therapy is preceded by living in strict compliance with the directions mentioned in Ayurvedic classics, various methods of body cleansing and other non-medicinal strategies like sexual health promoting conduct, behavior and diet. Certain individualized herbal and herbo-mineral combinations are administered as per the nature of a person according to the Ayurveda. Many limitations need to be considered before considering the use of theses therapy like lack of scientific studies, possibilities of adulteration in the herbal and herbo-mineral combinations available in market and possibilities of unexpected side-effects etc., The article calls upon initiating research in this area so that claims of ancient Ayurvedic texts could be substantiated and vajikaran therapy may be utilized by modern medicine. PMID:23858267

  10. Ginkgo biloba for antidepressant-induced sexual dysfunction.

    Science.gov (United States)

    Cohen, A J; Bartlik, B

    1998-01-01

    In an open trial ginkgo biloba, an extract derived from the leaf of the Chinese ginkgo tree and noted for its cerebral enhancing effects, was found to be 84% effective in treating antidepressant-induced sexual dysfunction predominately caused by selective serotonin reuptake inhibitors (SSRIs, N = 63). Women (n = 33) were more responsive to the sexually enhancing effects of ginkgo biloba than men (N = 30), with relative success rates of 91% versus 76%. Ginkgo biloba generally had a positive effect on all 4 phases of the sexual response cycle: desire, excitement (erection and lubrication), orgasm, and resolution (afterglow). This study originated from the observation that a geriatric patient on ginkgo biloba for memory enhancement noted improved erections. Patients exhibited sexual dysfunction secondary to a variety of antidepressant medications including selective serotonin reuptake inhibitor (SSRIs), serotonin and nonrepinephrine reuptake inhibitor (SNRIs) monoamine oxidase inhibitor (MAOIs), and tricyclics. Dosages of ginkgo biloba extract ranged from 60 mg qd to 120 mg bid (average = 209mg/d). The common side effects were gastrointestinal disturbances, headache, and general central nervous system activation. The article includes a discussion of presumed pharmacologic mechanisms, including effects on platelet activating factor, prostaglandins, peripheral vasodilatation, and central serotonin and norepinephrine receptor factor modulation.

  11. Sexual dysfunction and chronic illness: the role of flexibility in coping.

    Science.gov (United States)

    Barsky, Jennifer L; Friedman, Michael A; Rosen, Raymond C

    2006-01-01

    Sexual dysfunction is common among individuals with chronic illnesses and is associated with distress and reduced quality of life. Because of the long-term, often irreversible nature of sexual dysfunction in chronic illness and limitations of pharmacological treatments, there is a need to understand cognitive and behavioral coping processes in this population. We present a model of coping with sexual dysfunction that focuses on the construct of flexibility, including the definition of sexual functioning and its centrality to overall self-concept. We describe how this model can be applied in a comprehensive approach to treating sexual dysfunction in individuals with chronic illnesses. PMID:16809251

  12. Sexual medicine disparities between Asia and North America: commentary on male sexual dysfunction in Asia

    Institute of Scientific and Technical Information of China (English)

    Benjamin F Katz; Doron S Stember; Harris M Nagler

    2011-01-01

    @@ In a recently published article in Asian Journal of Andrology, Ho et al.1 examine prevalence,attitudes, and treatment patterns related to sexual dysfunction in Asia and contrast them with those of Western society.They highlight the relative paucity of data with respect to erectile dysfunction (ED), premature ejaculation, and hypogonadism in the Asian population.Although the authors make a commendable attempt to characterize sexual dysfunction in Asia, there are multiple factors that complicate interpretation of published prevalence rates.Confounding factors affecting interpretation of these studies include the methodology of identification of the studied cohorts, ages of study participants, survey response rates, definitions of ED, and strategies and lengths of time for data collection.

  13. Sexual dysfunction in patients with alcohol and opioid dependence

    Directory of Open Access Journals (Sweden)

    Sandeep Grover

    2014-01-01

    Full Text Available There are limited numbers of studies which have evaluated the sexual dysfunction (SD in patients with alcohol and opioids dependence. This article reviews the existing literature. Electronic searches were carried out using the PubMed, Google Scholar, and ScienceDirect to locate the relevant literature. Subjects addicted to heroin or on methadone maintenance treatment (MMT or buprenorphine maintenance treatment (BMT show higher rates of SD in comparison to the general population. SD rates have ranged 34-85% for heroin addicts, 14-81% for MMT, 36-83% for BMT, and 90% for naltrexone maintenance. The rates of SD in alcohol-dependent population have ranged 40-95.2%, with rates being consistently much higher in alcohol-dependent population than in the healthy controls or social drinkers. The common SDs reported have been erectile dysfunction followed by premature ejaculation, retarded ejaculation and decreased sexual desire among men, and dyspareunia and vaginal dryness among women. This review suggests that long-term use of alcohol and opioids are associated with SD in almost all domains of sexual functioning. There is a need to increase the awareness of clinicians about this association as many times SD in patients with substance abuse lead to poor treatment compliance and relapse. Further, there is a need to carry out more number of studies to understand the relationship in a better way.

  14. The incidence of sexual dysfunction in patients attending Dutch general practitioners.

    OpenAIRE

    Kedde, H.; Donker, G.; Leusink, P.; Kruijer, H.

    2011-01-01

    Data on patients with a sexual dysfunction were collected in 45 Dutch general practices between 2003 and 2008. The aim of the study was to determine the incidence of patients with a sexual dysfunction, associated health problems, and related interventions performed by their general practitioners (GPs). The study design was a dynamic cohort study comparing 6 years of data on patients with a sexual dysfunction. Participating GPs were asked to record weekly all consulting patients who presented ...

  15. Does erectile dysfunction drug use contribute to risky sexual behavior?

    Institute of Scientific and Technical Information of China (English)

    Wayne J. G. Hellstrom

    2010-01-01

    @@ Erectile dysfunction (ED) is a common sexual problem affecting up to one-third of men through-out their lives. According to the Massachusetts Male Aging Study (MMAS), ED affects an estimated 52% of men between the ages of 40 and 70. With the approval of silde-nafil (USA in March 1998), the first phosphodiesterase type 5 (PDE-5) inhibitor to be made available for treatment of ED, and the subse-quent approval of vardenafil (USA in August 2003) and tadalafil (USA in November 2003), the PDE-5 inhibitor class of drugs has rapidly become the first-line therapy for ED of varying etiologies and se-verities.

  16. Sexual dysfunction among Ghanaian men presenting with various medical conditions

    Directory of Open Access Journals (Sweden)

    Quaye Lawrence

    2010-10-01

    Full Text Available Abstract Background Several medical conditions can affect and disrupt human sexuality. The alteration of sexuality in these medical conditions often hinder effective communication and empathy between the patients and their sexual partners because of cultural attitudes, social norms and negative feelings such as anxiety and guilt. Validated and standardized sexual inventories might therefore help resolve this problem. The objective of this cross-sectional study was to obtain data on the prevalence of male sexual dysfunction (SD among Ghanaians with various medical conditions residing in Kumasi. Methods The Golombok Rust Inventory of Sexual Satisfaction (GRISS was administered to 150 Ghanaian men with various medical conditions between 19 and 66 years old (mean ± standard deviation: 40.01 ± 12.32 years domiciled in the Kumasi metropolis. Results Out of the total 150 questionnaires administered, 105 (70.0% men returned the questionnaires. Questionnaires from 3 men were incomplete, leaving 102 complete and evaluable questionnaires, indicating a 68.0% response rate. Of the remaining 102 men, 88.2% were married, 70.6% had attained higher education, 88.2% were non-smokers. Whereas 54.9% were engaged in exercise, 61.8% indulged in alcoholic beverages. The prevalence of the various medical conditions include: diabetes (18%, hypertension (24.5%, migraine (11.8%, ulcer (7.8%, surgery (6.9%, STD (3.9 and others (26.5%. The prevalence of SD among the respondents in the study was 59.8%. The highest prevalence of SD was seen among ulcer patients (100%, followed by patients who have undergone surgery (75%, diabetes (70%, hypertension (50%, STD (50% and the lowest was seen among migraine patients (41.7%. Conclusions SD rate is high among Ghanaian men with medical conditions (about 60% and vary according to the condition and age.

  17. Male sexual dysfunctions and multimedia immersion therapy (follow-up).

    Science.gov (United States)

    Optale, Gabriele; Marin, Silvia; Pastore, Massimiliano; Nasta, Alberto; Pianon, Carlo

    2003-06-01

    The aim of the study was to evaluate the efficiency, after 1 year, of combined use of psychodynamic psychotherapy integrating virtual reality (VR) for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in 160 heterosexual males who had neither any prior sexual therapy nor had made use (either before, during or after therapy) of any specific pharmaceuticals for the treatment of primary sexual dysfunction. All subjects had given their informed consent. After a clinical diagnosis in an andrologic center, 50 presumably psychological ED (average age 43.7 years), 60 mixed ED (53.9 years) and 50 primary PE (39 years) who suffered these problems over 6 months were undergoing a cycle of 12 sessions, over a 25-week period, of psychotherapy, integrating an audio CD and helmet with miniature television screens that projected specially designed CD-ROM program on the ontogenetic development of male sexual identity. The clinical follow up was done after 6 and 12 months after the cycle. After one year, the overall partial (two times out of three) and complete positive response rate for psychological ED was 75%, for mixed ED was 47% and for PE was 54%. We considered drop-out cases as only before the 7th session of the treatment cycle, the drop-outs after session 7 and the patients that did not show up for follow-up are counted as negative results. Two patients reported nausea and one, vertigo during the first 15-min virtual reality experience. Considering the particular way that full-immersion virtual reality involves the subject who experiences it, we hypothesized that this methodological approach could speed up the therapeutic process. The evidence that positive results persist over time allows us to hypothesize that certain changes in cerebral function can be possible and that these changes are correlated to favorable sexual performance in the male.

  18. Comparison of Sexual Dysfunction Using the Female Sexual Function Index following Surgical Treatments for Uterine Fibroids

    Directory of Open Access Journals (Sweden)

    Allison Ryann Louie

    2012-01-01

    Full Text Available Uterine fibroids are a common problem in women. Statistics showing 20–50% of fibroids produce symptoms and consequently patients seek surgical intervention to improve their quality of life. Treatments for fibroids are typically successful in controlling the fibroid disease, yet sexual function following invasive surgical treatments for fibroids can be jeopardized. The Sexual Function Index (FSFI is a valid instrument producing quantifiable reproducible results. In this paper three case reports are evaluated by the FSFI and compared between the following treatment groups: hysterectomy, myomectomy, and uterine embolization. Our goal is to illustrate how each of these treatment outcomes can result in sexual dysfunction and therefore decreased quality of life. Effects of invasive fibroid treatments on sexual functioning would be helpful in guiding patient’s ultimate decisions regarding treatment.

  19. Evaluation the Frequency of Sexual Dysfunction in Infertile Men, Fatemieh Hospital, Hamadan

    OpenAIRE

    H. Babolhavaeji; M. Feizian

    2008-01-01

    Introduction & Objective: Sexual dysfunction is called to inability to get or keep a successful sexual intercourse. The term “sexual dysfunction” may also be used to describe other problems that interfere with sexual intercourse, such as inability to achieve erection and problems with ejaculation or orgasm. Damage to nerves, arteries, smooth muscles and fibrous tissues, often as a result of a disease, are the most common cause of erectile dysfunction. The aim of the present study was to evalu...

  20. Prevalence and Predictive Factors of Sexual Dysfunction in Iranian Women: Univariate and Multivariate Logistic Regression Analyses

    Science.gov (United States)

    Direkvand-Moghadam, Ashraf; Suhrabi, Zainab; Akbari, Malihe

    2016-01-01

    Background Female sexual dysfunction, which can occur during any stage of a normal sexual activity, is a serious condition for individuals and couples. The present study aimed to determine the prevalence and predictive factors of female sexual dysfunction in women referred to health centers in Ilam, the Western Iran, in 2014. Methods In the present cross-sectional study, 444 women who attended health centers in Ilam were enrolled from May to September 2014. Participants were selected according to the simple random sampling method. Univariate and multivariate logistic regression analyses were used to predict the risk factors of female sexual dysfunction. Diffe rences with an alpha error of 0.05 were regarded as statistically significant. Results Overall, 75.9% of the study population exhibited sexual dysfunction. Univariate logistic regression analysis demonstrated that there was a significant association between female sexual dysfunction and age, menarche age, gravidity, parity, and education (Pwomen suffer from sexual dysfunction. A lack of awareness of Iranian women's sexual pleasure and formal training on sexual function and its influencing factors, such as menarche age, gravida, and level of education, may lead to a high prevalence of female sexual dysfunction. PMID:27688863

  1. Evaluation the Frequency of Sexual Dysfunction in Infertile Men, Fatemieh Hospital, Hamadan

    Directory of Open Access Journals (Sweden)

    H. Babolhavaeji

    2008-07-01

    Full Text Available Introduction & Objective: Sexual dysfunction is called to inability to get or keep a successful sexual intercourse. The term “sexual dysfunction” may also be used to describe other problems that interfere with sexual intercourse, such as inability to achieve erection and problems with ejaculation or orgasm. Damage to nerves, arteries, smooth muscles and fibrous tissues, often as a result of a disease, are the most common cause of erectile dysfunction. The aim of the present study was to evaluate the frequency of sexual dysfunction in patients referred to Fatemieh infertility clinic, Hamadan.Materials & Methods: In this cross-sectional study all males referred to Fatemieh infertility center in 2005, were entered the study. All patients were clinically examined and their medical histories were obtained. Data such as age, accusation, education, history of smoking and opioid abusing, sexual dysfunction, inability to achieve orgasm, premature ejaculation and the frequency of intercourse were entered in the questionnaires. Data was analyzed using SPSS 13 and 2 statistical test.Results: The mean age of patients studied was 32.37.4 years (20-65 years. From 245 cases, 135 (55.1% had sexual dysfunction. The most common sexual dysfunction was premature ejaculation(38.8%. Other sexual dysfunctions were impotence with 16.3% , lack of sexual desire with 12.2% and orgasm disorder with 10.6% respectively. 65.9% patients were uneducated or had elementary education , 27.4% had diploma , and 6.7% had academic education. 23.7% of patients had addiction and 34.1% were smoker.Conclusion : This study showed that most common etiology of sexual dysfunction was premature ejaculation. Other sexual dysfunctions were: impotence, sexual desire disorder and orgasm disorder respectively.

  2. Male sexual dysfunction and infertility associated with neurological disorders

    Science.gov (United States)

    Fode, Mikkel; Krogh-Jespersen, Sheila; Brackett, Nancy L; Ohl, Dana A; Lynne, Charles M; Sønksen, Jens

    2012-01-01

    Normal sexual and reproductive functions depend largely on neurological mechanisms. Neurological defects in men can cause infertility through erectile dysfunction, ejaculatory dysfunction and semen abnormalities. Among the major conditions contributing to these symptoms are pelvic and retroperitoneal surgery, diabetes, congenital spinal abnormalities, multiple sclerosis and spinal cord injury. Erectile dysfunction can be managed by an increasingly invasive range of treatments including medications, injection therapy and the surgical insertion of a penile implant. Retrograde ejaculation is managed by medications to reverse the condition in mild cases and in bladder harvest of semen after ejaculation in more severe cases. Anejaculation might also be managed by medication in mild cases while assisted ejaculatory techniques including penile vibratory stimulation and electroejaculation are used in more severe cases. If these measures fail, surgical sperm retrieval can be attempted. Ejaculation with penile vibratory stimulation can be done by some spinal cord injured men and their partners at home, followed by in-home insemination if circumstances and sperm quality are adequate. The other options always require assisted reproductive techniques including intrauterine insemination or in vitro fertilization with or without intracytoplasmic sperm injection. The method of choice depends largely on the number of motile sperm in the ejaculate. PMID:22138899

  3. Male sexual dysfunction and infertility associated with neurological disorders

    Institute of Scientific and Technical Information of China (English)

    Mikkel Fode; Sheila Krogh-Jespersen; Nancy L Brackett; Dana A Ohl; Charles M Lynne; Jens Sonksen

    2012-01-01

    Normal sexual and reproductive functions depend largely on neurological mechanisms.Neurological defects in men can cause infertility through erectile dysfunction,ejaculatory dysfunction and semen abnormalities.Among the major conditions contributing to these symptoms are pelvic and retroperitoneal surgery,diabetes,congenital spinal abnormalities,multiple sclerosis and spinal cord injury.Erectile dysfunction can be managed by an increasingly invasive range of treatments including medications,injection therapy and the surgical insertion of a penile implant.Retrograde ejaculation is managed by medications to reverse the condition in mild cases and in bladder harvest of semen after ejaculation in more severe cases.Anejaculation might also be managed by medication in mild cases while assisted ejaculatory techniques including penile vibratory stimulation and electroejaculation are used in more severe cases.If these measures fail,surgical sperm retrieval can be attempted.Ejaculation with penile vibratory stimulation can be done by some spinal cord injured men and their partners at home,followed by in-home insemination if circumstances and sperm quality are adequate.The other options always require assisted reproductive techniques including intrauterine insemination or in vitrofertilization with or without intracytoplasmic sperm injection.The method of choice depends largely on the number of motile sperm in the ejaculate.

  4. Male sexual dysfunctions: immersive virtual reality and multimedia therapy.

    Science.gov (United States)

    Optale, Gabriele; Pastore, Massimiliano; Marin, Silvia; Bordin, Diego; Nasta, Alberto; Pianon, Carlo

    2004-01-01

    The study describes a therapeutic approach using psycho-dynamic psychotherapy integrating virtual environment (VE) for resolving impotence or better erectile dysfunction (ED) of presumably psychological or mixed origin and premature ejaculation (PE). The plan for therapy consists of 12 sessions (15 if a sexual partner was involved) over a 25-week period on the ontogenetic development of male sexual identity, and the methods involved the use of a laptop PC, joystick, Virtual Reality (VR) helmet with miniature television screen showing a new specially-designed CD-ROM programs using Virtools with Windows 2000 and an audio CD. This study was composed of 30 patients, 15 (10 suffering from ED and 5 PE) plus 15 control patients (10 ED and 5 PE), that underwent the same therapeutic protocol but used an old VR helmet to interact with the old VE using a PC Pentium 133 16 Mb RAM. We also compared this study with another study we carried out on 160 men affected by sexual disorders, underwent the same therapeutic protocol, but treated using a VE created (in Superscape VRT 5.6) using always Windows 2000 with portable tools. Comparing the groups of patients affected by ED and PE, there emerged a significant positive results value without any important differences among the different VE used. However, we had a % increase of undesirable physical reactions during the more realistic 15-minute VR experience using Virtools development kit. Psychotherapy alone normally requires long periods of treatment in order to resolve sexual dysfunctions. Considering the particular way in which full-immersion VR involves the subject who experiences it (he is totally unobserved and in complete privacy), we hypothesise that this methodological approach might speed up the therapeutic psycho-dynamic process, which eludes cognitive defences and directly stimulates the subconscious, and that better results could be obtained in the treatment of these sexual disorders. This method can be used by any

  5. USE OF TRANSDERMAL GEL OF SILDENAFIL CITRATE IN SEXUAL DYSFUNCTION

    Directory of Open Access Journals (Sweden)

    Harshid Patel , Amit Maniyar and Hiren Patel*

    2012-11-01

    Full Text Available Premature Ejaculation (PE is one of the most common forms of Sexual Dysfunction and is thought to affect up to 30 % of men. This is the most frequently encountered sexual complaint of men and couples. The physical problem associated with premature ejaculation can be simply described as “over-sensitivity” of the penis. Psychological causes of PE are often associated with “performance anxiety” – anxiety relating to sexual intercourse. The most common treatment today is the oral treatment with phosphodiesterase -5 (PDE-5 inhibitors. There are currently three different inhibitors available Sildenafil, Vardenafil, and Tadalafil. Sildenafil citrate is a drug of choice used in the treatment of premature ejaculation disorder. It was licensed for use in the United States in 1998; Sildenafil has shown in studies that it improves ED in men regardless of disease etiology, severity of disease, or even age. Transdermal gel has gained more and more importance because the gel based formulations are better percutaneously absorbed than creams and ointment bases. Transdermal drug delivery systems are defined as self-contained, discrete dosage forms which, when applied to the intact skin, deliver the drug, through the skin, at a controlled rate to the systemic circulation. Present Status - A review by Barry in 2001 showed, the transdermal route has vied with oral treatment as the most successful innovative research area in drug delivery.

  6. Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction

    NARCIS (Netherlands)

    Vitkova, Marianna; Rosenberger, Jaroslav; Krokavcova, Martina; Szilasiova, Jarmila; Gdovinova, Zuzana; Groothoff, Johan W.; van Dijk, Jitse P.

    2014-01-01

    Purpose: Bladder, bowel and sexual dysfunction are often overlooked symptoms in patients with multiple sclerosis (MS) and can be associated with lower health-related quality of life (HRQoL). The aim is to explore the association of bladder, bowel and sexual dysfunction with HRQoL in MS patients stra

  7. Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction in Adolescents: A Review.

    Science.gov (United States)

    Scharko, Alexander M.

    2004-01-01

    Objective: To review the existing literature on selective serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction in adolescents. Method: A literature review of SSRI-induced adverse effects in adolescents focusing on sexual dysfunction was done. Nonsexual SSRI-induced adverse effects were compared in adult and pediatric populations.…

  8. The incidence of sexual dysfunction in patients attending Dutch general practitioners.

    NARCIS (Netherlands)

    Kedde, H.; Donker, G.; Leusink, P.; Kruijer, H.

    2011-01-01

    Data on patients with a sexual dysfunction were collected in 45 Dutch general practices between 2003 and 2008. The aim of the study was to determine the incidence of patients with a sexual dysfunction, associated health problems, and related interventions performed by their general practitioners (GP

  9. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy

    NARCIS (Netherlands)

    vanBasten, JPA; Hoekstra, HJ; vanDriel, MF; Droste, JHJ; JankerPool, G; vandeWiel, HBM; Sleijfer, DT; Schraffordt Koops, H.

    1997-01-01

    Purpose: To establish the prevalence of sexual dysfunctions after different treatment modalities for non-seminomatous testicular germ cell tumor (NSTGCT) and to investigate whether treatment-induced angiopathy and neuropathy is related to sexual dysfunction. Patient and Methods: A questionnaire asse

  10. Prevalence of sexual dysfunction and impact of contraception in female German medical students

    OpenAIRE

    Wallwiener, Lisa-Maria

    2010-01-01

    This study’s objective was to investigate the prevalence and types of female sexual dysfunction (FSD) and the relationship between hormonal contraception and FSD in female German medical students. Moreover, the influence of sex hormones in oral contraceptives on female sexual function was compared. An online questionnaire based on the Female Sexual Function Index (FSFI) with additional questions on contraception, sexual activity and other factors that may influence sexual function was com...

  11. The effect of fatigue and fibromyalgia on sexual dysfunction in women with chronic fatigue syndrome.

    Science.gov (United States)

    Blazquez, Alicia; Ruiz, Eva; Aliste, Luisa; García-Quintana, Ana; Alegre, José

    2015-01-01

    Sexual dysfunction in patients with chronic fatigue syndrome is attracting growing interest but, to date, few studies have analyzed it. For this reason, the authors evaluated sexual dysfunction in women with chronic fatigue syndrome (using the Golombok Rust Inventory of Sexual Satisfaction) and explore correlations with fatigue and other symptoms. Sexual dysfunction was greater in patients with chronic fatigue syndrome (n = 615) with a higher number of cognitive, neurological, and neurovegetative symptoms, concomitant fibromyalgia, Sjögren's syndrome, or myofascial pain syndrome, and more intense fatigue (p <.05).

  12. [Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment].

    Science.gov (United States)

    Marthol, H; Hilz, M J

    2004-03-01

    Sexual dysfunction is defined as "disturbances in sexual desire and in the psychophysiological changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty". The female sexual response cycle consists of three phases: desire, arousal, and orgasm. Various organs of the external and internal genitalia, e.g. vagina, clitoris, labia minora, vestibular bulbs, pelvic floor muscles and uterus, contribute to female sexual function. During sexual arousal, genital blood flow and sensation are increased. The vaginal canal is moistened (lubrication). During orgasm, there is rhythmical contraction of the uterus and pelvic floor muscles. Within the central nervous system, hypothalamic, limbic-hippocampal structures play a central role for sexual arousal. Sexual arousal largely depends on the sympathetic nervous system. Moreover, nonadrenergic/noncholinergic neurotransmitters (NANC), e.g. vasoactive intestinal polypeptide (VIP) and nitric oxide (NO), are involved in smooth muscle relaxation and enhancement of genital blood flow. Furthermore, various hormones may influence female sexual function. Estrogen has a significant role in maintaining vaginal mucosal epithelium as well as sensory thresholds and genital blood flow. Androgens primarily affect sexual desire, arousal, orgasm and the overall sense of well-being. The internationally accepted classification of female sexual dysfunction consists of hypoactive sexual desire disorders, sexual aversion disorders, sexual arousal disorders, orgasmic disorders and sexual pain disorders. Vascular insufficiency, e.g. due to atherosclerosis, and neurologic diseases, e.g. diabetic neuropathy, are major causes of sexual dysfunction. Additionally, sexual dysfunction may be due to changes in hormonal levels, medications with sexual side effects or of psychological origin. For the diagnosis of female sexual dysfunction, a detailed history should be taken initially, followed by a physical examination

  13. Sexual dysfunction in multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

    Science.gov (United States)

    Richards, Tiffany A; Bertolotti, Page A; Doss, Deborah; McCullagh, Emily J

    2011-08-01

    The World Health Organization describes sexuality as a "central aspect of being human throughout life and encompasses sex, gender identities and roles, sexual orientation, eroticism, pleasure, intimacy, and reproduction. Sexuality is influenced by the interaction of biological, psychological, social, economic, political, cultural, ethical, legal, historical, religious, and spiritual factors." Currently, no research has been conducted regarding sexual dysfunction in patients with multiple myeloma; therefore, information related to the assessment and evaluation of sexual dysfunction is gleaned from other malignancies and diseases. In this article, members of the International Myeloma Foundation's Nurse Leadership Board discuss the definition, presentation, and causes of sexual dysfunction; provide recommendations for sexual assessment practices; and promote discussion among patients with multiple myeloma, their healthcare providers, and their partners.

  14. Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management

    Directory of Open Access Journals (Sweden)

    Marco de Tubino Scanavino

    2011-01-01

    Full Text Available Sexual dysfunctions in HIV-positive men are associated with an increase in risky sexual behavior and decreased adherence to antiretroviral drug regimens. Because of these important public health issues, we reviewed the literature on the pathophysiology, associated factors and clinical management of sexual dysfunction in HIV-positive men. The goal was to investigate the current research on these issues. Literature searches were performed in June 2011 on PubMed, Web of Science, and PsycInfo databases with the keywords “AIDS” and “sexual dysfunction” and “HIV” and “sexual dysfunction”, resulting in 54 papers. Several researchers have investigated the factors associated with sexual dysfunction in HIV-positive men. The association between sexual dysfunction and antiretroviral drugs, particularly protease inhibitors, has been reported in many studies. The lack of standardized measures in many studies and the varying study designs are the main reasons that explain the controversial results. Despite some important findings, the pathophysiology of sexual dysfunction in the HAART era still not completely understood. Clinical trials of testosterone replacement therapy have shown the treatment to be beneficial to the improvement of sexual dysfunctions related to hypogonadism. However, there are not enough psychological intervention studies to make conclusions regarding the therapeutic effects of psychotherapy.

  15. Determinants of sexual dysfunction among clinically diagnosed diabetic patients

    Directory of Open Access Journals (Sweden)

    Sarpong Charity

    2011-05-01

    Full Text Available Abstract Background Diabetes mellitus is a chronic disease that can result in various medical, psychological and sexual dysfunctions (SD if not properly managed. SD in men is a common under-appreciated complication of diabetes. This study assessed the prevalence and determinants of SD among diabetic patients in Tema, Greater Accra Region of Ghana. Method Sexual functioning was determined in 300 consecutive diabetic men (age range: 18-82 years visiting the diabetic clinic of Tema General Hospital with the Golombok Rust Inventory of Sexual Satisfaction (GRISS questionnaire, between November, 2010 and March, 2011. In addition to the socio-demographic characteristics of the participants, the level of glycosylated haemoglobin, fasting blood sugar (FBS and serum testosterone were assessed. All the men had a steady heterosexual relationship for at least 2 years before enrolment in the study. Results Out the 300 participants contacted, the response rate was 91.3% after 20 declined participation and 6 incomplete data were excluded All the respondents had at least basic education, 97.4% were married, 65.3% were known hypertensive, 3.3% smoked cigarettes, 27% took alcoholic beverages and 32.8% did some form of exercise. The 69.3% SD rate observed in this study appears to be related to infrequency (79.2%, non-sensuality (74.5%, dissatisfaction with sexual acts (71.9%, non-communication (70.8% and impotence (67.9%. Other areas of sexual function, including premature ejaculation (56.6% and avoidance (42.7% were also substantially affected. However, severe SD was seen in only 4.7% of the studied population. The perceived "adequate", "desirable", "too short" and "too long intra-vaginal ejaculatory latency time (IELT are 5-10, 5-10, 1-2 and 15-30 minutes respectively. Testosterone correlates negatively with glycated haemoglobin (HBA1c, FBS, perceived desirable, too short IELT, and weight as well as waist circumference. Conclusion SD rate from this study is high

  16. Determinants of sexual dysfunction among clinically diagnosed diabetic patients

    Science.gov (United States)

    2011-01-01

    Background Diabetes mellitus is a chronic disease that can result in various medical, psychological and sexual dysfunctions (SD) if not properly managed. SD in men is a common under-appreciated complication of diabetes. This study assessed the prevalence and determinants of SD among diabetic patients in Tema, Greater Accra Region of Ghana. Method Sexual functioning was determined in 300 consecutive diabetic men (age range: 18-82 years) visiting the diabetic clinic of Tema General Hospital with the Golombok Rust Inventory of Sexual Satisfaction (GRISS) questionnaire, between November, 2010 and March, 2011. In addition to the socio-demographic characteristics of the participants, the level of glycosylated haemoglobin, fasting blood sugar (FBS) and serum testosterone were assessed. All the men had a steady heterosexual relationship for at least 2 years before enrolment in the study. Results Out the 300 participants contacted, the response rate was 91.3% after 20 declined participation and 6 incomplete data were excluded All the respondents had at least basic education, 97.4% were married, 65.3% were known hypertensive, 3.3% smoked cigarettes, 27% took alcoholic beverages and 32.8% did some form of exercise. The 69.3% SD rate observed in this study appears to be related to infrequency (79.2%), non-sensuality (74.5%), dissatisfaction with sexual acts (71.9%), non-communication (70.8%) and impotence (67.9%). Other areas of sexual function, including premature ejaculation (56.6%) and avoidance (42.7%) were also substantially affected. However, severe SD was seen in only 4.7% of the studied population. The perceived "adequate", "desirable", "too short" and "too long intra-vaginal ejaculatory latency time (IELT) are 5-10, 5-10, 1-2 and 15-30 minutes respectively. Testosterone correlates negatively with glycated haemoglobin (HBA1c), FBS, perceived desirable, too short IELT, and weight as well as waist circumference. Conclusion SD rate from this study is high but similar to

  17. The effects of self-focused attention, performance demand, and dispositional sexual self-consciousness on sexual arousal of sexually functional and dysfunctional men

    NARCIS (Netherlands)

    Lankveld, van J.J.; Hout, van den M.A.; Schouten, E.G.

    2004-01-01

    Sexually functional (N = 26) and sexually dysfunctional heterosexual men with psychogenic erectile disorder (N = 23) viewed two sexually explicit videos. Performance demand was manipulated through verbal instruction that a substantial genital response was to be expected from the videos. Self-focused

  18. Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China.

    Directory of Open Access Journals (Sweden)

    Minying Zhang

    Full Text Available OBJECTIVE: To investigate whether methadone maintenance treatment (MMT is correlated with sexual dysfunction in heroin-dependent men and to determine the prevalence and risk factors of sexual dysfunction among men on MMT. METHODS: The study included a retrospective survey and a cross-sectional survey which contained interviews of 293 men who are currently engaged in MMT. The results of the two surveys were compared. For a subset of 43 participants, radioimmunoassay was additionally conducted using retrospective and prospective blood samples to test the levels of plasma testosterone and luteinizing hormone. Other study evaluations were the International Index of Erectile Function (IIEF-15, and Self-rating Depression Scale. RESULTS: Sexual dysfunction in all five IIEF-15 domains (erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction was strongly associated with long-term use of heroin. A decrease in the severity of sexual dysfunction was associated with MMT initiation. Erectile dysfunction, lack of sexual desire, inability to orgasm, and lack of intercourse satisfaction were significantly correlated with increasing age of the participants. Methadone dose and duration of methadone treatment were not found to be associated with sexual dysfunction. The level of plasma testosterone significantly declined during methadone treatment, but results from multivariate analysis indicated low levels of testosterone were not the main cause of sexual dysfunction. No correlation between reported depression status and sexual function was found. CONCLUSIONS: While high levels of sexual dysfunction were reported by heroin-dependent men in our study before and after MMT initiation, MMT appears to be correlated with improved sexual function in the population of the study.

  19. Sexual dysfunctions after prostate cancer radiation therapy; Dysfonctions sexuelles apres irradiation pour cancer de la prostate

    Energy Technology Data Exchange (ETDEWEB)

    Droupy, S. [Service d' urologie-andrologie, CHU Caremeau, 30 - Nimes (France)

    2010-10-15

    Sexual dysfunctions are a quality of life main concern following prostate cancer treatment. After both radiotherapy and brachytherapy, sexual function declines progressively, the onset of occurrence of erectile dysfunction being 12-18 months after both treatments. The pathophysiological pathways by which radiotherapy and brachytherapy cause erectile dysfunction are multi-factorial, as patient co-morbidities, arterial damage, exposure of neurovascular bundle to high levels of radiation, and radiation dose received by the corpora cavernosa at the crurae of the penis may be important in the aetiology of erectile dysfunction. Diagnosis and treatment of postradiation sexual dysfunctions must integrate pre-therapeutic evaluation and information to provide to the patient and his partner a multidisciplinary sexual medicine management. (authors)

  20. Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants

    Directory of Open Access Journals (Sweden)

    David S. Baldwin

    2013-01-01

    Full Text Available Pleasurable sexual activity is an essential component of many human relationships, providing a sense of physical, psychological, and social well-being. Epidemiological and clinical studies show that depressive symptoms and depressive illness are associated with impairments in sexual function and satisfaction, both in untreated and treated patients. The findings of randomized placebo-controlled trials demonstrate that most of the currently available antidepressant drugs are associated with the development or worsening of sexual dysfunction, in a substantial proportion of patients. Sexual difficulties during antidepressant treatment often resolve as depression lifts but can endure over long periods and may reduce self-esteem and affect mood and relationships adversely. Sexual dysfunction during antidepressant treatment is typically associated with many possible causes, but the risk and type of dysfunction vary with differing compounds and should be considered when making decisions about the relative merits and drawbacks of differing antidepressants. A range of interventions can be considered when managing patients with sexual dysfunction associated with antidepressants, including the prescription of phosphodiesterase-5 inhibitors, but none of these approaches can be considered “ideal.” As treatment-emergent sexual dysfunction is less frequent with certain drugs, presumably related to differences in their pharmacological properties, and because current management approaches are less than ideal, a reduced burden of treatment-emergent sexual dysfunction represents a tolerability target in the development of novel antidepressants.

  1. Prevalence of Sexual Concerns and Sexual Dysfunction among Sexually Active and Inactive Men and Women with Screen-Detected Type 2 Diabetes

    DEFF Research Database (Denmark)

    Bjerggaard, Mette; Charles, Morten; Kristensen, Ellids;

    2015-01-01

    inactive men and women with type 2 diabetes and of sexual dysfunction (SD) among sexually active. METHODS: Data from the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care-Denmark study was used. A total of 1,170 Danish patients with screen-detected type...... 2 diabetes attended a health examination, including assessment of sexual concerns using self-report questionnaires and of SD using the Female Sexual Function Index (FSFI-R) and the International Index of Erectile Function (IIEF-5) instruments. MAIN OUTCOME MEASURES: The main outcome measures used...... active and sexually inactive people with type 2 diabetes. Bjerggaard M, Charles M, Kristensen E, Lauritzen T, Sandbæk A, and Giraldi A. Prevalence of sexual concerns and sexual dysfunction among sexually active and inactive men and women with screen-detected type 2 diabetes. Sex Med 2015;3:302-310....

  2. Psychological and interpersonal dimensions of sexual function and dysfunction in women: An update

    OpenAIRE

    Althof, Stanley E; Needle, Rachel B.

    2013-01-01

    Introduction We reviewed the psychological and interpersonal dimensions of female sexual function and dysfunction. Methods We identified articles published in 1970–2013 using the keywords ‘female sexual dysfunction’, ‘sexual desire’, ‘sexual arousal’, ‘female orgasmic disorder’, ‘sex therapy’, ‘psychotherapy’, ‘behaviour therapy’ and ‘Internet therapy’. Over 200 articles were reviewed (Level of evidence 2b). Results and conclusions We identified the major psychological variables affecting fem...

  3. Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study

    DEFF Research Database (Denmark)

    Jensen, S B; Gluud, C

    1985-01-01

    Sexual dysfunction in men with alcoholic cirrhosis was investigated in young (less than 56 years) outpatients with steady female partners. Sixty-one per cent (11/18) claimed sexual dysfunction, with erectile dysfunction and/or reduced sexual desire being the most common symptoms. Comparing patients...... not significantly different comparing alcoholic cirrhotic men to chronic alcoholic men without overt liver disease (matched for duration of alcoholism, age and duration of partnership) and to insulin-dependent diabetic men (matched for age and duration of partnership). However, all groups had a significantly (p...

  4. Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain

    DEFF Research Database (Denmark)

    Ebdrup, Bjørn H; Knop, Filip K; Ishøy, Pelle L;

    2012-01-01

    are already compromised in normal weight patients with schizophrenia. Here we outline the current strategies against antipsychotic-induced weight gain, and we describe peripheral and cerebral effects of the gut hormone glucagon-like peptide-1 (GLP-1). Moreover, we account for similarities in brain changes...... between schizophrenia and overweight patients. DISCUSSION: Current interventions against antipsychotic-induced weight gain do not facilitate a substantial and lasting weight loss. GLP-1 analogues used in the treatment of type 2 diabetes are associated with significant and sustained weight loss...... in overweight patients. Potential effects of treating schizophrenia patients with antipsychotic-induced weight gain with GLP-1 analogues are discussed. CONCLUSIONS: We propose that adjunctive treatment with GLP-1 analogues may constitute a new avenue to treat and prevent metabolic and cerebral deficiencies...

  5. Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

    Directory of Open Access Journals (Sweden)

    Brandl EJ

    2011-08-01

    Full Text Available Tessa JM Wallace, Clement C Zai, Eva J Brandl, Daniel J MüllerNeurogenetics Section, Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, CanadaAbstract: Antipsychotic-induced weight gain is a serious side effect of antipsychotic medication that can lead to increased morbidity, mortality, and non-compliance in patients. Numerous single nucleotide polymorphisms have been studied for association with antipsychotic-induced weight gain in an attempt to find genetic predictors of this side effect. An ability to predict this side effect could lead to personalized treatment plans for predisposed individuals, which could significantly decrease the prevalence and severity of weight gain. Variations in the serotonin receptor 2c gene (HTR2C have emerged as promising candidates for prediction of antipsychotic-induced weight gain. Specifically, the well-studied -759C/T promoter polymorphism has been associated with weight gain in diverse populations, although some studies have reported no association. This discrepancy is likely due to heterogeneity in study design with respect to ethnicity, treatment duration, and other variables. Notably, the association between HTR2C and antipsychotic-induced weight gain appears strongest in short-term studies on patients with limited or no previous antipsychotic treatment. Other, less extensively studied promoter polymorphisms (-697C/G, -997G/A, and -1165A/G have also emerged as potential predictors of antipsychotic-induced weight gain. Conversely, the well-studied intronic polymorphism Cys23Ser does not appear to be associated. With further research on both HTR2C and other genetic and environmental predictors of antipsychotic-induced weight gain, a predictive test could one day be created to screen patients and provide preventative or alternative treatment for those who are predisposed to this serious side effect.Keywords: HTR2C, pharmacogenomics, promoter polymorphism

  6. Sexual dysfunction and dissatisfaction in chronic hepatitis C patients

    Directory of Open Access Journals (Sweden)

    Bruno Cópio Fábregas

    2014-10-01

    Full Text Available Introduction The prevalence of sexual dysfunction (SD and dissatisfaction with sexual life (DSL in patients with chronic hepatitis C virus infection (CHC was jointly investigated via a thorough psychopathological analysis, which included dimensions such as fatigue, impulsiveness, psychiatric comorbidity, health-related quality of life (HRQL and sociodemographic and clinical characteristics. Methods Male and female CHC patients from an outpatient referral center were assessed using the Brief Fatigue Inventory, the Barrat Impulsiveness Scale, the Beck Depression Inventory (BDI, the Hospital Anxiety and Depression Scale, the Hamilton Anxiety Scale (HAM-A, and the World Health Organization Quality of Life Scale-Brief Version (WHOQOL-BREF. Structured psychiatric interviews were performed according to the Mini-International Neuropsychiatric Interview. SD was assessed based on specific items in the BDI (item 21 and the HAM-A (item 12. DSL was assessed based on a specific question in the WHOQOL-BREF (item 21. Multivariate analysis was performed according to an ordinal linear regression model in which SD and DSL were considered as outcome variables. Results SD was reported by 60 (57.1% of the patients according to the results of the BDI and by 54 (51.4% of the patients according to the results of the HAM-A. SD was associated with older age, female gender, viral genotype 2 or 3, interferon-α use, impulsiveness, depressive symptoms, antidepressant and benzodiazepine use, and lower HRQL. DSL was reported by 34 (32.4% of the patients and was associated with depressive symptoms, anxiety symptoms, antidepressant use, and lower HRQL. Conclusions The prevalence of SD and DSL in CHC patients was high and was associated with factors, such as depressive symptoms and antidepressant use. Screening and managing these conditions represent significant steps toward improving medical assistance and the HRQL of CHC patients.

  7. Sexual dysfunction among female patients of reproductive age in a hospital setting in Nigeria.

    Science.gov (United States)

    Fajewonyomi, Benjamin A; Orji, Ernest O; Adeyemo, Adenike O

    2007-03-01

    Although sexual dysfunction is an important public-health problem in Nigeria, little research has been conducted on this topic in Nigeria. This cross-sectional study was conducted to determine the prevalence of sexual dysfunction and their correlates among female patients of reproductive age using a questionnaire. Respondents were recruited from the out-patients clinics of a teaching hospital setting in Ile-Ife/ Ijesa administrative health zone, Osun State, Nigeria. Of 384 female patients interviewed, 242 (63%) were sexually dysfunctional. Types of sexual dysfunction included disorder of desire (n=20; 8.3%), disorder of arousal (n=l 3; 5.4%), disorder of orgasm (n=154; 63.6%), and painful coitus (dyspareunia) (n=55; 22.7%). The peak age of sexual dysfunction was observed among the age-group of 26-30 years. Women with higher educational status were mostly affected. The reasons for unsatisfactory sexual life mainly included psychosexual factors and medical illnesses, among which included uncaring partners, present illness, excessive domestic duties, lack of adequate foreplay, present medication, competition among wives in a polygamous family setting, previous sexual abuse, and guilt-feeling of previous pregnancy termination among infertile women. The culture of male dominance in the local environment which makes women afraid of rejection and threats of divorce if they ever complain about sexually-related matters might perpetrate sexual dysfunction among the affected individuals. Sexual dysfunction is a real social and psychological problem in the local environment demanding urgent attention. It is imperative to carry out further research in society at large so that the health and lifestyles of affected women and their partners could be improved.

  8. Sexual dysfunction among female patients of reproductive age in a hospital setting in Nigeria.

    Science.gov (United States)

    Fajewonyomi, Benjamin A; Orji, Ernest O; Adeyemo, Adenike O

    2007-03-01

    Although sexual dysfunction is an important public-health problem in Nigeria, little research has been conducted on this topic in Nigeria. This cross-sectional study was conducted to determine the prevalence of sexual dysfunction and their correlates among female patients of reproductive age using a questionnaire. Respondents were recruited from the out-patients clinics of a teaching hospital setting in Ile-Ife/ Ijesa administrative health zone, Osun State, Nigeria. Of 384 female patients interviewed, 242 (63%) were sexually dysfunctional. Types of sexual dysfunction included disorder of desire (n=20; 8.3%), disorder of arousal (n=l 3; 5.4%), disorder of orgasm (n=154; 63.6%), and painful coitus (dyspareunia) (n=55; 22.7%). The peak age of sexual dysfunction was observed among the age-group of 26-30 years. Women with higher educational status were mostly affected. The reasons for unsatisfactory sexual life mainly included psychosexual factors and medical illnesses, among which included uncaring partners, present illness, excessive domestic duties, lack of adequate foreplay, present medication, competition among wives in a polygamous family setting, previous sexual abuse, and guilt-feeling of previous pregnancy termination among infertile women. The culture of male dominance in the local environment which makes women afraid of rejection and threats of divorce if they ever complain about sexually-related matters might perpetrate sexual dysfunction among the affected individuals. Sexual dysfunction is a real social and psychological problem in the local environment demanding urgent attention. It is imperative to carry out further research in society at large so that the health and lifestyles of affected women and their partners could be improved. PMID:17615910

  9. Laser irradiation of penile blood as treatment of sexual dysfunctions

    Science.gov (United States)

    Koultchavenia, Ekaterina V.; Khomyakov, Victor T.

    2001-05-01

    40-60% of the men of average age suffer from the violations of sexual functions. Impotence doesn't make direct threat to life; nevertheless this disease essentially reduces quality of life, and consequently deserves the most steadfast attention. There are many methods of treatment of erectile dysfunction. However they are connected with a reception of medicines, which is expensive and has a number of contraindications, or with invasive procedures, or with surgical intervention, that also not always is desirable. We have developed the original device permitting to cause passive erection by creation of a local decompression. The second stage is the effect by an infrared laser radiation (denseness of a potency 4.2 mWt/sm2, continuous radiation with length of a wave 0.89 microns, exposition 5 minutes) on erection glans penis. We observed 24 patients with the complaints on insufficient erection (18), premature ejaculation (6); 2 patients in addition presented the complaint on small sizes of the penis. Age of the patients was 24-46 years, on the average 34.3 years. All have received treatment from 15 sessions in day.

  10. Investigation of the difference between the expression and presence of sexual symptoms and dysfunction in depressed women treated with fluoxetine

    Directory of Open Access Journals (Sweden)

    Ali Fakhari

    2015-11-01

    Full Text Available Introduction: The present study aimed at investigating the difference between the expression and presence of sexual symptoms and dysfunction in depressed women treated with fluoxetine, and the possibility of sexual dysfunction following consumption of fluoxetine. Methods: This cross-sectional analytic study was conducted on 44 women candidates for receiving fluoxetine after the diagnosis of depression. Patients’ complaints of sexual dysfunction were collected and compared using Arizona Sexual Experiences Scale (ASEX questionnaire during their first visit and 2 months after receiving fluoxetine. Two-way data were analyzed using chi-square test, and Wilcoxon Signed Ranks test was used to study ordinal variables in SPSS software. Results: This study indicates that there is a significant difference between the final score of the ASEX questionnaire and that of each question before and after the consumption of fluoxetine. Using ASEX scale, it was indicated that 11 (25.0% and 27 (61.4% of participants suffered from sexual dysfunction at their first and second visit, respectively, and that there is a correlation between the expression of sexual dysfunction symptoms and sexual dysfunction disorder. Conclusion: Results indicate that consumption of fluoxetine causes sexual dysfunction, and there is a correlation between the expression of sexual dysfunction symptoms and sexual dysfunction disorder. Moreover the fewer participants complain about symptoms, the more the chance of sexual dysfunction.

  11. The Gay Men Sex Studies: prevalence of sexual dysfunctions in Belgian HIV+ gay men

    OpenAIRE

    Vansintejan J; Janssen J; Van De Vijver E; Vandevoorde J; Devroey D

    2013-01-01

    Johan Vansintejan, Joris Janssen, Erwin Van De Vijver, Jan Vandevoorde, Dirk Devroey Department of Family Medicine, Vrije Universiteit Brussel (VUB), Brussels, Belgium Abstract: The aim of this Internet-based survey was to investigate the prevalence and associated predictors of sexual dysfunctions in Belgian self-reported HIV-positive men who have sex with other men. Of the 72 participants, 56% had a mild-to-severe erectile dysfunction, and 15% reported a hypoactive sexual desire disorder. Th...

  12. The Gay Men Sex Studies: prevalence of sexual dysfunctions in Belgian HIV+ gay men

    OpenAIRE

    Vansintejan, Johan

    2013-01-01

    Johan Vansintejan, Joris Janssen, Erwin Van De Vijver, Jan Vandevoorde, Dirk Devroey Department of Family Medicine, Vrije Universiteit Brussel (VUB), Brussels, Belgium Abstract: The aim of this Internet-based survey was to investigate the prevalence and associated predictors of sexual dysfunctions in Belgian self-reported HIV-positive men who have sex with other men. Of the 72 participants, 56% had a mild-to-severe erectile dysfunction, and 15% reported a hypoactive sexual desire disorder. T...

  13. Prevalence of Sexual Concerns and Sexual Dysfunction among Sexually Active and Inactive Men and Women with Screen‐Detected Type 2 Diabetes

    Science.gov (United States)

    Charles, Morten; Kristensen, Ellids; Lauritzen, Torsten; Sandbæk, Annelli; Giraldi, Annamaria

    2015-01-01

    Abstract Introduction Type 2 diabetes negatively impacts sexual health. Only limited information is available regarding sexual health among sexually inactive patients with type 2 diabetes. Aim The aim of this study was to examine the prevalence of sexual concerns among sexually active and sexually inactive men and women with type 2 diabetes and of sexual dysfunction (SD) among sexually active. Methods Data from the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen‐Detected Diabetes in Primary Care‐Denmark study was used. A total of 1,170 Danish patients with screen‐detected type 2 diabetes attended a health examination, including assessment of sexual concerns using self‐report questionnaires and of SD using the Female Sexual Function Index (FSFI‐R) and the International Index of Erectile Function (IIEF‐5) instruments. Main Outcome Measures The main outcome measures used regarding sexual concerns are the following: prevalence of failure to fill sexual needs, of experiencing sexual distress, finding it important to have a good sexual life, and additionally, prevalence of SD. Results Data regarding sexual activity status during the last 12 months were available among 583 men and 377 women. Seventeen percent of men and 47% of women reported to be sexually inactive, among whom 57% of men and 42% of women reported failure to fill sexual needs; 31% of men and 10% of women that it was important to have a good sexual life, and 32% of men and 11% of women that they were experiencing sexual distress. Around half of men and women were excluded from the SD analysis, mainly because of reporting lack of sexual intercourse during the last 4 weeks. Among those included, 54% of men and 12% of women were found to have SD. Conclusions Sexual inactivity is highly prevalent among middle‐aged and older men and women with early type 2 diabetes and these patients often have sexual concerns. The high exclusion rates when assessing SD using the FSFI

  14. Racial Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality?

    Science.gov (United States)

    Burnett, Arthur L

    2016-03-01

    Among diverse subject areas in the field of prostate cancer management, treatment-related sexual dysfunction complications persist today as a significant potential problem for all men receiving treatment for this disease. The conjecture that African-American men are disproportionately affected by this problem among ethnic groups is not trivial and warrants attention in view of the possibility that its risk profile, whether real or perceived, may influence clinical management decisions impacting survival outcomes in this high-prostate cancer-risk population. A literature review was performed to define the occurrence and significance of sexual dysfunction after prostate cancer treatment in African-American men, with an emphasis on clinically localized treatment. Data retrieved from population-based as well as single-center investigations are conflicting with regard to the extent and quality of life relevance of sexual dysfunction following prostate cancer treatments in African-American men, relative to that of ethnically different counterparts. Some reports suggest a relatively greater trend in African-American men than other ethnic groups toward obtaining clinical management for sexual dysfunction and experiencing psychosocial effects from it, lending additional support for the possibly greater effect of this problem in African-American men. Although further studies are needed to define sexual dysfunction after prostate cancer treatment and ascertain its bother and impact on quality of life in African-American men, survivorship care that encompasses sexual dysfunction management should proceed with appropriate attention given to cultural, educational, and psychosocial variables.

  15. Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review

    Science.gov (United States)

    Jain, Seema; Andridge, Rebecca; Hellings, Jessica A.

    2016-01-01

    Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed a chart review of 15 adolescents and adults meeting DSM-IV-TR criteria for ASD, all with antipsychotic-associated weight gain, who received low dose loxapine in an attempt to taper or…

  16. Sexual dysfunctions and difficulties in denmark: prevalence and associated sociodemographic factors

    DEFF Research Database (Denmark)

    Christensen, Birgitte S; Grønbaek, Morten; Osler, Merete;

    2011-01-01

    Sexual dysfunctions and difficulties are common experiences that may impact importantly on the perceived quality of life, but prevalence estimates are highly sensitive to the definitions used. We used questionnaire data for 4415 sexually active Danes aged 16-95 years who participated in a nationa...

  17. Major Depressive Disorder, Obsessive-Compulsive Disorder, and Generalized Anxiety Disorder: Do the Sexual Dysfunctions Differ?

    OpenAIRE

    Kendurkar, Arvind; Kaur, Brinder

    2008-01-01

    Objectives: Major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and generalized anxiety disorder (GAD) are known to have significant impact on sexual functioning. They have been studied individually. Therefore, this study was planned to compare the sexual dysfunction between MDD, OCD, and GAD with healthy subjects as controls.

  18. Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone

    NARCIS (Netherlands)

    M. van Bruggen; T. van Amelsvoort; L. Wouters; P. Dingemans; L. de Haan; D. Linszen

    2009-01-01

    Atypical antipsychotics interfere with central and peripheral neurotransmitter systems and with hormonal production. In this study we compared the effect of olanzapine and risperidone on hormonal state and sexual function (by using the Questionnaire for Sexual Dysfunction, QSD) in 40 patients with a

  19. The prevalence of sexual dysfunction in the female health care providers in Jeddah, Saudi Arabia

    OpenAIRE

    Rouzi, Abdulrahim A; Nora Sahly; Dana Sawan; Souzan Kafy; Faten Alzaban

    2015-01-01

    The objective of this study was to determine the prevalence of sexual dysfunction in Saudi and non-Saudi female health care providers in Jeddah, Saudi Arabia. One -hundred twenty (60 Saudi and 60 non-Saudi) sexually active female health care professionals in Jeddah, Saudi Arabia, were anonymously surveyed using the English version of the female sexual function index questionnaire. The individual domain scores for pain, arousal, lubrication, orgasm, satisfaction, pain, and overall score for th...

  20. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction.

    Science.gov (United States)

    Gama, Carlos Rb; Lasmar, Ricardo; Gama, Gustavo F; Abreu, Camila S; Nunes, Carlos P; Geller, Mauro; Oliveira, Lisa; Santos, Alessandra

    2014-01-01

    This is a qualitative-quantitative study based on hospital records of female patients of reproductive age, presenting sexual dysfunction, and treated with 250 mg Tribulus terrestris extract (1 tablet thrice daily for 90 days). Safety monitoring included vital signs, physical examination, laboratory tests, and occurrence of adverse events. Efficacy analysis included results of the Female Sexual Function Index (FSFI), dehydroepiandrosterone (DHEA) levels together with total and free testosterone, and the patient and physician assessments. There was a statistically significant improvement in total FSFI scores (P terrestris extract is safe and effective in the treatment of female sexual dysfunction. PMID:25574150

  1. Definitions of women's sexual dysfunction reconsidered : advocating expansion and revision

    NARCIS (Netherlands)

    Basson, R; Leiblum, S; Brotto, L; Derogatis, L; Fourcroy, J; Fugl-Meyer, K; Graziottin, A; Heiman, [No Value; Laan, E; Meston, C; Schover, L; van Lankveld, J; Schultz, WW

    2003-01-01

    In light of various shortcomings of the traditional nosology of women's sexual disorders for both clinical practice and research, an international multi-disciplinary group has reviewed the evidence for traditional assumptions about women's sexual response. It is apparent that fullfillment of sexual

  2. Epidemiology of sexual dysfunction in Asia compared to the rest of the world

    Institute of Scientific and Technical Information of China (English)

    Ronald W Lewis

    2011-01-01

    There have been a limited number of epidemiological studies published on sexual disorders in persons from Asia.This paper aims to assess the reports of sexual dysfunction epidemiologicai studies published in the English language that involved Asian countries.Key points are summarized in this paper from nine epidemiological papers on sexual dysfunction from Asia that were published in the English language.Seven met the criteria for evidence-based studies reaching a Prins score of at least 10 or more.Papers included in this report came from national and regional representative studies in peer review journals.These results for sexual dysfunction in the nine papers are summarized for various sexual dysfunctions in men and women in Asian countries.In three of these,worldwide data were presented in the same paper allowing comparisons with Asian data on prevalence rates.Detailed descriptions from each of these studies are presented in paragraph form.More detailed data on erectile dysfunction(ED)is presented in a tabular form.Collectively,there seems to be a need for country-and population-specific further descriptive and analytical epidemiological studies in all of the sexual disorders from Asia.This critical review paper should help guide these studies for reaching evidence-based literature standards.

  3. A Preliminary Study of Sexual Dysfunction in Male Opioid-Dependants under Methadone Maintenance Treatment

    Directory of Open Access Journals (Sweden)

    Masoudeh Babakhanian

    2011-08-01

    Full Text Available Introduction: Sexual dysfunction is one of the prevalent problems of opiate-dependent patients. The current preliminarily study examines sexual dysfunction in a group of opiate-dependent patients before and after 6 months of MMT. Methods: The current study is a cross-sectional study. The numbers of 30 opiate-dependent patients were selected of Cheraghiyan clinic in Damghan, Iran. Demographics questionnaire and the International Index of Erectile Function were administered before and after treatment. Results: Erectile function showed an increase and intercourse satisfactions completely improved. Sexual desire and overall satisfaction increased, showing slight improvement while orgasmic function increased showing no improvement. Discussion: The findings revealed the prevalence of sexual dysfunction and improvement of some component in patients after treatment. Future studies are needed to explore the roles of other factors.

  4. Sexual dysfunction in patients with psoriasis and psoriatic arthritis--a systematic review.

    Science.gov (United States)

    Kurizky, Patricia Shu; Mota, Licia Maria Henrique da

    2012-12-01

    Psoriasis is a cutaneous-articular disease, whose incidence ranges from 1% to 3%. Stress tends to be a triggering or aggravating factor in psoriasis. In addition, the disease itself can generate emotional stress because of its lesions. Several psychological disorders can be associated with psoriasis, and feelings such as rage, depression, shame, and anxiety have been commonly reported, which can culminate in social isolation and sexual dysfunction. Despite being a common complaint among patients with psoriasis, sexual dysfunction has been rarely reported in the literature. This study aimed at performing a systematic review of the prevalence of sexual dysfunction in psoriasis and psoriatic arthritis, assessing the role played by factors such as depression and severity of disease in this relation. This systematic review showed that data on the sexual difficulties of patients with psoriasis are scarce. The hypotheses to explain sexual dysfunction in that group of patients include the severity of skin findings, the psychological effects of the condition on the patient, concerns of the sexual partner, and side effects of the medical treatments for psoriasis. Those data emphasize that this type of symptomatology is frequently neglected in medical practice, and stress the importance of assessing the impact of psoriasis regarding not only cutaneous and joint involvements, but also psychosocial and sexual impairments. Considering the sociocultural diversities of each population, a specific study of the Brazilian population to provide more information about our patients is required.

  5. Functional neuroanatomy in depressed patients with sexual dysfunction: blood oxygenation level dependent functional MR imaging

    International Nuclear Information System (INIS)

    To demonstrate the functional neuroanatomy associated with sexual arousal visually evoked in depressed males who have underlying sexual dysfunction using Blood Oxygenation Level Dependent-based fMRI. Ten healthy volunteers (age range 21-55: mean 32.5 years), and 10 depressed subjects (age range 23-51: mean 34.4 years, mean Beck Depression Inventory score of 39.6 ± 5.9, mean Hamilton Rating Scale Depression (HAMD)-17 score of 33.5 ± 6.0) with sexual arousal dysfunction viewed erotic and neutral video films during functional magnetic resonance imaging (fMRI) with 1.5 T MR scanner (GE Signa Horizon). The fMRI data were obtained from 7 oblique planes using gradient-echo EPI (flip angle/TR/TE=90 .deg. /6000 ms/50 ms). The visual stimulation paradigm began with 60 sec of black screen, 150 sec of neutral stimulation with a documentary video film, 30 sec of black screen, 150 sec of sexual stimulation with an erotic video film followed by 30 sec of black screen. The brain activation maps and their quantification were analyzed by SPM99 program. There was a significant difference of brain activation between two groups during visual sexual stimulation. In depressed subjects, the level of activation during the visually evoked sexual arousal was significantly less than that of healthy volunteers, especially in the cerebrocortical areas of the hypothalamus, thalamus, caudate nucleus, and inferior and superior temporal gyri. On the other hand, the cerebral activation patterns during the neutral condition in both groups showed no significant differences (ρ < 0.01). This study is the first demonstration of the functional neuroanatomy of the brain associated with sexual dysfunction in depressed patients using fMRI. In order to validate our physiological neuroscience results, further studies that would include patients with other disorders and sexual dysfunction, and depressed patients without sexual dysfunction and their treatment response are needed

  6. Functional neuroanatomy in depressed patients with sexual dysfunction: blood oxygenation level dependent functional MR imaging

    Energy Technology Data Exchange (ETDEWEB)

    Yang, Jong Chul [Chonnam National Univ. Hospital, Kwangju (Korea, Republic of)

    2004-06-15

    To demonstrate the functional neuroanatomy associated with sexual arousal visually evoked in depressed males who have underlying sexual dysfunction using Blood Oxygenation Level Dependent-based fMRI. Ten healthy volunteers (age range 21-55: mean 32.5 years), and 10 depressed subjects (age range 23-51: mean 34.4 years, mean Beck Depression Inventory score of 39.6 {+-} 5.9, mean Hamilton Rating Scale Depression (HAMD)-17 score of 33.5 {+-} 6.0) with sexual arousal dysfunction viewed erotic and neutral video films during functional magnetic resonance imaging (fMRI) with 1.5 T MR scanner (GE Signa Horizon). The fMRI data were obtained from 7 oblique planes using gradient-echo EPI (flip angle/TR/TE=90 .deg. /6000 ms/50 ms). The visual stimulation paradigm began with 60 sec of black screen, 150 sec of neutral stimulation with a documentary video film, 30 sec of black screen, 150 sec of sexual stimulation with an erotic video film followed by 30 sec of black screen. The brain activation maps and their quantification were analyzed by SPM99 program. There was a significant difference of brain activation between two groups during visual sexual stimulation. In depressed subjects, the level of activation during the visually evoked sexual arousal was significantly less than that of healthy volunteers, especially in the cerebrocortical areas of the hypothalamus, thalamus, caudate nucleus, and inferior and superior temporal gyri. On the other hand, the cerebral activation patterns during the neutral condition in both groups showed no significant differences ({rho} < 0.01). This study is the first demonstration of the functional neuroanatomy of the brain associated with sexual dysfunction in depressed patients using fMRI. In order to validate our physiological neuroscience results, further studies that would include patients with other disorders and sexual dysfunction, and depressed patients without sexual dysfunction and their treatment response are needed.

  7. Terapia sexual y normalización: significados del malestar sexual en mujeres y hombres diagnosticados con disfunción sexual Sexual therapy and normalization: meanings of sexual discontent in women and men diagnosed with sexual dysfunction

    Directory of Open Access Journals (Sweden)

    Eva Alcántara Zavala

    2009-01-01

    Full Text Available En los últimos veinticinco años, instituciones y profesionales interesados en brindar terapia sexual se han establecido en las áreas urbanas de México. El tratamiento de las disfunciones sexuales es tanto farmacéutico como conductual. Estudios sociohistóricos han señalado las particularidades y limitaciones de las aproximaciones biomédicas a los malestares sexuales. En este estudio presentamos una serie de reflexiones en torno a la noción de disfunción sexual y los presupuestos bioconductuales que sostienen su tratamiento en terapia sexual. El objetivo del estudio fue comprender los significados del malestar sexual en un grupo abierto y mixto de terapia sexual, que se llevó a cabo en la ciudad de México en sesiones semanales de dos horas. Aunque se realizaron observaciones de las sesiones durante un año, para un análisis detallado se seleccionaron veinte de ellas. En esas sesiones participaron intermitentemente tres mujeres terapeutas sexuales, y quince mujeres y diez hombres diagnosticados con algún tipo de disfunción sexual. Un análisis cualitativo de los diálogos demostró que los significados de malestar sexual están fuertemente ligados al establecimiento de un modelo ideal de normalidad sexual. Este modelo se refiere a un estándar de desempeño sexual al cual las personas debían adaptarse con el objetivo de cumplir con los estándares de normalidad. El género es un elemento constitutivo de dicho modelo, inequidades y relaciones significantes de poder son reguladas, reproducidas y reafirmadas a través del modelo que sostiene la terapia sexual.In the last 25 years, professionals and institutions who are interested in spreading sexual therapy have become firmly established in urban areas of Mexico. The treatment of sexual dysfunctions includes both pharmaceutical treatment and sexual training. Sociohistorical studies have indicated the particularities and limitations of biomedical approaches to sexual difficulties. In

  8. 亚洲男性性功能障碍%Male sexual dysfunction in Asia

    Institute of Scientific and Technical Information of China (English)

    Christopher CK Ho; Praveen Singam; Goh Eng Hong; Zulkifii Md Zainuddin

    2011-01-01

    Sex has always been a taboo subject in Asian society. However, over the past few years, awareness in the field of men's sexual health has improved, and interest in sexual health research has recently increased. The epidemiology and prevalence of erectile dysfunction,hypogonadism and premature ejaculation in Asia are similar in the West. However, several issues are specific to Asian males, including culture and beliefs, awareness, compliance and the availability of traditional/complementary medicine. In Asia, sexual medicine is still in its infancy, and a concerted effort from the government, relevant societies, physicians and the media is required to propel sexual medicine to the forefront of health care.

  9. Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone

    Directory of Open Access Journals (Sweden)

    Hong Liu-Seifert

    2009-01-01

    Full Text Available Hong Liu-Seifert1, Bruce J Kinon1, Christopher J Tennant2, Jennifer Sniadecki1, Jan Volavka31Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; 2CJT Biomedical Consulting, South Lake Tahoe, CA, USA; 3New York University, New York, NY, USAObjective: To better understand sexual dysfunction in patients with schizophrenia and its associations with prolactin and reproductive hormones.Methods: This was a secondary analysis of an open-label, one-day study (N = 402. The primary objective of the study was to assess the prevalence of hyperprolactinemia in patients with schizophrenia who had been treated with conventional antipsychotics or risperidone. Other atypical antipsychotics available at the time of the study were not included due to a more favorable prolactin profile.Results: The majority of patients (59% of females and 60% of males reported impairment of sexual function. In postmenopausal females, risk of impaired sexual interest was increased by 31% for every 10 ng/ml increase in prolactin (p = 0.035. In males, lower testosterone was associated with higher prolactin (p < 0.001 and with orgasmic (p = 0.004 and ejaculatory dysfunction (p = 0.028.Conclusion: These findings suggest that hyperprolactinemia may be associated with sexual dysfunction. They also provide more information on the relationships between prolactin, reproductive hormones, and sexual dysfunction. Sexual dysfunction is an understudied yet important consideration in the treatment of schizophrenia. More attention is warranted in this area as it may provide opportunities for improved quality of life and adherence to treatment for patients.Keywords: sexual dysfunction, schizophrenia, hyperprolactinemia, antipsychotics, risperidone

  10. Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus

    DEFF Research Database (Denmark)

    Fedder, J; Kaspersen, Maja Døvling; Brandslund, I;

    2013-01-01

    Retrograde ejaculation (RE) and erectile dysfunction may be caused by diabetes mellitus (DM), but the prevalence of RE among DM patients is unknown. A prospective, blinded case-control study comparing men with DM with matched controls according to RE and erectile dysfunction was performed. Twenty...

  11. The Gay Men Sex Studies: prevalence of sexual dysfunctions in Belgian HIV+ gay men

    Directory of Open Access Journals (Sweden)

    Vansintejan J

    2013-04-01

    Full Text Available Johan Vansintejan, Joris Janssen, Erwin Van De Vijver, Jan Vandevoorde, Dirk Devroey Department of Family Medicine, Vrije Universiteit Brussel (VUB, Brussels, Belgium Abstract: The aim of this Internet-based survey was to investigate the prevalence and associated predictors of sexual dysfunctions in Belgian self-reported HIV-positive men who have sex with other men. Of the 72 participants, 56% had a mild-to-severe erectile dysfunction, and 15% reported a hypoactive sexual desire disorder. The prevalence of premature ejaculation and anodyspareunia was 18% for both. Independent predictors for erectile dysfunction were frequency of masturbation, frequency of sex with partner, use of erectile enhancement drugs, having a passive sex role, and not having a steady relationship. Independent predictors for hypoactive sexual desire disorder were frequency of masturbation and having a lower lifetime number of sexual partners. Independent predictors for premature ejaculation were not having a steady relationship, having a lower lifetime number of sexual partners, and a lower level of education. The only independent predictor for anodyspareunia was having an active sex role. Keywords: homosexuality/male, sexual dysfunction, HIV, epidemiology

  12. A Multidisciplinary Approach to Sexual Dysfunction in Medical Education

    Science.gov (United States)

    Foley, Sallie; Wittmann, Daniela; Balon, Richard

    2010-01-01

    Objective: Addressing sexual health concerns in medical practice has been an emerging concept for the past two decades. However, there have been very few educational opportunities in medical training that would prepare future physicians for such a responsibility. Since assessing and treating sexual problems requires knowledge that encompasses many…

  13. In search of animal models for male sexual dysfunction

    NARCIS (Netherlands)

    Chan, J.S.W.

    2010-01-01

    Around half of all men have sexual problems. The main complaints and prevalence are orgasmic disorders (10%), premature ejaculation (PE) (27%), and erectile difficulties (10%). These statistics do not include the sexual side effects of medications such as antidepressants. Research experiments in hum

  14. Abordagem das disfunções sexuais femininas The assessment and management of female sexual dysfunction

    Directory of Open Access Journals (Sweden)

    Lúcia Alves da Silva Lara

    2008-06-01

    Full Text Available A disfunção sexual tem alta prevalência entre as mulheres. No entanto, os médicos raramente avaliam a vida sexual de suas pacientes, ou por se sentirem desconfortáveis em abordar a sexualidade ou porque desconhecem as técnicas de investigação. O modelo PILSET (PLISSIT, uma técnica de abordagem da função sexual humana, é composto por quatro elementos: permissão, informação limitada, sugestão específica e terapia sexual, que favorecem o diálogo entre o médico e a paciente, permitindo o acesso às queixas sexuais. A terapêutica consta de medidas de aconselhamento e orientações básicas sobre a função sexual, farmacoterapia e intervenções nos aspectos anátomo-funcionais do aparato sexual, com impacto positivo na vida sexual da mulher. Esta revisão mostra como usá-lo. Adicionalmente, vários aspectos da função sexual feminina, como prevalência, diagnóstico e outras modalidades de tratamento são discutidos.Sexual dysfunction prevalence is high among women. However, doctors rarely ask about their patients' sexual life, because they feel uncomfortable or because their knowledge about investigation techniques is insufficient. The PLISSIT model, a useful tool to access human sexual function, is composed by four elements: permission, limited information, specific suggestions, and intensive therapy, that favor dialogue between the doctor and the patient allowing the access to the sexual complaints. The therapeutics consists of counseling measures, drug prescription, basic orientations about sexual function and interventions on anatomic and functional aspects of the sexual apparatus with positive impact in the woman's sexual life. The present review shows how to use it. In addition, many aspects of female sexual dysfunction are discussed, such as prevalence, diagnostic and treatment options for female sexual dysfunction.

  15. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.

    Science.gov (United States)

    Charron, Alexandra; Hage, Cynthia El; Servonnet, Alice; Samaha, Anne-Noël

    2015-12-01

    Antipsychotic treatment can produce supersensitivity to dopamine receptor stimulation. This compromises the efficacy of ongoing treatment and increases the risk of relapse to psychosis upon treatment cessation. Serotonin 5-HT2 receptors modulate dopamine function and thereby influence dopamine-dependent responses. Here we evaluated the hypothesis that 5-HT2 receptors modulate the behavioural expression of antipsychotic-induced dopamine supersensitivity. To this end, we first treated rats with the antipsychotic haloperidol using a clinically relevant treatment regimen. We then assessed the effects of a 5-HT2 receptor antagonist (ritanserin; 0.01 and 0.1mg/kg) and of a 5-HT2A receptor antagonist (MDL100,907; 0.025-0.1mg/kg) on amphetamine-induced psychomotor activity. Antipsychotic-treated rats showed increased amphetamine-induced locomotion relative to antipsychotic-naïve rats, indicating a dopamine supersensitive state. At the highest dose tested (0.1mg/kg for both antagonists), both ritanserin and MDL100,907 suppressed amphetamine-induced locomotion in antipsychotic-treated rats, while having no effect on this behaviour in control rats. In parallel, antipsychotic treatment decreased 5-HT2A receptor density in the prelimbic cortex and nucleus accumbens core and increased 5-HT2A receptor density in the caudate-putamen. Thus, activation of either 5-HT2 receptors or of 5-HT2A receptors selectively is required for the full expression of antipsychotic-induced dopamine supersensitivity. In addition, antipsychotic-induced dopamine supersensitivity enhances the ability of 5-HT2/5-HT2A receptors to modulate dopamine-dependent behaviours. These effects are potentially linked to changes in 5-HT2A receptor density in the prefrontal cortex and the striatum. These observations raise the possibility that blockade of 5-HT2A receptors might overcome some of the behavioural manifestations of antipsychotic-induced dopamine supersensitivity. PMID:26508706

  16. Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain

    OpenAIRE

    Venkataram Shivakumar; Naveen Jayaram; Rao, Naren P.; Ganesan Venkatasubramanian

    2012-01-01

    Antipsychotic induced weight gain is the most common and distressing side effect. This also affects the compliance toward the treatment and hence the prognosis. Non - pharmacological interventions such as exercise and diet modifications alone might not be sufficient most of the times; also ensuring compliance toward this is difficult in patients with psychiatric illness. So, the role of weight - reducing drugs become important. In this case report, we describe the use of low - dose topiramate...

  17. Pilot study of sexual dysfunction in patients with psoriasis: Influence of biologic therapy

    Directory of Open Access Journals (Sweden)

    Ricardo Ruiz-Villaverde

    2011-01-01

    Full Text Available Background: Psoriasis is a chronic skin disease that affects 1 to 3% of the population in most industrialized countries. It is commonly associated with a variety of psychological problems including low self-esteem, depression, suicidal thoughts, and sexual dysfunction. Materials and Methods : We have performed a pilot study in which we have tried to assess the impact on sexual dysfunction in patients with psoriasis who have started treatment with biological therapy using validated indexes in Spanish: International Index of Erectile Function for men and female sexual function index in women. Results : Considering the men and women from our study, an improvement in FSFI by an average of 9.5 and 6.3 points is observed, respectively. Conclusion: We considered our series as a first step for a more detailed approach to the study of sexual function in patients with psoriasis.

  18. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction

    OpenAIRE

    Carlos R.B. Gama; Ricardo Lasmar; Gama, Gustavo F; Abreu, Camila S; Nunes, Carlos P; Mauro Geller; Lisa Oliveira; Alessandra Santos

    2014-01-01

    This is a qualitative–quantitative study based on hospital records of female patients of reproductive age, presenting sexual dysfunction, and treated with 250 mg Tribulus terrestris extract (1 tablet thrice daily for 90 days). Safety monitoring included vital signs, physical examination, laboratory tests, and occurrence of adverse events. Efficacy analysis included results of the Female Sexual Function Index (FSFI), dehydroepiandrosterone (DHEA) levels together with total and free testosteron...

  19. Male gonadal function in coeliac disease: 1. Sexual dysfunction, infertility, and semen quality

    OpenAIRE

    Farthing, M J G; Edwards, C R W; Rees, L H; Dawson, A M

    1982-01-01

    The prevalence of hypogonadism, sexual dysfunction and abnormalities of semen quality was determined in 28 consecutive males with coeliac disease. These observations were related to jejunal morphology and nutritional status, and were compared with findings in 19 men with Crohn's disease of similar age and nutritional status. Two of the 28 coeliacs (7%) had clinical evidence of hypogonadism but impotence and decreased sexual activity occurred more commonly, the latter apparently improving afte...

  20. Incidence of sexual dysfunction in men after cardiac surgery in Afshar hospital, Yazd

    OpenAIRE

    Seyed Khalil Foruzan-Nia; Mohammad Hassan Abdollahi; Seyed Hossein Hekmatimoghaddam; Seyedeh Mahdiyeh Namayandeh; Mohammad Hadi Mortazavi

    2011-01-01

    Background: Successful rehabilitation of cardiac surgery patients should include consideration of their sexual activity, but there is paucity of data regarding this matter. Objective: This study determined the incidence and type of sexual dysfunction in our patients. Materials and Methods: Two hundred-seventy nine men with age under 70 years old who had coronary artery bypass graft (CABG), valvular, or other types of cardiac surgery from Dec. 2006 until Dec. 2007 were enrolled in this descrip...

  1. Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence

    Directory of Open Access Journals (Sweden)

    Santosh Ramdurg

    2015-01-01

    Full Text Available Introduction: People suffering from substance dependence suffer from various sexual dysfunctions and are at risk for indulging in various high-risk sexual behaviors and thus are vulnerable to acquire various infections such as HIV/AIDS and other sexually transmitted infections. AIM: The aim of the study was to evaluate the correlation between sexual dysfunction and high-risk sexual behavior in opioid-dependent men receiving buprenorphine and naltrexone maintenance therapy. Materials and Methods: Semi-structured questionnaire, brief male sexual functioning inventory and HIV-risk taking behavior scale was administered to a sample of 60 sexually active men, receiving buprenorphine (n = 30 and naltrexone (n = 30 maintenance therapy for opioid dependence. Results: The main outcomes are correlation between severity of sexual dysfunction and HIV-risk taking behavior. The study results showed 83% of the men on buprenorphine and 90% on naltrexone reported at least one of the sexual dysfunction symptoms. There was a negative correlation between sexual dysfunction and HIV-risk taking behavior that suggest severe the dysfunction, higher the risk taking behavior. Significant correlation was present with overall sexual dysfunction and HIV-risk taking behavior (P = 0.028 and in naltrexone receiving group premature ejaculation versus HIV-risk taking behavior however, (P = 0.022, P < 0.05 there were no significant differences among both the groups except above findings. Conclusion: Conclusion was treatment is associated with sexual dysfunctions and HIV-risk taking behavior, which has clinical implication. Future research should explore this further using biochemical analyses.

  2. Is Internet Pornography Causing Sexual Dysfunctions? A Review with Clinical Reports.

    Science.gov (United States)

    Park, Brian Y; Wilson, Gary; Berger, Jonathan; Christman, Matthew; Reina, Bryn; Bishop, Frank; Klam, Warren P; Doan, Andrew P

    2016-08-05

    Traditional factors that once explained men's sexual difficulties appear insufficient to account for the sharp rise in erectile dysfunction, delayed ejaculation, decreased sexual satisfaction, and diminished libido during partnered sex in men under 40. This review (1) considers data from multiple domains, e.g., clinical, biological (addiction/urology), psychological (sexual conditioning), sociological; and (2) presents a series of clinical reports, all with the aim of proposing a possible direction for future research of this phenomenon. Alterations to the brain's motivational system are explored as a possible etiology underlying pornography-related sexual dysfunctions. This review also considers evidence that Internet pornography's unique properties (limitless novelty, potential for easy escalation to more extreme material, video format, etc.) may be potent enough to condition sexual arousal to aspects of Internet pornography use that do not readily transition to real-life partners, such that sex with desired partners may not register as meeting expectations and arousal declines. Clinical reports suggest that terminating Internet pornography use is sometimes sufficient to reverse negative effects, underscoring the need for extensive investigation using methodologies that have subjects remove the variable of Internet pornography use. In the interim, a simple diagnostic protocol for assessing patients with porn-induced sexual dysfunction is put forth.

  3. Which are the male factors associated with female sexual dysfunction (FSD)?

    Science.gov (United States)

    Maseroli, E; Fanni, E; Mannucci, E; Fambrini, M; Jannini, E A; Maggi, M; Vignozzi, L

    2016-09-01

    It has been generally assumed that partner's erectile dysfunction, premature, and delayed ejaculation play a significant role in determining female sexual dysfunction (FSD). This study aimed to evaluate the role of the male partner's sexual function, as perceived by women, in determining FSD. A consecutive series of 156 heterosexual women consulting our clinic for FSD was retrospectively studied. All patients underwent a structured interview and completed the Female Sexual Function Index (FSFI). FSFI total score decreased as a function of partner's age, conflicts within the couple, relationship without cohabitation and the habit of engaging in intercourse to please the partner; FSFI total score increased as a function of frequency of intercourse, attempts to conceive and fertility-focused intercourse. FSFI total score showed a negative, stepwise correlation with partner's perceived hypoactive sexual desire (HSD) (r = -0.327; p libido, FSFI total score was significantly lower when their partner's libido was low (p = 0.041); the correlation disappeared if the patient also experienced HSD. In conclusion, the presence of erectile dysfunction, premature, and delayed ejaculation of the partner may not act as a primary contributing factor to FSD, as determined by FSFI scores; conversely, women's sexuality seems to be mostly impaired by the perceived reduction in their partner's sexual interest. PMID:27409983

  4. Is Internet Pornography Causing Sexual Dysfunctions? A Review with Clinical Reports.

    Science.gov (United States)

    Park, Brian Y; Wilson, Gary; Berger, Jonathan; Christman, Matthew; Reina, Bryn; Bishop, Frank; Klam, Warren P; Doan, Andrew P

    2016-01-01

    Traditional factors that once explained men's sexual difficulties appear insufficient to account for the sharp rise in erectile dysfunction, delayed ejaculation, decreased sexual satisfaction, and diminished libido during partnered sex in men under 40. This review (1) considers data from multiple domains, e.g., clinical, biological (addiction/urology), psychological (sexual conditioning), sociological; and (2) presents a series of clinical reports, all with the aim of proposing a possible direction for future research of this phenomenon. Alterations to the brain's motivational system are explored as a possible etiology underlying pornography-related sexual dysfunctions. This review also considers evidence that Internet pornography's unique properties (limitless novelty, potential for easy escalation to more extreme material, video format, etc.) may be potent enough to condition sexual arousal to aspects of Internet pornography use that do not readily transition to real-life partners, such that sex with desired partners may not register as meeting expectations and arousal declines. Clinical reports suggest that terminating Internet pornography use is sometimes sufficient to reverse negative effects, underscoring the need for extensive investigation using methodologies that have subjects remove the variable of Internet pornography use. In the interim, a simple diagnostic protocol for assessing patients with porn-induced sexual dysfunction is put forth. PMID:27527226

  5.  The Effect of Amantadine on Clomipramine Induced Sexual Dysfunction in Male Rats

    Directory of Open Access Journals (Sweden)

    K Kumar Eswar

    2011-11-01

    Full Text Available  Objective: Several studies have reported that Clomipramine has the ability to suppress male rat sexual behavior. Literature indicatesthat the activation of brain D2 receptors causes facilitation of penile erection, and a number of reports have indicated dopamine’s involvement in sexual function. Hence this study was undertaken to investigate the effect of Amantadine, a dopamine agonists on the Clomipramine induced sexual dysfunction. Methods: The study subjects involved a total of 48 males and 48 females, 4 months old Sprague-Dawley albino rats, all housed in a group of six males and females separately in plexi glass cages in an acclimatized colony room (25±0.50C maintained on a 12/12 hr light/dark cycle. The male rats were randomly divided into four groups of 12 male rats each. Group I served as controls. Group II, III, and IV were treated with Amantadine (9 mg/kg body weight, p.o 30 min, prior to the treatment with 13.5 mg/kg, 27 mg/Kg and 54 mg/Kg bodyweight p.o of Clomipramine respectively for 60 days. The control group received vehicle 1 ml/kg p.o. The sexual behavior of the male rats was observed to determine the following parameters: mount latency, intromission latency, ejaculation latency, post ejaculatory pause, and intromission frequency. As well as the sexual behavior; serum testosterone and histopathology of the testes were also investigated in this study. Results: The results indicate that Amantadine in all aspects failed to antagonize Clomipramine induced sexual dysfunction in male rats. Even the sexual competence of male rats treated with 1/2 therapeutic dose (TD of Clomipramine failed to regain their sexual competence in the presence of Amantadine. Testicular damage and decline in testosterone levels continued in the presence of Amantadine. Conclusion: Overall, the results suggest that Amantadine could not be a safe antidote to antagonize Clomipramine induced sexual dysfunction.

  6. Female sexual dysfunction in patients with sub-stance-related disorders

    Directory of Open Access Journals (Sweden)

    Alessandra Diehl

    2013-01-01

    Full Text Available OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, Fagerstrom Test for Nicotine Dependence, and Arizona Sexual Experience Scale were also administered. RESULTS: The sample consisted of 105 women who had a mean age of 34.8 years (SD = 12.1, range = 18-65 and were predominantly heterosexual (74.3%, single (47.6%, Caucasian (50.5%, catholic (36.2%, and educated only to the level of primary education (40%, with a monthly family income of up to one minimum salary (37.5%. In 42.9% of the patients, crack was the drug of choice; 47.6% of the sample qualified for the Drug Abuse Screening Test (substantial problems related to drugs, 43.8% exhibited Short Alcohol Dependence Data (moderate or severe dependency, 47.6% exhibited Fagerstrom Test for Nicotine Dependence (high or very high nicotine dependence. The prevalence of sexual dysfunction symptoms was 34.2% (95% CI = [25.3, 44.1], and a high level of nicotine dependence and low income increased the chances of having sexual dysfunction by 2.72-fold and 2.54 fold, respectively. An association was also observed between female sexual dysfunction symptoms and schooling and levels of drug dependence. CONCLUSIONS: Female sexual dysfunction symptoms were common among this sample and primarily associated with high levels of nicotine use.

  7. A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers

    Directory of Open Access Journals (Sweden)

    Dolatshahi

    2016-06-01

    Full Text Available Background Increased prevalent use of methamphetamine is a global public challenge. Information on drug use can be helpful in preventing high-risk behavior related to drug abuse. Objectives This study aims to investigate the sexual function changes related to methamphetamine use in the male clients of public and private addiction treatment centers. Patients and Methods In this qualitative study, 45 men (35 methamphetamine users, 5 family members of the users, and 5 psychiatrists or physicians who were famous for treating or researching addiction are involved. An in-depth interview was done with therapists and key individuals. Results The results show that the effects of methamphetamine on sexual function are not identical. The first usage is concomitant with the increased duration of sex, an increase in the quality and quantity of sexual pleasure, a delighted orgasm, and feeling more control of the sex act. These effects gradually decrease. A decreased libido and various sexual dysfunctions such as erectile dysfunction, premature ejaculation, and losing control during the sex act will appear over time. Conclusions There are differences in the libido and sexual functions of methamphetamine users. Personal perceptions of one’s sexual function may be affected by cognitive changes resultant from the drug. Drug-use prevention, addiction treatments, appropriate sexual behavior education, and harm reduction are priorities.

  8. Recent studies on aphrodisiac herbs for the management of male sexual dysfunction--a review.

    Science.gov (United States)

    Malviya, Neelesh; Jain, Sanjay; Gupta, Vipin Bihari; Vyas, Savita

    2011-01-01

    An aphrodisiac is a type of food or drink that has the effect of making those who eat or drink it more aroused in a sexual way. Aphrodisiacs can be categorized according to their mode of action into three groups: substances that increase libido (i.e., sexual desire, arousal), substances that increase sexual potency (i.e., effectiveness of erection) and substances that increase sexual pleasure. Some well-known aphrodisiacs are Tribulus terrestrins, Withania somnifera, Eurycoma longifolia, Avena sativa, Ginko biloba, and Psoralea coryifolia. Ethnobotanical surveys have indicated a large number of plants as aphrodisiacs. The paper reviews the recent scientific validation on traditionally used herbal plants as aphrodisiac herbs for the management of sexual disorder erectile dysfunction. PMID:21485695

  9. Male gonadal function in coeliac disease: 1. Sexual dysfunction, infertility, and semen quality.

    Science.gov (United States)

    Farthing, M J; Edwards, C R; Rees, L H; Dawson, A M

    1982-07-01

    The prevalence of hypogonadism, sexual dysfunction and abnormalities of semen quality was determined in 28 consecutive males with coeliac disease. These observations were related to jejunal morphology and nutritional status, and were compared with findings in 19 men with Crohn's disease of similar age and nutritional status. Two of the 28 coeliacs (7%) had clinical evidence of hypogonadism but impotence and decreased sexual activity occurred more commonly, the latter apparently improving after gluten withdrawal. Of the married coeliacs, 19% had infertile marriages, a value greater than expected in the general population. Hypogonadism and sexual dysfunction were not detected in our patients with Crohn's disease. Seminal analysis in coeliacs revealed marked abnormalities of sperm morphology and motility, but only the former appeared to improve after gluten withdrawal. Similar abnormalities, however, were also detected in patients with Crohn's disease, although, unlike the coeliacs, 46% also had reduced concentrations of spermatozoa. Semen quality in coeliac disease could not be clearly related to general or specific (serum vitamin B(12) and red cell folate) nutritional deficiencies or to fertility, although sperm motility was markedly reduced in two of the three coeliacs with infertile marriages. The presence of antisperm antibodies did not appear to be an important aetiological factor in male infertility in coeliac disease. The pathogenesis of infertility and sexual dysfunction in coeliac disease remains unclear, suggesting that factors such as endocrine dysfunction or other specific nutritional deficiency may be involved. PMID:7200931

  10. The place of female sexual dysfunction in the urological practice : Results of a Dutch Survey

    NARCIS (Netherlands)

    Bekker, Milou; Beck, Jacky; Putter, Hein; van Driel, Mels; Pelger, Rob; Nijeholt, August Lycklama A.; Elzevier, Henk

    2009-01-01

    Introduction. Female sexual dysfunction (FSD) is a highly prevalent and often underestimated problem. There is a strong association between urological complaints and FSD. Aims. The purpose of this survey was to evaluate how Dutch urologists address FSD in their daily practice. Methods. We performed

  11. Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer

    DEFF Research Database (Denmark)

    Sunesen, K G; Nørgaard, M; Lundby, L;

    2015-01-01

    AIM: The objective of primary radiotherapy for anal cancer is to remove cancer while maintaining anorectal function. However, little is known about anorectal function among long-term survivors without colostomy. Using a cross-sectional questionnaire study, we examined symptoms and distress relate...... function. CONCLUSION: Distressing long-term anorectal and sexual dysfunction was common after radiotherapy for anal cancer, and morbidity due to urinary dysfunction was moderate.......AIM: The objective of primary radiotherapy for anal cancer is to remove cancer while maintaining anorectal function. However, little is known about anorectal function among long-term survivors without colostomy. Using a cross-sectional questionnaire study, we examined symptoms and distress related...... to the dysfunction of pelvic organs after radiotherapy for anal cancer. METHOD: A questionnaire regarding anorectal, urinary and sexual symptoms was sent to anal cancer patients without recurrence or colostomy, diagnosed during 1996-2003, and treated with curative intent (chemo)radiotherapy at three Danish centres...

  12. Female Sexual Dysfunction Among the Wives of Opioid-Dependent Males in Iran

    Directory of Open Access Journals (Sweden)

    Anvar Abnavi

    2016-02-01

    Full Text Available Background Opiate abuse in males has significant effects on their sexual functions. In contrast, sexuality in females is a multidimensional issue that can strongly be affected by several factors in their partners. However, only a limited number of studies have assessed the role of males’ opioid dependency in their female partners’ sexual function. Objectives The present study aimed to evaluate the effect of males’ opioid dependency on their wives’ sexual function compared to the sexual function of the females whose husbands were not opioid dependent. Patients and Methods This study included 340 women who were selected through convenience sampling and divided into a control (females whose husbands were not opioid dependent and a case group (women whose husbands were opioid dependent. The data were collected through an interview according to the DSM-IV-R criteria for female sexual dysfunctions by a senior female medical student who was one of the researchers. Finally, the data were entered into the SPSS statistical software (v. 15 and analyzed using the t-test and chi-square test. Results According to the results, the frequency of hypoactive sexual desire disorder and sexual aversion disorder in the control group was significantly higher than that of the case group (P < 0.05. Conclusions The results showed that having an addicted husband could strongly affect some sexual domains in women. It could change the pattern of desire and motivation for sexual contact in females and alter their attitude toward the sexual relationship, thereby causing disturbances in the females’ normal sexual function.

  13. Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.

    Directory of Open Access Journals (Sweden)

    Xianbin Li

    Full Text Available OBJECTIVE: To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia. METHODS: POPULATION: adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prolactin level with or without prolactin-related symptoms. INTERVENTIONS: adjunctive aripiprazole vs. adjunctive placebo. OUTCOME MEASURES: adverse events and efficacy of treatment. STUDIES: randomized controlled trials. RESULTS: Five randomized controlled trials with a total of 639 patients (326 adjunctive aripiprazole, 313 adjunctive placebo met the inclusion criteria. Adjunctive aripiprazole was associated with a 79.11% (125/158 prolactin level normalization rate. Meta-analysis of insomnia, headache, sedation, psychiatric disorder, extrapyramidal symptom, dry mouth, and fatigue showed no significant differences in the adjunctive aripiprazole treatment group compared with the placebo group (risk difference (Mantel-Haenszel, random or fixed -0.05 to 0.04 (95% confidence interval -0.13 to 0.16; I(2 =0% to 68%, P=0.20 to 0.70. However, sedation, insomnia, and headache were more frequent when the adjunctive aripiprazole dose was higher than 15 mg/day. Meta-analysis of the prolactin level normalization indicated adjunctive aripiprazole was superior to placebo (risk difference (Mantel-Haenszel, random 0.76 (95% confidence interval 0.67 to 0.85; I(2 =43%, P<0.00001. The subgroup analysis confirmed that the subjects who received adjunctive aripiprazole 5 mg/day showed a degree of prolactin normalization similar to that of all participants. No significant differences between groups in discontinuation and improvements of psychiatric symptoms. CONCLUSION: Adjunctive aripiprazole is both safe and effective as a reasonable choice treatment for patients with antipsychotic-induced hyperprolactinemia. The appropriate dose of adjunctive aripiprazole may be 5 mg/day.

  14. A review of the potential of medicinal plants in the management and treatment of male sexual dysfunction.

    Science.gov (United States)

    Malviya, N; Malviya, S; Jain, S; Vyas, S

    2016-10-01

    Male sexual dysfunction is a common disorder that appears to be a consequence of a wide range of physical and psychological conditions. Due to mental stress, insufficient physical exercise and various aetiological factors, human being's life is becoming less pleasant, which leads to incapability to have sexual pleasure. The allopathic drugs used for sexual dysfunction are believed to produce a variety of side effects and affect other physiological processes and, ultimately, general health. Therefore, the search for natural supplement from medicinal plants is being intensified probably because of less side effects availability and affordability. Ethnobotanical surveys have indicated a large number of plants traditionally used as aphrodisiacs but only few of them are scientifically validated for the management and treatment of male sexual dysfunction. This article has summarised the medicinal plants traditionally recommended and scientifically validated for the management and treatment of male sexual dysfunction. PMID:27681645

  15. Male sexual dysfunction and infertility associated with neurological disorders

    DEFF Research Database (Denmark)

    Fode, Mikkel; Krogh-Jespersen, Sheila; Brackett, Nancy L;

    2012-01-01

    in more severe cases. If these measures fail, surgical sperm retrieval can be attempted. Ejaculation with penile vibratory stimulation can be done by some spinal cord injured men and their partners at home, followed by in-home insemination if circumstances and sperm quality are adequate. The other options...... and retroperitoneal surgery, diabetes, congenital spinal abnormalities, multiple sclerosis and spinal cord injury. Erectile dysfunction can be managed by an increasingly invasive range of treatments including medications, injection therapy and the surgical insertion of a penile implant. Retrograde ejaculation...

  16. Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain

    Directory of Open Access Journals (Sweden)

    Venkataram Shivakumar

    2012-01-01

    Full Text Available Antipsychotic induced weight gain is the most common and distressing side effect. This also affects the compliance toward the treatment and hence the prognosis. Non - pharmacological interventions such as exercise and diet modifications alone might not be sufficient most of the times; also ensuring compliance toward this is difficult in patients with psychiatric illness. So, the role of weight - reducing drugs become important. In this case report, we describe the use of low - dose topiramate as a weight - reducing agent, in a patient with a bipolar affective disorder - mania with psychotic symptoms, who had significant risperidone - induced weight gain.

  17. Sexual Dysfunction, Depression and Quality of Life in Patients With HIV Infection

    Science.gov (United States)

    Amini Lari, Mahmood; Faramarzi, Hosain; Shams, Mesbah; Marzban, Maryam; Joulaei, Hasan

    2013-01-01

    Objective: In Iran, psychological aspect of HIV infection is poorly understood. The purposes of this study were to evaluate sexual dysfunction, depression rate and health-related quality of life and evaluate the association between sexual dysfunction, depression and quality of life in a group of HIV+ subjects in Shiraz, Iran. Methods: In this cross-sectional study, 278 male HIV-positive patients who had referred to voluntary counseling and testing and methadone maintenance therapy centers were recruited based on convenience sampling from May to October 2010. The purpose of the study was explained and interested individuals provided informed consent and completed validated questionnaires [Medical Outcomes Study Short Form-36 (SF-36(, Brief Male Sexual Function Inventory (BMSFI), Beck Depression Inventory-short form(BDI)] to assess overall health related quality of life (HRQOL), sexual function, and depression. Results: Average age of the participants was 34.9 ± 10.7 years and 37.5% were severely depressed. Ordinal logistic regression indicated that sexual drive (-0.15; CI: -0.28 to -0.027), ejaculation (-1.91, CI: -2.71 to -1.12), and problem assessment (-0.098, CI: -0.17 to -0.02) had significant effect on depression type. Depression was significantly correlated with poorer quality of life in all domains. Pearson’s correlation coefficients between the BMSFI and the domains of SF-36 indicated that sexual drive (r= 0.215), ejaculation (r= 0.297) and problem assessment (r= 0.213) were significantly correlated with emotional wellbeing. Conclusion: Sexual function and depression showed association with quality of life. Effective treatment of depression and sexual function may improve the quality of life of HIV-infected person. Declaration of interest: None. PMID:24644501

  18. Sweet Bee Venom Pharmacopuncture May be Effective for Treating Sexual Dysfunction

    Directory of Open Access Journals (Sweden)

    Pavel Lee

    2014-09-01

    Full Text Available Sexual dysfunction (SD is a health problem which occurs during any phase of the sexual response cycle that keeps the individual or couple from experiencing satisfaction from the sexual activity. SD covers a wide variety of symptoms like in men, erectile dysfunction and premature or delayed ejaculation, in women, spasms of the vagina and pain with sexual intercourse, in both sexes, sexual desire and response. And pharmacopuncture, i.e. injection of subclinical doses of drugs, mostly herb medicine, in acupoints, has been adopted with successful results. This case report showed the effect of bee venom on SD. A 51-year-old male patient with SD, who had a past history of taking Western medication to treat his SD and who had previously undergone surgery on his lower back due to a herniated disc, received treatments using pharmacopuncture of sweet bee venom (SBV at Gwanwon (CV4, Hoeeum (CV1, Sinsu (BL23, and Gihaesu (BL24 for 20 days. Objectively, the patient showed improvement on most items on the International Index for Erectile Dysfunction (IIEF like 28 to 29 out of perfect score 30 for erectile function, 10 to 10 out of perfect score 10 for orgasmic function, 6 to 8 out of perfect score 10 for sexual desire, 10 to 13 out of perfect score 15 for satisfaction with intercourse, and 6 to 8 out of perfect score 10 for overall satisfaction; subjectively, his words, the tone of his voice and the look of confidence in his eyes all indicated improvement. Among the variety of effects of SBV pharmacopuncture, urogenital problems such as SD may be health problems that pharmacopuncture can treat effectively.

  19. Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study

    Directory of Open Access Journals (Sweden)

    Erik Johnsen

    2011-01-01

    Full Text Available Introduction. Sexual dysfunction (SD and hyperprolactinemia are frequently reported in patients with psychotic disorders and have the potential for severe complications but investigations in males are particularly scarce. The primary aims were to determine the prevalence of SD and hyperprolactinemia in male patients and to investigate whether associations exist between SD and prolactin levels. Methods. Cross-sectional data were obtained at discharge from the hospital or 6 weeks after admittance for patients acutely admitted for psychosis and treated with a second-generation antipsychotic drug. Results. Half the patients reported diminished sexual desire and more than a third reported erectile and ejaculatory dysfunctions with no differences among the drugs. More than half the sample was hyperprolactinemic. No association was found between prolactin levels and SD. Conclusion. High rates of SD and hyperprolactinemia were found in male patients and should be a treatment target. SD and hyperprolactinemia were not correlated.

  20. Female sexual dysfunction in patients with sub-stance-related disorders

    OpenAIRE

    Alessandra Diehl; Rosiane Lopes da Silva; Ronaldo Laranjeira

    2013-01-01

    OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence...

  1. Testicular prosthesis: Patient satisfaction and sexual dysfunctions in testis cancer survivors

    Directory of Open Access Journals (Sweden)

    Francesco Catanzariti

    2016-10-01

    Full Text Available Purpose: We studied patient satisfaction about sexual activity after prosthesis implantation using validated questionnaires with the aim to discover if testicular prosthesis could be responsible of sexual dysfunctions (erectile dysfunction or premature ejaculation. Materials and Methods: We evaluated a total of 67 men who underwent radical orchiectomy for testicular cancer and a silicon testicular prosthesis implantation from January 2008 to June 2014 at our Hospital. These patients completed 5 validated questionnaires the day before orchiectomy and 6 months after surgery: the International Index of Erectile Function 5 (IIEF5, the Premature Ejaculation Diagnostic Tool (PEDT, the Body Exposure during Sexual Activities Questionnaire (BESAQ, the Body-Esteem Scale and the Rosenberg Self- Esteem Scale. We also evaluated 6 months after surgery any defects of the prosthesis complained by the patients. Results: The questionnaires completed by patients didn’t show statistically significant changes for erectile dysfunction (p > 0.05 and premature ejaculation (p > 0.05. On the contrary the psychological questionnaires showed statistically significant change for the BESAQ (p < 0.001 and the Body Esteem Scale (p < 0.001, but not for the Rosenberg Self-Esteem Scale (p > 0,05. A total of 15 patients (22.37% were dissatisfied about the prosthesis: the most frequent complaint (8 patients; 11.94% was that the prosthesis was firmer than the normal testis. Conclusions: Testicular prosthesis implantation is a safe surgical procedure that should be always proposed before orchiectomy for cancer of the testis. The defects complained by patients with testicular prosthesis are few, they don’t influence sexual activity and they aren’t able to cause erectile dysfunction or premature ejaculation.

  2. Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study

    OpenAIRE

    Hugo A. Jørgensen; Else-Marie Løberg; Erik Johnsen; Rune Kroken; Eirik Kjelby

    2011-01-01

    Introduction. Sexual dysfunction (SD) and hyperprolactinemia are frequently reported in patients with psychotic disorders and have the potential for severe complications but investigations in males are particularly scarce. The primary aims were to determine the prevalence of SD and hyperprolactinemia in male patients and to investigate whether associations exist between SD and prolactin levels. Methods. Cross-sectional data were obtained at discharge from the hospital or 6 weeks after admitta...

  3. Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study

    Directory of Open Access Journals (Sweden)

    Sperduti Isabella

    2009-09-01

    Full Text Available Abstract Background Sexual dysfunction following surgery for rectal cancer may be frequent and often severe. The aim of the present study is to evaluate the occurrence of this complication from both a clinical point of view and by means of neurophysiological tests. Methods We studied a group of 57 patients submitted to rectal resection for adenocarcinoma. All the patients underwent neurological, psychological and the following neurophysiological tests: sacral reflex (SR, pudendal somatosensory evoked potentials (PEPs, motor evoked potential (MEPs and sympathetic skin responses (SSRs. The results were compared with a control group of 67 rectal cancer patients studied before surgery. Only 10 of these patients could be studied both pre- and postoperatively. 10 patients submitted to high dose preoperative chemoradiation were studied to evaluate the effect of this treatment on sexual function. Statistical analysis was performed by means of the two-tailed Student's t test for paired observations and k concordance test. Results 59.6% of patients operated reported sexual dysfunction, while this symptom occurred in 16.4% in the control group. Moreover, a significantly higher rate of alterations of the neurophysiological tests and longer mean latencies of the SR, PEPs, MEPs and SSRs were observed in the patients who had undergone resection. In the 10 patients studied both pre and post-surgery impotence occurred in 6 of them and the mean latencies of SSRs were longer after operation. In the 10 patients studied pre and post chemoradiation impotence occurred in 1 patient only, showing the mild effect of these treatments on sexual function. Conclusion Patients operated showed severe sexual dysfunctions. The neurophysiological test may be a useful tool to investigate this complication. The neurological damage could be monitored to decide the rehabilitation strategy.

  4. Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series

    Directory of Open Access Journals (Sweden)

    Kingshuk Lahon

    2011-01-01

    Full Text Available Sexual dysfunction affects patients′ quality of life. It can occur secondary to physical or mental disorders, substance abuse and treatment with prescription drugs like antidepressants. We wanted to study the prevalence of sexual dysfunction associated with antidepressant use in the psychiatric unit of a tertiary care hospital and assess for causality, severity and preventability. We did a retrospective data collection from case records of patients on antidepressants from the Psychiatry outpatient clinic of a tertiary care teaching hospital during the period 1 st January 2006 to 31 st December 2006, excluding those with complaints of sexual dysfunction prior to treatment. Data are presented as a case series. Documented adverse events were subjected to analysis for causality, severity and preventability using Naranjo′s, modified Hartwig and Siegel and modified Schumock and Thornton′s Preventability scales respectively. Out of 169 patients, four patients developed sexual dysfunction (2.36% associated with duloxetine, mirtazapine, trazodone and sertraline. We observed a possible causal relationship of mild to moderately severe ADR (sexual dysfunction which was not preventable. Prevalence of antidepressant associated sexual dysfunction was lower than quoted in Western literature probably due to the retrospective nature of our study design. Active monitoring and intervention can greatly improve the quality of life and compliance to treatment.

  5. Review of Naturopathy of Medical Mushroom, Ophiocordyceps Sinensis, in Sexual Dysfunction

    Science.gov (United States)

    Jiraungkoorskul, Kanitta; Jiraungkoorskul, Wannee

    2016-01-01

    Sexual dysfunctions including desire, arousal, orgasm, and pain disorders are increasing worldwide due to etiological factors and aging. Several types of treatment are claimed in modern medicine, but they have serious side effects and higher costs. In fact, alternative approaches, such as the intake of plants, fungi, and insects, or their extracts, have also been practiced to enhance sexuality and ameliorate illness with notable successes. However, the scientific evidence related to the mechanisms and efficacy of these alternative medicines is both scarce and all too often unconvincing. Ophiocordyceps sinensis is an Ascomycetes fungus parasitic to Lepidoptera larvae, and has long been used as medicine to treat many illnesses and promote longevity in Chinese society. Previous investigations have shown that O. sinensis has many pharmacological activities. This review has focused on illustrating that O. sinensis can enhance libido and sexual performance, and can restore impaired reproductive functions, such as impotency or infertility, in both sexes. PMID:27041868

  6. Review of Naturopathy of Medical Mushroom, Ophiocordyceps Sinensis, in Sexual Dysfunction.

    Science.gov (United States)

    Jiraungkoorskul, Kanitta; Jiraungkoorskul, Wannee

    2016-01-01

    Sexual dysfunctions including desire, arousal, orgasm, and pain disorders are increasing worldwide due to etiological factors and aging. Several types of treatment are claimed in modern medicine, but they have serious side effects and higher costs. In fact, alternative approaches, such as the intake of plants, fungi, and insects, or their extracts, have also been practiced to enhance sexuality and ameliorate illness with notable successes. However, the scientific evidence related to the mechanisms and efficacy of these alternative medicines is both scarce and all too often unconvincing. Ophiocordyceps sinensis is an Ascomycetes fungus parasitic to Lepidoptera larvae, and has long been used as medicine to treat many illnesses and promote longevity in Chinese society. Previous investigations have shown that O. sinensis has many pharmacological activities. This review has focused on illustrating that O. sinensis can enhance libido and sexual performance, and can restore impaired reproductive functions, such as impotency or infertility, in both sexes. PMID:27041868

  7. Influence of sexual performance anxiety on Erectile Dysfunction%性操作焦虑对阴茎勃起障碍的影响研究

    Institute of Scientific and Technical Information of China (English)

    刘明矾

    2002-01-01

    Objective: To understand psychological factors involved in erectile dysfunction. Methods: The erectile dysfunction rating scale (EDRS), State-trait anxiety inventory (STAI), and sexual psychological questionnaire (self-designed) were administered to 74 cases (30 psychogenic ED patients and 44 normal control objects).Results: High levels of sexual performance anxiety were found to affect patients' self-evaluation and coping responses. Sexual performance anxiety, deficient sexual sensitivity and poor communication techniques were the major contributing factors of psychogenic erectile dysfunction.Conclusion: Sexual performance anxiety constitutes a significant factor of erective dysfunction.

  8. Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors

    Science.gov (United States)

    Thor, Maria; Olsson, Caroline E.; Oh, Jung Hun; Alsadius, David; Pettersson, Niclas; Deasy, Joseph O.; Steineck, Gunnar

    2016-01-01

    Aim The involvement of various penile structures in radiotherapy (RT)-induced sexual dysfunction among prostate cancer survivors remains unclear and domains beyond erectile dysfunction such as orgasm, and pain have typically not been considered. The purpose of this study was to investigate sexual dysfunction post-RT for localized prostate cancer and to examine whether radiation dose to different penile structures can explain these symptoms. Methods We investigated sexual dysfunction in two treated prostate cancer cohorts and in one non-pelvic-irradiated cohort, 328 sexually active men part of an unselected, population-based study conducted in 2008. The treated subjects were prescribed primary/salvage external-beam RT to 70 Gy@2.0 Gy/fraction. Absorbed RT doses (Dmean and Dmax) of the corpora cavernosa (CC), the penile bulb (PB), and the total penile structure (CC + PB) were related to 13 patient-reported symptoms on sexual dysfunction by means of factor analysis (FA) and logistic regression. Results Three distinct symptom domains were identified across all cohorts: “erectile dysfunction” (ED, two to five symptoms), “orgasmic dysfunction” (OD, two to four symptoms), and “pain” (two to three symptoms). The strongest predictor for ED symptoms was CC + PB Dmax (P = 0.001–0.03), CC and PB Dmean predicted OD symptoms equally well (P = 0.03 and 0.02–0.05, respectively), and the strongest predictor for pain symptoms was CC + PB Dmean (P = 0.02–0.03). Conclusion Sexual dysfunction following RT was separated into three main domains with symptoms related to erectile dysfunction, orgasmic dysfunction, and pain. Chances for intact sexual functionality may be increased if dose to the total penile structure can be restricted for these domains in the planning of RT. PMID:26564611

  9. Antipsychotic-induced extrapyramidal syndromes and cytochrome P-450 2D6 genotype : a case-control study

    NARCIS (Netherlands)

    Schillevoort, [No Value; de Boer, A; van der Weide, J; Steijns, LSW; Roos, RAC; Jansen, PAF; Leufkens, HGM

    2002-01-01

    To study the association between polymorphism of the cytochrome P-450 2D6 gene (CYP2D6) and the risk of antipsychotic-induced extrapyramidal syndromes, as measured by the use of anti parkinsonian medication. Data for this case-control study were obtained from a psychiatric hospital where newly admit

  10. Androgens – a common biological marker of sleep disorders and selected sexual dysfunctions?

    Directory of Open Access Journals (Sweden)

    Holka-Pokorska, Justyna

    2014-08-01

    Full Text Available The relationship between sleep disturbances and sexual dysfunctions still remains unclear. The links which indicate the importance of central nervous system and sleep mechanisms in regulations of the endocrine system seem to have bilateral character; the nature of such associations is not fully understood. The aim of the paper is to describe the influence of androgens on the relations between sexual functioning and sleep functions in patients of both sexes. The physiological role of the androgens is described with the emphasis put on the specific action of these hormones in sleep regulation, as well as the mutual relations between the regulatory role of sleep on the sexual apparatus. The newest data suggest that the androgenic hormonal profile is linked to the sleep rhythm, but not to the chronobiological diurnal rhythm in male patients. This may constitute the purpose for further research on the role of androgens in the connections between sexual and sleep disturbances. Up to date there is little known about androgens’ role in sleep regulation in women. The influence of sexual activity disturbances as behavioral factors influencing the severity and the persistence of insomnia as well as their position among other factors important for the triggering of insomnia requires further scientific exploration.

  11. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication

    DEFF Research Database (Denmark)

    Gregersen, Nina; Jensen, Pernille Tine; Giraldi, Annamaria Elena

    2006-01-01

    The frequency of female sexual dysfunction increases with age, and the menopausal transition has a negative effect on the sexuality. Pharmacological treatment options for female sexual dysfunction during the peri- and post-menopause include hormone therapy or sildenafil. A limited number...... estrogen relieves vaginal dryness and dyspareunia. Recent knowledge on side effects related to hormone therapy necessitates careful evaluation of the indication for hormone therapy and the duration of postmenopausal hormone therapy should be as short as possible. Long-term side effects of testosterone have...... not yet been fully investigated. A positive effect of sildenafil has been observed in a limited group of women; those with arousal problems but with no desire problems. The results suggest an intensified focus on new pharmaceutical products for the treatment of female sexual dysfunction...

  12. How to recognize late-onset hypogonadism in men with sexual dysfunction

    Institute of Scientific and Technical Information of China (English)

    Giovanni Corona; Giulia Rastrelli; Linda Vignozzi; Edoardo Mannucci; Mario Maggi

    2012-01-01

    Late-onset hypogonadism (LOH) has been considered the most common form of male hypogonadism with a prevalence of approximately 1 in 100 men.Diagnosis of LOH should be made in symptomatic men with unequivocally low serum testosterone (T) levels.However,its clinical presentation is often insidious and difficult to recognize because it is characterized by nonspecific symptoms that make differential diagnosis with physiological ageing problematic.Sexual dysfunction is the most important determinant for medical consultation and the most specific symptom associated with low T.We therefore analysed a consecutive series of 1734 subjects who attended our unit for sexual dysfunction to investigate the associations between low T (different thresholds),sexual parameters,medical history data (delayed puberty,pituitary disease or cryptorchidism) and their physical exam results.Metabolic parameters,in particular waist circumference,display the greatest accuracy in detecting low T.We found that only the association of several symptoms and signs could significantly raise the clinical suspicion of low T.Structured inventories,which cluster together symptoms and signs of hypogonadism,can help clinicians suspect androgen deficiency.In particular,structured interviews,such as ANDROTEST,have been demonstrated to have a greater accuracy when compared to self reported questionnaires indetecting low T levels.

  13. COMT Val158Met Polymorphism, Executive Dysfunction, and Sexual Risk Behavior in the Context of HIV Infection and Methamphetamine Dependence

    Directory of Open Access Journals (Sweden)

    C. A. Bousman

    2010-01-01

    Full Text Available Catechol-O-methyltransferease (COMT metabolizes prefrontal cortex dopamine (DA, a neurotransmitter involved in executive behavior; the Val158Met genotype has been linked to executive dysfunction, which might increase sexual risk behaviors favoring HIV transmission. Main and interaction effects of COMT genotype and executive functioning on sexual risk behavior were examined. 192 sexually active nonmonogamous men completed a sexual behavior questionnaire, executive functioning tests, and were genotyped using blood-derived DNA. Main effects for executive dysfunction but not COMT on number of sexual partners were observed. A COMT x executive dysfunction interaction was found for number of sexual partners and insertive anal sex, significant for carriers of the Met/Met and to a lesser extent Val/Met genotypes but not Val/Val carriers. In the context of HIV and methamphetamine dependence, dopaminergic overactivity in prefrontal cortex conferred by the Met/Met genotype appears to result in a liability for executive dysfunction and potentially associated risky sexual behavior.

  14. Effect of Chlorophytum Borivilianum Santapau and Fernandes on Sexual Dysfunction in Hyperglycemic Male Rats

    Institute of Scientific and Technical Information of China (English)

    Mayank; Thakur; Shilpi; Bhargava; Werner; Praznik; Renate; Loeppert; Vinod; K; Dixit

    2009-01-01

    Objective:To investigate the effects of Chlorophytum borivilianum(CB) on sexual dysfunction, loss of body weight,and lack of libido in hyperglycemic rats induced with streptozotocin or alloxan.Methods: Wistar strain male albino rats were divided into five groups of six animals each:the control group(2% polyvinylpyrollidone solution),the streptozotocin control group(50 mg/kg),the alloxan control group(100 mg/kg), the streptozotocin + CB treated group(200 mg/kg),and the alloxan + CB treated group(200 mg/kg...

  15. Does Bicycle Riding Impact the Development of Lower Urinary Tract Symptoms and Sexual Dysfunction in Men?

    Science.gov (United States)

    Kim, Dong Gon; Kim, Dae Woong

    2011-01-01

    Purpose This study was designed to determine whether men who engaged in recreational bicycle riding are more likely to be affected by lower urinary tract symptoms (LUTS) and sexual dysfunction than are man who exercised by amateur marathon running with less perineal impact. Materials and Methods A total of 22 healthy male amateur bicyclists and 17 healthy male amateur marathoners were enrolled in the study. We evaluated questionnaires including the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF), serum prostate-specific antigen (PSA), uroflowmetric values, postvoid residual (PVR) urine volume, and transrectal ultrasound of the prostate in all subjects. We also compared the prevalence of urination disorders (UD) and erectile dysfunction (ED). Results There were no significant differences between the two groups in age, body mass index, comorbidities, or exercise habits (p>0.05). Mean total and subscale scores of the IPSS and IIEF and the prevalence of UD (8/22 vs. 4/17, p=0.494) and ED (11/22 vs. 10/17, p=0.748) were not significantly different between the two groups. Also, there were no significant differences between the two groups in uroflowmetric parameters such as peak urinary flow rates, voided urine volume, PVR urine volume, prostate volume, or serum PSA level. Conclusions Bicycle riding seems to have no measurable hazardous effect on voiding function or sexual function in men who cycled recreationally. PMID:21687396

  16. Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes

    Directory of Open Access Journals (Sweden)

    Lior eGreenbaum

    2015-02-01

    Full Text Available Antipsychotic-induced movement disorders are major side effects of antipsychotic drugs among schizophrenia patients, and include antipsychotic-induced parkinsonism (AIP and tardive dyskinesia (TD. Substantial pharmacogenetic work has been done in this field, and several susceptibility variants have been suggested. In this paper, the genetics of antipsychotic-induced movement disorders is considered in a broader context. We hypothesize that genetic variants that are risk factors for AIP and TD may provide insights into the pathophysiology of Parkinson's disease (PD. Since loss of dopaminergic stimulation (albeit pharmacological in AIP and degenerative in PD is shared by the two clinical entities, genes associated with susceptibility to AIP may be modifier genes that influence clinical expression of PD sub-phenotypes, such as age at onset, disease severity or rate of progression. This is due to their possible functional influence on compensatory mechanisms for striatal dopamine loss. Better compensatory potential might be beneficial at the early and later stages of the PD course. AIP vulnerability variants may also be related to latent impairment in the nigrostriatal pathway, affecting its functionality, and leading to subclinical dopaminergic deficits in the striatum. Susceptibility of PD patients to early development of L-dopa induced dyskinesia (LID, is an additional relevant sub-phenotype. LID may share a common genetic background with TD, with which it shares clinical features. Genetic risk variants may predispose to both phenotypes, exerting a pleiotropic effect. According to this hypothesis, elucidating the genetics of antipsychotic-induced movement disorders may advance our understanding of multiple aspects of PD and it clinical course, rendering this a potentially rewarding field of study.

  17. Genitourinary disorders of old age: therapeutic considerations including counseling for sexual dysfunction.

    Science.gov (United States)

    Finkle, A L

    1978-10-01

    Genitourinary tissues undergo physical changes with advancing age, due partly to hormonal alterations. However, the greatest influence on continuing sexual function during aging is emotional and is directly related to the psychologic history of the individual patient. The interested professional can help his patient substantially by simply taking time to listen, a process which permits identification of any psychogenic basis for the sexual dysfunction. The entire approach and method of counseling presuppose that psychogenic impotence is the most common form of the problem. This preliminary effort can do no harm. Should it fail, the patient can be referred to other consultants who use more protracted or sophisticated modalities. With the elderly, the clinician can advise patients to share interpersonal warmth and to enjoy the satisfaction of body contact at any age at which this desire and capacity persist. To the aging person, the totality of sexual meaning is more significant than performance or technique. The sympathetic counselor who renders supportive reassurance to the patient usually can expect beneficial results. PMID:701694

  18. Genitourinary disorders of old age: therapeutic considerations including counseling for sexual dysfunction.

    Science.gov (United States)

    Finkle, A L

    1978-10-01

    Genitourinary tissues undergo physical changes with advancing age, due partly to hormonal alterations. However, the greatest influence on continuing sexual function during aging is emotional and is directly related to the psychologic history of the individual patient. The interested professional can help his patient substantially by simply taking time to listen, a process which permits identification of any psychogenic basis for the sexual dysfunction. The entire approach and method of counseling presuppose that psychogenic impotence is the most common form of the problem. This preliminary effort can do no harm. Should it fail, the patient can be referred to other consultants who use more protracted or sophisticated modalities. With the elderly, the clinician can advise patients to share interpersonal warmth and to enjoy the satisfaction of body contact at any age at which this desire and capacity persist. To the aging person, the totality of sexual meaning is more significant than performance or technique. The sympathetic counselor who renders supportive reassurance to the patient usually can expect beneficial results.

  19. Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.

    Science.gov (United States)

    Brandl, E J; Tiwari, A K; Zai, C C; Nurmi, E L; Chowdhury, N I; Arenovich, T; Sanches, M; Goncalves, V F; Shen, J J; Lieberman, J A; Meltzer, H Y; Kennedy, J L; Müller, D J

    2016-08-01

    Antipsychotic-induced weight gain (AIWG) is a common side effect with a high genetic contribution. We reanalyzed genome-wide association study (GWAS) data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) selecting a refined subset of patients most suitable for AIWG studies. The final GWAS was conducted in N=189 individuals. The top polymorphisms were analyzed in a second cohort of N=86 patients. None of the single-nucleotide polymorphisms was significant at the genome-wide threshold of 5x10(-8). We observed interesting trends for rs9346455 (P=6.49x10(-6)) upstream of OGFRL1, the intergenic variants rs7336345 (P=1.31 × 10(-5)) and rs1012650 (P=1.47 × 10(-5)), and rs1059778 (P=1.49x10(-5)) in IBA57. In the second cohort, rs9346455 showed significant association with AIWG (P=0.005). The combined meta-analysis P-value for rs9346455 was 1.09 × 10(-7). Our reanalysis of the CATIE GWAS data revealed interesting new variants associated with AIWG. As the functional relevance of these polymorphisms is yet to be determined, further studies are needed.The Pharmacogenomics Journal advance online publication, 1 September 2015; doi:10.1038/tpj.2015.59. PMID:26323598

  20. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.

    Science.gov (United States)

    Dimitropoulos, K; Karatzas, A; Papandreou, C; Daliani, D; Zachos, I; Pisters, L L; Tzortzis, V

    2016-05-01

    Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) represents an integral part of multidisciplinary treatment of advanced germ cell cancer; however, it is associated with a high complications rate. The present study aimed to describe sexual disorders in 53 patients with testicular cancer who underwent full bilateral, non-nerve-sparing PC-RPLND in our institution, focusing beyond ejaculatory dysfunction. The International Index for Erectile Function (IIEF) questionnaire was used as diagnostic tool of male sexual functioning pre-operatively and three months after RPLND, while post-operatively patients were asked to describe and evaluate changes in selected sexual parameters. Study findings demonstrate mixed pattern of changes in sexual functioning, with no difference in erectile functioning before and after operation. However, orgasmic function and intercourse and overall sexual satisfaction were found significantly impaired post-operatively. Sexual desire and frequency of attempted sexual intercourses were found significantly increased post-operatively, in comparison with pre-operative levels. With regard to patients' subjective perception on sexual functioning alterations after PC-RPLND, a significant number of patients reported higher levels of sexual desire, no difference in erectile function and worse orgasmic function and satisfaction post-operatively. Thus, patients subjected to PC-RPLND should be closely and routinely evaluated due to close relationship of sexual dissatisfaction with secondary psychological disorders. PMID:26268684

  1. Giving In to Arousal or Staying Stuck in Disgust? Disgust-Based Mechanisms in Sex and Sexual Dysfunction

    NARCIS (Netherlands)

    de Jong, Peter J.; van Overveld, Mark; Borg, Charmaine

    2013-01-01

    Sex and disgust seem like strange bedfellows. The premise of this review is that disgust-based mechanisms nevertheless hold great promise for improving our understanding of sexual behavior, including dysfunctions. Disgust is a defensive emotion that protects the organism from contamination. Accordin

  2. Ego Deficiencies in the Areas of Pleasure, Intimacy, and Cooperation: Guidelines in the Diagnosis and Treatment of Sexual Dysfunctions

    Science.gov (United States)

    Levay, Alexander N.; Kagle, Arlene

    1977-01-01

    Psychopathology, in the form of a deficiency in ego functions of pleasure, intimacy, or cooperation, is usually associated with sexual dysfunctions that prove refractory to sex therapy techniques alone. Each deficiency forms a distinct clinical syndrome with specific treatment requirements, necessitating further diagnostic subcategorization of…

  3. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.

    Science.gov (United States)

    Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao

    2016-04-01

    Second generation antipsychotic drugs (SGAs) cause substantial body weight gain/obesity and other metabolic side-effects such as dyslipidaemia. Their antagonistic affinity to the histaminergic H1 receptor (H1R) has been identified as one of the main contributors to weight gain/obesity side-effects. The effects and mechanisms of betahistine (a histaminergic H1R agonist and H3 receptor antagonist) have been investigated for ameliorating SGA-induced weight gain/obesity in both animal models and clinical trials. It has been demonstrated that co-treatment with betahistine is effective in reducing weight gain, associated with olanzapine in drug-naïve patients with schizophrenia, as well as in the animal models of both drug-naïve rats and rats with chronic, repeated exposure to olanzapine. Betahistine co-treatment can reduce food intake and increase the effect of thermogenesis in brown adipose tissue by modulating hypothalamic H1R-NPY-AMPKα (NPY: neuropeptide Y; AMPKα: AMP-activated protein kinase α) pathways, and ameliorate olanzapine-induced dyslipidaemia through modulation of AMPKα-SREBP-1-PPARα-dependent pathways (SREBP-1: Sterol regulatory element binding protein 1; PPARα: Peroxisome proliferator-activated receptor-α) in the liver. Although reduced locomotor activity was observed from antipsychotic treatment in rats, betahistine did not affect locomotor activity. Importantly, betahistine co-treatment did not influence the effects of antipsychotics on serotonergic receptors in the key brain regions for antipsychotic therapeutic efficacy. However, betahistine co-treatment reverses the upregulated dopamine D2 binding caused by chronic olanzapine administration, which may be beneficial in reducing D2 supersensitivity often observed in chronic antipsychotic treatment. Therefore, these results provide solid evidence supporting further clinical trials in treating antipsychotics-induced weight gain using betahistine in patients with schizophrenia and other mental

  4. Quality of life among women with sexual dysfunction undergoing hemodialysis: a cross-sectional observational study

    Directory of Open Access Journals (Sweden)

    Santos Paulo

    2012-08-01

    Full Text Available Abstract Background Sexual function among women undergoing hemodialysis (HD is under-studied and there is no consensus about the effect of sexual dysfunction (SD on their quality of life (QoL. We aimed to determine the prevalence of SD and to compare QoL between women undergoing maintenance HD with and without SD. Methods We included female end-stage renal disease (ESRD patients undergoing HD during June 2011 in the only renal unit in the north of Ceará state, northeastern Brazil. The criteria for inclusion were age between 18 and 55, at least three months on dialysis and being sexually active. Women using antidepressant medication were excluded. We used the Female Sexual Function Index (FSFI, which evaluates six domains of sexual function, including desire, arousal, lubrication, orgasm, satisfaction and pain. The patients were classified as presenting SD if the total FSFI score was less than 26. For QoL evaluation, we used the validated Brazilian version of SF-36. This is a widely used 36-item questionnaire covering eight dimensions of QoL. Demographic data, time on dialysis, underlying etiology of ESRD, and laboratory measures were assessed in unit records. Results Of a total of 58 women, 46 (79.3% presented SD. There were lower scores related to physical functioning (48.2 vs. 71.2; p = 0.007, bodily pain (45 vs. 67.5; p = 0.010, vitality (52.1 vs. 69.1; p = 0.026 and social functioning (57.2 vs. 76.1; p = 0.034 among women with SD compared to women without SD. Physical functioning and role-physical presented positive linear correlation with FSFI scores, respectively, r = 0.322 (p = 0.013 and r = 0.345 (p = 0.007. Conclusion The prevalence of SD among women on HD is very high, reaching nearly 80%. Women on HD with SD had worse QoL, especially physical aspects of QoL, when compared to women without SD. Therefore, approaches aiming to improve QoL among women undergoing HD should be considered.

  5. Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia

    Science.gov (United States)

    Kayhan, Fatih; Küçük, Adem; Satan, Yılmaz; İlgün, Erdem; Arslan, Şevket; İlik, Faik

    2016-01-01

    Background We aimed to investigate the current prevalence of sexual dysfunction (SD), mood, anxiety, and personality disorders in female patients with fibromyalgia (FM). Methods This case–control study involved 96 patients with FM and 94 healthy women. The SD diagnosis was based on a psychiatric interview in accordance with the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria. Mood and anxiety disorders were diagnosed using the Structured Clinical Interview. Personality disorders were diagnosed according to the Structured Clinical Interview for DSM, Revised Third Edition Personality Disorders. Results Fifty of the 96 patients (52.1%) suffered from SD. The most common SD was lack of sexual desire (n=36, 37.5%) and arousal disorder (n=10, 10.4%). Of the 96 patients, 45 (46.9%) had a mood or anxiety disorder and 13 (13.5%) had a personality disorder. The most common mood, anxiety, and personality disorders were major depression (26%), generalized anxiety disorder (8.3%), and histrionic personality disorder (10.4%). Conclusion SD, mood, and anxiety disorders are frequently observed in female patients with FM. Pain plays a greater role in the development of SD in female patients with FM. PMID:26937190

  6. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China.

    Science.gov (United States)

    Xia, Yinghua; Zhang, Di; Li, Xiaoming; Chen, Wen; He, Qun; Jahn, Heiko J; Li, Xin; Chen, Jun; Hu, Pei; Ling, Li

    2013-01-01

    Methadone maintenance treatment (MMT) has become an important modality of substitution treatment for opioid addicts in China since 2006. However, data are limited regarding the change in sexual function from heroin use to MMT and the influence of sexual dysfunction (SD) during MMT on patient's life and treatment. Face-to-face in-depth interviews were conducted with 13 male and 14 female MMT patients, five of their partners, and three clinicians. The interviews took place in four MMT clinics in Guangdong Province between August 2010 and February 2011. The patients and their partners were asked separately for their perceptions of patient's sexual function during MMT, and the influence of SD on personal/family life and treatment. The main SD problems patients perceived were libido inhibition and decreased sexual pleasure. Methadone was thought to have a stronger inhibition effect on sexual desire than heroin. SD decreased quality of patient's sexual life and damaged intimate relationships. There was a gender difference in coping with SD. Men generally tended to refuse, escape, or alienate their partners. Women tended to hide sexual listlessness, endure sexual activity and tried to satisfy their partners. SD might increase risk of voluntary dropout from treatment and illicit drug use during treatment. Patients with SD did not get any effective therapy from clinicians and they also lacked skills on coping with SD-related problems. Sexual dysfunction prevented patients from reconstructing a normal intimate relationship, and affected stability of maintenance treatment. Response to patient's SD and SD-related problems from clinicians was inadequate. There is a need to develop a clinical guide to deal with both SD itself and SD-related problems. PMID:23092392

  7. Electroencephalographic activity during sexual behavior: a novel approach to the analysis of drug effects on arousal and motivation relevant for sexual dysfunctions.

    Science.gov (United States)

    Hernández-González, Marisela; Guevara, Miguel Angel; Agmo, Anders

    2014-06-01

    The neurobiological bases of human sexual behavior are only partly understood. The etiology of most human sexual dysfunctions is not understood at all. Nevertheless, substantial progress has been made in the treatment of some male sexual disorders. The prime example should be erectile deficiency, where several efficient and safe treatments are available. Pharmacological treatment for premature ejaculation is also available, although it is still in an early stage. Disorders of sexual desire have attracted much attention when women are affected but far less so when men are concerned. Whereas animal models appropriate for testing treatments for problems with erection and premature ejaculation are available, it is questionable whether such models of the desire disorders have predictive validity. There seems to be many factors involved both in reduced and enhanced sexual desire, most of which are unknown. In this review we present some data suggesting that an electroencephalographic analysis of brain activity during exposure to sexually relevant stimuli in male rats and men and during execution of sexual behaviors in male rats may provide useful information. The effects of a commonly used drug, ethanol, on the electroencephalogram recorded during sexual events in rats and men are also described. Although this approach to the analysis of the central nervous activity associated with sexual desire, arousal and behavior is still in its infancy, the data obtained so far show a remarkable similarity between men and rats. This suggests that animal studies of electroencephalographic responses to drugs in sexual contexts may be useful for predicting effects in the human male. PMID:24534418

  8. PREVALENCE OF SEXUAL DYSFUNCTION, INSOMNIA AND DETERIORATION OF THE QUALITY OF LIFE IN HYSTERECTOMYZED WOMEN (IN SPANISH

    Directory of Open Access Journals (Sweden)

    Saavedra-Orozco Héctor

    2014-04-01

    Full Text Available Introduction: the hysterectomy is a surgical procedure used for the treatment of uterine pathologies. It has been demonstrated that this procedure could affect negatively different fields and to impact the quality of life (QoL. Objective: to assess the sexual function, insomnia and the QoL in a group of hysterectomized women. Methods: cross-sectional study carried out with three validated scales: The short 6-item Female Sexual Function Index (FSFI-6, the Athens Insomnia Scale (AIS and the Menopause Rating Scale (MRS; in women with one or more years since the hysterectomy, aged between 40-59 years, belonging to afrodescendant and mestizo ethnic groups, who were from the department of Bolivar, Colombia. The participants were selected from their own communities. Results: 202 women were included in the study, with average age: 50±5.0 years. 10.8% were single, 85.1% were in free union and 3.8% were divorced or widowed. 69.8% were mestizo. The average score in the sexual grade between women with sexual partner was 11.3±4.0 (Range from 0 to 20, the higher the score, the better satisfaction. 29.7% had bilateral oophorectomy, 28.7% had unilateral oophorectomy and 41.5% kept the two ovaries. Just 20.3% used hormonal therapy. The sexual dysfunction was presented in the 71.7% of women, with disorder in orgasm in the 50.9%. 71.2% of women presented insomnia with an average score of 8.1±4.5. 28.6% expressed night awakenings. 42.5% of women manifested severe deterioration of the quality of life, 22.7%, 37.6% and 52.9% expressed deterioration of the somatic, psychological and urogenital domain, respectively. 90.4% of women had vasomotor symptoms and 25.7% reported to have severe or very severe sexual disorders. The presence of sexual dysfunction and insomnia had OR for severe deterioration of the quality of life of 2.1 and 2.4, respectively. Conclusions: the presence of sexual dysfunction and insomnia was high; both of them increased twice the risk of severe

  9. MEIS1, a Promising Candidate Gene, Is Not Associated with the Core Symptoms of Antipsychotic-Induced Restless Legs Syndrome in Korean Schizophrenia Patients

    Science.gov (United States)

    Kang, Seung-Gul; Lee, Seung-Hwan; Kim, Leen

    2015-01-01

    Objective Restless legs syndrome (RLS) is a distressing sleep disorder to which individuals appear to be genetically predisposed. In the present study, we assumed that antipsychotic-induced RLS symptoms were attributable to differences in individual genetic susceptibility, and investigated whether MEIS1, a promising candidate gene, was associated with antipsychotic-induced RLS symptoms in schizophrenia patients. Methods All subjects were diagnosed with schizophrenia by board-certified psychiatrists using the Korean version of the Structured Clinical Interview for DSM-IV. We assessed antipsychotic-induced RLS symptoms in 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group. Genotyping was performed for the rs2300478 and rs6710341 polymorphisms of the MEIS1 gene. Results We divided subjects into RLS symptom (n=96) and non-symptom (n=94) groups. There was no significant between-group difference in the genotype or allele frequencies of the two polymorphisms investigated, nor in the frequency of the rs2300478-rs6710341 haplotype. Conclusion Our data do not suggest that the rs2300478 and rs6710341 polymorphisms of the MEIS1 gene are associated with the core symptoms of antipsychotic-induced RLS in schizophrenia; different genetic mechanisms may underlie antipsychotic-induced vs. primary RLS. PMID:25866529

  10. Clinical correlates of enlarged prostate size in subjects with sexual dysfunction

    Directory of Open Access Journals (Sweden)

    Giovanni Corona

    2014-10-01

    Full Text Available Digito-rectal examination (DRE of the prostate provides useful information on the state of prostate growth and on the presence of suspected peripheral nodules. The aim of this study is to describe the clinical and biochemical correlates of finding an enlarged prostate size at DRE in subjects with sexual dysfunction (SD. A consecutive series of 2379 patients was retrospectively studied. The analysis was focused on a subset of subjects (n = 1823; mean age 54.7 ± 11.4 selected for being free from overt prostatic diseases. Several parameters were investigated. After adjusting for confounders, the presence of an enlarged prostate size at DRE was associated with a higher risk of metabolic syndrome (HR = 1.346 (1.129-1.759; P = 0.030, type 2 diabetes mellitus (HR = 1.489 (1.120-1.980; P = 0.006, increased LDL cholesterol (>100 mg dl−1 ; HR = 1.354 (1.018-1.801; P = 0.037 and increased mean blood pressure (BP values (HR = 1.017 (1.007-1.027 for each mmHg increment; P = 0.001. Accordingly, enlarged prostate size was also associated with a higher risk of arteriogenic erectile dysfunction (ED, as well as with other andrological conditions, such as varicocele and premature ejaculation (PE. PSA levels were significantly higher in subjects with enlarged prostate size when compared to the rest of the sample (HR = 3.318 (2.304; 4.799 for each log unit increment in PSA levels; P < 0.0001. Arteriogenic ED, according to different criteria, was also associated with increased PSA levels. In conclusion, our data support the need to examine prostate size either by clinical (DRE or biochemical (PSA inspection in subjects with SD, in order to have insights into the nature of the SD and the metabolic and cardiovascular (CV background of the patient.

  11. Examining Sexual Dysfunction in Non‐Muscle‐Invasive Bladder Cancer: Results of Cross‐Sectional Mixed‐Methods Research

    Directory of Open Access Journals (Sweden)

    Marc A. Kowalkowski, PhD

    2014-08-01

    Conclusions: Survivors' sexual symptoms may result from NMIBC, comorbidities, or both. These results inform literature and practice by raising awareness about the frequency of symptoms and the impact on NMIBC survivors' intimate relationships. Further work is needed to design symptom management education programs to dispel misinformation about contamination post‐treatment and improve quality of life. Kowalkowski MA, Chandrashekar A, Amiel GE, Lerner SP, Wittmann DA, Latini DM, and Goltz HH. Examining sexual dysfunction in non‐muscle‐invasive bladder cancer: Results of cross‐sectional mixed‐methods research. Sex Med 2014;2:141–151.

  12. Clinical correlates of enlarged prostate size in subjects with sexual dysfunction

    Institute of Scientific and Technical Information of China (English)

    Giovanni Corona; Mauro Gacci; Elisa Maseroli; Giulia Rastrelli; Linda Vignozzi; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi

    2014-01-01

    Digito‑rectal examination(DRE) of the prostate provides useful information on the state of prostate growth and on the presence of suspected peripheral nodules. The aim of this study is to describe the clinical and biochemical correlates of ifnding an enlarged prostate size at DRE in subjects with sexual dysfunction(SD). Aconsecutive series of 2379patients was retrospectively studied. The analysis was focused on a subset of subjects(n=1823; mean age 54.7±11.4) selected for being free from overt prostatic diseases. Several parameters were investigated. After adjusting for confounders, the presence of an enlarged prostate size at DRE was associated with a higher risk of metabolic syndrome(HR=1.346(1.129–1.759);P=0.030), type2 diabetes mellitus(HR=1.489(1.120–1.980);P=0.006), increased LDL cholesterol(>100mgdl−1; HR=1.354(1.018–1.801);P=0.037) and increased mean blood pressure(BP) values(HR=1.017(1.007–1.027) for each mmHg increment;P=0.001). Accordingly, enlarged prostate size was also associated with a higher risk of arteriogenic erectile dysfunction(ED), as well as with other andrological conditions, such as varicocele and premature ejaculation(PE). PSA levels were signiifcantly higher in subjects with enlarged prostate size when compared to the rest of the sample(HR=3.318(2.304; 4.799) for each log unit increment in PSA levels;P<0.0001). Arteriogenic ED, according to different criteria, was also associated with increased PSA levels. In conclusion, our data support the need to examine prostate size either by clinical(DRE) or biochemical(PSA) inspection in subjects with SD, in order to have insights into the nature of the SD and the metabolic and cardiovascular(CV) background of the patient.

  13. Sexual dysfunction is more than twice as frequent in Danish female predialysis patients compared to age- and gender-matched healthy controls

    DEFF Research Database (Denmark)

    Prescott, Lotte; Eidemak, Inge; Harrison, Adrian Paul;

    2014-01-01

    diagnosed depression and 54 randomly assigned healthy female controls completed the questionnaires Female Sexual Function Index, Female Sexual Distress Scale, and the Major Depression Inventory. RESULTS: Predialysis patients reported lower Female Sexual Function Index scores compared to the controls (14.......2 ± 2.1 vs. 20.1 ± 1.7, respectively, p = 0.048), more frequent sexual distress (44 vs. 22 %, respectively, p = 0.044), and more frequent sexual dysfunction (41 vs. 17 %, respectively, p = 0.041). There was no difference between the patients' and the controls' depression scores (12.2 ± 2.2 vs. 8.6 ± 1.......1, respectively, p = 0.180). CONCLUSION: Sexual dysfunction was found to be more than two times as frequent in Danish female predialysis patients with CKD stage 4-5 compared to age- and gender-matched healthy controls, and this result emphasizes the need for attention towards sexual function in the treatment...

  14. PA03.23. To Evaluate the efficacy of “Vajikar Kalp” in Male sexual dysfunction

    Science.gov (United States)

    Khedkar, Amol

    2013-01-01

    Purpose: To evaluate the efficacy of an aphrodisiac preparation in male sexual dysfunction. Method: The Vajikar Kalp was administered in 30 patients at the dosage of 2 gms twice a day with luke warm cow's milk. The combination was made of 1.Asparagus Racemosa - 500 mg, 2.Tribulus Terrestris - 500 mg, 3. Mucuna Pruriens - 500 mg, 4. Withania Somnifera - 500 mg. Patients were observed on days 0, 15, 30, 60 and 90. International Index of Erectile Function was used to assess the improvement. Other subjective parameters were also checked before and after the treatment. Result: The Clinical Study was conducted for making the data more reliable and authentic. In a 90 day Study Kalp offered significant improvement in Erectile Dysfunction, Libido, and Ejaculation & Orgasm. Kalp offered statistically significant increase in Testosterone level. Vajikar Kalp offered significant increase in sexual desire, intercourse frequency, intercourse satisfaction and orgasmic function. Conclusion: The study demonstrated that the Vaijkar Kalp made of herbs was effective in improving male sexual dysfunction.

  15. Sexual dysfunction in women with diabetes%女性糖尿病性功能障碍

    Institute of Scientific and Technical Information of China (English)

    周洁; 吴敏; 楼青青; 刘超

    2012-01-01

    糖尿病作为一种常见的全球性疾病,使公共医疗的负担日益加重,性功能障碍作为糖尿病并发症之一也越来越受到全球广泛关注.本文将对女性糖尿病性功能障碍的定义、危险因素、发病机制进行综述,并提供循证医学的相关治疗措施.%Diabetes mellitus is a worldwide disease and a growing public health burden.Female sexual function in patients with diabetes mellitus is complex and encompasses physical and emotional well-being across the lifespan.This review aims to discuss the development of sexual dysfunction in women with diabetes,while defining the parameters of dysfunction,and to present suggested risk factors and pathogenetic pathways,while offering evidencebased strategies for the evaluation of sexual dysfunction and management.

  16. No difference in sexual dysfunction after transabdominal preperitoneal (TAPP) approach for inguinal hernia with fibrin sealant or tacks for mesh fixation

    DEFF Research Database (Denmark)

    Pommergaard, Hans Christian; Burcharth, J; Andresen, K;

    2016-01-01

    study was to compare fibrin sealant versus tacks for fixation of mesh regarding sexual dysfunction in males and females. METHODS: Using the Danish Hernia Database, patients operated laparoscopically for groin hernia with a transabdominal preperitoneal (TAPP) procedure with fibrin sealant or tacks for...... mesh fixation were sent a questionnaire regarding sexual dysfunction. Sexually active patients without recurrence were evaluated in this study. RESULTS: Pain during sexual activity was present in 115 of 1019 (11.3 %) males and 17 of 147 (11.6 %) females. There was no difference between fibrin sealant...... and tacks for mesh fixation and no difference between genders. Pain intensity, characteristics and origin were comparable between fibrin sealant and tacks for both genders. We found a relationship between a higher rate of sexual dysfunction and lower age for both genders. CONCLUSION: We found no...

  17. Linguistic Changes in Expressive Writing Predict Psychological Outcomes in Women With History of Childhood Sexual Abuse and Adult Sexual Dysfunction

    OpenAIRE

    Pulverman, Carey S.; Lorenz, Tierney A.; Meston, Cindy M.

    2014-01-01

    An expressive writing treatment was recently reported to reduce depressive symptoms and improve sexual function and satisfaction in a sample of female survivors of childhood sexual abuse (Meston, Lorenz, & Stephenson, 2013). We conducted a linguistic analysis of this data to determine whether pre-to posttreatment changes in participants’ language use were associated with the improvements in sexuality and depression. Linguistic Inquiry and Word Count (LIWC), a program that counts the use of wo...

  18. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

    DEFF Research Database (Denmark)

    Fink-Jensen, Anders; Schmidt, Lene S; Dencker, Ditte;

    2011-01-01

    A delicate balance exists between the central dopaminergic and cholinergic neurotransmitter systems with respect to motor function. An imbalance can result in motor dysfunction as observed in Parkinson's disease patients and in patients treated with antipsychotic compounds. Cholinergic receptor a...

  19. Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial

    NARCIS (Netherlands)

    S.B. Hummel; J.J.D.M. van Lankveld; H.S.A. Oldenburg; D.E.E. Hahn; E. Broomans; N.K. Aaronson

    2015-01-01

    Background: Sexual dysfunction is a prevalent, long-term complication of breast cancer and its treatment and can be treated effectively with face-to-face sexual counselling. However, relatively few women actually opt for face-to-face sex therapy, with many women indicating that it is too confronting

  20. Sexual Excitability and Dysfunctional Coping Determine Cybersex Addiction in Homosexual Males.

    Science.gov (United States)

    Laier, Christian; Pekal, Jaro; Brand, Matthias

    2015-10-01

    Cybersex addiction (CA) has been mostly investigated in heterosexual males. Recent findings have demonstrated an association between CA severity and indicators of sexual excitability, and that coping by sexual behaviors mediated the relationship between sexual excitability and CA symptoms. The aim of this study was to test this mediation in a sample of homosexual males. Seventy-one homosexual males were surveyed online. Questionnaires assessed symptoms of CA, sensitivity to sexual excitation, pornography use motivation, problematic sexual behavior, psychological symptoms, and sexual behaviors in real life and online. Moreover, participants viewed pornographic videos and indicated their sexual arousal before and after the video presentation. Results showed strong correlations between CA symptoms and indicators of sexual arousal and sexual excitability, coping by sexual behaviors, and psychological symptoms. CA was not associated with offline sexual behaviors and weekly cybersex use time. Coping by sexual behaviors partially mediated the relationship between sexual excitability and CA. The results are comparable with those reported for heterosexual males and females in previous studies and are discussed against the background of theoretical assumptions of CA, which highlight the role of positive and negative reinforcement due to cybersex use.

  1. Sexual Excitability and Dysfunctional Coping Determine Cybersex Addiction in Homosexual Males.

    Science.gov (United States)

    Laier, Christian; Pekal, Jaro; Brand, Matthias

    2015-10-01

    Cybersex addiction (CA) has been mostly investigated in heterosexual males. Recent findings have demonstrated an association between CA severity and indicators of sexual excitability, and that coping by sexual behaviors mediated the relationship between sexual excitability and CA symptoms. The aim of this study was to test this mediation in a sample of homosexual males. Seventy-one homosexual males were surveyed online. Questionnaires assessed symptoms of CA, sensitivity to sexual excitation, pornography use motivation, problematic sexual behavior, psychological symptoms, and sexual behaviors in real life and online. Moreover, participants viewed pornographic videos and indicated their sexual arousal before and after the video presentation. Results showed strong correlations between CA symptoms and indicators of sexual arousal and sexual excitability, coping by sexual behaviors, and psychological symptoms. CA was not associated with offline sexual behaviors and weekly cybersex use time. Coping by sexual behaviors partially mediated the relationship between sexual excitability and CA. The results are comparable with those reported for heterosexual males and females in previous studies and are discussed against the background of theoretical assumptions of CA, which highlight the role of positive and negative reinforcement due to cybersex use. PMID:26374928

  2. Psychosocial Impairment as a Possible Cause of Sexual Dysfunction among Young Men with Mild Androgenetic Alopecia: A Cross-sectional Crowdsourcing Web-based Study

    OpenAIRE

    Alejandro Molina-Leyva; Isabel Caparros-delMoral; Pilar Gomez-Avivar; Mercedes Alcalde-Alonso; Jose Juan Jimenez-Moleon

    2016-01-01

    Finasteride 1 mg, one of the main treatments for male androgenetic alopecia (MAGA), may produce sexual dysfunction, but young men with MAGA could experience high psychosocial impairment because of changes in body image. Dissatisfaction with body image has been linked to an increase in problems with sexual function. To date no study has considered the possible effect of psychological impairment on sexual function of men with MAGA. Aim of our study was to explore the effect of psychosocial impa...

  3. Linguistic changes in expressive writing predict psychological outcomes in women with history of childhood sexual abuse and adult sexual dysfunction.

    Science.gov (United States)

    Pulverman, Carey S; Lorenz, Tierney A; Meston, Cindy M

    2015-01-01

    An expressive writing treatment was recently reported to reduce depressive symptoms and improve sexual function and satisfaction in a sample of female survivors of childhood sexual abuse (Meston, Lorenz, & Stephenson, 2013). We conducted a linguistic analysis of this data to determine whether pre- to posttreatment changes in participants' language use were associated with the improvements in sexuality and depression. Linguistic Inquiry and Word Count (LIWC), a program that counts the use of word categories within a text, was used to evaluate the impact of several word categories, previously associated with changes in mental health (Frattaroli, 2006), and shown to differ between childhood sexual abuse survivors and nonabused women (Lorenz & Meston, 2012), on treatment outcomes. A reduction in the use of the word "I" and an increase in positive emotion words were associated with decreased depression symptoms. A reduction in the use of "I" and negative emotion words were associated with improvement in sexual function and sexual satisfaction. The findings suggest that, because language may serve as an implicit measure of depression and sexual health, monitoring language changes during treatment may provide a reliable indicator of treatment response free of the biases of traditional self-report assessments. PMID:25793593

  4. Sexual dysfunctions after transurethral resection of the prostate (TURP: evidence from a retrospective study on 264 patients

    Directory of Open Access Journals (Sweden)

    Carlo Pavone

    2015-03-01

    Full Text Available Objectives: Benign prostatic hyperplasia (BPH and sexual dysfunctions are diseases with a high prevalence in aged men. Several studies have found a link between BPH and LUTS resulting from deterioration in sexual function in men aged 50 years and older for whom TURP is considered the gold standard. The impact of TURP on sexual functions still remain uncertain, nor is it clear what pathophysiological mechanism underlying the emergence of new episodes of Erectile Dysfunction (ED following TURP in patients with normal sexual function before surgery, while retrograde ejaculation and ejaculate volume reduction represent a clear side effect; derived from BPH treatment. The aim of this study was to retrospectively evaluate the effects of transurethral resection of the prostate (TURP on sexual function in patients operated in the period 2008-2012 at the Department of Urology of the University Hospital P. Giaccone, and at Villa Sofia-Cervello Hospital- Palermo. Secondary objective was to reconnect the sample data to interventional practice and international standards. Materials and methods: The retrospective longitudinal study was conducted on 264 of the 287 recruitable patients, aged between 50 and 85 years, suffering from BPH who underwent to TURP in the period 2008-2012. Telephone interviews were conducted and the International Index of Erectile Function (IIEF was administered to assess sexual function. Patients enrolled were asked to respond to the test by referring at first to their sexual status in the period before surgery and subsequently to the state of their sexual function after treatment so as to obtain, for each patient, a pre- and post-TURP questionnaire in order to get comparisons that corresponding to reality and to avoid overestimation of the dysfunctional phenomenon. Results: In the pre-TURP, the 94.32% of the sample reported being sexually active, with good erectile function in 41.3% of cases, ED mild/moderate in 51.5% and complete ED

  5. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India

    Directory of Open Access Journals (Sweden)

    Singh J

    2009-01-01

    Full Text Available Background: Reports from India on the prevalence and determinants of female sexual dysfunction (FSD are scant. Aims: To determine the prevalence and risk factors for FSD. Settings and Design: A cross-sectional survey in a medical outpatient clinic of a tertiary care hospital. Materials and Methods: We administered a Tamil version of the Female Sexual Function Index (FSFI to 149 married women. We evaluated putative risk factors for FSD. We elicited participant′s attributions for their sexual difficulties. Statistical Analysis: We estimated the prevalence of possible FSD and sexual difficulties from published FSFI total and domain cut-off scores. We used logistic regression to identify risk factors for possible FSD. Results: FSFI total scores suggested FSD in two-thirds of the 149 women (73.2%; 95% confidence intervals [CI] 65.5% to 79.6%. FSFI domain scores suggested difficulties with desire in 77.2%; arousal in 91.3%; lubrication in 96.6%; orgasm in 86.6%, satisfaction in 81.2%, and pain in 64.4%. Age above 40 years (odds ratios [OR] 11.7; 95% CI 3.4 to 40.1 and fewer years of education (OR 1.2; 95% CI 1.0 to 1.3 were identified by logistic regression as contributory. Women attributed FSD to physical illness in participant or partner, relationship problems, and cultural taboos but none had sought professional help. Conclusions: Sexual problems suggestive of dysfunction, as suggested by FSFI total and domain scores, are highly prevalent in the clinic setting, particularly among women above 40 and those less educated, but confirmation using locally validated cut-off scores of the FSFI is needed.

  6. Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors

    Science.gov (United States)

    Corona, Giovanni; Giorda, Carlo B.; Cucinotta, Domenico; Guida, Piero; Nada, Elisa

    2016-01-01

    Aims To present the longitudinal data of the SUBITO-DE study, a prospective survey involving male patients with new or recently diagnosed type 2 diabetes mellitus (T2DM) (<24 months). Materials and Methods Sexual function was assessed in male patients with T2DM at baseline (phase 1) and after a mean follow-up of 18 months (phase 2). Standard metabolic parameters and sexual and depressive symptoms were evaluated. Results Six of the 499 enrolled patients died of different causes during phase 1. Of the 493 surviving men invited to participate in phase 2, 450 (mean age 59.0±9.0 years) (90.2%) accepted and 43 (8.2%) were lost to follow-up. As compared to baseline, the proportion of the men who reported improvement in erectile dysfunction (ED) at follow-up was nearly double that of the men who reported worsening of ED (22.6% vs. 12.8%). The increase in frequency of sexual activity the men reported at follow-up assessment indicates that many never treated before baseline were taking an ED drug during the study period (106 subjects). Phosphodiesterase type 5 inhibitors (PDE5i) were the ED drugs most commonly taken at both baseline and follow-up. An overall improvement over baseline values was observed in metabolic targets for T2DM and depressive symptoms. Conversely, no change in lifestyle behaviors was recorded during the study. Conclusions Sexual dysfunction is a major concern in men with T2DM. The SUBITO-DE study demonstrates that, when combined with adequate counseling and tailored PDE5i therapy, an integrated approach to achieving metabolic targets in men with T2DM can improve sexual function as well as depressive symptoms. PMID:27706160

  7. Cholinergic, noradrenergic and GABAergic control of sexual behaviour

    DEFF Research Database (Denmark)

    Nedergaard, Per

    2000-01-01

    acethylcholine, noradrenalin, GABA, sexual dysfunction, erectile dysfunction, rat, human, male, female......acethylcholine, noradrenalin, GABA, sexual dysfunction, erectile dysfunction, rat, human, male, female...

  8. Healthy Sexuality

    Medline Plus

    Full Text Available ... disease, dysfunction, or infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships, ... pleasure and satisfaction. Sex also has many other positive health benefits, such as reducing stress, improving self- ...

  9. Healthy Sexuality

    Medline Plus

    Full Text Available ... sexual health as “…a state of physical, emotional, mental and social well-being in relation to sexuality; it is not merely the absence of disease, dysfunction, or infirmity. Sexual health requires a positive ...

  10. PA03.23. To Evaluate the efficacy of “Vajikar Kalp” in Male sexual dysfunction

    OpenAIRE

    Khedkar, Amol; ,

    2013-01-01

    Purpose: To evaluate the efficacy of an aphrodisiac preparation in male sexual dysfunction. Method: The Vajikar Kalp was administered in 30 patients at the dosage of 2 gms twice a day with luke warm cow's milk. The combination was made of 1.Asparagus Racemosa - 500 mg, 2.Tribulus Terrestris - 500 mg, 3. Mucuna Pruriens - 500 mg, 4. Withania Somnifera - 500 mg. Patients were observed on days 0, 15, 30, 60 and 90. International Index of Erectile Function was used to assess the improvement. Othe...

  11. The Association of Lyme Disease With Loss of Sexual Libido and the Role of Urinary Bladder Detrusor Dysfunction

    OpenAIRE

    Puri, Basant K.; Shah, Mussadiq; Peter O. O. Julu; Kingston, Michele C; Monro, Jean A.

    2014-01-01

    Purpose The primary aim was to carry out a pilot study to compare the loss of sexual libido between a group of Lyme disease patients and a group of matched controls. The secondary aim was to evaluate whether loss of libido in Lyme disease patients is associated with urinary bladder detrusor dysfunction. Methods A group of 16 serologically positive Lyme disease patients and 18 controls were queried directly about loss of libido. Results The 2 groups were matched with respect to age, sex, body ...

  12. Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial

    Directory of Open Access Journals (Sweden)

    Ahmed Mahmoud

    2011-01-01

    Full Text Available The impact of antipsychotic drug treatment on sexual function was investigated during a randomised trial comparing first generation antipsychotics (FGAs to (nonclozapine second generation antipsychotics (SGAs. Sexual function and quality of life were (rater-blind assessed in 42 patients with DSM-IV schizophrenia (aged 18–65 using the self-report version of the Derogatis Interview for Sexual Function (DISF-SR and the Heinrichs Quality of Life Scale (QLS, prior to, and 12 weeks following, a change in medication from an FGA drug to either an FGA or SGA drug. SGAs significantly improved sexual function compared to FGAs. Change in sexual function was associated with change in quality of life. Where impaired sexual functioning is a distressing adverse effect of treatment with an FGA agent, consideration should be given to switching to an SGA.

  13. Evaluation of the Family Physician Assistants’ Views to Sexual Dysfunction in a Training and Research Hospital

    Directory of Open Access Journals (Sweden)

    Yusuf A. Güçlü1

    2016-03-01

    Full Text Available Aim: The aim of the study is to investigate the view of sight of the family medicine residents about the sexual education and sexual functional disorders. Methods: A sectional descriptive questionnaire form study is designed at Tepecik Training Research Hospital during May and June 2013. The questionnaire about sexual education and sexual functional disorders is applied to all the family medicine residents who agreed to participate the study. Data are decoded in Microsoft Excel program; descriptive statistics are made. Results: 56 Family Medicine residents with an average age of 29,7±4,0 years were participated in the study. 27 (48.2% of the residents were male while 29 (51.8% were female. The overall rates of the beliefs about the primary care physicians must be interested in sexual problems were 87,5% (n=49; primary care physicians are responsible for sexual educations 75% (n=42. Though 53,6% of them told that they aren’t comfortable at talking sexual problems with the patients. Majority of the residents (78,6%; n=44 thought that they have a lack of knowledge about sexual functional disorders. Only one (1,8% of them was using sexual function scales while examining a patient. Conclusion: Majority of the Family Medicine residents know the role of primary health care physicians’ role at sexual disorders. They were aware about the importance of sexual education in primary care. Though there is a lack of knowledge and need about sexual disorders during the residency programs of family medicine.

  14. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

    OpenAIRE

    Fink-Jensen, Anders; Schmidt, Lene S.; Dencker, Ditte; Schülein, Christina; Wess, Jürgen; Wörtwein, Gitta; Woldbye, David P.D.

    2011-01-01

    A delicate balance exists between the central dopaminergic and cholinergic neurotransmitter systems with respect to motor function. An imbalance can result in motor dysfunction as observed in Parkinson’s disease patients and in patients treated with antipsychotic compounds. Cholinergic receptor antagonists can alleviate extrapyramidal symptoms in Parkinson’s disease and motor side effects induced by antipsychotics. The effects of anticholinergics are mediated by muscarinic receptors of which ...

  15. The Facts About Sexual (Dys)function in Schizophrenia : An Overview of Clinically Relevant Findings

    NARCIS (Netherlands)

    de Boer, Marrit K; Castelein, Stynke; Wiersma, Durk; Schoevers, Robert A; Knegtering, Henderikus

    2015-01-01

    A limited number of studies have evaluated sexual functioning in patients with schizophrenia. Most patients show an interest in sex that differs little from the general population. By contrast, psychiatric symptoms, institutionalization, and psychotropic medication contribute to frequently occurring

  16. Female sexual dysfunction in young adult women - Impact of age and lifestyle

    Science.gov (United States)

    Stoian, Dana; PAter, Liana; Pater, Flavius; Craciunescu, Mihaela

    2014-12-01

    Female sexual function is a difficult entity to be assessed. Subjective factors and interview biases can change the perception of it. Using validated questionnaires can improve the scientific approach to this matter. There is a huge difference of severity and incidence among young, apparent healthy women, which are in a harmonious relationship. We evaluated 320 healthy women, with stable sexual active relationship, with no know depressive disease, endocrinological and metabolic pathology, no premature menopause, no malignancy. We compose a mathematic model to study the impact of age, and body weight on the sexual function, with FSFI total score as surrogate marker. We observed that even in healthy women, increase in age and/or weight/body mass significantly impair general sexual function.

  17. Sexual dysfunction in men in the first 9 months after myocardial infarction [Dysfunkcje seksualne u mężczyzn w ciągu pierwszych 9 miesięcy po przebytym zawale serca

    OpenAIRE

    Puchalski, Bartosz; Szymański, Filip; Kowalik, Robert; Filipiak, Krzysztof Jerzy

    2013-01-01

    Objectives. The aim of the study is to assess the frequency of sexual dysfunction in men after myocardial infarction (MI).Methods. 62 men were asked to fill IIEF 15 to assess sexual dysfunction 3 and 9 months after MI.Results. Erectile dysfunction (ED), orgasmic dysfunction, decreased sexual desire, decreased intercourse satisfaction, decreased overall satisfaction were recognized respectively by: 61.3%, 24.2%, 62.9%, 71%, 54.8% of men 3 months after MI, and 51.6%, 17.7%, 58.1%, 77.4%, 59.7% ...

  18. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men.

    Science.gov (United States)

    Pastuszak, A W; Badhiwala, N; Lipshultz, L I; Khera, M

    2013-09-01

    Few studies have objectively examined the relationship between depression and various stages of sexual function. Here we associate depression and sexual function using validated questionnaires. A retrospective review of 186 men was performed; demographics and serum hormone levels were obtained. Responses to questionnaires evaluating depressive symptoms (Patient Health Questionnaire (PHQ-9)), sexual function (International Index of Erectile Function (IIEF)) and hypogonadal symptoms (quantitative Androgen Decline in the Aging Male (qADAM)) completed by each patient were correlated using Spearman's rank correlation. Mean±s.d. subject age: 52.6±12.7 years; mean serum hormone levels: TT 429.8±239.2 ng dl(-1), free testosterone 9.72±7.5 pg ml(-1) and estradiol 34.4±22.8 pg ml(-1). Negative correlations were observed between total PHQ-9 score and the sexual desire (ρ=-0.210, P=0.006), intercourse satisfaction (ρ=-0.293, Ppsychological as well as physical aspects of sexual function. PMID:23466661

  19. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study

    OpenAIRE

    Akhtari, Elham; Raisi, Firoozeh; Keshavarz, Mansoor; Hosseini, Hamed; Sohrabvand, Farnaz; Bioos, Soodabeh; Kamalinejad, Mohammad; Ghobadi, Ali

    2014-01-01

    Background Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. De...

  20. Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea

    DEFF Research Database (Denmark)

    Steinke, E; Palm Johansen, P; Fridlund, B;

    2016-01-01

    dysfunction, while for men factors included BMI, hormonal status and inflammatory markers. Continuous positive airway pressure (CPAP) not only improved clinical measures such as excessive daytime sleepiness but also the erectile and orgasmic function. Nevertheless, sildenafil was superior CPAP with regard...

  1. Sexual Dysfunction After Conventional and Endovascular AAA Repair: Results of the DREAM Trial.

    NARCIS (Netherlands)

    Prinssen, M.; Buskens, E.; Nolthenius, R.P.T.; Sterkenburg, S. van; Teijink, J.A.; Blankensteijn, J.D.

    2004-01-01

    Purpose: To assess sexual function in the first postoperative year after elective endovascular aneurysm repair (EVAR) and open repair (OR) of abdominal aortic aneurysm (AAA).Methods: In the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial, 153 patients (141 men; mean age 71 years, ran

  2. The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

    Science.gov (United States)

    Traish, Abdulmaged M; Mulgaonkar, Ashwini; Giordano, Nicholas

    2014-06-01

    With aging, abnormal benign growth of the prostate results in benign prostate hyperplasia (BPH) with concomitant lower urinary tract symptoms (LUTS). Because the prostate is an androgen target tissue, and transforms testosterone into 5α-dihydrotestosterone (5α-DHT), a potent androgen, via 5α-reductase (5α-R) activity, inhibiting this key metabolic reaction was identified as a target for drug development to treat symptoms of BPH. Two drugs, namely finasteride and dutasteride were developed as specific 5α-reductase inhibitors (5α-RIs) and were approved by the U.S. Food and Drug Administration for the treatment of BPH symptoms. These agents have proven useful in the reducing urinary retention and minimizing surgical intervention in patients with BPH symptoms and considerable literature exists describing the benefits of these agents. In this review we highlight the adverse side effects of 5α-RIs on sexual function, high grade prostate cancer incidence, central nervous system function and on depression. 5α-Rs isoforms (types 1-3) are widely distributed in many tissues including the central nervous system and inhibition of these enzymes results in blockade of synthesis of several key hormones and neuro-active steroids leading to a host of adverse effects, including loss of or reduced libido, erectile dysfunction, orgasmic dysfunction, increased high Gleason grade prostate cancer, observed heart failure and cardiovascular events in clinical trials, and depression. Considerable evidence exists from preclinical and clinical studies, which point to significant and serious adverse effects of 5α-RIs, finasteride and dutasteride, on sexual health, vascular health, psychological health and the overall quality of life. Physicians need to be aware of such potential adverse effects and communicate such information to their patients prior to commencing 5α-RIs therapy. PMID:24955220

  3. Prevalence of sexual dysfunction and its associated factors in women aged 40-65 years with 11 years or more of formal education: a population-based household survey

    Directory of Open Access Journals (Sweden)

    Ana L. R. Valadares

    2008-01-01

    Full Text Available OBJECTIVE: To evaluate the prevalence of sexual dysfunction and its associated factors in middle-aged women with 11 years or more of formal education. METHODS: A cross-sectional, population-based study was carried out using an anonymous, self-response questionnaire. A total of 315 Brazilian-born women, 40-65 years of age with 11 years or more of schooling, participated in the study. The instrument used in the evaluation was based on the Short Personal Experiences Questionnaire. Sexual dysfunction was calculated from the mean score of sexual responsiveness (pleasure in sexual activities, excitation and orgasm, frequency of sexual activities and libido. Sociodemographic and clinical factors were evaluated. Poisson multiple regression analysis was carried out and the prevalence ratios with respective 95% confidence intervals (95%CI were calculated. RESULTS: The prevalence of sexual dysfunction was 35.9% among our study population. Multiple regression analysis showed that sexual dysfunction was positively associated with older age (prevalence ratios=1.04; 95%CI:1.01-1.07 and with the presence of hot flashes (prevalence ratios=1.37; 95%CI:1.04-1.80. Having a sexual partner (PR=0.47; 95%CI:0.34-0.65 and feeling well or excellent (prevalence ratios= 0.68; 95%CI: 0.52-0.88 were factors associated with lower sexual dysfunction scores. CONCLUSIONS: Sexual dysfunction was present in more than one-third of women that were 40-65 years of age with 11 years or more of formal education. Within that age group, older age and hot flashes were associated with higher sexual dysfunction scores, whereas feeling well and having a sexual partner were associated with better sexuality.

  4. Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion

    Science.gov (United States)

    Abler, Birgit; Seeringer, Angela; Hartmann, Antonie; Grön, Georg; Metzger, Coraline; Walter, Martin; Stingl, Julia

    2011-01-01

    Sexual dysfunction is a common side effect of selective serotonin reuptake inhibitors (SSRIs) like paroxetine in the treatment of depression, imposing a considerable risk on medication adherence and hence therapeutic success. Bupropion, a norepinephrine and dopamine reuptake inhibitor, is recommended as an alternative treatment without adverse effects concerning sexual arousal and libido. We investigated the neural bases of paroxetine-related subjective sexual dysfunction when compared with bupropion and placebo. We scanned 18 healthy, heterosexual males in a randomized, double-blind, within-subject design while watching video clips of erotic and nonerotic content under steady-state conditions after taking 20 mg of paroxetine, 150 mg of bupropion, and placebo for 7 days each. Under paroxetine, ratings of subjective sexual dysfunction increased compared with placebo or bupropion. Activation along the anterior cingulate cortex (ACC), including subgenual, pregenual, and midcingulate cortices, in the ventral striatum and midbrain was decreased when compared with placebo. In contrast, bupropion let subjective ratings and ACC activations unchanged and increased activity of brain regions including posterior midcingulate cortex, mediodorsal thalamus, and extended amygdala relative to placebo and paroxetine. Brain regions that have been related to the processing of motivational (ventral striatum), emotional, and autonomic components of erotic stimulation (anterior cingulate) in previous studies showed reduced responsiveness under paroxetine in our study. Drug effects on these regions may be part of the mechanism underlying SSRI-related sexual dysfunction. Increased activation under bupropion may point to an opposite effect that may relate to the lack of impaired sexual functioning. PMID:21544071

  5. Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression

    OpenAIRE

    Thibault Renoir; Zajac, Michelle S; Xin Du; Pang, Terence Y.; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Hannan, Anthony J

    2011-01-01

    Depression is the most common psychiatric disorder in Huntington's disease (HD) patients. In the general population, women are more prone to develop depression and such susceptibility might be related to serotonergic dysregulation. There is yet to be a study of sexual dimorphism in the development and presentation of depression in HD patients. We investigated whether 8-week-old male and female R6/1 transgenic HD mice display depressive-like endophenotypes associated with serotonergic impairme...

  6. Influence of cyproheptadine on clomipramine induced sexual dysfunction in male rats

    Directory of Open Access Journals (Sweden)

    D. Sheshadri Shekar

    2016-08-01

    Conclusions: The cyproheptadine a drug used as appetizer has the ability to elevate testosterone levels; it has also protected the testis from clomipramine induced damage. The sexual behaviour of the rats which were under treatment with clomipramine was also restored partially in TD and 2TD whereas the rats which were under and frac12; TD clmp treatment were restored to normal. [Int J Basic Clin Pharmacol 2016; 5(4.000: 1359-1365

  7. Sexual Problems

    Medline Plus

    Full Text Available ... is similar to what happens when a person has a phobia or fear. Hypoactive sexual desire disorder, ... There are many clitoral devices, but only one has FDA-approval for treatment of female sexual dysfunction. ...

  8. Clinical investigation of menopausal women with sexual dysfunction%绝经期女性性功能障碍的相关因素分析

    Institute of Scientific and Technical Information of China (English)

    林丽; 鲍云云; 蔡珠华

    2014-01-01

    目的:调查分析绝经期女性性功能障碍情况。方法:选取我院2011年3月至2012年3月收治的围绝经期女性共210例。通过调查问卷的形式调查患者的性功能障碍情况。结果:选出的210例绝经期患者功能障碍发生率为75.2%。不同年龄段的绝经女性其性功能障碍评分有显著性差异:50岁以上患者的评分均明显要低于50岁以下患者,50岁以上患者的女性性功能障碍评分为(20.2±1.2)分,而50岁以下的患者的得分则是(23.5±1.0)分。50岁以下的绝经女性其性功能障碍主要表现为性满意度低和性高潮障碍,两者的发生率分别为88.6%和72.7%;而50岁以上患者的主要性功能障碍主要表现在性欲和性唤起两方面,其发生率分别是69.3%和75.4%。结论:影响绝经女性出现性功能障碍的因素包括患者年龄、基础疾病以及雌激素的补充。50岁以下的绝经女性性功能障碍主要表现为性满意度低,以及性高潮障碍;50岁以上患者的性功能障碍主要表现在性欲和性唤起两方面。%Objectives:To investigate the sexual dysfunction of outpatient menopausal women.Methods:210 perimenopausal women admitted to our hospital from March 2011 to March 2012 were surveyed through ques-tionnaires to learn their sexual dysfunction condition.Results:75.2% of the 210 menopausal patients had sexual dysfunction problem.The sexual dysfunction score of menopausal women at different ages were significantly differ-ent:scores of patients over 50 (23.5 ±1.0)were significantly lower than patients below 50(20.2 ±1.2).For menopausal women below 50 years old,the sexual dysfunction mainly included low sexual satisfaction (88.6%) and orgasm (72.7%);while for patients over 50,they were difficulty in sexual desire (69.3%)and arousal (75. 4%).Conclusions:Factors of sexual dysfunction in postmenopausal females include age,underlying disease,and estrogen supplement

  9. Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction.

    Science.gov (United States)

    Lowenstein, L; Shechter, A; Porst, H; Tripodi, F; Reisman, Y

    2016-01-01

    Androgen deficiency syndrome is a commonly diagnosed condition. The aim of this study was to investigate common clinical practices of specialists in the field of sexual medicine regarding androgen replacement treatment for men and women. Attendees of the 16th Annual Congress of the European Society of Sexual Medicine held in January 2014 in Istanbul, Turkey, were asked to participate in a survey during the congress days. A 24-item self-report, closed-question questionnaire was distributed. Three sections were accessed: sociodemographic data, professional background and personal practice patterns regarding androgen substitution in men and women. A total of 133 physicians (mean age 47 years; range 25-79) completed the survey. Responses were inconsistent regarding the lab tests used for primary evaluation of male androgen deficiency. The majority of participants (62%) recommended testosterone replacement therapy for symptomatic men with testosterone levels libido and testosterone levels in women. Only 42% and 53% reported they would prescribe testosterone to women with low libido, premenopausal and postmenopausal, respectively. This survey showed discrepancies among physicians regarding testosterone replacement therapy for men and women. PMID:26865099

  10. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.

    Science.gov (United States)

    Bobes, J; Garc A-Portilla, M P; Rejas, J; Hern Ndez, G; Garcia-Garcia, M; Rico-Villademoros, F; Porras, A

    2003-01-01

    Atypical antipsychotics seem to differ mainly in their tolerability profile. The aim of this cross-sectional study, the Estudio de Investigaci n de Resultados en Esquizofrenia (Outcomes Research Study in Schizophrenia; EIRE study), was to assess in a clinical setting the frequency of several side-effects related to haloperidol, risperidone, olanzapine, and quetiapine. This article addresses sexual dysfunction and other reproductive side-effects (gynecomastia, menorrhage, amenorrhea, and galactorrhea). We recruited outpatients diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994) criteria and who had received a single antipsychotic (risperidone, olanzapine, quetiapine, or haloperidol) for at least 4 weeks. During a single visit, we collected data, including demographic and clinical characteristics, current antipsychotic and concomitant treatment, and adverse effects listed in a modified version of the UKU Scale. We used a Chi-squared test to determine pairs comparisons of the frequency of adverse reactions between treatments. To estimate risk of a given adverse reaction with a given treatment, we used a logistic regression method. We assessed 636 evaluable patients out of 669 recruited. Frequency of sexual dysfunction was high with haloperidol (38.1%) and also with olanzapine (35.3%), quetiapine (18.2%), and risperidone (43.2%). We found the frequency of other reproductive side-effects to be relatively low with all four drugs: haloperidol (6.9%), olanzapine (6.4%), quetiapine (2.7%), and risperidone (11.7%). Sexual dysfunction appeared to be dose-related with haloperidol, risperidone, and olanzapine. Risperidone and olanzapine showed a higher risk of sexual dysfunction and other reproductive sideeffects than haloperidol. Quetiapine showed a lower risk of sexual dysfunction during short-term treatment ( 12 weeks) are lacking. Our results suggest that none of the atypical

  11. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.

    Science.gov (United States)

    Bobes, J; Garc A-Portilla, M P; Rejas, J; Hern Ndez, G; Garcia-Garcia, M; Rico-Villademoros, F; Porras, A

    2003-01-01

    Atypical antipsychotics seem to differ mainly in their tolerability profile. The aim of this cross-sectional study, the Estudio de Investigaci n de Resultados en Esquizofrenia (Outcomes Research Study in Schizophrenia; EIRE study), was to assess in a clinical setting the frequency of several side-effects related to haloperidol, risperidone, olanzapine, and quetiapine. This article addresses sexual dysfunction and other reproductive side-effects (gynecomastia, menorrhage, amenorrhea, and galactorrhea). We recruited outpatients diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994) criteria and who had received a single antipsychotic (risperidone, olanzapine, quetiapine, or haloperidol) for at least 4 weeks. During a single visit, we collected data, including demographic and clinical characteristics, current antipsychotic and concomitant treatment, and adverse effects listed in a modified version of the UKU Scale. We used a Chi-squared test to determine pairs comparisons of the frequency of adverse reactions between treatments. To estimate risk of a given adverse reaction with a given treatment, we used a logistic regression method. We assessed 636 evaluable patients out of 669 recruited. Frequency of sexual dysfunction was high with haloperidol (38.1%) and also with olanzapine (35.3%), quetiapine (18.2%), and risperidone (43.2%). We found the frequency of other reproductive side-effects to be relatively low with all four drugs: haloperidol (6.9%), olanzapine (6.4%), quetiapine (2.7%), and risperidone (11.7%). Sexual dysfunction appeared to be dose-related with haloperidol, risperidone, and olanzapine. Risperidone and olanzapine showed a higher risk of sexual dysfunction and other reproductive sideeffects than haloperidol. Quetiapine showed a lower risk of sexual dysfunction during short-term treatment ( 12 weeks) are lacking. Our results suggest that none of the atypical

  12. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction

    Institute of Scientific and Technical Information of China (English)

    Vittorio Magri; Emanuele Montanari; Vi(s)nja (S)kerk; Alemka Markoti(c); Emanuela Marras; Antonella Restelli; Kurt G Naber; Gianpaolo Perletti

    2011-01-01

    We previously demonstrated the safety and efficacy of fluoroquinolone-macrolide combination therapy in category Ⅱ chronic bacterial prostatitis (CBP).The aim of this study is to retrospectively compare the microbiological and clinical findings of two treatment schemes for CBP based on the combination of azithromycin (500 mg,thrice-weekly) with a once-daily 500-or 750-mg dose of ciprofloxacin (Cipro-500 or Cipro-750 cohort,respectively).Combined administration of azithromycin (1500 mg week-1) with ciprofloxacin at the rate of 750 mg day-1 for 4 weeks rather than at 500 mg day-1 for 6 weeks increased the eradication rates from 62.35% to 77.32% and the total bacteriological success from 71.76% to 85.57%.A significant decrease in pain and voiding signs/symptoms and a significant reduction in inflammatory leukocyte counts and serum prostate-specific antigen (PSA) were sustained throughout an 18-month follow-up period in both groups.Ejaculatory pain,haemospermia and premature ejaculation were significantly attenuated on microbiological eradication in both groups,but the latter subsided more promptly in the Cipro-750 cohort.In total,59 Cipro-750 patients showed mild-to-severn erectile dysfunction (ED) at baseline,while 22 patients had no ED on microbiological eradication and throughout the follow-up period.In conclusion fluoroquinolone-macrolide therapy resulted in pathogen eradication and CBP symptom attenuation,including pain,voiding disturbances and sexual dysfunction.A once-daily 750-mg dose of ciprofloxacin for 4 weeks showed enhanced eradication rates and lower inflammatory white blood cell counts compared to the 500-mg dose for 6 weeks.Our results are open to further prospective validation.

  13. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

    Directory of Open Access Journals (Sweden)

    Thibault Renoir

    Full Text Available Depression is the most common psychiatric disorder in Huntington's disease (HD patients. In the general population, women are more prone to develop depression and such susceptibility might be related to serotonergic dysregulation. There is yet to be a study of sexual dimorphism in the development and presentation of depression in HD patients. We investigated whether 8-week-old male and female R6/1 transgenic HD mice display depressive-like endophenotypes associated with serotonergic impairments. We also studied the behavioral effects of acute treatment with sertraline. We found that only female HD mice exhibited a decreased preference for saccharin as well as impaired emotionality-related behaviors when assessed on the novelty-suppressed feeding test (NSFT and the forced-swimming test (FST. The exaggerated immobility time displayed by female HD in the FST was reduced by acute administration of sertraline. We also report an increased response to the 5-HT(1A receptor agonist 8-OH-DPAT in inducing hypothermia and a decreased 5-HT(2A receptor function in HD animals. While tissue levels of serotonin were reduced in both male and female HD mice, we found that serotonin concentration and hydroxylase-2 (TPH2 mRNA levels were higher in the hippocampus of males compared to female animals. Finally, the antidepressant-like effects of sertraline in the FST were blunted in male HD animals. This study reveals sex-specific depressive-related behaviors during an early stage of HD prior to any cognitive and motor deficits. Our data suggest a crucial role for disrupted serotonin signaling in mediating the sexually dimorphic depression-like phenotype in HD mice.

  14. Depression,Antidepressants and Male Sexual Dysfunction%抑郁和抗抑郁药物与男性性功能障碍

    Institute of Scientific and Technical Information of China (English)

    李宏军

    2009-01-01

    抑郁、抗抑郁药物及男性性功能障碍三者关系密切,本文系统阐述了三者的相互关系,简要介绍了常用抗抑郁药物分类及其不良反应,重点论述了抑郁及抗抑郁药物对男性性功能的不良影响、抗抑郁药物治疗男性性功能障碍及注意事项,对男科临床工作有一定指导和借鉴意义.%Depression,antidepressants and male sexual dysfunction are closely correlated.This article aims to expound their complicated correlation and give a brief introduction to the classification and adverse effects of common antidepressants.focusing on the influences of depression and antidepressants on male sexual dysfunction,the treatment of male sexual dysfunction with antidepressants, and the points for attention in the medication,which might offer some guidance for the clinical practice in andrology.

  15. Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism.

    Science.gov (United States)

    Nagashima, Takuya; Shirakawa, Hisashi; Nakagawa, Takayuki; Kaneko, Shuji

    2016-01-01

    Atypical antipsychotics are associated with an increased risk of hyperglycaemia, thus limiting their clinical use. This study focused on finding the molecular mechanism underlying antipsychotic-induced hyperglycaemia. First, we searched for drug combinations in the FDA Adverse Event Reporting System (FAERS) database wherein a coexisting drug reduced the hyperglycaemia risk of atypical antipsychotics, and found that a combination with vitamin D analogues significantly decreased the occurrence of quetiapine-induced adverse events relating diabetes mellitus in FAERS. Experimental validation using mice revealed that quetiapine acutely caused insulin resistance, which was mitigated by dietary supplementation with cholecalciferol. Further database analysis of the relevant signalling pathway and gene expression predicted quetiapine-induced downregulation of Pik3r1, a critical gene acting downstream of insulin receptor. Focusing on the phosphatidylinositol 3-kinase (PI3K) signalling pathway, we found that the reduced expression of Pik3r1 mRNA was reversed by cholecalciferol supplementation in skeletal muscle, and that insulin-stimulated glucose uptake into C2C12 myotube was inhibited in the presence of quetiapine, which was reversed by concomitant calcitriol in a PI3K-dependent manner. Taken together, these results suggest that vitamin D coadministration prevents antipsychotic-induced hyperglycaemia and insulin resistance by upregulation of PI3K function. PMID:27199286

  16. Effects ofDracaena arborea (Dracaenaceae) on sexual dysfunction in 4 weeks hyperglycemic male rats

    Institute of Scientific and Technical Information of China (English)

    Wankeu-Nya M; Watcho P; Nguelefack TB; Carro-Juarez M; Tapondjou L; Kamanyi A

    2014-01-01

    Objective:To investigate the effects ofDracaena arborea(D. arborea) on the sexual behavior parameters in experienced type-1 diabetic rats.Methods:Aqueous and ethanol(100 and500 mg/kg respectively) extracts of dried root barks ofD. arborea, sildenafil citrate(1.44 mg/kg), trimethylamine-N-oxide(TMAO,20 mg/kg) and distilled water(10 mL/kg) were orally administered to4 weeks streptozotocin-induced diabetic rats.Mount latency and frequency (ML,MF), intromission latency and frequency(IL,IF) and post-ejaculatory interval(PEI) were measured by ejaculatory series during90 min once a week for4 weeks.Glycemia was determined at the beginning and at the end of the treatment.Results:D. arborea did not show any major antihyperglycemic effects.Compared to the control group, a significant(P<0.05-0.001) increase inMF andIF was noticed in rats treated with sildenafil citrate(89.71% and90.07% respectively), aqueous(500 mg/kg,88.08% and88.74% respectively) and ethanol(100 mg/kg;89.53% and89.17 respectively) extracts ofD. arborea after two weeks(series1) of treatment.ML,IL andPEI were significantly(P<0.05-0.001) decreased after4 weeks of daily treatment [sildenafil citrate(96.31, 96.31% and34.98%), andD. arborea aqueous500 mg/kg(94.33,94.33% and66.60%) and ethanol extracts100 mg/kg(96.98,97.08% and64.26%)].Conclusions:These aphrodisiac potentials of D. arborea in experienced diabetic rats could be due to the antioxidant and androgenic properties of phenols, flavonoids, saponins and sterols revealed in the plant extracts.

  17. Effects of aqueous extract ofCnestis ferruginea (Vahl ex De Cantolle) root on paroxetine-induced sexual dysfunction in male rats

    Institute of Scientific and Technical Information of China (English)

    Yakubu Musa Toyin; Nurudeen Quadri Olaide

    2012-01-01

    Objective:To determine the effects of the aqueous extract ofCnestis ferruginea root on paroxetine-induced sexual dysfunction in maleWistar rats.Methods:The extract (13,26 and52 mg/kg body weight) and the reference herbal drug,PowmaxM (7.14 mg/kg body weight) were administered orally to paroxetine-induced sexually impaired male rats, once daily for5 d and their sexual behaviour parameters were monitored and computed.Theserum hormones (testosterone, follicle stimulating and luteinizing hormones) were determined at the end of the exposure period.Results:Administration of paroxetine to sexually active male rats significantly (P<0.05) reduced the mount frequency (MF), intromission frequency (IF), and ejaculation frequency (EF), whereas mount latency (ML), intromission latency (IL), ejaculatory latency (EL) and post-ejaculatory interval (PEI) were increased.The extracts progressively reversed the trends ofMF,IF,EF,ML,IL,EL andPEI in the paroxetin-treated animals towards the control values throughout the exposure period.The sexual behaviour parameters compared well with thePowmaxM-treated animals but not comparable to the distilled water administered animals. In addition, all the doses of the extract elevated (P<0.05) the levels of serumLH andFSH and decreased testosterone contents.Conclusions:The aqueous extract ofCnestis ferruginea root at the doses of13,26 and52 mg/kg body weight restored sexual competence at least to a reasonable extent in sexually impaired/sluggish male rats with the highest dose producing the best efficacy. The results support the folkloric claim of the plant for the management of sexual disorder in males.

  18. Healthy Sexuality

    Medline Plus

    Full Text Available ... over the course of a lifetime. The World Health Organization has defined sexual health as “…a state of physical, emotional, mental and ... the absence of disease, dysfunction, or infirmity. Sexual health requires a positive and respectful approach to sexuality ...

  19. 催眠治疗吸毒患者性功能障碍一例报告%Hypnosis to treat drug addicts case reports of sexual dysfunction

    Institute of Scientific and Technical Information of China (English)

    龚建南; 刘玉芳

    2014-01-01

    Objective:Enhancedmethadoneoutpatientrehabilitationmotivation,reducepsychologicaldependenceondrugs. Methods:Treatment with hypnosis new group withdrawal reactions and sexual dysfunction.Results:Withdrawal reaction is lighter, mood,sexual function,social function recovery.During 5 years tracking,personal integrity is good.Conclusion:Drug addicts’sexual dysfunction can’t rule out the influence of psychological factors.Psychological treatment to the patient’s recent treatment and long-term follow-up are very role.%目的:增强美沙酮门诊病人戒毒动机,减少对毒品的心理依赖。方法:用催眠术治疗新入组病人戒断反应和性功能障碍。结果:戒断反应较轻,情绪改善,性功能恢复,社会功能恢复。5年追踪,操守良好。结论:吸毒者性功能障碍不能排除心理因素的影响。心理治疗对病人的近期疗和远期疗效都有很作用。

  20. Female Sexual Dysfunction

    Science.gov (United States)

    ... what’s going on. Sometimes a better line of communication is all that is needed. If necessary, you may want to get counseling, by yourself or with your partner. Sex therapy, usually a later step in the process, ...

  1. 抗抑郁药物致性功能障碍的临床研究进展%Clinical Research Progress of Antidepressant Drugs Causing Sexual Dysfunction

    Institute of Scientific and Technical Information of China (English)

    林国华(综述); 江回春(审校)

    2016-01-01

    Antidepressants not only has the antidepressant and anxiolytic clinical effects , but also adverse reactions.General adverse antidepressant effects can be divided into central and peripheral side effects,where the influence of antidepressants on sexual function belongs to peripheral side effects .Antide-pressant drugs causing sexual dysfunction has become a consensus.Therefore,when selecting antidepressant, the adverse effect on sexual function should be taken into account,and the patient′s sexual function change after medication should be inquired ,so as to develop individualized treatment program ..%抗抑郁药除了具有抗抑郁及抗焦虑的临床治疗作用外,同样具有不良反应。抗抑郁药物的不良反应一般可分为中枢性不良反应和外周性不良反应。其中抗抑郁药物对患者性功能的影响属于外周性不良反应。抗抑郁药物会引起性功能障碍已成为共识。因此,在选择抗抑郁药物时应考虑到性功能方面的不良反应,了解患者服药后性功能的变化,以制订个性化的处理方案。

  2. Sexual dysfunctions in patients with functional pituitary adenomas%功能性垂体腺瘤患者性功能障碍的研究进展

    Institute of Scientific and Technical Information of China (English)

    周任远

    2012-01-01

    Pituitary tumors not only can be the main cause of various endocrine symptoms, but also have a major effect on sexual development and function. The link between functional pituitary adenomas and sexual functions is gradually accounted at clinical level. The mechanism may be correlated with the impairment of the hypothalamic-pituitary-gonadal axis. Pituitary tumors firstly should be treated. Then, supplement testosterone or phosphodiesterase 5 inhibitors may be used to treat sexual dysfunction. The aim of this review was to summarize the latest progress about the incidence, clinical symptoms, pathogenesis, diagnosis and treatment of sexual dysfunction in patients with pituitary adenoma.%功能性垂体腺瘤不仅会产生内分泌紊乱的症状,而且常引发性功能障碍.功能性垂体瘤与性功能之间的关系逐渐得到重视,其发生机制可能与垂体肿瘤影响下丘脑-垂体-性腺轴有关.治疗上应首先治疗垂体肿瘤原发病,在肿瘤被切除或控制后,则可选择补充睾酮或应用磷酸二酯酶5型抑制剂治疗性功能障碍.本文就功能性垂体腺瘤患者性功能障碍的发病率、临床表现、发病机制、诊断及治疗的最新研究进展作一综述.

  3. Change to Either a Nonandrogenic or Androgenic Progestin-Containing Oral Contraceptive Preparation is Associated with Improved Sexual Function in Women with Oral Contraceptive-Associated Sexual Dysfunction

    DEFF Research Database (Denmark)

    Davis, Susan R; Bitzer, Johannes; Giraldi, Annamaria;

    2013-01-01

    It is a commonly held belief that combined oral contraceptive (COC) pills containing an androgenic progestin may be less likely to impair sexual function than COCs containing an anti-androgenic progestin.......It is a commonly held belief that combined oral contraceptive (COC) pills containing an androgenic progestin may be less likely to impair sexual function than COCs containing an anti-androgenic progestin....

  4. Current Issues in the Evaluation and Treatment of Sexual Disturbance.

    Science.gov (United States)

    Beutler, Larry E.

    1986-01-01

    Discusses causes of sexual disturbance, assessment of sexual dysfunction, treatment of sexual dysfunction, psychological issues associated with chronic physical illness and sexual behavior, theory and treatment in child molestation, and the psychosocial outcomes of sex reassignment surgery. (BL)

  5. Disfunção sexual em pacientes com câncer do colo uterino avançado submetidas à radioterapia exclusiva Sexual dysfunction in patients with advanced cervical cancer submitted to exclusive radiotherapy

    Directory of Open Access Journals (Sweden)

    Bebiana Calisto Bernardo

    2007-02-01

    Full Text Available OBJETIVO: identificar disfunções sexuais em pacientes com câncer de colo uterino submetidas à radioterapia exclusiva pela técnica de braquiterapia de alta taxa de dose. MÉTODOS: foi realizado um estudo descritivo do tipo corte transversal no período de janeiro a junho de 2004. O estudo envolveu 71 pacientes selecionadas de acordo o perfil estabelecido e que vinham sendo seguidas no ambulatório de pélvis do Hospital do Câncer de Pernambuco. Os dados foram coletados a partir de um questionário estruturado, complementado por um exame ginecológico visando investigar queixas de disfunção sexual após a radioterapia. Foi utilizado o programa estatístico Epi-Info 6.04 para processamento e análise dos dados. A análise descritiva foi feita pela média, mediana, valores máximo e mínimo. Para análise bivariada foram realizados os testes de homogeneidade marginal e McNemar, considerando um nível de significância de 5%. RESULTADOS: das complicações ginecológicas identificadas, destacam-se fibrose, estenose e atrofia vaginais (98,6, 76,1 e 71,8% dos casos, respectivamente. As disfunções sexuais identificadas foram: frigidez e falta de lubrificação, de excitação e de orgasmo, que ocorreram em 76,1% dos casos, falta de libido em 40,8% e vaginismo em 5,6% dos casos. CONCLUSÕES: as disfunções sexuais são freqüentes em pacientes com câncer do colo uterino avançado tratadas com radioterapia exclusiva utilizando o protocolo de braquiterapia de alta taxa de dose. Atenção específica deve ser dada à anamnese sexual e ao exame ginecológico durante o acompanhamento destas pacientes.PURPOSE: to identify sexual dysfunctions in patients with cancer of the uterine cervix submitted to exclusive radiotherapy, using the high dose rate (HDR brachytherapy technique. METHODS: a descriptive transversal study from January to June of 2004. The study involved 71 selected patients who had been followed in the pelvis outpatient clinic from the

  6. Sexual Problems

    Medline Plus

    Full Text Available ... include hormone therapy, antidepressants, phosphodiesterase inhibitors, which are drugs often used for erectile dysfunction, and other medications. ... may improve sexual function. A group of antidepressant drugs called selective serotonin reuptake inhibitors, or SSRIs, often ...

  7. Using a three-dimension head mounted displayer in audio-visual sexual stimulation aids in differential diagnosis of psychogenic from organic erectile dysfunction.

    Science.gov (United States)

    Moon, K-H; Song, P-H; Park, T-C

    2005-01-01

    We designed this study to compare the efficacy of using a three-dimension head mounted displayer (3-D HMD) and a conventional monitor in audio-visual sexual stimulation (AVSS) in differential diagnosis of psychogenic from organic erectile dysfunction (ED). Three groups of subjects such as psychogenic ED, organic ED, and healthy control received the evaluation. The change of penile tumescence in AVSS was monitored with Nocturnal Electrobioimpedance Volumetric Assessment and sexual arousal after AVSS was assessed by a simple question as being good, fair, or poor. Both the group of healthy control and psychogenic ED demonstrated a significantly higher rate of normal response in penile tumescence (P<0.05) and a significantly higher level of sexual arousal (P<0.05) if stimulated with 3-D HMD than conventional monitor. In the group of organic ED, even using 3-D HMD in AVSS could not give rise to a better response in both assessments. Therefore, we conclude that using a 3-D HMD in AVSS helps more to differentiate psychogenic from organic ED than a conventional monitor in AVSS.

  8. PREVALENCE OF SEXUAL DYSFUNCTION, INSOMNIA AND DETERIORATION OF THE QUALITY OF LIFE IN HYSTERECTOMYZED WOMEN (IN SPANISH)

    OpenAIRE

    Saavedra-Orozco Héctor; Monterrosa-Castro Álvaro; Caraballo-Olave Elida; Ulloque-Caamaño Liezel; Rincón-Niño Erika

    2014-01-01

    Introduction: the hysterectomy is a surgical procedure used for the treatment of uterine pathologies. It has been demonstrated that this procedure could affect negatively different fields and to impact the quality of life (QoL). Objective: to assess the sexual function, insomnia and the QoL in a group of hysterectomized women. Methods: cross-sectional study carried out with three validated scales: The short 6-item Female Sexual Function Index (FSFI-6), the Athens Insomnia Sc...

  9. 平凉市中老年男性性功能调查报告%Prevalence of aging male sexual dysfunction in Pingliang City

    Institute of Scientific and Technical Information of China (English)

    韩晓峰; 任江玲; 胡黎明; 许克新

    2011-01-01

    目的 调查平凉市中老年男性性欲低下、勃起功能障碍(erectile dysfunction,ED)、射精障碍的患病情况.方法 采用分层多阶段整群不等比例随机抽样方法,选择城区6个居委会和郊区20个行政村1539名年龄≥50岁男性作为调查对象,分别记录国际勃起功能问卷(IIEF-5)评分及男性性功能问卷(O'Leafy 1995)评分,应用χ2检验分析调查数据.结果 符合标准的调查对象1 230人,年龄50~89(62.5±9.6)岁.平均IIEF-5(9.4±8.6)分.以IIEF-5评分0~21分诊断为ED,总ED患病率92.27%,性欲低下57.96%,射精障碍36.91%.各年龄组间(10岁/组)ED、性欲低下、射精障碍患病率差异有统计学意义(P<0.0001),各年龄组间不同程度ED患病率差异有统计学意义(P<0.0001).结论 随年龄增加ED、性欲低下、射精障碍的患病率逐渐增加,ED患病率最高.%Objective To investigate the prevalence of aging male sexual dysfunction in Pingliang City, Gansu Province.MethodS A cross-sectional study was performed in 6 urban communities and 20 villages in the suburbs of Jingning County,with 1539 males aged over 50 enrolled. The International Index of Erectile Function-5 (IIEF-5) and Brief Male Scxual Function Inventory foi Urology (O' Leary 1995) were recorded and analyzed. Results 1230 subjects were included in the survey, average age (62. 5± 9. 6) years, ranging 50~89. The mean score of IIEF-5 was 9. 4± 8. 6. The prevalence of erectile dysfunction (ED) , defined as IIEF-5 between 0~21, was 92. 27% . The incidence of reduction of sexual desire and defective ejaculation was 57 . 96 % and 36 . 91% , respectively. There was positive correlation between the prevalence of ED. reduction of sexual desire, defective ejaculation and age. Conclusions The incidence of ED, reduction of sexual desire and defective ejaculation are positively correlated with age. And ED ranks the first among these sexual dysfunctions.

  10. Disfunção sexual em pacientes com psoríase e artrite psoriásica - uma revisão sistemática Sexual dysfunction in patients with psoriasis and psoriatic arthritis - a systematic review

    Directory of Open Access Journals (Sweden)

    Patricia Shu Kurizky

    2012-12-01

    of its lesions. Several psychological disorders can be associated with psoriasis, and feelings such as rage, depression, shame, and anxiety have been commonly reported, which can culminate in social isolation and sexual dysfunction. Despite being a common complaint among patients with psoriasis, sexual dysfunction has been rarely reported in the literature. This study aimed at performing a systematic review of the prevalence of sexual dysfunction in psoriasis and psoriatic arthritis, assessing the role played by factors such as depression and severity of disease in this relation. This systematic review showed that data on the sexual difficulties of patients with psoriasis are scarce. The hypotheses to explain sexual dysfunction in that group of patients include the severity of skin findings, the psychological effects of the condition on the patient, concerns of the sexual partner, and side effects of the medical treatments for psoriasis. Those data emphasize that this type of symptomatology is frequently neglected in medical practice, and stress the importance of assessing the impact of psoriasis regarding not only cutaneous and joint involvements, but also psychosocial and sexual impairments. Considering the sociocultural diversities of each population, a specific study of the Brazilian population to provide more information about our patients is required.

  11. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial

    Directory of Open Access Journals (Sweden)

    Farnia V

    2015-03-01

    Full Text Available Vahid Farnia,1 Mehdi Shirzadifar,2 Jalal Shakeri,1 Mansour Rezaei,3 Hafez Bajoghli,4,5 Edith Holsboer-Trachsler,6 Serge Brand6,7 1Substance Abuse Prevention Research Center, Psychiatry Department, Kermanshah University of Medical Sciences, Kermanshah, Iran; 2Student Research Center, Psychiatry Department, Kermanshah University of Medical Sciences, Kermanshah, Iran; 3Department of Statistics and Epidemiology, Kermanshah University of Medical Sciences, Kermanshah, Iran; 4Iranian National Center for Addiction Studies, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran; 5ASEAN Institute for Health Development, Mahidol University, Nakhon Pathom, Thailand; 6Psychiatric Clinics of the Center for Affective, Stress and Sleep Disorders, Psychiatric Hospital of the University of Basel, Basel, Switzerland; 7Sport Science Section, Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland Background: A substantial disadvantage of psychopharmacological treatment of major depressive disorder (MDD with selective serotonin-reuptake inhibitors (SSRIs is the impact on sexual dysfunction. The aim of the present study was to investigate whether the oil of Rosa damascena can have a positive influence on SSRI-induced sexual dysfunction (SSRI-I SD of male patients who are suffering from MDD and are being treated with SSRIs.Method: In a double-blind, randomized, and placebo-controlled clinical trial, a total of 60 male patients treated with an SSRI and suffering from MDD (mean age =32 years and SSRI-I SD were randomly assigned to take either verum (R. damascena oil or a placebo. Patients completed self-ratings of depression and sexual function at baseline, at 4 weeks later, and at the end of the study, 8 weeks after it started.Results: Over time, sexual dysfunction improved more in the verum group than in the control group. Improvements were observed in the verum group from week 4 to week

  12. Treinamento dos músculos do assoalho pélvico nas disfunções sexuais femininas Pelvic floor muscle training in female sexual dysfunctions

    Directory of Open Access Journals (Sweden)

    Virginia Pianessole Piassarolli

    2010-05-01

    Full Text Available OBJETIVO: avaliar o efeito do treinamento dos músculos do assoalho pélvico (TMAP sobre as disfunções sexuais femininas. MÉTODOS: para esse ensaio clínico com abordagem antes e depois, foram incluídas 26 mulheres que apresentavam diagnóstico de disfunção sexual (transtorno de desejo sexual, de excitação, orgástico e/ou dispareunia. As participantes foram avaliadas antes, na metade (após cinco sessões e ao final do tratamento (após dez sessões, por meio da palpação vaginal bidigital (avaliação da força dos músculos do assoalho pélvico-MAP, eletromiografia (EMG intravaginal (captação das amplitudes de contração dos MAP e Female Sexual Function Index (FSFI, questionário de avaliação da função sexual. As mulheres foram submetidas ao TMAP em diferentes posições, por dez sessões (uma ou duas vezes na semana. Para análise estatística, utilizou-se frequências absolutas e relativas para características clínicas e força dos MAP. Empregou-se teste de Friedman para comparação dos escores dos domínios do FSFI e valores da EMG, t de Student para associação entre esses valores e características das mulheres e Wilcoxon para modificação percentual da EMG. O teste Mann-Whitney permitiu comparar esses valores com características clínicas. Para correlacionar os valores da EMG com escore total médio, utilizou-se teste de correlação de Spearman. Adotou-se nível de significância de pPURPOSE: to evaluate the effect of pelvic floor muscle training (PFMT on female sexual dysfunctions. METHODS: twenty-six women with a diagnosis of sexual dysfunction (sexual desire, arousal, orgasmic disorders and/or dyspareunia were included in a clinical trial with a before/after approach . The assessment was carried out before, during (after five sessions and at the end of the treatment (after ten sessions by two-digit palpation (assessment of pelvic floor muscle, PFM, strength, intravaginal electromyography (EMG (capture of PFM

  13. 18β-Glycyrrhetinic Acid, a Novel Naturally Derived Agent, Suppresses Prolactin Hyperactivity and Reduces Antipsychotic-Induced Hyperprolactinemia in In Vitro and In Vivo Models.

    Science.gov (United States)

    Wang, Di; Zhang, Yongfeng; Wang, Chunyue; Jia, Dongxu; Cai, Guangsheng; Lu, Jiahui; Wang, Di; Zhang, Zhang-Jin

    2016-09-01

    The purpose of this study was to examine the effects of 18β-glycyrrhetinic acid (GA), a novel naturally derived agent, in suppressing prolactin (PRL) hyperactivity and reducing antipsychotic-induced hyperprolactinemia (hyperPRL) and the underlying mechanisms in in vitro and in vivo models. GA treatment for 24 h inhibited PRL synthesis and secretion in MMQ cells and cultured pituitary cells in a dose-dependent fashion; but this effect was not reproduced in GH3 cells that lack the expression of functional dopamine D2 receptors. GA suppressed elevated PRL level and growth hormone, and normalized several sex hormones in a rat model of hyperPRL, produced by repeated injection of the dopamine blocker metoclopramide. GA also modulated the expression 5-HT1A and 5-HT2A receptors in both in vivo and in vitro models. These results indicate that GA is effective in suppressing PRL hyperactivity caused by the blockade of dopamine D2 receptors. This suppressive effect of GA may be related to its modulation of the serotonergic system. This study provides additional evidence in support of GA as an adjunct for the treatment of hyperPRL.

  14. Penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) responds to low-power laser irradiation : a case study and hypothesis about the role of transient receptor potential (TRP) ion channels

    NARCIS (Netherlands)

    Waldinger, Marcel D; van Coevorden, Ruben S; Schweitzer, Dave H; Georgiadis, Janniko

    2015-01-01

    Treatment of paroxetine-induced penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) by Low-power Laser Irradiation (LPLI) is unknown in medical literature. The aim of the current article is to report partial efficacy of LPLI for paroxetine-induced persistent penile anesthesia. We report on a ma

  15. Penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) responds to low-power laser irradiation : A case study and hypothesis about the role of transient receptor potential (TRP) ion channels

    NARCIS (Netherlands)

    Waldinger, Marcel D.; van Coevorden, Ruben S.; Schweitzer, Dave H.; Georgiadis, Janniko

    2015-01-01

    Treatment of paroxetine-induced penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) by Low-power Laser Irradiation (PLO is unknown in medical literature. The aim of the current article is to report partial efficacy of LPLI for paroxetine-induced persistent penile anesthesia. We report on a male

  16. Female Sexual Dysfunction:Classification and Definitions%女性性功能障碍的分类及定义

    Institute of Scientific and Technical Information of China (English)

    廖秦平; 李婷

    2013-01-01

    女性性功能障碍(female sexual dysfunction,FSD)是一种十分常见的疾病,严重影响女性的身心健康.国际上常用的女性性功能障碍分类标准有世界卫生组织(WHO)的国际疾病和相关健康问题统计学分类-10(International Classifications of Diseases-10,ICD-10)、精神障碍诊断与统计学手册第4版和第5版(The Diagnostic and Statistical Manual of Mental Disorders-Ⅳ~Ⅴ,DSM-Ⅳ~Ⅴ)和国际专家认可的女性性功能障碍分类(The Consensus-based Classification of Female Sexual Dysfunction,CCFSD)等多个命名系统.这些命名系统均基于性反应周期的线性模型,将FSD分为4大类:性欲障碍、性唤起障碍、性高潮障碍和性交疼痛障碍.ICD-10、DSM-Ⅳ~Ⅴ和CCFSD命名系统及诊断标准随着人们对女性性功能障碍认识的不断深入和临床经验的不断积累而逐渐完善.然而,由于女性性反应十分复杂,这些命名系统均存在一定的缺陷,故需要进一步统一明确FSD的分类,完善FSD定义及诊断标准.

  17. Disfunción sexual asociada al uso de gabapentina en el tratamiento del dolor central Associated sexual dysfunction to the use of gabapentin in the treatment of the central pain

    Directory of Open Access Journals (Sweden)

    E. Calderón

    2006-06-01

    Full Text Available El dolor neuropático de origen central es uno de los síndromes dolorosos más complejos, su tratamiento es difícil y, en general, poco satisfactorio. Gabapentina (GBP es un anticonvulsivante usado en el tratamiento de la epilepsia, dolor neuropático, desórdenes bipolares, y es generalmente bien tolerado. Los anticonvulsivantes de segunda generación cuentan entre sus ventajas con una menor incidencia de efectos secundarios. No obstante, estamos hablando de fármacos relativamente nuevos, sobre todo para su utilización al margen de los trastornos no epilépticos, como es el caso del dolor neuropático, por lo que es necesario un estudio y seguimiento más completo de sus posibles efectos secundarios. Presentamos 2 casos de disfunción sexual en hombre y mujer en relación con la administración de gabapentina para control del dolor de origen central. El aumento de la concentración de serotonina podría ser la causa de las alteraciones sexuales relacionadas con el tratamiento con GBP a las dosis utilizadas en nuestros pacientes, superiores a 1.800 mg/día. Este efecto es dosis-dependiente y el tratamiento consiste en disminuir o ajustar la dosis para maximizar el intervalo de tiempo entre la toma previa y el acto sexual.The neuropathic central pain, is one of the more complex painful syndromes, its treatment is difficult and, in general, little satisfactory. Gabapentin (GBP, it is a anticon-vulsant used in the treatment of the epilepsy, neuropathic pain, disorder bipolar, and it is generally well tolerated The anticonvulsants of second generation count between their advantages with a smaller incidence of secondary effects. However, we are considering of relatively new drugs, mainly for its use to the margin of epilepsy, as it is the case of the neuropathic pain. For this reason it is necessary a study and more complete pursuit of its possible secondary effects. We presented 2 cases of sexual dysfunction in a man and a woman in relation to

  18. Current approach to sexual disfunctions in women

    OpenAIRE

    Abdulkadir Tepeler; Levend Özkan; Hikmet Yaşar

    2010-01-01

    Even though sexual problems and sexual dysfunction are commonly observed in the society, a significant majority of the problems are not reported to the doctors, and due to this fact, remain unaddressed. In our country, the studies about sexual dysfunction are limited in number but in recent years there has been an increase in these studies. The ratio of sexual dysfunction is higher in women than the ratio in men (43%; 31%). However, there are few treatment modality about women sexual dysfunct...

  19. Stress affects a gastrin-releasing peptide system in the spinal cord that mediates sexual function: implications for psychogenic erectile dysfunction.

    Directory of Open Access Journals (Sweden)

    Hirotaka Sakamoto

    Full Text Available BACKGROUND: Many men suffering from stress, including post-traumatic stress disorder (PTSD, report sexual dysfunction, which is traditionally treated via psychological counseling. Recently, we identified a gastrin-releasing peptide (GRP system in the lumbar spinal cord that is a primary mediator for male reproductive functions. METHODOLOGY/PRINCIPAL FINDINGS: To ask whether an acute severe stress could alter the male specific GRP system, we used a single-prolonged stress (SPS, a putative rat model for PTSD in the present study. Exposure of SPS to male rats decreases both the local content and axonal distribution of GRP in the lower lumbar spinal cord and results in an attenuation of penile reflexes in vivo. Remarkably, pharmacological stimulation of GRP receptors restores penile reflexes in SPS-exposed males, and induces spontaneous ejaculation in a dose-dependent manner. Furthermore, although the level of plasma testosterone is normal 7 days after SPS exposure, we found a significant decrease in the expression of androgen receptor protein in this spinal center. CONCLUSIONS/SIGNIFICANCE: We conclude that the spinal GRP system appears to be a stress-vulnerable center for male reproductive functions, which may provide new insight into a clinical target for the treatment of erectile dysfunction triggered by stress and psychiatric disorders.

  20. Idade e distúrbios psicológicos: variáveis associadas à disfunção sexual no período pós-infarto Age and psychologic disorders: variables associated to post-infarction sexual dysfunction

    Directory of Open Access Journals (Sweden)

    Luciano Janussi Vacanti

    2005-08-01

    Full Text Available OBJETIVO: As informações sobre a disfunção sexual (DS após o infarto do miocárdio (IM são esparsas, principalmente em nosso meio e em relação aos seus preditores. Avaliamos pacientes de ambos os sexos, com vida sexual ativa e sem disfunção sexual prévia ao IM, para estudar a incidência de DS após o IM, e identificar as possíveis variáveis associadas às mesmas. MÉTODOS: Estudamos consecutivamente 43 pacientes, utilizando questionários estruturados para diagnóstico das DS e dos distúrbios psicológicos (DP. Analisamos a influência dos fatores de risco clássicos para aterosclerose, dos DP e do uso de medicamentos na ocorrência de DS até o sexto mês após o IM. RESULTADOS: Após o IM, 91% dos pacientes reiniciaram a atividade sexual. Vinte e seis pacientes (60% apresentaram disfunção sexual até o 6º mês da alta hospitalar (9 com ejaculação precoce, 15 com disfunção erétil e 20 com desejo sexual hipoativo. Os pacientes com DP apresentaram disfunção sexual em maior freqüência que aqueles sem DP (100%x47%, p=0,001. O grupo com disfunção sexual era significativamente mais velho que o grupo sem disfunção sexual: 53±8,9 anos versus 47±8,7 anos (p=0,04. CONCLUSÃO: Os pacientes apresentaram significativa redução da freqüência da atividade sexual e elevada incidência de DS após o infarto agudo do miocárdio. A presença de DP e a idade mais elevada estiveram associadas à maior incidência de DS após o infarto.OBJECTIVE: Data on sexual disfunction (SD after myocardial infarction (MI are sketchy, especially in our community and in regard to predictors. Both males and females, with active sexual life and no sexual dysfunction prior to MI were evaluated in order to investigate SD incidence after MI, as well as to identify the possible variables associated. METHODS: Forty-three patients were studied consecutively, through structured questionnaires for SD and psychological disorders (PD diagnosis. The

  1. Novel concepts about normal sexual differentiation of reproductive neuroendocrine function and the developmental origins of female reproductive dysfunction: the sheep model.

    Science.gov (United States)

    Foster, D L; Jackson, L M; Padmanabhan, V

    2007-01-01

    The neuroendocrine regulation of GnRH secretion plays a central role in timing gamete release in both sexes. This regulation is more complex in the female because the discontinuous release of ova is more complex than the continuous release of spermatozoa. This review provides an evolving understanding of the sex differences in reproductive neuroendocrine controls and how these differences arise. The rules for sexual differentiation of steroid feedback control of GnRH secretion conceptually parallel the well-established principles that underlie the sexual differentiation of the internal and external genitalia. In the context of the neuroendocrine regulation of the ovarian cycle, and using the sheep as a model, four steroid feedback controls for GnRH secretion are inherent (default). They require no ovarian developmental input to function appropriately during adulthood. Two steroid feedback controls regulate the preovulatory surge mode of GnRH secretion, and two regulate the pulsatile mode. If the individual is a male, three steroid feedback controls of GnRH secretion become unnecessary or irrelevant, and these are abolished or become functionally inoperative through programmed reductions in hypothalamic sensitivity. This central programming occurs through exposure of presynaptic GnRH neurons in the developing male brain to the androgenic and estrogenic actions of testicular steroids. In precocial species such as ruminants, this programming begins well before birth. Understanding how GnRH secretion normally becomes sexually differentiated is of practical importance to determining how inappropriate hormonal environments during development can variously malprogram the neuroendocrine system to produce a variety of reproductive dysfunctions relating to patterning of gonadotropin secretion. PMID:17491142

  2. A Streetcar Named "Derousal"? A Psychophysiological Examination of the Desire-Arousal Distinction in Sexually Functional and Dysfunctional Women.

    Science.gov (United States)

    Sarin, Sabina; Amsel, Rhonda; Binik, Yitzchak M

    2016-01-01

    Research indicates that desire and arousal problems are highly interrelated in women. Therefore, hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD) were removed from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and a new diagnostic category, female sexual interest/arousal disorder (FSIAD), was created to include both arousal and desire difficulties. However, no research has tried to distinguish these problems based on psychosocial-physiological patterns to identify whether unique profiles exist. This study compared psychosocial-physiological patterns in a community sample of 84 women meeting DSM-IV (American Psychiatric Association, 2000 ) criteria for HSDD (n = 22), FSAD (n = 18), both disorders (FSAD/HSDD; n = 25), and healthy controls (n = 19). Women completed self-report measures and watched neutral and erotic films while genital arousal (GA) and subjective arousal (SA) were measured. Results indicated that GA increased equally for all groups during the erotic condition, whereas women with HSDD and FSAD/HSDD reported less SA than controls or FSAD women. Women in the clinical groups also showed lower concordance and greater impairment on psychosocial variables as compared to controls, with women with FSAD/HSDD showing lowest functioning. Results have important implications for the classification and treatment of these difficulties. PMID:26457746

  3. Disfunção erétil: resultados do estudo da vida sexual do brasileiro Erectile dysfunction: results of the Brazilian sexual life study

    Directory of Open Access Journals (Sweden)

    Carmita Helena Najjar Abdo

    2006-12-01

    Full Text Available OBJETIVO: Estimar a prevalência da disfunção erétil (DE e fatores de risco associados em amostra da população brasileira. MÉTODOS: Estudo transversal com amostra de conveniência de 2.862 homens, maiores de 18 anos, por meio de questionário anônimo e auto-responsivo. A prevalência de DE na amostra foi obtida mediante questão global derivada diretamente da definição de DE. Os dados foram submetidos a testes Qui-quadrado e t de Student. Foram utilizadas análises de regressão logística para cálculos dos riscos. RESULTADOS: A prevalência encontrada de DE foi 45,1% (31,2% mínima, 12,2% moderada e 1,7% completa. Indivíduos com DE apresentaram comprometimento da auto-estima, dos relacionamentos interpessoais, menos relações sexuais por semana, mais relações extraconjugais, queixas de falta de desejo sexual e ejaculação rápida. Comparados aos homens com idades entre 18 e 39 anos, aqueles com 60 a 69 têm 2,2 (95% IC; 1,4-3,4; p OBJETIVE: To estimate the prevalence of ED and related risk factors in a sample of the Brazilian male population. METHODS: Cross-sectional study was carried out with a convenience sample of 2,862 men, 18 years of age or older, using an anonymous self-administered questionnaire. ED prevalence in the sample was obtained by a general question which was directly derived from the ED definition. Data were submitted to chi-square or Student's t tests. Logistic regression analyses were used for risk factor calculations. RESULTS: The prevalence of ED was 45.1% (31.2% mild, 12.2% moderate and 1.7% complete. Subjects with ED presented lower self-esteem, hindered interpersonal relationships, fewer sexual intercourses per week, more extra-marital relationships, complaints of lack of libido and premature ejaculation. When compared with men aged 18-39 years, men aged 60-69 presented 2.2 higher risk of ED (95% CI; 1.4-3.4; p < 0.01, whereas men aged 70 or older presented 3.0 higher risk of ED (95% CI; 1.4-6.3; p < 0

  4. The correlation between emotional distress and aging males’ symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men

    Directory of Open Access Journals (Sweden)

    Chen CY

    2013-06-01

    Full Text Available Ching-Yen Chen,1,4,5 Chin-Pang Lee,1,4 Yu Chen,2,4,5 Jun-Ran Jiang,3,4,5 Chun-Lin Chu,1,4,5 Chun-Liang Chen3,4,5 1Department of Psychiatry, 2Department of Urology, 3Department of Traditional Chinese Medicine, 4Men’s Health Center, Chang Gung Memorial Hospital at Linkou, Taiwan; 5School of Medicine, Chang Gung University, Taoyuan, Taiwan Background: Andropause and psychiatric disorders are associated with various symptoms in aging males and are part of the differential diagnosis of depression and anxiety. This study was designed to investigate the relationship between symptoms of aging, anxiety, and depression, and to determine if sexual dysfunction could be a differentiating characteristic in the psychiatric outpatient clinic. Methods: One hundred seventy-six male psychiatric outpatients participated in the study and completed self-reported measures assessing symptoms of aging, depression, and anxiety. Symptoms of aging were assessed by the Aging Males’ Symptoms scale. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale. Erectile dysfunction was considered if a response to item 15 on the Aging Males’ Symptoms scale (impaired sexual potency was rated with 4 or 5 points. Affective disturbance was assessed by the total scores of the Hospital Anxiety and Depression Scale. Results: Age was correlated with less anxiety and more sexual symptoms. Anxiety and depression were associated with more severe symptoms of aging, and depression was associated with more sexual symptoms than was anxiety. Impaired sexual potency was the only sexual symptom not significantly associated with depression and anxiety. Depression was associated with an interspousal age gap of ≥6 years. The point prevalence of erectile dysfunction was 28.4%, and age and affective disturbance were associated with the risk of erectile dysfunction. Conclusion: Impaired sexual potency should raise the suspicion of androgen deficiency rather than depression

  5. Sexual Abuse and Sexual Functioning in a Chronic Pelvic Pain Sample

    Science.gov (United States)

    Randolph, Mary E.; Reddy, Diane M.

    2006-01-01

    Sexual abuse, particularly childhood sexual abuse, has been linked to chronic pelvic pain and to sexual dysfunction, though the sexual functioning of survivors of sexual abuse has not been studied in a chronic pain population. Sixty-three women with chronic pelvic pain completed measures of sexual function, sexual abuse, and pain. Using an index…

  6. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial.

    Science.gov (United States)

    Zenico, T; Cicero, A F G; Valmorri, L; Mercuriali, M; Bercovich, E

    2009-04-01

    Lepidium meyenii (Maca) is a cultivated root belonging to the brassica family used in the Andean region for its supposed aphrodisiac properties. We carried out a double-blind clinical trial on 50 Caucasian men affected by mild erectile dysfunction (ED), randomised to treatment with Maca dry extract, 2400 mg, or placebo. The treatment effect on ED and subjective well-being was tested administrating before and after 12 weeks the International Index of Erectile Function (IIEF-5) and the Satisfaction Profile (SAT-P). After 12 weeks of treatment, both Maca- and placebo-treated patients experienced a significant increase in IIEF-5 score (P < 0.05 for both). However, patients taking Maca experienced a more significant increase than those taking placebo (1.6 +/- 1.1 versus 0.5 +/- 0.6, P < 0.001). Both Maca- and placebo-treated subjects experienced a significant improvement in psychological performance-related SAT-P score, but the Maca group higher than that of placebo group (+9 +/- 6 versus +6 +/- 5, P < 0.05). However, only Maca-treated patients experienced a significant improvement in physical and social performance-related SAT-P score compared with the baseline (+7 +/- 6 and +7 +/- 6, both P < 0.05). In conclusion, our data support a small but significant effect of Maca supplementation on subjective perception of general and sexual well-being in adult patients with mild ED. PMID:19260845

  7. 南京市城区女性性功能障碍的调查%An investigation on female sexual dysfunction among urban Chinese women in Nanjing

    Institute of Scientific and Technical Information of China (English)

    张爱霞; 潘连军; 陈湘玉; 潘锋; 阚延静

    2011-01-01

    目的:女性性功能障碍(FSD)是影响女性生活质量的常见疾病,有关中国女性FSD的报道少见.本研究探讨南京城区女性FSD的发病情况,为制定中国女性FSD的防治策略提供依据.方法:本研究为回顾性调查,调查对象为2008年8月至2009年3月在南京医科大学附属南京市妇幼保健院进行健康体检的20岁以上女性及其女性陪护人.采用女性性功能指数(FSFI)问卷评估性功能,以FSFI评分总分<25分作为FSD的诊断标准.以各单项评分的中位数作为诊断各类型性功能障碍的标准.结果:共发放问卷1 002份,收回有效问卷609份,有效问卷回收率60.8%.本组女性FSFI得分(24.21±4.40)分,随着年龄增长,FSFI评分及各单项评分逐渐下降.本调查各年龄组总的FSD发生率为56.8%,随年龄增长,FSD发生率逐渐增加,<29岁组为47.1%,30~39岁组为57.0%,40~49组为75.0%,50岁以上高达90.3%.最常见的性功能障碍类型为性满意度下降(43.2%),其次为性高潮障碍(41.7%)、性交疼痛(40.2%)、性欲低下(35.1%)、阴道润滑障碍(31.4%)及性唤起困难(29.6%).结论:FSD是困扰中国城市女性的常见问题,最常见的类型为性满意度下降及性高潮障碍.%Objective: Female sexual dysfunction (FSD) is a common problem affecting women's quality of life. However, reports are rarely seen on sexual problems in Chinese women. This study is to investigate the prevalence of FSD among urban Chinese women in Nanjing and offer some evidence for the establishment of preventative measures for FSD in China. Methods: A cross-sectional hospital-based survey was conducted in Nanjing, China between August 2008 and March 2009. The sexual function of 609 women aged 20 - 56 years from the urban area of Nanjing were investigated using the Female Sexual Function Index ( FSFI ). The total FSFI score of < 25 was used as the diagnostic criterion for FSD. Results: The total FSFI score was 24.21 ± 4.40 in this group of women

  8. Sexuality Following Radical Prostatectomy

    DEFF Research Database (Denmark)

    Fode, Mikkel; Serefoglu, Ege C; Albersen, Maarten;

    2016-01-01

    INTRODUCTION: Radical prostatectomies can result in urinary incontinence and sexual dysfunction. Traditionally, these issues have been studied separately, and the sexual problem that has received the most focus has been erectile dysfunction. AIM: To summarize the literature on sexually related side...... effects and their consequences after radical prostatectomy and focus on the occurrence and management of problems beyond erectile dysfunction. METHODS: The literature on sexuality after radical prostatectomy was reviewed through a Medline search. Original research using quantitative and qualitative...... methodologies was considered. Priority was given to studies exploring aspects of sexuality other than erectile function. MAIN OUTCOME MEASURES: The prevalence, predictive factors, and management of post-prostatectomy sexual problems beyond erectile dysfunction. RESULTS: Most patients will develop urinary...

  9. An investigation on female sexual dysfunction in nurses%护士职业群体性功能障碍的调查

    Institute of Scientific and Technical Information of China (English)

    林小丹; 邱金花; 高锐; 方东萍; 朱秀兰; 张振香

    2013-01-01

    Objective To investigate the prevalence of female sexual dysfunction (FSD) among nurses in Fuzhou and offer some evidences for the establishment of preventative measures for FSD in China. Methods The sexual function of female nurses aged 20~56 years from 3 Three a hospitals in Fuzhou were investigated using the Female Sexual Function Index (FSFI) between October 2012 and March 2013. The total FSFI score of<25 was used as the diagnostic criterion for FSD. Results The total FSFI score was 23.72±6.40 in this group of women, and it decreased as age grew. The overall prevalence of FSD in nurses was 47.1%. The prevalence of FSD in nurses was 33.3%, 53.3%, 46.7%and 80.0%in the<29yr, 30~39yr, 40~49yr and≥50yr groups, respectively. Hyposexuality and sexual satisfaction domains were the most affected with 93.1%and 82.8%of the participants having sexual dysfunction, while vaginal dryness domain was rarely affected with 42.5%. The incidence of FSD increased with the increase of frequency of night shift. Nurses from emergency department got higher incidence of FSD, followed by from surgical and internal department. Conclusion The most common sexual problem in nurses was hyposexuality. Female age was a risk factor of FSD, different departments and frequency of night shift could affect the incidence of FSD.%目的:通过调查分析福州地区护士职业群体女性性功能障碍(FSD)的发病情况,为护士职业群体FSD的防治措施制定提供依据。方法2012年10月至2013年3月,采用女性性功能指数(FSFI)问卷对福州市3家综合性三级甲等医院护士职业群体性功能进行评估,以FSFI评分总分<25分作为FSD的诊断标准,以各单项评分的中位数作为诊断各类型性功能障碍的标准。结果共发放问卷500份,收回有效问卷435份,有效问卷回收率87.0%。本组女性FSFI得分(23.72±6.40)分,随着年龄增长,FSFI评分及各单项评分总体呈下降趋势。护士职

  10. The Diagnosis and Treatment of Sexual Dysfunction Males with Idiopathic Hyperprolactinemia%男性特发性高泌乳素血症致性功能障碍的诊治

    Institute of Scientific and Technical Information of China (English)

    余勇军; 祝存海; 邓辉; 叶昶; 马春清; 陈晓春

    2011-01-01

    目的 探讨男性特发性高泌乳素血症致性功能障碍的临床特征和治疗方法,提高男性特发性高泌乳素血症的诊治水平.方法 用甲磺酸溴隐亭治疗特发性高泌乳素血症的男性患者10例:包括性欲低下10例、勃起功能障碍8例、生精障碍2例.结果 所有患者经甲磺酸溴隐亭(1.25~2.50 mg/d)规律治疗1~24个月,10例患者的性欲得到提高,勃起功能改善8例,生精障碍2例得到缓解.其中3例患者治疗后性满意度不高,并且其血清睾酮水平相对较低,加服十一酸睾酮(40 mg/次,1~2次/d)治疗,0.5~2个月后患者的性满意度得到进一步改善.结论 男性特发性高泌乳素血症所致的性功能障碍较为少见,病因不明,甲磺酸溴隐亭治疗效果良好.高泌乳素血症应引起男科医生的高度重视.%Objective To discuss the clinical feature and diagnosis and treatment of sexual dysfunction males with idiopathic hyperprolactinemia. Methods 10 cases of sexual dysfunction males with idiopathic hyperprolactinemia were retrospectively analyzed. After the clinical evaluation,all the patients were treated with bromocriptine mesylate. Results Of all patients, 10 males presented with complaints of sexual dysfunction, 10 with libido loss,8 with erectile dysfunction and 2 with dyszoospermia. After the bromocriptine mesylate treatment, serum prolactin level of all patients declined and returned to the normal range. All patients' sexual function improved. Conclusion Idiopathic hyperprolactinemia occurred uncommonly in sexual dysfunction males. Bromocriptine therapy may benefit the patients. More attention should be paid to that symptom.

  11. Hypoactive sexual desire disorder caused by antiepileptic drugs

    OpenAIRE

    M Singh; Manish Bathla; Martin, A. (Alan); Aneja, J.

    2015-01-01

    Female sexual dysfunction is common but poorly understood sexual problem in women. Sexual dysfunction in female is multi-factorial in origin and also observed with intake of drug acting on central nervous system. This case report describes a female epileptic patient who developed sexual dysfunction with intake of antiepileptic drugs.

  12. Hypoactive sexual desire disorder caused by antiepileptic drugs

    Directory of Open Access Journals (Sweden)

    M Singh

    2015-01-01

    Full Text Available Female sexual dysfunction is common but poorly understood sexual problem in women. Sexual dysfunction in female is multi-factorial in origin and also observed with intake of drug acting on central nervous system. This case report describes a female epileptic patient who developed sexual dysfunction with intake of antiepileptic drugs.

  13. Clinical trial of sexual dysfunctions in male patients with pituitary adenomas%垂体腺瘤男性患者性功能障碍的临床观察

    Institute of Scientific and Technical Information of China (English)

    周任远; 王国民; 张跃辉; 施国伟; 何家扬; 蒋为众; 李士其

    2012-01-01

    Objective To explore the clinical features and related factors of sexual dysfunctions in male patients with pituitary adenomas.Methods The questionnaires of sexual functions were collected from 86 male patients with pituitary adenomas. We examined the clinical features of sexual dysfunctions and analyzed the correlations between sexual behaviors and age,tumor type,invasiveness,tumor size,serum levels of prolactin (PRL) and testosterone.Results The incidence of sexual dysfunctions was 80.2% (69/86).Sexual dysfunctions were found in 84.6% (66/78) of the patients with functioning pituitary adenomas and 37.5% (3/8) of those with non-functioning pituitary adenoma respectively.In the PRL group,the incidence of erectile dysfunctions was 92.1% (35/38) and it was higher than those in the FSH (folliclestimulating hormone) and GH (growth hormone) groups (P < 0.05).In the FSH group,the incidence of reduced sexual desire was 78.3% (18/23).In the GH group,the incidence of erectile dysfunctions was 70.6% ( 12/17 ) and the incidence of reduced sexual desire or ejaculation dysfunction was lower than that of the PRL/FSH group (P < 0.05).Conclusion The incidence of sexual dysfunctions is quite high in males with pituitary adenomas,especially for those with functioning pituitary adenomas.The clinical features of sexual dysfunctions vary in different types of functioning pituitary adenoma. The incidence of erectile dysfunctions is the highest in the PRL group.Pathological type of pituitary tumors is a major risk factor of sexual dysfunctions.%目的 了解垂体腺瘤男性患者性功能障碍(SD)的发病特征和影响因素.方法 回顾性调查和分析86例男性垂体腺瘤患者术前性功能情况,总结不同类型垂体腺瘤男性患者SD的发病特征,分析SD与年龄、肿瘤类型、侵袭性、大小、血泌乳素水平和睾酮水平的相关性.结果 垂体腺瘤男性患者SD的发生率为80.2%( 69/86).其中,功能性垂

  14. Alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide improve erectile function, sexual quality of life, and ejaculation function in patients with moderate mild-moderate erectile dysfunction: a prospective, randomized, placebo-controlled, single-blinded study.

    Science.gov (United States)

    Sansalone, Salvatore; Leonardi, Rosario; Antonini, Gabriele; Vitarelli, Antonio; Vespasiani, Giuseppe; Basic, Dragoslav; Morgia, Giuseppe; Cimino, Sebastiano; Russo, Giorgio Ivan

    2014-01-01

    We aimed to evaluate the efficacy of oral therapy with alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide (Tradamix TX1000) in patients with erectile dysfunction (ED) at 3 months of follow-up. From January 2013 to September 2013, 177 patients diagnosed with mild-moderate ED (IIEF-EF < 26) were enrolled in this multicenter, single-blinded, placebo-controlled study and randomized in Group A (Tradamix, n = 87) and Group B (placebo, n = 90). Penile color Doppler ultrasound measures, IIEF-15 questionnaire, male sexual health questionnaire-ejaculation disorder (MSHQ-EjD), and sexual quality of life (SQoL-M) were collected. We observed significant changes of the IIEF-15 in Group A (mean difference: 11.54; P < 0.05) at 3 months versus Group B (P < 0.05). PSV (P < 0.05), IIEF-intercourse satisfaction (P < 0.05), IIEF-orgasmic function (mean P < 0.05), IIEF-sexual desire (P < 0.05), IIEF-overall satisfaction (P < 0.05), MSHQ-EjD (mean difference: 1.21; P < 0.05), and SQoL-M (mean difference: 10.2; P < 0.05) were significantly changed in Group A versus baseline and Group B. Patients with moderate arterial dysfunction showed significant increase of PSV (P < 0.05), IIEF-EF (P < 0.05), MSHQ-EjD (P < 0.05), and SQoL-M (P < 0.05) in Group A. Therapy with Tradamix improves erectile and ejaculation function and sexual quality of life in patients with mild-moderate ED and in particular for those with moderate arterial dysfunction. PMID:25136552

  15. Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study

    Directory of Open Access Journals (Sweden)

    Salvatore Sansalone

    2014-01-01

    Full Text Available We aimed to evaluate the efficacy of oral therapy with alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide (Tradamix TX1000 in patients with erectile dysfunction (ED at 3 months of follow-up. From January 2013 to September 2013, 177 patients diagnosed with mild-moderate ED (IIEF-EF < 26 were enrolled in this multicenter, single-blinded, placebo-controlled study and randomized in Group A (Tradamix, n=87 and Group B (placebo, n=90. Penile color Doppler ultrasound measures, IIEF-15 questionnaire, male sexual health questionnaire-ejaculation disorder (MSHQ-EjD, and sexual quality of life (SQoL-M were collected. We observed significant changes of the IIEF-15 in Group A (mean difference: 11.54; P<0.05 at 3 months versus Group B (P<0.05. PSV (P<0.05, IIEF-intercourse satisfaction (P<0.05, IIEF-orgasmic function (mean P<0.05, IIEF-sexual desire (P<0.05, IIEF-overall satisfaction (P<0.05, MSHQ-EjD (mean difference: 1.21; P<0.05, and SQoL-M (mean difference: 10.2; P<0.05 were significantly changed in Group A versus baseline and Group B. Patients with moderate arterial dysfunction showed significant increase of PSV (P<0.05, IIEF-EF (P<0.05, MSHQ-EjD (P<0.05, and SQoL-M (P<0.05 in Group A. Therapy with Tradamix improves erectile and ejaculation function and sexual quality of life in patients with mild-moderate ED and in particular for those with moderate arterial dysfunction.

  16. Human Sexual Desire Disorder: Do We Have a Problem?

    Science.gov (United States)

    McNab, Warren L.; Henry, Jean

    2006-01-01

    Hypoactive Sexual Desire Disorder (HSDD), loss of sexual desire for sexual activity, is one of the most common sexual dysfunctions of men and women in the United States. This article presents an overview of this specific sexual dysfunction including incidence, possible causes, treatment options, and the role of the health educator in addressing…

  17. 性功能障碍患者心理状况调查分析及护理干预%Investigation and Analysis of Psychological Status of Patients with Sexual Dysfunction and Nursing Intervention

    Institute of Scientific and Technical Information of China (English)

    夏旭

    2014-01-01

    Objective:Through the investigation of the psychological status of patients with sexual dysfunction,used effective nursing intervention measures,in order to better serve the patients.Method:Symptom checklist 90(SCL-90) and the statistical method were used to analyse the patients psychological status investigation, and formulate relevant nursing measures.Result:There were statistical significance differences in force,sexual dysfunction in patients with somatization,anxiety, psychoticism factor score and the number of positive items compared with the norm(P<0.05),psychological and social problems of sexual dysfunction patients often accompanied by more.Conclusion:Through the analysis of sexual dysfunction in patients with psychological,coupled with effective nursing intervention,can inspire and mobilize the enthusiasm of patients,reduce the psychological burden of patients and the pressure,to enhance the confidence of the patients, the family affection, staff care about inter early rehabilitation.%目的:通过调查分析性功能障碍患者的心理状况,有效应用护理措施干预,以期更好服务于患者。方法:应用症状自评量表(SCL-90)和统计学方法对患者心理状况调查分析,制定相关护理措施。结果:性功能障碍患者强迫、躯体化、焦虑、精神病性因子分及阳性项目数与常模比较显著高,差异有统计学意义(P<0.05),性功能障碍患者常常伴有较多的心理社会问题。结论:通过对性功能障碍患者的心理分析,加上有效地护理干预,可以启发和调动患者的积极性,减轻患者的心理负担和压力,增强患者的治疗信心,使其在家人的亲情中、医护人员的关心间早日康复。

  18. 抗精神病药引起体重增加的药物基因组学研究进展%Pharmacogenomics of antipsychotics induced weight gain

    Institute of Scientific and Technical Information of China (English)

    伍海姗; 赵丽萍; 赵靖平; 陈晋东

    2013-01-01

    Weight gain is a common adverse reaction of antipsychotic treatment,and the mechanism of weight gain induced by antipsychotics is complex and uncertain,in which individual differences in genetic polymorphisms may play an important role.This paper reviewed the related genes of antipsychotics-induced weight gain.HTR2C and leptin gene are considered to be the highest risk of weight gain.Recent studies showed a growing number of genes were related to antipsychotics-induced weight gain.The paper analyzed the relationship between antipsychotic agents and weight gain from the point of pharmacogenomics research,designed to provide a theoretical basis for future clinical personalized medication.%体重增加是抗精神病药治疗中常见的不良反应,抗精神病药引起体重增加的机制复杂且不确定,个体差异与遗传多态性可能在其中发挥了重要的作用.本文综述了与抗精神病药源性体重增加的相关基因研究进展,其中HTR2C和瘦素基因被认为是引起体重增加风险最高的基因,新近的研究显示越来越多的基因被发现与抗精神病药物引起的体重增加相关.本文主要从药物基因组学的研究角度分析抗精神病药与体重增加的关系,旨在为以后临床个体化用药提供理论依据.

  19. 性自慰行为与静脉性勃起功能障碍的相关性分析%Correlation between sexual masturbation behavior and venous erectile dysfunction

    Institute of Scientific and Technical Information of China (English)

    刘勇刚; 孙毅海; 陶卫琦; 刘昕; 黄才胜; 黄超斌

    2014-01-01

    目的:探讨性自慰行为与静脉性勃起功能障碍的相关性。方法对173例确诊为静脉性勃起功能障碍患者的性自慰行为资料进行logistic回归分析,以初次性自慰年龄、频率、性自慰病程、性自慰时是否伴有阴茎不适症状,以及性自慰时期是否有性伴侣等5项因素为变量指标。结果性自慰频率、性自慰病程和性自慰时是否伴有阴茎不适症状与静脉性勃起功能障碍依次相关,P值分别为0.0069、0.0108、0.0195,标准化回归系数分别为0.4925、0.3687、0.2943;而性自慰时期是否有性伴侣和初次性自慰年龄与静脉性勃起功能障碍无显著相关性(P>0.05)。结论性自慰频率、性自慰病程以及是否伴有阴茎不适症状与静脉性勃起功能障碍的发生有密切关系。%Objective To study the correlation between sexual masturbation behavior and venous erectile dysfunction. Methods The clinical data of sexual masturbation behavior in 173 patients with venous erectile dysfunction were recorded and statistically analyzed with logistic regression model. Age of the first time masturbation, frequency, duration, penis symptoms, and sex partner were taken as variables. Results Venous erectile dysfunction was significantly related to the frequency, duration, penis symptoms. The P values were 0.0069,0.0108 and0.0195 The standard regression coefficients were 0.4925, 0.3687, and 0.2943 respectively. Sex partner and age of the first time masturbation were not associated with the venous erectile dysfunction (P>0.05). Conclusion Venous erectile dysfunction is corrected with the frequency, duration, penis symptoms in sexual masturbation behavior.

  20. Comparison of the Effects of Elaeagnus angustifolia Flower Capsule and Sildenafil Citrate Tablet on Anxiety Resulting From Sexual Dysfunction in Women Referring to the Selected Clinics of Shiraz University of Medical Sciences.

    Science.gov (United States)

    Zeinalzadeh, Sanaz; Akbarzadeh, Marzieh; Mohagheghzadeh, Abdolali; Faridi, Pouya; Sayadi, Mehrab

    2016-07-01

    Dissatisfaction from sexual relationships can result in deprivation as well as problems, such as depression, anxiety, and destruction of family's mental health. One hundred twenty-five women (18 to 40 years) who suffered from hypoactive sexual desire disorder were divided into Elaeagnus angustifolia flower (4.5 g g daily for 35 days), sildenafil citrate tablet (50 mg for 4 weeks), and control groups. The study data were collected using the Female Sexual Function Index and Spielberger's questionnaire and measurement of thyroid-stimulating hormone and prolactin hormone. In the Elaeagnus angustifolia group, the mean score of state and trait anxiety decreased after the intervention. In the sildenafil citrate group also, the mean score of state anxiety decreased from 22.15 ± 4.98 to 20.1 ± 5.15 (P = .001) and that of trait anxiety decreased from 23.07 ± 4.44 to 21.55 ± 4.82 (P = .002) after the intervention. Consumption of sildenafil citrate tablet was effective in reduction of the mean score of anxiety resulting from sexual dysfunction. PMID:26224722

  1. Inhibited Sexual Desire and Sexual Avoidance

    OpenAIRE

    Morse, William I.

    1985-01-01

    Inhibited sexual desire (ISD) is one of the most common sexual dysfunctions, especially in women. Family physicians have an opportunity to recognize ISD before the associated problems become entrenched, and to guide couples toward satisfactory resolution. A summary is presented of current thinking on ISD and its causes. Case reports and observations about frequency of and treatment for ISD are included. Much less has been written about sexual avoidance in the presence of desire. A definition ...

  2. Current approach to sexual disfunctions in women

    Directory of Open Access Journals (Sweden)

    Abdulkadir Tepeler

    2010-12-01

    Full Text Available Even though sexual problems and sexual dysfunction are commonly observed in the society, a significant majority of the problems are not reported to the doctors, and due to this fact, remain unaddressed. In our country, the studies about sexual dysfunction are limited in number but in recent years there has been an increase in these studies. The ratio of sexual dysfunction is higher in women than the ratio in men (43%; 31%. However, there are few treatment modality about women sexual dysfunction. Most commonly observed sexual dysfunctions in women are loss of sexual interest/desire, sexual arousal dysfunctions, orgasm dysfunctions, dyspareunia, vaginismus and sexual anxiety. In DSM-IV-TR, sexual dysfunction is treated by taking stress and interfamily relation problems into consideration. According to WHO’s definition, sexual health refers the combination of physical, emotional, intellectual and social sexual existense with the techniques that would increase personality communication and love. Sexual problems damage this combination, and cause pyschological and social problems. J Clin Exp Invest 2010; 1(3: 235-240

  3. Orgasmic dysfunction

    Science.gov (United States)

    ... of a satisfying, intimate experience for both partners. Sexual desire will often decline, and sex occurs less often. ... sexual stimulation and response Learning to clearly communicate sexual needs and desires, verbally or non-verbally How to make sex ...

  4. Sexual function in women receiving maintenance dialysis.

    Science.gov (United States)

    Seethala, Srikanth; Hess, Rachel; Bossola, Maurizio; Unruh, Mark L; Weisbord, Steven D

    2010-01-01

    While substantial attention has been paid to the issue of sexual dysfunction in men on chronic dialysis, less is known about this problem in women with end-stage renal disease. We sought to assess sexual dysfunction in women on chronic dialysis and determine whether patients discuss this problem with their providers and receive treatment. We prospectively enrolled women receiving chronic hemodialysis or peritoneal dialysis in Pittsburgh, PA. We asked patients to complete the 19-item Female Sexual Function Index (FSFI) to assess sexual function and a 5-item survey that assessed whether patients had discussed sexual dysfunction with their providers and/or received treatment for this problem in the past. We enrolled 66 patients; 59 (89%) on hemodialysis and 7 (11%) on peritoneal dialysis. All patients completed the FSFI, of whom 53 (80%) had FSFI scores <26.55, consistent with the presence of sexual dysfunction. Of 37 patients who were married or residing with a significant other, 27 (73%) had sexual dysfunction. Among 24 participants who reported having been sexually active over the previous 4 weeks, 11 (46%) had sexual dysfunction. Only 21% of patients with sexual dysfunction had discussed this problem with their gynecologist, renal or primary provider, and 3 (6%) reported having received treatment. Sexual dysfunction is common in women on dialysis, even among patients who are married or residing with a significant other and those who are sexually active. However, few women discuss this issue with their providers or receive treatment.

  5. The CopenHeartSF trial—comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function

    DEFF Research Database (Denmark)

    Johansen, Pernille Palm; Zwisler, Ann-Dorthe; Svendsen, Jesper Hastrup;

    2013-01-01

    Sexuality is an important part of people's physical and mental health. Patients with heart disease often suffer from sexual dysfunction. Sexual dysfunction has a negative impact on quality of life and well-being in persons with heart disease, and sexual dysfunction is associated with anxiety...

  6. Psychotherapy in sexual dysfunction caused by chronic prostates%心理治疗在慢性前列腺炎引起性功能障碍的疗效分析

    Institute of Scientific and Technical Information of China (English)

    黄海; 钟智勇; 黄健; 许可慰; 姚友生; 郭正辉; 谢文练

    2008-01-01

    目的 探讨心理治疗在慢性前列腺炎(CP)引起的性功能障碍中的治疗效果.方法 CP引起的性功能障碍患者253例,其中早泄191例,勃起功能障碍62例,随机单盲分为2组,对照组112例采用常规系统治疗,试验组141例采用系统治疗联合心理治疗,对比分析2组患者治疗前、后的中国早泄患者性功能-5评分表(CIPE-5)与国际勃起功能指数-5评分表(IIEF-5)的变化,评价心理治疗在CP引起早泄和勃起功能障碍中的作用.结果 对照组早泄患者有59.3%症状明显改善,勃起功能障碍患者有54.8%症状明显改善;试验组早泄患者有75.5%症状明显改善,勃起功能障碍患者61.3%症状明显改善.早泄的有效率2组之间有统计学意义(P0.05).结论 心理治疗在CP引起的性功能障碍中具有一定的治疗效果,联合系统治疗可以明显提高有效率.%Objective To observe the therapeutic effect of psychotherapy in sexual dysfunction caused by chronic prostates. Methods Two hundred and fifty three patients of chronic prostatitis with sexual dysfunction, were randomly divided into experimental group (112 cases) and control group( 141 cases). Experimental group received general therapy and psychotherapy, control group only had general therapy. Two scoring systems, Chinese index of sexual function for premature ejaculation ( CIPE-5 ) and the International Index of Erectile Function ( IIEF-5 ) were used in this study. Results In experimental group, 75.5% of premature ejaculation was improved, which was significantly higher than control group( 59.3% ). Conclusion psychotherapy combined with general therapy showed a better outcome in treatment of sexual dysfunction caused by chronic prostates.

  7. Effects of Kegel exercise on postpartum female sexual dysfunction%凯格尔训练治疗产后女性性功能障碍的效果观察

    Institute of Scientific and Technical Information of China (English)

    冯小丽; 李先锋; 吴瑾

    2012-01-01

    Objective To investigate the effects of Kegel exercise in the treatment of postpartum female sexual dysfunction. Methods A total of 134 women undergoing childbirth from Oct 2008 to Oct 2010, aged 21-24 years old, were diagnosed as postpartum female sexual dysfunction (PPFSD) according to the scale of PPFSD and underwent full treatment course of Kegel exercise. The women were randomly divided into the rehabilitation group (n= 68) and the con-trol group (n=66). The rehabilitation group were treated with Kegel exercise under the guidance of a doctor, 5~30 min, 2-3 times/day,for 8 weeks. While the control group had conventional health education. After treatment, the intensity of pelvic floor muscle contraction, frequency of sexual intercourse, and incidence of sexual intercourse pain were evaluat-ed and compared between the two groups. Results The rehabilitation group showed significantly better outcomes re-garding the intensity of pelvic floor muscle contraction, frequency of sexual intercourse, and incidence of sexual inter-course pain (P0.05). Conclusion Kegel exercise is a simple but effective treatment for postpartum female sexual dysfunction, which is worthy for application in primary hospitals.%目的 探讨凯格尔训练方法治疗产后女性性功能障碍的疗效.方法 选取珠海市第二人民医院2008年10月至2010年10月分娩的产妇中,通过《产后女性性功能障碍诊断量化表及评分表》自制的问卷调查表确诊为产后女性性功能障碍并坚持治疗至疗程结束134例患者(年龄21~42岁)为研究对象,将其随机分为康复组(n=68)及对照组(n=66).康复组在医生指导下进行一对一的性健康教育及凯格尔训练指导,2~3次/d,每次练习15~30 min,持续8周以上.对照组实施常规的健康教育.疗程结束后分别对两组患者的盆底肌收缩力、性生活频度、及性交痛发生率等方面进行评估.结果 康复组在盆底肌收缩力、性生活频度、性生活

  8. Sexuality and chronic illness.

    Science.gov (United States)

    Steinke, Elaine E

    2013-11-01

    Sexual function is often affected in individuals living with chronic illness and their partners, and multiple comorbidities increase the likelihood of sexual dysfunction. This review focuses on the areas of cardiovascular disease, respiratory conditions, and cancer, all areas for which there are practical, evidence-based strategies to guide sexual counseling. Although nurses have been reluctant to address the topic of sexuality in practice, a growing number of studies suggest that patients want nurses to address their concerns and provide resources to them. Thus, nurses must be proactive in initiating conversations on sexual issues to fill this gap in practice. PMID:24066783

  9. [Physiology and physiopathology of sexuality].

    Science.gov (United States)

    Cuzin, Béatrice

    2016-01-01

    From desire to orgasm, sexuality, in women and men, is underpinned by a complex organic, psychological and emotional function. Sexual dysfunction encompasses diverse aetiologies, including chronic diseases and iatrogenesis resulting from medication or surgery. The effects of a chronic disease can have an impact on all phases of the sexual response. PMID:27317816

  10. Clinical study of kuntai capsule on female sexual dysfunction with type II diabetes%坤泰胶囊治疗女性 II 型糖尿病患者性功能障碍的临床研究

    Institute of Scientific and Technical Information of China (English)

    李志杰; 韩世愈; 史焱; 朱宏

    2014-01-01

    目的:探讨坤泰胶囊对女性II型糖尿病患者性功能障碍(FSD)的治疗效果。方法:选取44例FSD患者,随机分为对照组和观察组,各22例。观察组给予坤泰胶囊口服治疗,对照组给予西地那非治疗,比较两组患者治疗前后睾酮(T)和雌激素(E2)的水平,并用女性性功能量表(FSFI)测量两组患者治疗前后的性功能变化。结果:观察组治疗后的T和E2水平较治疗前明显升高(P<0.05),对照组治疗前后无明显变化(P>0.05);观察组较治疗前性功能障碍得到了改善,在性欲、性唤起、性高潮、满意度维度以及总体满意度均明显优于治疗前与对照组(P<0.05),对照组仅在阴道润滑度及疼痛维度较治疗前有所改善(P<0.05)。结论:坤泰胶囊能有效地改善女性II型糖尿病患者性功能障碍,其机制可能与提高T水平以及E2水平有关。%Objectives:To evaluate the clinical effects of Kuntai capsule for female sexual dysfunction with type II diabetes (FSD).Methods:44 patients with FSD were randomly divided into control group and observation group,with 22 cases in each group.The patients in observation group were given Kuntai capsule orally,while pa-tients in the control group were given Sildenafil citrate.The levels of testosterone (T)and estradiol (E2)were com-pared before and after treatment in both groups,and sexual function were measured using the female sexual function index (FSFI).Results:The levels of T and E2 in observation group after treatment were significantly elevated com-pared with those before treatment (P0.05 );sexual dysfunction of patients in the observation group was been improved than those before treatment and in control group,which inclued sexual desire,arousal,orgasm,satisfaction and overall satisfaction (P<0.05 ),vagi-nal lubrication and pain dimension were been improved in the control group only than before treatment(P<0

  11. Effect of the transvaginal total laparoscopic rectal cancer radical resection on female sexual dysfunction%经阴道完全腹腔镜直肠癌根治术对女性性功能障碍的影响

    Institute of Scientific and Technical Information of China (English)

    朱畅; 潘凯; 谢海慧; 夏利刚

    2015-01-01

    目的::探讨经阴道腹腔镜直肠癌根治术对女性性功能的影响。方法:选取64例女性直肠癌患者,观察组31例经阴道完全腹腔镜直肠癌根治术,对照组33例常规腹腔镜直肠癌根治术,分别于术后6、12个月进行问卷调查或电话随访,记录患者术后的性功能变化情况,比较2种手术方式对女性患者性功能的影响。结果:术后6个月观察组患者阴道湿润度、性交痛和性生活满意度均差于对照组(P0.05)。结论:阴道完全腹腔镜直肠癌根治术后由于阴道干燥,短期内会对女性性功能造成一定影响,但随时间推移可恢复到与行常规腹腔镜手术相同的水平。%Objective:To explore the effects of the transvaginal total laparoscopic rectal cancer radical resection on female sexual dysfunction. Methods:Sixty-four female rectal cancer patients were randomly divided into the experimental group(31 cases) and control group(33 cases). The experimental group and control group were treated with the transvaginal total laparoscopic and conventional laparoscopic rectal cancer radical resection,respectively. All patients were followed up using questionnaire survey or call after 6 and 12 months of operation,the sexual function of patients was recorded. The effects of two kinds of operation methods on sexual function were compared. Results:The vaginal moisture,pain during sex and sexual satisfaction in experimental group were worse than those in control group after 6 months of operation(P 0. 05). Conclusions:Because of the vaginal dryness,the transvaginal total laparoscopic rectal cancer radical resection has certain effects on female sexual function. With the time over,the female sexual function can recover the level of the patients treated with conventional laparoscopic rectal cancer radical resection.

  12. Autonomic Nervous System Dysfunction in Parkinson's Disease.

    Science.gov (United States)

    Zesiewicz, Theresa A.; Baker, Matthew J.; Wahba, Mervat; Hauser, Robert A.

    2003-03-01

    Autonomic nervous system (ANS) dysfunction is common in Parkinson's disease (PD), affects 70% to 80% of patients, and causes significant morbidity and discomfort. Autonomic nervous system dysfunction symptoms in PD include sexual dysfunction, swallowing and gastrointestinal disorders, bowel and bladder abnormalities, sleep disturbances, and derangements of cardiovascular regulation, particularly, orthostatic hypotension. Autonomic nervous system dysfunction in PD may be caused by an underlying degenerative process that affects the autonomic ganglia, brainstem nuclei, and hypothalamic nuclei. Anti-parkinsonian medications can cause or worsen symptoms of ANS dysfunction. The care of a PD patient with ANS dysfunction relies on its recognition and directed treatment, including coordinated care between the neurologist and appropriate subspecialist. Pharmacotherapy may be useful to treat orthostasis, gastrointestinal, urinary, and sexual dysfunction.

  13. Sexual dysfunction, depression, and anxiety in young women according to relationship status: an online survey Disfunção sexual, depressão e ansiedade em mulheres jovens de acordo com o status de relacionamento: uma pesquisa on-line

    Directory of Open Access Journals (Sweden)

    Valeska Martinho Pereira

    2013-01-01

    Full Text Available BACKGROUND: Sexual dysfunction is a common, still poorly understood problem among women. Being or not in a relationship seems to be a risk factor for sexual dysfunction. OBJECTIVES: To evaluate the presence of sexual problems, anxiety, and depression in young women and to correlate findings with current relationship status (single, in a committed relationship, or married. METHODS: Data were collected trough an online survey from a total of 155 women aged between 20 and 29 years. Sociodemographic data were collected, and both the Hospital Anxiety and Depression scale and the Female Sexual Function Index were applied. Data were statistically analyzed using the chi-square and Kruskal-Wallis tests, and groups were compared in 2 x 2 matrices using the Mann-Whitney test. RESULTS: Single women showed a significantly higher prevalence of problems in the lubrication (45.3%, orgasm (53.1%, satisfaction (67.2%, and pain (50% domains and also in total Female Sexual Function Index scores (60.9% in comparison with the other groups. Additionally, significantly higher depression scores were found among single women (5.89±3.3 in comparison to those in a committed relationship (4.05±2.83. Anxiety scores were similar in all groups. CONCLUSION: Our findings suggest that single women have a poorer sexual function and are more likely to have mood disorders in comparison to their peers involved in stable relationships.CONTEXTO: Disfunção sexual é um problema comum e ainda pouco compreendido entre mulheres. Estar ou não em um relacionamento parece ser um fator de risco para disfunção sexual. OBJETIVO: Avaliar a presença de problemas sexuais, ansiedade e depressão em jovens mulheres e correlacionar os achados ao estado de relacionamento atual (solteiras, em relacionamento sério ou casadas. MÉTODOS: Dados foram coletados através de pesquisa on-line de um total de 155 mulheres com idade entre 20 e 29 anos. Foram coletados dados sociodemográficos, e a Escala

  14. Flibanserin for Treating Hypoactive Sexual Desire Disorder

    OpenAIRE

    Sang, Jae Hong; Kim, Tae-Hee; Kim, Soo Ah

    2016-01-01

    There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorde...

  15. Analysis of sexual dysfunction after Mile’s operation in young male patients%青年男性直肠癌患者 Mile’s 术后性功能变化分析

    Institute of Scientific and Technical Information of China (English)

    荣桂芳; 陈智彬

    2015-01-01

    Objectives:To analyze the sexual function in young male patients with rectal carcinoma after Mile’s surgery,in order to improve the sexual function.Methods:Questionnaires were administered to the 86 young male patients after rectal Mile’s surgery at the 3 rd month and 6 th month respectively,including the Self -Rat-ing Anxiety Scale (SAS)and the International Index of Erectile Function questionnaire (IIEF)to understand the risk factors for their sexual dysfunction.All the questions were designed to understand the factors of sexual dysfunc-tion and the relationships among them.Results:A total of 82 valid questionnaires were collected.All the 82 young male patients had varying degrees of anxiety in the two surveys.According to the SAS score,there were 26 (31 .71 %)cases reporting mild anxiety in the first survey versus 42 (51 .22%)cases in second survey,38 (46.34%)cases showing moderate anxiety versus 21 (25.61 %),and 1 8 (21 .95%)cases indicating severe anxi-ety versus 9 (1 0.97%)respectively.All patients had sexual desire disorder and decreased sexual satisfaction:34 (53.96%)cases in the first survey showed erectile dysfunction versus 26 (41 .27%)in the second survey;1 8 (28.57%)cases had insertion obstacle vs.23 (36.51 %)cases in the second survey;and 38 (60.32%)cases suffered from sexual desire decreased vs.1 6 (25.4%)cases in the second survey.The sexual dysfunction presen-ted better postoperative at the 6 th month than 3 rd month (χ2 =1 0.1 1 ,P <0.05),and the SAS evaluation was nega-tively correlated with sexual dysfunction both at postoperative 6 th month and 3 rd month (r =1 .052 and r =1 .1 7,P <0.05).The incidence of ED in the second survey decreased compared with the first survey,with statically signifi-cant difference (χ2 =1 0.1 1 ,P <0.05).Conclusions:Operation injury and postoperative psychological obstacles (such as anxiety,depression,and social intercourse disorders)are main factors leading to sexual dysfunction.It is of clinical significance

  16. 南京城区宫颈疾病女性性功能障碍调查研究%Investigation of Female Sexual Dysfunction in Patients of Cervical Disease in Nanjing City

    Institute of Scientific and Technical Information of China (English)

    雷雨; 阚延静; 潘连军

    2013-01-01

    Objective: To investigate the incidence and risk factors of female sexual dysfunction (FSD) in patients of cervical disease. Methods: A retrospective survey on women aged 18-55 years old with normal coitus in the cervical out-patients of Maternity and Child Health Hospital Affiliated to Nanjing Medical University was conducted. Different HPV genotypes were detected in cervical exfoliated cells by the method of PCR and membrane of the hybrid. Any type of HPV which had been detected can be seen as HPV positive. The cervical specialists through conventional gynecologial examination learned women who suffered from cervical disease. Female sexual function index (FSFI) questionnaire was applied to assess sex condition in nearly a month. Multiple Logistic regression analysis was used to analyze independent risk factors. Results: In the 2 045 copies of the questionnaires, 472 cases were refused, and 458 cases were removed. Totally, 1 573 subjects completed the questionnaires and 1115 (71%) valid questionnaires that met the ctiteria were finally included for analysis. There were 486 (43.6%) women with cervical disease in 1 115 patients. There were 254 (52.3%) cases who have sexual dyfunction in patients with cervical disease. The results had a significant difference between cervical disease group and normal group. The score of patients reduced in sexual desire, sexual arousal, vaginal lubrication, orgasm, sexual satisfaction and sexual pain (P cervical hypertrophy > cervical erosion > cervical polyp. Conclusion: In Nanjing city, the FSD incidence is high in out-patients of cervical disease. It is necessary to strengthen promotion of sexual health, implement regular physical examination of reproductive system and form a good sexual life to reduce the FSD incidence.%目的:了解宫颈疾病女性性功能障碍(female sexual dysfunction,FSD)患病率及危险因素.方法:采用回顾性调查方法,对在南京医科大学附属南京妇幼保

  17. Diagnosis and treatment of male sexual dysfunction caused by hyperprolactinemia%血高催乳素血症导致男性性功能障碍的诊治分析

    Institute of Scientific and Technical Information of China (English)

    杨雪峰; 杨土生; 郭善媚

    2014-01-01

    目的:分析血高催乳素血症导致的男性性功能障碍的诊断与治疗策略。方法:回顾性分析我院男科2011年至2012年收治的32名血高催乳素血症导致的男性性功能障碍患者的诊疗资料,总结血高催乳素血症导致男性性功能障碍的诊断与治疗方法。所有数据均建立Excel 2013数据库,并采取SPSS19.0的统计学软件进行数据分析,计量资料均采取t检验,分析治疗前后患者血清性激素的变化。结果:32例患者中有特发性高催乳素血症23例(71.88%)、有垂体腺瘤4例(12.50%)、有微腺瘤5例(15.63%)。有勃起功能障碍29例(90.63%)、有性欲减退32例(100.00%)、有性高潮障碍7例(21.88%)。32例患者治疗后的血清催乳素含量明显低于治疗前,差异具有统计学意义(P<0.01)。32例患者治疗后的黄体生成素、卵泡刺激素以及睾酮水平均要明显高于治疗前,差异具有统计学意义(P<0.01)。经治疗后32例患者的勃起功能障碍、性欲减退以及高潮障碍等症状均有所改善。结论:高催乳素血症导致的男性性功能障碍经过病史采集、临床特征、勃起功能指数测定、体格检查、激素测定以及垂体的影像学检查可明确诊断,甲磺酸溴隐亭与十一酸睾酮的治疗效果较好,值得临床推广。%Objectives:To analyze the diagnostic and therapeutic strategies of male sexual dysfunction caused by hyperprolactinemia.Methods:A retrospective analysis of the data of 32 male subjects with sexual dys-function caused by hyperprolactinemia treated in our hospital from 201 1 to 2012 was conducted to summarize the di-agnostic and therapeutic methods of male sexual dysfunction caused by hyperprolactinemia.All data were put into Excell2013 database and statistical software SPSS19.0 was used for data analysis;measurement data were taken t test to analyze the changes of serum sex hormones before

  18. Studies on sexual function of patients with erectile dysfunction-no sexual life using self-estimation index of erectile function-no sexual life%阴茎勃起功能自我评价表对中青年无性生活勃起功能障碍患者的多维评估

    Institute of Scientific and Technical Information of China (English)

    张志超; 袁亦铭; 高冰; 彭靖; 宋卫东; 辛钟成; 金杰; 郭应禄

    2011-01-01

    Objective To estabalish a new conception, Erectile Dysfunction-no sexual life (ED-NS), so as create an evaluating questionnaire, Self-estimation Index of erectile function-No sexual life (SIEF-NS) so as to investigate its clinical reliability. Methods The conception of ED-NS was identified and the SIEF-NS questionnaire was established. Patients who complained of ED-NS and normal controls were enrolled into the research and assessed the erectile function was assessed with SIEF-NS.The SIEF-NS includes 12 questions, such as sexual libido, general erectile function, nocturnal penile erection, erectile function during foreplay, erectile function during audio-video sexual stimulation,confidence, depression, etc and each question has 5 point scales. Results Sixty-one ED-NS patients and 57 controls were enrolled into the study and assessed erectile function with SIEF-NS. The mean score of each question and integral score of SIEF-NS in ED-NS patients were significantly different from normal controls (P<0. 05). When the integral score was 35 points according to the ROC curve of integral score, the sensitivity of SIEF-NS was 88.5% and specificity was 96. 5%. Conclusions ED-NS is a new conception to define patients who have erectile dysfunction without sexual life. SIEFNS is suggested to be a useful method for the evaluation of ED-NS patients.%目的 确立无性生活勃起功能障碍(ED-NS)的定义,制定ED-NS问卷调查表评估勃起功能状态,并判断其效果.方法确立ED-NS定义,并设计制定勃起功能自我评价表(SIEFNS).收集符合ED-NS定义患者和正常对照病例作为研究对象,并分为ED-NS和正常对照2组.ED-NS患者61例,年龄18~38(26.2±4.3)岁;正常对照组57例,年龄18~33(24.9±4.1)岁.分别填写SIEF-NS问卷.问卷共有12个问题,涉及性欲、总体勃起情况、夜间和晨起勃起情况、异性相处条件下勃起情况和视听觉性刺激下勃起情况5个方面,每个问题分为5分,收集各项问题评

  19. Sexual function and obesity

    DEFF Research Database (Denmark)

    Larsen, S H; Wagner, G; Heitmann, B L

    2007-01-01

    OBJECTIVE: To review the literature on the relationship between obesity and sexual function. METHOD: A search in the medical literature from 1966 and onwards was carried out through Medline and Embase for publications on obesity, in combination with Medical Subject Heading words related to sexual...... function and dysfunction. COMMENTS: Four prospective and seven cross-sectional studies were found describing association between obesity and erectile dysfunction (ED). One cross-sectional study was found describing obesity and female sexual dysfunction (FSD). The prospective studies on ED all demonstrated...... activity among both men and women after weight loss intervention. CONCLUSION: Support for the assumption that obesity is associated with ED was found in both prospective and cross-sectional studies. FSD was not adequately described in the literature and prospective studies are needed here. Results from...

  20. Sexual Harassment and Sexual Bulllying

    Science.gov (United States)

    ... a Friend Who Cuts? Sexual Harassment and Sexual Bullying KidsHealth > For Teens > Sexual Harassment and Sexual Bullying ... being sexually harassed or bullied. What Are Sexual Bullying and Harassment? Just like other kinds of bullying, ...

  1. Sexual abuse evaluation in urological practice

    OpenAIRE

    Beck, Jacobus Johannes Hendrikus

    2013-01-01

    The primary aim of this study is to investigate the prevalence of sexual abuse in a urological outpatient clinic. Can differences been made in urological population, i.e. general urological clinic, a university urological clinic and a tertiary university pelvic floor clinic? Do urologists inquire about female sexual dysfunction and sexual abuse history? And if so, what percentage of the Dutch urologist does so? What do sexual abuse patients think about screening for sexual abuse history? Can ...

  2. 盆底生物反馈电刺激联合盆底肌肉锻炼治疗性功能障碍30例临床分析%The clinical analysis of treatment of 30 cases with sexual dysfunction with biofeedback pelvic floor electrical stimulation and pelvic floor muscle exercise

    Institute of Scientific and Technical Information of China (English)

    周玉萍; 高霞; 岳艳; 张毅

    2012-01-01

    目的:观察盆底生物反馈电刺激联合盆底肌肉锻炼治疗性功能障碍的效果.方法:选择产后及围绝经期性功能障碍患者各30例,将其随机分为研究组(采用PHEIX神经肌肉治疗仪联合盆底肌肉锻炼)30例与对照组(采用传统的心理治疗结合药物治疗)30例,通过调查,评估盆底肌康复治疗女性性功能障碍的效果.结果:研究组的盆底肌收缩时间、阴道内压力、性生活满意程度、性感程度自我评价、他人评价、性生活质量处于高水平等指标均明显优于对照组(P<0.01).结论:盆底生物反馈电刺激联合盆底肌肉锻炼治疗性功能障碍是一种经济、实用、有效、合理的方法.%Objective: To evaluate the effects of the biofeedback pelvic floor electrical stimulation and pelvic floor muscle exercise on sexual dysfunction. Methods: Thirty postpartum and menopause cases with sexual dysfunction were andomly divided into the study group (treatment with PHEIX neuromuscular instrument) and pelvic floor muscle exercise and the control group(traetment with traditional psychotherapy and drug). The effects of pelvic floor muscle exercise on sexual dysfunction were evaluted using the " female sexual dysfunction diagnostic scale and the scoring sheet" survey. Results:The contraction time of pelvic floor muscle,the pressure within the vagina, sexual satisfaction, the sexy degree of self-evaluation, other evaluations and the quality of sexual life of the study group were better than these of the control group ( P < 0. 01 ). Conclusions:Treatment of sexual dysfunction with the biofeedback pelvic floor electrical stimulation and pelvic floor muscle exercise is an economical, practical, effective and reasonable approach.

  3. Neurally augmented sexual function.

    Science.gov (United States)

    Meloy, S

    2007-01-01

    Neurally Augmented Sexual Function (NASF) is a technique utilizing epidural electrodes to restore and improve sexual function. Orgasmic dysfunction is common in adult women, affecting roughly one quarter of populations studied. Many male patients suffering from erectile dysfunction are not candidates for phosphdiesterase therapy due to concomitant nitrate therapy. Positioning the electrodes at roughly the level of the cauda equina allows for stimulation of somatic efferents and afferents as well as modifying sympathetic and parasympathetic activity. Our series of women treated by NASF is described. Our experience shows that the evaluation of potential candidates for both correctable causes and psychological screening are important considerations. PMID:17691397

  4. [Erectile and Ejaculatory Dysfunction].

    Science.gov (United States)

    Gross, Oliver; Sulser, Tullio; Eberli, Daniel

    2015-11-25

    The inability to achieve an erection of the penis sufficient for sexual activity is called erectile dysfunction (ED). In most cases, the diagnosis can be made by medical history. The prevalence of ED in men at the age of 65 has been reported to be up to 50%. Premature ejaculation has a prevalence, up to 20% and is the most frequent ejaculatory dysfunction. The etiology of ED can involve psychological, vascular, neurogenic, hormonal or urogenital pathologies. The main pathophysiological mechanisms of ED are vascular disorders such as diabetes mellitus and atherosclerosis. Because of the common pathophysiology, patients diagnosed with ED should have a diagnostic work-up for systemic vascular pathologies to prevent concomitant cardiac events. Treatment options include invasive and non-invasive procedures. PMID:26602851

  5. Psychogenic erectile dysfunction. Classification and management.

    Science.gov (United States)

    Rosen, R C

    2001-05-01

    Psychogenic factors are involved alone or in combination with organic causes in a substantial number of cases of erectile dysfunction. Epidemiologic studies have implicated the role of depressed mood, loss of self-esteem, and other psychosocial stresses in the cause of erectile dysfunction. A new definition and classification of psychogenic erectile dysfunction has been proposed based on recent clinical and research findings. According to this new classification, psychogenic erectile dysfunction is categorized as generalized or situational type, with subcategories of each type proposed. Traditional treatment approaches for psychogenic erectile dysfunction have included anxiety reduction and desensitization procedures, cognitive-behavioral interventions, guided sexual stimulation techniques, and couples' or relationship counseling. Recently, these approaches increasingly have been combined with pharmacologic therapy such as sildenafil. Special situations have been identified in which combining psychosocial interventions with medical therapy is recommended. These situations include problems of sexual initiation, low sexual desire, other sexual dysfunctions, and significant couples' or relationship problems. More research is needed on the role of psychosocial interventions in the treatment of erectile dysfunction.

  6. Endorsement of Models Describing Sexual Response of Men and Women with a Sexual Partner

    DEFF Research Database (Denmark)

    Giraldi, Annamaria; Kristensen, Ellids; Sand, Michael

    2015-01-01

    : For women, we measured desire, arousal, lubrication, orgasm, sexual satisfaction, pain during sexual activity, sexual distress, and satisfaction with sexual life. For men, we measured erectile function, orgasm, desire, intercourse satisfaction, overall satisfaction, and satisfaction with sexual life...... Index, Female Sexual Distress Scale, and the International Index of Erectile Function were used to describe sexual function. Also, participants completed questionnaires with written descriptions of different sexual responses to describe their most experienced sexual response. MAIN OUTCOME MEASURE......, erectile dysfunction and dissatisfaction with sexual life were significantly related to endorsement of the Basson model or none of the models (P = 0.01). CONCLUSIONS: No single model of sexual response could describe men's and women's sexual responses. The majority of men and women with no sexual...

  7. Imaging for evaluation of erectile dysfunction

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Seung Hyup [Seoul National University College of Medicine, Seoul (Korea, Republic of)

    2001-03-15

    Penile erection is a complex phenomenon that includes coordinated intraaction of the nervous, arterial, venous, and sinusoidal systems. A defect in any of these systems may result in erectile dysfunction. Erectile dysfunction is defined as the consistent inability to generate or maintain an erection of sufficient rigidity for sexual intercourse. Although the introduction of sildenafil citrate made the information from imaging studies less critical in the management of the patients with erectile dysfunction, still the imaging studies such as Doppler US, penile arteriography, and cavemosonetry/cavemosography remain the major modalities in the evaluation of erectile dysfunction.

  8. Impact of Overactive Bladder Syndrome on Female Sexual Function

    Directory of Open Access Journals (Sweden)

    Serdar Toksöz

    2015-12-01

    Full Text Available The etiology of female sexual dysfunction includes psychological, physiological and iatrogenic causes. Physiological and iatrogenic causes are abdominal surgery, menopause, smoking, spinal cord injuries and some antipsychotic, antihypertensive, and antidepressant drugs. When assessing sexual function, sexual function questionnaires, such as the Female Sexual Function Index, and the Sexual Function Questionnaire are used. The prevalence of female sexual dysfunction is 43% and it has been reported to increase depending on menopause and age. Estrogen, estrogen + testosterone and tibolone, PDE5, apomorphine, bupropion and flibanserin are used in the treatment of female sexual dysfunction. Overactive bladder is a disease affecting the quality of life and is characterized by urgency, frequency, nocturia and urge incontinence with especially filling phase of the bladder resulting from loss of detrusor muscle inhibition. The prevalence of overactive bladder in women in the United States has been reported to be 16.9%. Lower urinary tract symptoms and overactive bladder syndrome are not known how to cause female sexual dysfunction. Menopause and partner status were the most important predictors for female sexual dysfunction. It has been reported that overactive bladder syndrome and urinary incontinence provide prediction of development of female sexual dysfunction. Shame, fear of incontinence, and urinary incontinence as well as urge sensation during sexual intercourse in individuals with overactive bladder syndrome have been reported to be the main factors causing female sexual dysfunction. Pathophysiological relationship between the two disorders has not been elucidated and further clinical and experimental studies are needed in this regard.

  9. Amelioration of sexual fantasies to sexual abuse cues in an adult survivor of childhood sexual abuse: a case study.

    Science.gov (United States)

    Wilson, Jane E; Wilson, Keith M

    2008-12-01

    Although sexual dysfunction of childhood sexual abuse survivors has received considerable attention, other sexual difficulties experienced by survivors of CSA, such as sexual fantasies to cues of sexual abuse, have received less attention. In this A-B design case study, a young adult female survivor of childhood sexual abuse presented for treatment at a Midwest rape crisis center. After successful treatment of post-traumatic stress disorder, she complained of unwanted sexual fantasies to sexual abuse cues and concomitant guilt and shame. Following baseline data collection, treatment consisted of self-applied aversion therapy to unwanted sexual arousal to sexual abuse cues. Decrease in sexual arousal to these cues was concurrent with the introduction of treatment. A concomitant decrease in guilt and shame occurred while self-ratings of control increased. PMID:18355799

  10. Challenges in sexual medicine

    DEFF Research Database (Denmark)

    Cellek, Selim; Giraldi, Annamaria

    2012-01-01

    The sexual medicine field has been in mode of revolution until recently. Like all other fields of biomedical research, the economic situation around the world has had a negative impact on the field's momentum-research funding bodies, regulatory bodies and pharmaceutical companies seem to have...... placed sexual medicine in their low-priority list. But this is not the only challenge the field is facing. The successful development of phosphodiesterase type 5 (PDE5) inhibitors for treatment of erectile dysfunction (ED) means that research in this area seems to have slowed. However, there remain...... several unmet medical needs within sexual medicine such as premature ejaculation, severe ED and hypoactive sexual desire disorder, which await novel therapeutic approaches. Despite these challenges, research into finding and developing such therapies is likely to continue in the sexual medicine field...

  11. An Exploration of Returning Veterans' Sexual Health Issues Using a Brief Self‐Report Measure

    Directory of Open Access Journals (Sweden)

    Gregory R. Beaulieu, PhD

    2015-12-01

    Conclusions: Screening using an empirically validated self‐report instrument indicates that there is a high prevalence of reported sexual dysfunction among recently deployed veterans. Analyses indicated that there are specific characteristics associated with both overall self‐reported sexual dysfunction and specific subtypes of sexual dysfunction. Active assessment of specific aspects of sexual dysfunction concerns may allow providers to identify and implement more precise sexual functioning interventions. Beaulieu GR, Latini DM, Helmer DA, Powers‐James C, Houlette C, and Kauth MR. An exploration of returning veterans sexual health issues using a brief self‐report measure. Sex Med 2015;3:287–294.

  12. The evolution of the female sexual response concept: Treatment implications

    OpenAIRE

    Damjanović Aleksandar; Duišin Dragana; Barišić Jasmina

    2013-01-01

    Sexual dysfunctions have been the most prevalent group of sexual disorders and include a large number of populations of both sexes. The research of sexual behavior and treatment of women with sexual distress arises many questions related to differences in sexual response of men and women. The conceptualization of this response in modern sexology has changed over time. The objective of our paper was to present the changes and evolution of the female’s sexual response concept in a summari...

  13. Encompassing Sexual Medicine within Psychiatry: Pros and Cons

    Science.gov (United States)

    Segraves, Robert Taylor

    2010-01-01

    Objective: This article examines the positive and negative aspects of psychiatry encompassing sexual medicine within its purview. Methods: MEDLINE searches for the period between 1980 to the present were performed with the terms "psychiatry," "sexual medicine," and "sexual dysfunction." In addition, sexual medicine texts were reviewed for chapters…

  14. Childhood Sexual Abuse

    Directory of Open Access Journals (Sweden)

    Evrim Aktepe

    2009-08-01

    Full Text Available Sexual abuse is defined as use of child or adolescent by the adults for satisfying of sexual urges and needs with forcing, threatening or tricking. Sexual abuse can be in the form of sexual abuse without touch, sexual touch, interfemoral intercourse, sexual penetration, and sexual exploitation. The prevalence of sexual abuse is reported as 10-40%. It is seen in female four times more than in males. Abusers are frequently male, only 5-15% of them are female. The abuse by females is usually towards male child. Thirty-fifty percent of abuse cases among child and adolescent are outside the family including strangers or familiar person. Some features of abusers are introvert personality, pedophilic and antisocial personality. Most of the abusers have a history of sexual abuse or aggression during childhood. Sexual intercourse between two people who are not allowed to marry by law is called as incest. Family pattern of incest is defined globally as disorganized and dysfunctional. The most commonly reported familial pattern is rigid and patriarchal family pattern with a harsh father using force quite frequently. The clinical features and impacts of the sexual abuse on the child varies according to the relation between abusers and the child, form of abuse, duration of abuse, presence of physical assault, developmental phase, child age and psychological development before the abuse. Sexual abuse history may result in psychiatric disorders including anxiety, depression, substance dependence, suicide act, borderline personality disorder, posttraumatic stress disorder. Abuse negatively affects interpersonal relationships and self esteem of abused individuals. Several studies reported close association between risky sexual behaviors in adulthood and a history of of sexual abuse during childhood. Four traumatic dynamics including traumatic sexuality with abuse, feeling of betrayal, weakness, and stigmatization exist in childhood abuse. Trauma can cause

  15. [Impact of aging on sexuality].

    Science.gov (United States)

    Degauquier, C; Absil, A-S; Psalti, I; Meuris, S; Jurysta, F

    2012-01-01

    Numerous authors on sexual behaviors have studied the link between the persistence of a sexually active life and progressive aging. The knowledge of sexual health in the elderly has shown that biological sexual aging is extremely diverse and heterogeneous in men as well as in women, and contradicts the stereotype of age that would inevitably alter the sexual biological response in each human. Sexual diseases (lubrication, dyspareunia, erectile dysfunction, inability to achieve orgasm) and diseases of aging that impact sexual function have a growing incidence but don't never touch 100% of individuals. There is a decline in sexual interest correlated with the life-span, but the negative effects of age on desire are related to health problems. Moreover, sexual desire is more correlated with personal attitudes toward sexuality than with biological factors and diseases. Several predictors account for the pursuit of an active sexuality (including the presence of a partner, good health, having good sexual self-esteem, enjoyable past experience, an attitude that values the importance of sex in couple relationship), but the most decisive factor to successfully face the specific markers of aging is the ability to adapt to a more sensory sexuality, less focused on performance and coitus. PMID:22891587

  16. [Sexuality in overweight and obesity].

    Science.gov (United States)

    Abrahamian, Heidemarie; Kautzky-Willer, Alexandra

    2016-03-01

    The association between obesity and sexual dysfunction has been described in many studies. Neurobiological, hormonal, vascular and mental disturbances are the main reasons in male and in female gender. Sexual interest and desire, sexual arousal, orgasm, painful intercourse and premature ejaculation can be involved. Data for prevalence of sexual function disturbances in obese people are scarce and most studies were small. For screening of sexual function we recommend the International Index of Erectile Function (IIEF)-Score, which contains 15 Items for males and the Female Sexual Function Index (FSFI), which contains 19 items for females. Treatment of sexual function disturbances include lifestyle changes with an increase of physical activity, weight control, healthy eating and smoking cessation. Testosterone substitution in cases of real hypogonadism and treatment with PDE-5 inhibitors are well documented treatment options in male individuals. New treatment options for female patients with variable effectiveness are fibanserin, testosterone, bupropione and oxytocin. PMID:26811242

  17. Defining characteristics, validated by specialists and manifested by patients: a study of the sexual dysfunction and ineffective sexuality pattern diagnoses Características definidoras validadas por especialistas y las manifestadas por pacientes: estudio de los diagnósticos disfunción y estándares de sexualidad ineficaces Características definidoras validadas por especialistas e as manifestadas por pacientes: estudo dos diagnósticos disfunção sexual e padrões de sexualidade ineficazes

    Directory of Open Access Journals (Sweden)

    Alexandra de Souza Melo

    2008-12-01

    Full Text Available This observational and descriptive study was carried out to validate the nursing diagnoses Sexual Dysfunction and Ineffective Sexuality Pattern and relate the relevance of the defining characteristics validated by experts with their incidence in patients. Validation by experts involved 32 specialists and 20 patients to verify clinical evidence. For the diagnosis Sexual Dysfunction, the experts attributed scores higher than 0.80 to seven defining characteristics; for Ineffective Sexuality Pattern, four characteristics received scores between 0.50 and 0.80. The clinical occurrence of these characteristics for the Sexual Dysfunction diagnosis ranged between 55% and 90% of the sample and, for Ineffective Sexuality Pattern, between 30% and 85% of the sample. The study contributed to the improvement of these diagnoses and to careful consideration on their defining characteristics according to experts and as observed in a given clientele.Con los objetivos de realizar la validación de los diagnósticos de enfermería Disfunción Sexual y Estándares de Sexualidad Ineficaces y relacionar la pertinencia de las características definidoras validadas por peritos en la incidencia de las mismas en pacientes, se realizó este estudio de observación y descriptivo. Para la validación por especialistas, se contó con 32 peritos y, para la verificación de las evidencias clínicas con 20 pacientes. Para el Diagnóstico Disfunción Sexual, los peritos atribuyeron puntajes mayores que 0,80 para 7 características definidoras y, para Estándares de Sexualidad Ineficaces, 4 de las características recibieron puntajes entre 0,50 y 0,80. La ocurrencia clínica de esas características para el diagnóstico Disfunción Sexual fue de 55 el 90% de la muestra y para Estándares de Sexualidad Ineficaces fue de 30 el 85% de la muestra. El estudio contribuyó para el perfeccionamiento de esos diagnósticos y reflexionar sobre las características definidoras de los mismos en

  18. Sexual Health

    Science.gov (United States)

    ... Youth Risk Behavior Survey Newest CDC data on teen risk behaviors Publications Check here to find the latest sexual ... Health (Medline Plus) Teen Sexual Health (Medline Plus) Teen Sexual Risk Behaviors Sexual Health and HIV/AIDS [1] WHO working ...

  19. Sexual Problems

    Medline Plus

    Full Text Available ... sexual pain disorders, for example, anal pain in homosexual men. Women with female sexual arousal disorder have ... You can optimize the sexual setting by enhancing communication with your partner, promoting non-sexual intimacy, and ...

  20. [Diagnosis and care of senile sexual problems].

    Science.gov (United States)

    Harima, Katsuki

    2013-10-01

    By aging process, sexual behaviors of elderly people may change. Some changes are normal ones, but may be misunderstood as abnormal by prejudice and ignorance of the senile sexuality. As the sexual function of elderly people is influenced by many factors, evaluation of it should include physical, pharmacological, psychological, and partner relational aspects. By using drug, some sexual dysfunctions may be improved. But treatment should not be focused only on penile-vaginal intercourse. Kissing, touching and other alternative sexual behaviors may be useful for the improvement of the senile sexual problems. PMID:24261217

  1. Sexual side effects induced by psychotropic drugs

    DEFF Research Database (Denmark)

    Kristensen, Ellids

    2002-01-01

    The majority of psychotropic drugs entail sexual side effects. The sexual side effects may reduce quality of life and may give rise to non-compliance. For example, 30-60 per cent of patients treated with antidepressants are known to develop a sexual dysfunction. However, some psychotropic drugs...... with no or very few sexual side effects have begun to emerge. The treatment of sexual side effects induced by psychotropic drugs may consist of: modified sexual habits, reduction in dosage, switching to another medication, possibly in combination with different psychotropic agents, other varieties...

  2. SEXUAL DYFUNCTIONS AND SOCIAL CRIMES: ITS EVOLUTIONARY, PSYCHOLOGICAL AND INTELLECTUAL ELEMENTS IN THE MODERN HUMAN MIND.

    OpenAIRE

    Sudhansu Kumar Dash

    2014-01-01

    Sexual dysfunctions are characterized by disturbance in sexual desire and in the psychophysiological changes that characterize the sexual response cycle and cause marked distress and personal difficulty. The paraphilias are characterized by recurrent, intense sexual urges, fantasies or behaviors that involve unusual objects, activities or situations and cause clinically significant distress or impairment in social, occupational or other important areas of functioning. Sexual disor...

  3. Female Sexual Victimization Among College Students: Assault Severity, Health Risk Behaviors, and Sexual Functioning.

    Science.gov (United States)

    Turchik, Jessica A; Hassija, Christina M

    2014-02-01

    The purpose of the present study was to examine the relationship between college women's sexual victimization experiences, health risk behaviors, and sexual functioning. A sample of 309 college women at a mid-sized Midwestern university completed measures assessing sexual victimization, sexual risk taking, substance use behaviors, sexual desire, sexual functioning, prior sexual experiences, and social desirability. Severity of sexual victimization was measured using a multi-item, behaviorally specific, gender-neutral measure, which was divided into four categories based on severity (none, sexual contact, sexual coercion, rape). Within the sample, 72.8% (n = 225) of women reported at least one experience of sexual victimization since age 16. Results from MANCOVAs and a multinomial logistic regression, controlling for social desirability and prior sexual experience, revealed that sexual victimization among female students was related to increased drug use, problematic drinking behaviors, sexual risk taking, sexual dysfunction, and dyadic sexual desire. In addition, findings indicated that women exposed to more severe forms of sexual victimization (i.e., rape) were most likely to report these risk-taking behaviors and sexual functioning issues. Implications for sexual assault risk reduction programming and treatment are discussed.

  4. Chronic Disease and Sexuality : A Generic Conceptual Framework

    NARCIS (Netherlands)

    Verschuren, Jesse E. A.; Enzlin, Paul; Dijkstra, Pieter U.; Geertzen, Jan H. B.; Dekker, Rienk

    2010-01-01

    Although sexual dysfunctions are frequently comorbid with many chronic diseases and their treatments, until recently, these dysfunctions have been neglected in both research and clinical practice. Fortunately, sexual functioning in the context of chronic disease has now begun to receive more scienti

  5. Dysfunctional voiding.

    Science.gov (United States)

    Chiozza, M L

    2002-01-01

    Wetting may be considered the Cinderella of paediatric medicine. Before discussing dysfunctional voiding, the milestones of the normal development of continence in the child and the definitions used to describe this topic are presented. Bladder storage requires (1): accommodation of increasing volumes of urine at low intravesical pressure and with appropriate sensation; (2): a bladder outlet that is closed and not modified during increase in intra-abdominal pressure; (3): absence of involuntary bladder contractions. Development of continence in the child involves three independent factors maturing concomitantly: (1) development of normal bladder capacity; (2) maturation of urethral sphincter function; (3) development of neural control over bladder-sphincter function. All these processes are discussed. Abnormalities of any of these maturational sequences, which run parallel and overlapping, may result in clinically evident abnormalities of bladder sphincter control. Although dysfunctional voiding (DV) in children is very common its prevalence has not been well studied and, to date, and its origin is not well known. In a correct evaluation of functional voiding we must take into account different elements: the bladder capacity (that increases during the first 8 years of life roughly 30 ml per year), the micturition frequency, post-void residual volumes, bladder dynamics, urinary flow rates. Thus the correct assessment of children with lower urinary tract dysfunction should include a detailed history. Signs of DV range from urge syndrome to complex incontinence patterns during the day and the night. In addition to incontinence problems, children may have frequency, urgency, straining to void, weak or interrupted urinary stream, urinary tract infections (UTIs) and chronic constipation with or without encopresis. DV are also referred in enuretic children who wet the bed more than one time per night and have a functional bladder capacity lower than attended for age

  6. Sexual dysfunction in women with diabetes mellitus

    DEFF Research Database (Denmark)

    Giraldi, Annamaria; Kristensen, Ellids

    2010-01-01

    Diabetes mellitus (DM) is an increasing health concern throughout the world. DM is categorized as either type 1 (DM-1) or type 2 (DM-2), where DM-1 represents a lack of insulin production, and DM-2 is characterized by a relative lack of insulin (i.e., decreased sensitivity to the effect of insulin...

  7. AB271. Sexual dysfunction in chronic prostatitis

    OpenAIRE

    Cho, In-Rae

    2016-01-01

    Chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS), or NIH category III prostatitis, is a clinical syndrome characterized by genital/ pelvic pain and lower urinary tract symptoms in the absence of urinary tract infection. CPPS is the most common prostatic disease in men younger than 50 years of age and the third most common in men older than 50 years of age. CP/CPPS is a complex entity with unclear etiology. Many articles reported that the high percentage of patients with CP/CPPS had...

  8. Personality and birth order in monozygotic twins adopted apart: a test of Sulloway's theory; Research Reviews: twin births and cancer risk in mothers, male sexual dysfunction, twin study of ultimatum game behavior; Human Interest: 'The Land of Twins', twin-like reunion-I, twin-like reunion-II.

    Science.gov (United States)

    Segal, Nancy L

    2008-02-01

    A brief overview of Sulloway's (1996) theory of birth order and personality is presented. A reared apart twin approach for testing his personality findings regarding openness to experience and conscientiousness in first borns and later borns is described. This is followed by summaries of three recent twin studies. The topics include cancer risk in mother of twins, sexual dysfunction in males and responder behavior during ultimatum games. This article concludes with a discussion of twinning rates and rituals among the Yoruba of western Nigeria, and descriptions of two unusual reunions between siblings and twins.

  9. The evolution of the female sexual response concept: Treatment implications

    Directory of Open Access Journals (Sweden)

    Damjanović Aleksandar

    2013-01-01

    Full Text Available Sexual dysfunctions have been the most prevalent group of sexual disorders and include a large number of populations of both sexes. The research of sexual behavior and treatment of women with sexual distress arises many questions related to differences in sexual response of men and women. The conceptualization of this response in modern sexology has changed over time. The objective of our paper was to present the changes and evolution of the female’s sexual response concept in a summarized and integrated way, to analyze the expanded and revised definitions of the female sexual response as well as implications and recommendations of new approaches to diagnostics and treatment according to the established changes. The lack of adequate empirical basis of the female sexual response model is a critical question in the literature dealing with this issue. Some articles report that linear models demonstrate more correctly and precisely the sexual response of women with normal sexual functions in relation to women with sexual dysfunction. Modification of this model later resulted in a circular model which more adequately presented the sexual response of women with sexual function disorder than of women with normal sexual function. The nonlinear model of female sexual response constructed by Basson incorporates the value of emotional intimacy, sexual stimulus and satisfaction with the relationship. Female functioning is significantly affected by multiple psychosocial factors such as satisfaction with the relationship, self-image, earlier negative sexual experience, etc. Newly revised, expanded definitions of female sexual dysfunction try to contribute to new knowledge about a highly contextual nature of woman’s sexuality so as to enhance clinical treatment of dysfunctions. The definitions emphasize the evaluation of the context of women’s problematic sexual experiences.

  10. Symptoms of Autonomic Dysfunction in Human Immunodeficiency Virus

    OpenAIRE

    Chow, Dominic; Nakamoto, Beau K.; Sullivan, Katherine; Sletten, David M; Fujii, Satomi; Umekawa, Sari; Kocher, Morgan; Kallianpur, Kalpana J; Shikuma, Cecilia M.; Low, Phillip

    2015-01-01

    This retrospective study evaluated the frequencies of symptoms associated with autonomic dysfunction in human immunodeficiency virus (HIV)-infected patients on stable combined antiretroviral therapy. Patients infected with HIV reported higher frequencies of dysautonomia symptoms compared with HIV-negative patients, particularly in the autonomic domains related to urinary, sleep, gastroparesis, secretomotor, pupillomotor, and male sexual dysfunction.

  11. Sexual Health in Hematopoietic Stem Cell Transplant Recipients

    Science.gov (United States)

    Li, Zhuoyan; Mewawalla, Prerna; Stratton, Pamela; Yong, Agnes S.M.; Shaw, Bronwen E.; Hashmi, Shahrukh; Jagasia, Madan; Mohty, Mohamad; Majhail, Navneet S.; Savani, Bipin N.; Rovó, Alicia

    2016-01-01

    Hematopoietic stem cell transplantation (HSCT) plays a central role in patients with malignant and, increasingly, nonmalignant conditions. As the number of transplants increases and the survival rate improves, long-term complications are important to recognize and treat to maintain quality of life. Sexual dysfunction is a commonly described but relatively often underestimated complication after HSCT. Conditioning regimens, generalized or genital graft-versus-host disease, medications, and cardiovascular complications as well as psychosocial problems are known to contribute significantly to physical and psychological sexual dysfunction. Moreover, it is often a difficult topic for patients, their significant others, and health care providers to discuss. Early recognition and management of sexual dysfunction after HSCT can lead to improved quality of life and outcomes for patients and their partners. This review focuses on the risk factors for and treatment of sexual dysfunction after transplantation and provides guidance concerning how to approach and manage a patient with sexual dysfunction after HSCT. PMID:26372459

  12. Sexual Problems

    Medline Plus

    Full Text Available ... and are classified into 4 main categories: sexual desire disorders, sexual arousal disorders, orgasmic disorders, and sexual pain disorders. ... is having little or no sexual fantasies and desire for sexual activity. This lack of desire is beyond what ...

  13. Radiotherapy for prostate cancer and sexual health

    NARCIS (Netherlands)

    L. Incrocci (Luca)

    2015-01-01

    textabstractSexual dysfunction is very common after treatment of prostate cancer. Radiation therapy together with radical prostatectomy is the most effective treatment for localized disease. Percentages of erectile dysfunction (ED) reported in prospective studies after external-beam radiotherapy (RT

  14. Sexual traumatic events and neurotic disorders picture – sexuality-related and sexuality-unrelated symptoms

    Directory of Open Access Journals (Sweden)

    Rutkowski, Krzysztof

    2013-06-01

    trauma is mainly focused on the area of sexual dysfunctions.

  15. The current treatment of erectile dysfunction

    Directory of Open Access Journals (Sweden)

    Maria Isabela Sarbu

    2016-10-01

    Full Text Available Erectile dysfunction (ED is the inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. It is the most frequent sexual dysfunction in elderly men and its prevalence increases with age. Ever since ED was recognized as a real health problem, several treatment options became available and some of them proved to be very efficient. PDE5 inhibitors are the mainstay treatment of ED. However, other treatment options such as intracorporal injections, surgery, vacuum devices and prosthesis are also available for patients who are unresponsive to PDE5 inhibitors. Since none of the treatment options available so far has proven ideal, research in the field of sexual medicine continues. The aim of this paper is to review the most advances in the treatment of ED.

  16. Healthy Sexuality

    Medline Plus

    Full Text Available ... safe sexual experiences, free of coercion, discrimination and violence. For sexual health to be attained and maintained, the sexual rights of all persons must be respected, protected and ...

  17. Sexual Problems

    Medline Plus

    Full Text Available ... You can optimize the sexual setting by enhancing communication with your partner, promoting non-sexual intimacy, and finding ways to keep sex special and exciting. Sexual aids include lubricants, moisturizers, ...

  18. Healthy Sexuality

    Medline Plus

    Full Text Available ... produces increased intensive sexual excitement and that produces sexual desire that she may not have had at first. Sometimes people worry about their sexual health and function. If you have these concerns, ...

  19. Healthy Sexuality

    Medline Plus

    Full Text Available ... anxiety, depression, stress, abuse, and poor body image. Memories of a sexual trauma can greatly influence how a person functions sexually. Social and interpersonal factors that can affect sexual function include relationship problems, religious beliefs, cultural ...

  20. Neurodevelopmental Biology Associated with Childhood Sexual Abuse

    Science.gov (United States)

    De Bellis, Michael D.; Spratt, Eve G.; Hooper, Stephen R.

    2011-01-01

    Child maltreatment appears to be the single most preventable cause of mental illness and behavioral dysfunction in the United States. Few published studies examine the developmental and the psychobiological consequences of sexual abuse. There are multiple mechanisms through which sexual abuse can cause post-traumatic stress disorder, activate…

  1. Sexual Hypnotherapy for Couples and Family Counselors.

    Science.gov (United States)

    Araoz, Daniel; Burte, Jan; Goldin, Eugene

    2001-01-01

    Presents the utilization of Ericksonian hypnotic techniques in conjunction with cognitive behavioral techniques collectively labeled the New Hypnosis, as they apply to the treatment of male and female sexual dysfunction within a counseling setting. Specific techniques to improve functioning throughout the five stages of sexual response are…

  2. Androgens and sexuality.

    Science.gov (United States)

    Hutchinson, K A

    1995-01-16

    A review of the literature reveals that the endocrine determinants of female sexuality are complex and difficult to characterize. In adolescent males, free testosterone directly affects sexual motivation, with social factors exerting little or no effect. In adolescent girls, by contrast, societal and peer pressure play a pivotal role in the appearance of certain sexual behaviors. Throughout a woman's life, hormonal and psychosocial factors are critical influences. It is possible that cyclic patterns of testosterone are less important for female sexual behavior than the "tonic" effect of overall testosterone levels. Although the estrogen dependence of the vaginal epithelium--important for postmenopausal women--has been clearly established, the role of other hormonal factors and treatments, particularly those involving androgens, in human female sexual behavior remains enigmatic. The search for an understanding of these relationships is not merely an interesting academic exercise but is necessary to determine what role, if any, androgens may play in the treatment of sexual dysfunction during the female reproductive years. PMID:7825630

  3. The Sexual Impact of Infertility Among Women Seeking Fertility Care

    Directory of Open Access Journals (Sweden)

    William D. Winkelman, MD

    2016-09-01

    Conclusion: In women seeking fertility treatment, younger age and female factor infertility were associated with increased sexual impact and thus these women are potentially at higher risk of sexual dysfunction. Providers should consider the role young age and an infertility diagnosis plays in a women’s sexual well-being.

  4. The impact of primary Sjogren's syndrome on female sexual function

    NARCIS (Netherlands)

    van Nimwegen, Jolien F.; Arends, Suzanne; van Zuiden, Greetje S.; Vissink, Arjan; Kroese, Frans G. M.; Bootsma, Hendrika

    2015-01-01

    Objective. Prevalence of vaginal dryness and dyspareunia is high in women with primary SS (pSS). Our aim was to compare sexual function and sexual distress in women with pSS with healthy controls, as well as to assess parameters that are associated with sexual dysfunction and distress in pSS. Method

  5. A new therapeutic approach for erectile dysfunction: Low intensity shockwaves

    Directory of Open Access Journals (Sweden)

    García-Perdomo, Herney Andrés

    2015-07-01

    Full Text Available Erectile dysfunction is the inability to achieve or sustain a penile erection for vaginal penetration and satisfactory sexual performance. It is the second most frequent problem of sexual dysfunction in men, after premature ejaculation, with an approximate prevalence rate of 30%. Most cases of erectile dysfunction have an organic origin, mostly vascular diseases, but it is also associated with psychological, neurological, and hormonal factors, or with structural alterations of the penis. Therapy with 5-phosphodiesterase inhibitors has been clinically effective, but some patients do not respond to it. Lowintensity shock waves may improve penile vascularity and blood flow, leading to better erections, and improvement of the quality of sexual performance. In this review several studies are included that show the effectiveness of this treatment for erectile dysfunction.

  6. The Effect of Sexual Cognitive-Behavioral Therapy on Females\\' Sexual Knowledge, Sexual Attitude, and Sexual Self-Confidence. A Case Study in Shiraz, Iran

    OpenAIRE

    Rahimi, E; A Shafiabadi; F Yunesi

    2009-01-01

    1.Nikkhoo MR. Avadais yance, Hamayak. Females Sexual life. 4th ed.Tehran: sokhan 2001 9-10. 2.Warnock JJ. Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment. CNS Drugs 200216(11):745-53. 3.Spence SH. Psychosexual therapy. Translation by Hassan tuzandejani, 1380. 3th ed. Tehran: Peyk farhang 199110. 4.Arman S. Females sexual dysfunction comparison between pre and post menopause. Journal of Arak university of medicine 2005 8(3):2-7. 5.Besharat MA. Sexu...

  7. The impact of non-urologic drugs on sexual function in men.

    Science.gov (United States)

    Fusco, Ferdinando; Franco, Marco; Longo, Nicola; Palmieri, Alessandro; Mirone, Vincenzo

    2014-03-01

    Sexual dysfunctions have commonly been reported as the resulting side effects of many drugs. To understand the impact of a single drug, the mechanism of action of the most commonly prescribed drugs and the physiological mechanisms of sexual function have to be taken into dual consideration. Psychotropic drugs (Antidepressants, Antipsychotics and Antiepileptic) in particular result in both short and long-term effects on sexual function. Antihypertensive drugs have also produced evidence certifying their role in determining sexual dysfunction. Patients affected with sexual dysfunction are often aged and assume several drugs and, while Iatrogenic sexual dysfunction is prevalent in men, urological drugs are not the only drugs to be held accountable. Many different drugs acting on different sites and with several mechanisms of action can induce sexual dysfunction. The drug classes involved are widely diffused and frequently assumed in combination therapies. PMID:24704935

  8. The impact of non-urologic drugs on sexual function in men

    Directory of Open Access Journals (Sweden)

    Ferdinando Fusco

    2014-03-01

    Full Text Available Sexual dysfunctions have commonly been reported as the resulting side effects of many drugs. To understand the impact of a single drug, the mechanism of action of the most commonly prescribed drugs and the physiological mechanisms of sexual function have to be taken into dual consideration. Psychotropic drugs (Antidepressants, Antipsychotics and Antiepileptic in particular result in both short and long-term effects on sexual function. Antihypertensive drugs have also produced evidence certifying their role in determining sexual dysfunction. Patients affected with sexual dysfunction are often aged and assume several drugs and, while Iatrogenic sexual dysfunction is prevalent in men, urological drugs are not the only drugs to be held accountable. Many different drugs acting on different sites and with several mechanisms of action can induce sexual dysfunction. The drug classes involved are widely diffused and frequently assumed in combination therapies.

  9. [Eating disorders and sexual function].

    Science.gov (United States)

    Kravvariti, V; Gonidakis, Fr

    2016-01-01

    groups of patients report more often than general population a lack of satisfaction from their sexual experiences. Other factors that are common to eating disorders and sexual dysfunction are personality traits, negative body-image, adverse childhood experiences, negative family climate and especially early traumatic experiences such as sexual abuse. Furthermore, comorbidity of eating disorders with depression may have a negative impact on the patient's sexual function. The treatment and improvement of sexual behavior is quite problematic when the patient is also suffering from an eating disorder. Eating Disorder patients are often very reluctant to discuss their sexual life with the therapist and to engage in any kind of therapeutic intervention. Comorbidity with a number of other disorders makes psychotherapy even more difficult for those patients. Furthermore, a considerable percentage of Anorexia Nervosa patients do not have any kind of sexual activity, at least until nutrition and weight are restored. PMID:27467034

  10. Breast cancer and sexual function.

    Science.gov (United States)

    Boswell, Erica N; Dizon, Don S

    2015-04-01

    As the most common malignancy affecting women within the United States, breast cancer can bring about multiple physical and psychological challenges. Among the greatest challenges are those associated with female sexual function. Chemotherapy, endocrine therapy, surgeries and radiation can all have a large effect in altering a woman's sexual health and function. Sexual concerns result in significant emotional distress, including sadness/depression, issues related to personal appearance, stigma, and negative impacts on personal relationships. In this article, we discuss some of the specific challenges that present with each type of treatment and the socio-physical impact they have on survivorship. Among the most detrimental to sexual function, are the use of chemotherapy and endocrine therapy. Additionally, anatomical changes that transpire in patients who have undergone surgery or radiation therapy (RT), disrupt perceptions of body image. Here we will discuss and also review the contemporary literature to determine effective management and treatment of sexual dysfunction. PMID:26816822

  11. Sexual Assault

    Science.gov (United States)

    ... been sexually assaulted. 6 , 7 Read more about violence in same-sex relationships . Sexual assault can happen to anyone of any age, race or ethnicity, religion, ability, appearance, sexual orientation, or gender identity. However, women have higher rates of sexual ...

  12. Healthy Sexuality

    Medline Plus

    Full Text Available ... reducing stress, improving self-esteem, and cardiovascular health. A person’s physical sexual response is an important part ... his or her sexuality. Let’s talk about how a woman’s body responds to sexual stimulation. During sexual ...

  13. A holistic approach to psychological sexual problems in women with diabetic husbands

    OpenAIRE

    Anahita Khodabakhshi Koolaee; Edalat Asadi; Ladan Mansoor; Leili Mosalanejad; Ali FathAbadi

    2014-01-01

    Background: One of negative and influential factor to chronic diseases is creation of sexual problems in the couple's sexual relationship. Sexual health is one of the most important factor in Sexual and marital satisfaction. Objective: This study aims to compare the relationship between couple burnout, sexual assertiveness, and sexual dysfunctional beliefs in women with diabetic and non-diabetic husbands. Materials and Methods: This cross sectional descriptive study was a causal comparative o...

  14. Sexual function among married menopausal women in Amol (Iran)

    OpenAIRE

    Shabnam Omidvar; Fatemeh Bakouie; Fatemeh Nasiri Amiri

    2011-01-01

    Background: Sexual activity is an important part of the human being's life but this instinct could be influenced by some factors such as diseases, drug using, aging, and menopause. But information about that is limited. Aim: The aim of this study is to determine the status of sexual activity among married menopausal women in Amol, Iran. Materials and Methods: This descriptive analytical study was conducted to describe the sexual activity and sexual dysfunction of women after menopause. Data w...

  15. Sexual function in lithium-treated manic-depressive patients

    DEFF Research Database (Denmark)

    Kristensen, Ellids; Jørgensen, Per

    1987-01-01

      Sexual function in 24 patients with major affective disorders who were given prophylactic lithium treatment was compared with that of a control group of surgical outpatients with no known psychiatric disease. Changes in sexual function during lithium treatment were also recorded retrospectively....... Sexual dysfunctions were described by about one-fourth of both female patients and controls. About one-third of the male patients and controls reported sexual dysfunctions. We cannot exclude tha lithium in combination with other psychotropic drugs may increase the frequency of sexual dysfunction. Changes...... in sexual function during lithium treatment were reported by one-fourth of the patients. Of these, four reported a positive influence of the treatment and five a negative influence. Statistically, significantly more patients than controls were dissatisfied with their present sex life....

  16. The Effect of Cognitive-Behavioral Teaching on Improvement of Women's Sexual Function with Hypoactive Sexual Desire Disorder

    OpenAIRE

    Najme-Sadat Hajivosough; Jahanshir Tavakolizadeh; Alireza Rajayi; Alireza Atarodi

    2012-01-01

    Background: Hypoactive sexual desire disorder as the most prevalent sexual dysfunction has a major role in marital relationships. The purpose of this study was to determine the effect of cognitive-behavioral teaching on improvement of women sexual function.Materials and Methods: In this semi experimental study, the sample size were 30 women that 15 were randomly selected for each experimental and control group of women with hypoactive sexual desire. At first the pretest was carried out in bot...

  17. Infantile sexuality

    DEFF Research Database (Denmark)

    Zeuthen, Katrine Egede; Gammelgård, Judy

    2010-01-01

    When first presented, Freud´s theory of infantile sexuality was a scandal. Not only was the claim that the small child sucking at the mother´s breast experiences a kind of pleasure that Freud without hesitation named sexual, the theory also turned the common understanding of human sexuality up...... vision of the sexual. Following a historic outline, we examine the theories that inspired by Laplanche, once more discuss infantile sexuality, and argue that infantile sexuality is clarified by combining the concept of the drive with what in effect is an inter-subjective point of view....

  18. Sexual Problems

    Medline Plus

    Full Text Available ... You can optimize the sexual setting by enhancing communication with your partner, promoting non-sexual intimacy, and ... devices. Vibrators and dildos can be used by men and women to increase sensation to the genitals. ...

  19. Sexual Problems

    Medline Plus

    Full Text Available ... or HSDD, is having little or no sexual fantasies and desire for sexual activity. This lack of ... Top Home | About Us | Reproductive Health Topics | News & Publications | Resources Site endowed by Advanced Reproductive Care, Inc. ( ...

  20. Sexual Problems

    Medline Plus

    Full Text Available ... You can optimize the sexual setting by enhancing communication with your partner, promoting non-sexual intimacy, and ... Reproductive Medicine. All Rights Reserved. ASRM Non Discrimination Policy | ASRM Web Site Terms & Conditions of Use | Web ...

  1. Sexual Problems

    Medline Plus

    Full Text Available ... pain disorders. If you are experiencing problems viewing this embedded video, please click here . Transcript Disorders of ... no sexual fantasies and desire for sexual activity. This lack of desire is beyond what normally happens ...

  2. Sexual Problems

    Medline Plus

    Full Text Available ... aids include lubricants, moisturizers, and sexual toys. Lubricants work by reducing friction between tissues. Many different types ... mental health providers who have specialized training in working with people with sexual concerns. Cognitive behavioral therapy ...

  3. Sexual Problems

    Medline Plus

    Full Text Available ... of low desire in women, there is some evidence that it may improve sexual experiences in postmenopausal ... men with low testosterone levels, there is some evidence that testosterone therapy may improve sexual function. A ...

  4. Sexual Problems

    Medline Plus

    Full Text Available ... You can optimize the sexual setting by enhancing communication with your partner, promoting non-sexual intimacy, and ... studies are needed to confirm its efficacy and safety. For men with low testosterone levels, there is ...

  5. Healthy Sexuality

    Medline Plus

    Full Text Available ... improving self-esteem, and cardiovascular health. A person’s physical sexual response is an important part of his ... may play a role include anxiety, depression, stress, abuse, and poor body image. Memories of a sexual ...

  6. Sexual Difficulties

    Science.gov (United States)

    ... difficulties Explore other publications and websites Age Page: Sexuality in Later Life - This brochure describes the normal ... effects of illness, disability, and emotional concerns of sexuality in later life. Atrophic Vaginitis (Copyright © UCLA Health ...

  7. Sexual Problems

    Medline Plus

    Full Text Available ... Smoking Cessation Links to Professional Societies and Organizations Home › Sexual Problems Sexual concern causing distress can be ... Find a Health Care Provider Back to Top Home | About Us | Reproductive Health Topics | News & Publications | Resources ...

  8. Sexual Problems

    Medline Plus

    Full Text Available ... concerns with your sexual partner. Because they are complex, sexual concerns are treated in many different ways. ... type of psychotherapy that focuses on how one’s thinking influences feelings and behavior. Sensate focus exercises are ...

  9. Sexual Violence

    Science.gov (United States)

    Sexual Violence Facts at a Glance 2012 Adults In a nationally representative survey of adults: 1 • Nearly 1 in ... 5.6% and 5.3%, respectively) experienced sexual violence other than rape, such as being made to ...

  10. Healthy Sexuality

    Medline Plus

    Full Text Available ... pleasurable and safe sexual experiences, free of coercion, discrimination and violence. For sexual health to be attained ... for Reproductive Medicine. All Rights Reserved. ASRM Non Discrimination Policy | ASRM Web Site Terms & Conditions of Use | ...

  11. Healthy Sexuality

    Medline Plus

    Full Text Available ... to its unaroused stated, called resolution. “Normal” sexual function has been described in many ways by different investigators. Most people think about sexual function as described by Masters and Johnson in the ...

  12. Sexual Problems

    Medline Plus

    Full Text Available ... a clinician. If you have a sexual concern, it is important to know that help is available. ... worker, or physical therapist. You may also find it helpful to discuss your concerns with your sexual ...

  13. Healthy Sexuality

    Medline Plus

    Full Text Available ... or afraid to talk about sex or sexuality, it’s important to bring up any concerns with your ... expression of a person as a sexual being. It involves the complex interplay of sex (whether a ...

  14. Time Out from Sex or Romance: Sexually Experienced Adolescents' Decisions to Purposefully Avoid Sexual Activity or Romantic Relationships.

    Science.gov (United States)

    Byers, E Sandra; O'Sullivan, Lucia F; Brotto, Lori A

    2016-05-01

    Researchers have given significant attention to abstinence among adolescents, but far less is known about purposeful avoidance of sexual activity (and relationship involvement). Typically, it is assumed that, once adolescents have initiated sexual activity, they will thereafter engage in sexual activity if given the opportunity. However, it is unclear whether that is true as some research indicates that many adolescents engage in sexual activity intermittently. Sexually experienced adolescents may purposefully avoid engaging in sexual activity for a period of time and, if so, this has implications for understanding their sexual decision-making. We used a mixed methods approach to investigate sexually experienced adolescents' decisions to purposefully avoid further sexual activity and/or romantic relationships with a focus on how common these decisions are and factors influencing them. Participants were 411 (56 % female) adolescents (16-21 years old) who completed an on-line survey that assessed reasons for each type of avoidance, religiosity, sexual esteem, sexual distress, sexual coercion, and dysfunctional sexual beliefs. Overall, 27 % of participants had engaged in sexual avoidance and 47 % had engaged in romantic avoidance. Significantly more female than male adolescents reported sexual and romantic avoidance. Adolescents' reasons for sexual avoidance included: lack of sexual pleasure or enjoyment, relationship reasons, negative emotions, values, fear of negative outcomes, negative physical experience, and other priorities. Reasons for romantic avoidance included: effects of previous relationship, not interested in commitment, wrong time, other priorities, negative emotions, no one was good enough, and sexual concerns. Logistical regressions were used to assess associations between age, religiosity, sexual esteem, sexual distress, experience of sexual coercion, and dysfunctional sexual beliefs and having engaged in romantic and/or sexual avoidance. The

  15. Time Out from Sex or Romance: Sexually Experienced Adolescents' Decisions to Purposefully Avoid Sexual Activity or Romantic Relationships.

    Science.gov (United States)

    Byers, E Sandra; O'Sullivan, Lucia F; Brotto, Lori A

    2016-05-01

    Researchers have given significant attention to abstinence among adolescents, but far less is known about purposeful avoidance of sexual activity (and relationship involvement). Typically, it is assumed that, once adolescents have initiated sexual activity, they will thereafter engage in sexual activity if given the opportunity. However, it is unclear whether that is true as some research indicates that many adolescents engage in sexual activity intermittently. Sexually experienced adolescents may purposefully avoid engaging in sexual activity for a period of time and, if so, this has implications for understanding their sexual decision-making. We used a mixed methods approach to investigate sexually experienced adolescents' decisions to purposefully avoid further sexual activity and/or romantic relationships with a focus on how common these decisions are and factors influencing them. Participants were 411 (56 % female) adolescents (16-21 years old) who completed an on-line survey that assessed reasons for each type of avoidance, religiosity, sexual esteem, sexual distress, sexual coercion, and dysfunctional sexual beliefs. Overall, 27 % of participants had engaged in sexual avoidance and 47 % had engaged in romantic avoidance. Significantly more female than male adolescents reported sexual and romantic avoidance. Adolescents' reasons for sexual avoidance included: lack of sexual pleasure or enjoyment, relationship reasons, negative emotions, values, fear of negative outcomes, negative physical experience, and other priorities. Reasons for romantic avoidance included: effects of previous relationship, not interested in commitment, wrong time, other priorities, negative emotions, no one was good enough, and sexual concerns. Logistical regressions were used to assess associations between age, religiosity, sexual esteem, sexual distress, experience of sexual coercion, and dysfunctional sexual beliefs and having engaged in romantic and/or sexual avoidance. The

  16. Sexual Problems

    Medline Plus

    Full Text Available ... ways to keep sex special and exciting. Sexual aids include lubricants, moisturizers, and sexual toys. Lubricants work ... a “maintenance therapy” that is applied regularly. Sexual aids, also known as “sex toys” can be used ...

  17. Healthy Sexuality

    Medline Plus

    Full Text Available ... shown that a women’s response intertwines both her physical and emotional sexual drive. This would explain how women can start, or be receptive to, a sexual encounter. For example, a woman may enter into sexual activity to increase emotional closeness and commitment without having ...

  18. Healthy Sexuality

    Medline Plus

    Full Text Available ... and Smoking Cessation Links to Professional Societies and Organizations Home › Healthy Sexuality Sexuality is the experience and/ ... the course of a lifetime. The World Health Organization has defined sexual health as “…a state of ...

  19. Healthy Sexuality

    Medline Plus

    Full Text Available ... provider or sexual counselor. Let’s begin with some definitions and explanations. Sexuality is the experience and/or ... affect sexual function include relationship problems, religious beliefs, cultural beliefs, and one’s upbringing. Sex is an important ...

  20. Healthy Sexuality

    Medline Plus

    Full Text Available ... Links to Professional Societies and Organizations Home › Healthy Sexuality Sexuality is the experience and/or expression of ... is an important part of his or her sexuality. Let’s talk about how a woman’s body responds ...

  1. Erectile Dysfunction (ED)

    Science.gov (United States)

    ... age. Is erectile dysfunction just a part of old age? Erectile dysfunction doesn't have to be a ... episode of impotence Feeling stressed, including stress from work or family situations Being troubled by problems in ...

  2. Prevalence of aging male sexual dysfunction in Beijing: the result from a community-based cross-sectional survey of BPC-BPH stndy group%北京市社区中老年男性性功能调查报告:BPC-BPH研究结果

    Institute of Scientific and Technical Information of China (English)

    邵强; 宋健; 孙少鹏; 田野; BPC-BPH研究小组

    2010-01-01

    目的 调查北京市社区中老年男性性欲低下、勃起功能障碍(ED)、射精障碍的患病情况.方法 采用分层多阶段整群不等比例随机抽样方法选择北京市15个社区1656名年龄≥50岁男性作为调查对象,分别记录国际勃起功能问卷(IIEF-5)评分及男性性功能问卷(O'Leary 1995),应用χ~2检验分析结果.结果 符合标准的调查对象共1644人.年龄50~93(64.5±9.8)岁.平均IIEF-5(9.4±8.6)分.以IIEF-5评分0~21诊断为ED,总ED患病率90.45%,性欲低下60.04%,射精障碍38.81%.各年龄组(10岁/组)间ED、性欲低下、射精障碍患病率差异有统计学意义(P<0.0001),各年龄组间不同程度ED患病率差异有统计学意义(P<0.0001).趋势检验表明随年龄增加,ED、性欲低下、射精障碍患病率逐渐增加(Z=10.1,P<0.0001),与年龄呈正相关性.结论 随年龄增加ED、性欲低下、射精障碍的患病率逐渐增加.ED患病率最高.%Objective To investigate the prevalence of aging male sexual dysfunction in Beijing.Methods A cross-sectional study was performed based on community of Beijing in men aged over 50 years old.The International Index of Erectile Function-5(IIEF-5),Brief Male Sexual Function Inventory for Urology(Orleary 1995)were recorded and analyzed.Results 1644 subjects were enrolled and the mean age was 64.5 years(range 50-93 years).The mean score of IIEF-5 was 9.4±8.6.The prevalence of erectile dysfunction(ED),defined as IIEF-5 between 0-21,was 90.45%.The incidence of reduction of sexual desire and defective ejaculation was 60.04%and 38.81%,respectively.There was positive correlation between the prevalence of ED,reduction of sexual desire,defective ejaculation and age.Conclusions The incidence of ED,reduction of sexual desire and defective ejaculation are positively correlated with age.Compared with high prevalence of ED,the incidences of sexual desire and defective ejaculation are lower.

  3. Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study

    OpenAIRE

    Salvatore Sansalone; Rosario Leonardi; Gabriele Antonini; Antonio Vitarelli; Giuseppe Vespasiani; Dragoslav Basic; Giuseppe Morgia; Sebastiano Cimino; Giorgio Ivan Russo

    2014-01-01

    We aimed to evaluate the efficacy of oral therapy with alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide (Tradamix TX1000) in patients with erectile dysfunction (ED) at 3 months of follow-up. From January 2013 to September 2013, 177 patients diagnosed with mild-moderate ED (IIEF-EF < 26) were enrolled in this multicenter, single-blinded, placebo-controlled study and randomized in Group A (Tradamix, n = 87) and Group B (placebo, n = 90). Penile color Doppler ultrasou...

  4. The relationship between overactive bladder and sexual activity in women

    Directory of Open Access Journals (Sweden)

    Patel Ankur S.

    2006-01-01

    Full Text Available PURPOSE: We assessed the relationships between bladder symptoms, demographic, and medical history variables and sexual dysfunction in women with overactive bladder (OAB disorder. MATERIALS AND METHODS: Seventy-eight women diagnosed with OAB completed self-administered questionnaires related to overall heath status, bladder function, and sexual function. Data were compiled for questionnaire responses, and multivariate logistic regression analyses were performed to determine predictors of sexual dysfunction. RESULTS: Bothersome bladder symptoms were reported by superscript three 60% of the sample. Sixty-percent of the sample was sexually active in the past month. Difficulty with sexual arousal, orgasm, and sexual enjoyment were reported by about 25% of the women. Sexual partner status was the best predictor of sexual arousal, orgasm, and sexual enjoyment. Menopausal status emerged as an important predictor of arousal and sexual enjoyment. CONCLUSION: The majority of women with symptoms of OAB viewed these symptoms as bothersome. However, the extent of symptom bother did not predict aspects of female sexual dysfunction (FSD. Instead, menopausal and partner status emerged as the best predictors of FSD in our sample.

  5. Pelvic radiotherapy and sexual function in men and women

    DEFF Research Database (Denmark)

    Incrocci, Luca; Jensen, Pernille Tine

    2013-01-01

    Despite the decrease in overall cancer incidence and mortality rates in developed countries since the early 1990 s, cancer remains a major public health problem. Sexual dysfunction is one of the more common consequences of cancer treatment....

  6. Primary Orgasmic Dysfunction: Diagnostic Considerations and Review of Treatment

    OpenAIRE

    Andersen, Barbara L.

    1983-01-01

    As a diagnostic category, primary orgasmic dysfunction includes all women who have never experienced orgasm under any circumstances except sleep or fantasy. However, the research samples of nonorgasmic women in clinical reports and empirical investigations are heterogeneous with regard to disruption of earlier phases of the sexual response cycle and emotional concomitants of the dysfunction. The major treatment models—systematic desensitization, sensate focus, directed masturbation, and hypno...

  7. Marriage and Sexuality from a Psychiatric Point of View

    Directory of Open Access Journals (Sweden)

    Ali Bozkurt

    Full Text Available Sexuality, taking on a shape in the interaction of psychological, social, and biological variables, may lose its functionality with the blockage of these components. Sexual dysfunction may be handled as if it is only a symptom being based on the decay of marital relationship in the content of therapy, and sexual dysfunction may be neglected by family and marriage therapists from time to time. Contrarily, sex therapists may show the tendency to handle the problem in aspect of only sexuality. In the relationships of all spouses, thought and emotional intimacy should not be neglected whatever sexual problem they may have. Factors determining happiness such as physical attractiveness, impressiveness, positive and negative attitudes, marriage age, children, socioeconomic conditions, common intentions, and hobbies, sexual life, have attracted the attention of investigators for long time. Most important element among these factors seems to be sexuality. In recent years, researchers have begun to consider interaction between sexuality and marriage much more. Marital life includes food, shelter, togetherness, satisfaction originated from positive marital relationships, sharing role to cause of sexual maturation, acceptance of social role, and responsibility, individual entrepreneurship, and supporting to creativity. Marriage, consisting of spouses completing each other in these fields, is the headstone of social development and maturation. It has been suggested that there is a role of sexual dysfunction in protecting the balance of marital relationships. According to this suggestion, these disorders may prevent any damage to self and conserve the border of ego. Moreover, we may suggest that sexual dysfunction breaks the marital relationship, removes the protective effect on marital balance if we consider the beneficial effects of sexuality in points of intimacy in thought and emotional fields. Sexuality can be only experienced with healthy personality

  8. Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

    Science.gov (United States)

    Baldwin, David S; Manson, Chris; Nowak, Magda

    2015-11-01

    Pleasurable sexual activity is important in many human relationships and can provide a sense of physical, emotional and social well-being. Depressive symptoms and depressive illness are associated with impairments in sexual function and sexual dissatisfaction in untreated and treated patients. Most currently available antidepressant drugs are associated with development or worsening of sexual dysfunction in a substantial proportion of patients. Sexual difficulties during antidepressant treatment often resolve as depression lifts, but can persist over long periods, reducing self-esteem and affecting mood and relationships adversely. Sexual difficulties during antidepressant treatment typically have many possible causes but the incidence and nature of dysfunction varies between drugs. Many interventions can be considered when managing sexual dysfunction associated with antidepressants but no approach is 'ideal'. Because treatment-emergent sexual difficulties are less frequent with certain drugs, presumably related to differences in pharmacological properties, and since current interventions are suboptimal, a lower incidence of sexual dysfunction is a relevant tolerability target when developing novel antidepressants. PMID:26519341

  9. Neurological rehabilitation: sexuality and reproductive health.

    Science.gov (United States)

    Aisen, Mindy Lipson

    2013-01-01

    Sexuality is the embodiment of sexual and reproductive activities involving complex interactions among biological, psychological, and social systems. An individual's perception of their sexuality, as well as society's perception, can have an inestimable impact on self-esteem, and hence willingness to openly address these issues Earle S (2001). Disability, facilitated sex and the role of the nurse. J Adv Nurs 3: 433-440. Such barriers to communication represent a real challenge to practicing clinicians. However, advances in treatment options obligate the clinician providing care to those with neurogenic sexual/reproductive dysfunction to learn to communicate effectively about these issues, provide effective therapies, and refer patients to appropriate specialists. This chapter will address counseling, an overview of male and female sexual and reproductive physiological responses in the case of an intact nervous system, and a description of the impact of disorders of the nervous system on sexual function and reproductive health. Treatment options are also reviewed.

  10. Female sexuality.

    Science.gov (United States)

    Rao, T S Sathyanarana; Nagaraj, Anil Kumar M

    2015-07-01

    Sex is a motive force bringing a man and a woman into intimate contact. Sexuality is a central aspect of being human throughout life and encompasses sex, gender identities and roles, sexual orientation, eroticism, pleasure, intimacy, and reproduction. Sexuality is experienced and expressed in thoughts, fantasies, desires, beliefs, attitudes, values, behaviors, practices, roles and relationships. Though generally, women are sexually active during adolescence, they reach their peak orgasmic frequency in their 30 s, and have a constant level of sexual capacity up to the age of 55 with little evidence that aging affects it in later life. Desire, arousal, and orgasm are the three principle stages of the sexual response cycle. Each stage is associated with unique physiological changes. Females are commonly affected by various disorders in relation to this sexual response cycle. The prevalence is generally as high as 35-40%. There are a wide range of etiological factors like age, relationship with a partner, psychiatric and medical disorders, psychotropic and other medication. Counseling to overcome stigma and enhance awareness on sexuality is an essential step in management. There are several effective psychological and pharmacological therapeutic approaches to treat female sexual disorders. This article is a review of female sexuality. PMID:26330647

  11. 北京地区多中心老年男性性功能障碍危险因素分析%Risk factors of sexual dysfunction in aged men in Beijing : a multicenter community-based cross-sectional survey

    Institute of Scientific and Technical Information of China (English)

    宋健; 邵强; 孙少鹏; 田野; 那彦群; BPC-BPH研究小组

    2012-01-01

    目的 调查北京地区≥50岁男性性功能障碍的患病情况及相关危险因素. 方法 采用分层多阶段整群不等比例随机抽样方法,选择截止到2008年6月1日北京地区15个社区常驻人口中1644例≥50岁男性作为研究对象,记录国际勃起功能问卷(IIEF-5)评分、男性性功能问卷( O'Leary 1995)、IPSS、体质量指数(body mas index,BMI)、前列腺体积,询问既往糖尿病、高血压、高血脂、心脑血管病等史,吸烟和饮酒情况.应用x2检验和Logistic回归法分析与性功能障碍相关的危险因素. 结果 本组勃起功能障碍(ED)、性欲低下和射精障碍的总患病率分别为90.45%、60.04%、38.81%.50 ~59岁、60 ~ 69岁、70 ~ 79岁和≥80岁年龄组间ED、性欲低下和射精障碍的患病率差异有统计学意义(P<0.05);多因素分析结果显示年龄与ED(β =0.12,P<0.05)、性欲低下(β=0.10,P<0.05)和射精障碍(β=0.08,P<0.05)相关,BMI与ED相关(β=0.07,P<0.05),高血压病、前列腺体积是性欲低下(β =0.37,0.08,P<0.05)和射精障碍(β=0.47,0.06,P<0.05)的危险因素;饮酒与射精障碍有关(β=-0.31,P<0.05). 结论 北京地区≥50岁男性ED、性欲低下患病率增加,射精障碍患病率降低,说明中老年男性可以有良好的射精功能,多种因素导致不能达到良好的勃起是影响性生活的主要原因.ED、性欲低下和射精障碍的患病率随年龄增加而增加,年龄是三者共同的危险因素.BMI是ED的危险因素,高血压病、前列腺体积是性欲低下和射精障碍的危险因素;饮酒与射精障碍有关.%Objective To investigate the prevalence of sexual dysfunction in aged men and associated risk factors in Beijing. Methods A cross-sectional study was performed in communities of Beijing involved 1656 men aged over 50 years.The International Index of Erectile Function-5 (IIEF-5),Brief Male Sexual Function Inventory for Urology ( O'Leary 1995 ) and

  12. How Serious Is Erectile Dysfunction in Men's Lives? Comparative Data From Korean Adults

    OpenAIRE

    Ji, Yoon Seob; Choi, Ji Woong; Ko, Young Hwii; Song, Phil Hyun; Jung, Hee Chang; Moon, Ki Hak

    2013-01-01

    Purpose Whereas sexual function has long been assumed to be an important component of adult men's lives, the impact of sexual dysfunction has not been estimated in parallel to other modern disease entities. We compared the seriousness of erectile dysfunction (ED) with that of other diseases by use of self-administered questionnaires. Materials and Methods Between January 2012 and July 2012, 434 healthy male volunteers (group 1) and 263 ED patients (group 2) were enrolled. The questionnaire co...

  13. 温肾软肝清化汤治疗肝硬化男性性功能减退综合征临床效果观察%Clinical effect of warming kidney and mild liver soup in the treatment of male sexual dysfunction syndrome of patients with liver cirrhosis

    Institute of Scientific and Technical Information of China (English)

    于姜标; 白春玲

    2014-01-01

    Objectives:To observe and analyze the clinical effects of warming kidney and mild liver soup in the treatment of male sexual dysfunction syndrome of patients with liver cirrhosis,to improve cure rate of male sexual dysfunction syndrome.Methods:120 cirrhosis patients with male sexual dysfunction syndrome in our hospital from January 201 1 to January 2012 were selected and randomly divided into observation group and control group by means of digital random method,60 cases in each group.Observation group received warming kidney and mild liver soup for treatment,while control group received oral Anluohuaxian pill for treatment.Changes in the sexual dysfunction, anorexia,fatigue and discomfort of the two groups were compared and levels ofalbumin (ALB),total bilirubin (TBiL),serum testosterone (T)values and aspartame aminotransferase (AST)were measured after treatment. Results:The total effective rate of the observation group and control group was 85.0% and 58.3% respectively, with statistically significant difference (P<0.05 );the level of TBiL,ALB,AST and T value in the two groups were significantly improved after treatment;and the improvement of each indicator in the observation group was bet-ter than control group,with statistically significant difference (P<0.05).Conclusion:Warming kidney and mild liver soup has significant effect in the treatment of male sexual dysfunction syndrome of patients with liver cirrhosis, which is worth promoting.%目的:观察并分析温肾软肝清化汤治疗肝硬化男性性功能减退综合征的临床效果,以提高肝硬化男性性功能减退综合征的临床治愈率。方法:选择医院2011年1月至2012年1月收治的120例肝硬化男性性功能减退综合征患者为研究对象,采用数字随机方法将其随机分成观察组和对照组,每组60例。观察组患者采用温肾软肝清化汤治疗,对照组患者口服安络化纤丸治疗,比较两组患者治疗结束后性功能减退、纳

  14. Risk factors for sexual dysfunction in male patients with obstructive sleep apnea and hypoventilation syndrome%阻塞性睡眠呼吸暂停低通气综合征引起男性性功能障碍危险因素分析

    Institute of Scientific and Technical Information of China (English)

    刘松; 陈颖; 郝钢跃; 贺正一

    2013-01-01

    目的 探讨男性阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者性功能障碍的危险因素.方法 采用国际勃起功能指数量表(IIEF-5)评估121例男性22~50岁OSAHS患者性功能,分为性功能正常组(65例)和性功能障碍组(56例).比较两组患者临床资料和多导睡眠图监测结果.部分性功能障碍患者进行持续气道正压(CPAP)治疗后再次以IIEF-5评价性功能.结果 性功能障碍组患者体质量指数(BMI)显著高于性功能正常组[(31.5±3.9) kg/m2与(30.1±3.5) kg/m2,t=6.897,P<0.01],有糖尿病病史者显著多于性功能正常组(18例与10例,x2=4.750,P<0.05),晨间血压升高者显著多于性功能正常组(38例与27例,x2 =8.381,P<0.01);性功能障碍组患者多导睡眠图监测显示,呼吸紊乱指数(RDI)、最长呼吸暂停时间(Tmax)、最低脉搏血氧饱和度(LSp02)、脉搏血氧饱和度低于90%时间占总睡眠(TST)时间比(T90%)、浅睡眠(S1+S2)占ST比、深睡眠(S3+S4)占TST比、快动眼睡眠(REM)占TST比等指标与性功能正常组之间差异有统计学意义(t值分别为5.290、2.253、3.770、7.536、6.599、3.935和5.536,P均<0.05).多因素Logistic回归分析显示,糖尿病病史、多导睡眠图监测中S1 +S2占TST比、RDI和LSp02对男性OSAHS患者出现性功能障碍有统计学意义,其OR值(95%可信区间)分别为2.10(1.17 ~5.01)、3.52(1.33 ~ 5.97)、1.45(1.08 ~2.95)和0.86(0.67~0.93),P均<0.05.20例性功能障碍患者持续气道正压治疗2个月后14例经IIEF-5评分(>21分)正常.结论 具有糖尿病病史,睡眠结构紊乱S1 +S2占TST比增多、RDI较高和LSpO2较低是男性OSAHS患者发生性功能障碍的独立危险因素.持续气道正压治疗可以显著改善男性OSAHS患者性功能.%Objective To investigate the risk factors of sexual dysfunction in male patients with obstructive sleep apnea and hypoventilation syndrome (OSAHS).Methods One hundred and twenty-one OSAHS male

  15. Sexual Health of Polish Athletes with Disabilities

    Directory of Open Access Journals (Sweden)

    Ryszard Plinta

    2015-06-01

    Full Text Available The purpose of this study was to determine sexual functioning of Polish athletes with disabilities (including paralympians. The study encompassed 218 people with physical disabilities, aged between 18 and 45 (149 men and 69 women. The entire research population was divided into three groups: Polish paralympians (n = 45, athletes with disabilities (n = 126 and non-athletes with disabilities (n = 47. The quality of sexual life of Polish paralympians was measured by using the Polish version of Female Sexual Function Index and International Index of Erectile Function. Clinically significant erectile dysfunctions were most often diagnosed in non-athletes (83.33% with 50% result of severe erectile dysfunctions, followed by athletes and paralympians with comparable results of 56.98% and 54.17% respectively (p = 0.00388. Statistically significant clinical sexual dysfunctions concerned lubrication, orgasm as well as pain domains, and prevailed among female non-athletes (68.42%, 68.42% and 57.89%. Practising sports at the highest level has a favourable effect on the sexuality of men and women with physical disabilities. Men with physical disabilities manifest more sexual disorders than women, an aspect which should be considered by health-care professionals working with people with disabilities.

  16. Internet Sexualities

    Science.gov (United States)

    Döring, Nicola

    The term “internet sexuality” (or OSA, online sexual activities) refers to sexual-related content and activities observable on the internet (cf. Adams, Oye, & Parker, 2003; Cooper, McLoughlin, & Campbell, 2000; Leiblum & Döring, 2002). It designates a variety of sexual phenomena (e.g., pornography, sex education, sexual contacts) related to a wide spectrum of online services and applications (e.g., websites, online chat rooms, peer-to-peer networks). If an even broader range of computer networks - such as the Usenet or bulletin board systems - is included in this extensional definition, one speaks of “online sexuality” or “cybersexuality.”

  17. Management of erectile dysfunction in hypertension:Tips and tricks

    Institute of Scientific and Technical Information of China (English)

    Margus; Viigimaa; Charalambos; Vlachopoulos; Antonios; Lazaridis; Michael; Doumas

    2014-01-01

    Arterial hypertension is a major risk factor for cardiovascular disease and affects approximately one third of the adult population worldwide. The vascular origin of erectile dysfunction is now widely accepted in the vast majority of cases. Erectile dysfunction is frequently encountered in patients with arterial hypertension and greatly affects their quality of life of hypertensive patients and their sexual partners. Therefore, the management of erectile dysfunction in hypertensive patients is of paramount importance. Unfortunately, erectile dysfunction remains under-reported, under-recognized, and under-treated in hypertensive patients, mainly due to the lack of familiarity with this clinical entity by treating physicians. This review aims to discuss the more frequent problems in the management of hypertensive patients with erectile dysfunction and propose ways to overcome these problems in everyday clinical practice.

  18. Perspectives on Sexual Health and Function of Recent Male Combat Veterans of Iraq and Afghanistan

    Directory of Open Access Journals (Sweden)

    Drew A. Helmer, MD, MS

    2015-09-01

    Conclusions: Sexual dysfunction in recent combat veterans can have important negative effects on their health and relationships. Our findings elucidate perceived contributory factors and preferred solutions, which can be applied by health‐care providers to improve the management of sexual dysfunction in these patients. Helmer DA, Beaulieu G, Powers C, Houlette C, Latini D, and Kauth M. Perspectives on sexual health and function of recent male combat veterans of Iraq and Afghanistan. Sex Med 2015;3:137–146.

  19. Sexual function 1-year after allogeneic hematopoietic stem cell transplantation

    DEFF Research Database (Denmark)

    Noerskov, K H; Schjødt, I; Syrjala, K L;

    2016-01-01

    Treatment with allogeneic hematopoietic stem cell transplantation (HSCT) is associated with short and long-term toxicities that can result in alterations in sexual functioning. The aims of this prospective evaluation were to determine: (1) associations between HSCT and increased sexual dysfunction...

  20. Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer.

    Science.gov (United States)

    Annam, Kiran; Voznesensky, Maria; Kreder, Karl J

    2016-04-01

    Cancer can cause sexual adverse effects by direct and indirect pathways. It can involve sexual organs, indirectly affect body image, or cause fatigue or depression with subsequent effects on libido. Erectile dysfunction (ED), the inability to obtain or maintain an erection firm enough for sexual intercourse, can also result from adverse effects of cancer treatment, such as fatigue, pain, or anxiety about therapy. In addition, depressed feelings about having cancer can affect sexuality, causing a range of signs and symptoms that can lead to ED. Chemotherapy, hormone therapy, surgery, and radiation can all cause sexual adverse effects. Additional factors that play a role include patient age and degree of ED before starting cancer treatment. In this article, we discuss how chemotherapy, hormone therapy, surgery, and radiation affect erectile function as well as possible treatment options for ED. PMID:27072383

  1. Investigation on the prevalence and the types of female sexual dysfunction(FSD) of 298 cases perimenopause women%298例围绝经期女性性功能障碍患病率及患病类型调查

    Institute of Scientific and Technical Information of China (English)

    王浅浅; 阮祥燕; 田玄玄; 崔亚美; 杜鹃; Diethelm Wallwiener; Alfred O.Mueck; 代荫梅

    2014-01-01

    Objective To investigate the prevalence and the types of female sexual dysfunction ( FSD) of perimenopause women in our clinic, and the influence of menopause , age, smoking, cohabitation time, the number of pregnancy and depression on female sexual function.Methods This was a cross-sectional study .The patients from Dept .of Gynecological Endocrinology in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University and menopausal women from different communities of Heilongjiang and Shandong Province were investigated with questionnaires of FSFI and self rating Depression Scale ( SDS) .All data were analyzed by SPSS 13.0.Results A total of 500 questionnaires were granted and 92.2% of those were recovered .298 questionnaires were included for analysis after screening in the end .The average total score of FSFI was 23.69 and the prevalence of FSD is 58.1% in perimenopause women according to the definition of FSD , the total score of FSFI below of 26.55, in our study.According to the 6 dimensions of FSFI , the prevalence of sexual desire disorder , sexual arousal disorder , orgasm disorder , sexual satisfaction disorder , sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5%and 28.5%orderly.Higher age and depression are risks for FSD (P0.05).Conclusion The prevalence of FSD of perimenopause women in our clinic is 58.1%, and the prevalence of sexual desire disorder , sexual arousal disorder , orgasm disorder , sexual satisfaction disorder , sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5%and 28.5%in turn.%目的:调查中国围绝经期女性性功能障碍的患病率和患病类型,以及绝经、年龄、抑郁心理、与性伴侣同居时间、吸烟、妊娠次数等因素对女性性功能的影响。方法采用横断面研究方法,应用女性性功能量表( Female Sexual Function Index ,FSFI)、抑郁自评量表( Self Rating Depression Scale ,SDS)

  2. 298例围绝经期女性性功能障碍患病率及患病类型调查%Investigation on the prevalence and the types of female sexual dysfunction(FSD) of 298 cases perimenopause women

    Institute of Scientific and Technical Information of China (English)

    王浅浅; 阮祥燕; 田玄玄; 崔亚美; 杜鹃; Diethelm Wallwiener; Alfred O.Mueck; 代荫梅

    2014-01-01

    Objective To investigate the prevalence and the types of female sexual dysfunction ( FSD) of perimenopause women in our clinic, and the influence of menopause , age, smoking, cohabitation time, the number of pregnancy and depression on female sexual function.Methods This was a cross-sectional study .The patients from Dept .of Gynecological Endocrinology in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University and menopausal women from different communities of Heilongjiang and Shandong Province were investigated with questionnaires of FSFI and self rating Depression Scale ( SDS) .All data were analyzed by SPSS 13.0.Results A total of 500 questionnaires were granted and 92.2% of those were recovered .298 questionnaires were included for analysis after screening in the end .The average total score of FSFI was 23.69 and the prevalence of FSD is 58.1% in perimenopause women according to the definition of FSD , the total score of FSFI below of 26.55, in our study.According to the 6 dimensions of FSFI , the prevalence of sexual desire disorder , sexual arousal disorder , orgasm disorder , sexual satisfaction disorder , sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5%and 28.5%orderly.Higher age and depression are risks for FSD (P0.05).Conclusion The prevalence of FSD of perimenopause women in our clinic is 58.1%, and the prevalence of sexual desire disorder , sexual arousal disorder , orgasm disorder , sexual satisfaction disorder , sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5%and 28.5%in turn.%目的:调查中国围绝经期女性性功能障碍的患病率和患病类型,以及绝经、年龄、抑郁心理、与性伴侣同居时间、吸烟、妊娠次数等因素对女性性功能的影响。方法采用横断面研究方法,应用女性性功能量表( Female Sexual Function Index ,FSFI)、抑郁自评量表( Self Rating Depression Scale ,SDS)

  3. Survey of cervical cancer survivors regarding quality of life and sexual function

    Directory of Open Access Journals (Sweden)

    Wenjuan Zhou

    2016-01-01

    Conclusion: The QOL and sexual function of cervical cancer survivors were lower than the general population. Treatment-related complications and sexual dysfunction significantly affected patients' QOL. Having health insurance was associated with better QOL. Sexual function was adversely affected by radiotherapy and radical hysterectomy.

  4. Sexuality and Down Syndrome

    Science.gov (United States)

    ... NDSS Home » Resources » Wellness » Sexuality » Sexuality & Down Syndrome Sexuality & Down Syndrome Human sexuality encompasses an individual's self- ... community standards for adult behavior. How Can Healthy Sexuality be Encouraged for Individuals with Down Syndrome? Creating ...

  5. Penisimplantater er en god sidste behandlingsmulighed for erektil dysfunction

    DEFF Research Database (Denmark)

    Giraldi, Laura; Felbo, Jakob; Sønksen, Jens;

    2015-01-01

    When other treatments fail, penile implants represent the last treatment option in erectile dysfunction. The most commonly used implant is the inflatable three-piece device, which allows the penis to be rigid for sexual intercourse and flaccid during the remaining time. Earlier penile implants were...

  6. Healthy Sexuality

    Medline Plus

    Full Text Available ... or other), gender roles (a person’s expression of social and behavioral norms), and sexual orientation (who a ... as “…a state of physical, emotional, mental and social well-being in relation to sexuality; it is ...

  7. Sexual Problems

    Science.gov (United States)

    ... with your sexual partner. Because they are complex, sexual concerns are treated in many different ways. Often, multiple types of treatment may be required and are used together to treat a problem. Education is important in understanding the anatomy and physiology ...

  8. Healthy Sexuality

    Medline Plus

    Full Text Available ... esteem, and cardiovascular health. A person’s physical sexual response is an important part of his or her ... There are also physical changes during the sexual response in men. During arousal, a man’s penis becomes ...

  9. Sexual Abuse

    Science.gov (United States)

    Navigation Physical Abuse Sexual Abuse Domestic Violence Psychological Abuse Financial Abuse Neglect Critical Issues What Communities Can Do The Role ... Abuse and Neglect Ramsey-Klawsnik, H. (1996). Assessing physical and sexual abuse in health care settings. In L.A. Baumhover & S. ...

  10. Healthy Sexuality

    Medline Plus

    Full Text Available ... defined sexual health as “…a state of physical, emotional, mental and social well-being in relation to ... a women’s response intertwines both her physical and emotional sexual drive. This would explain how women can ...

  11. Sexual Problems

    Medline Plus

    Full Text Available ... important to note that psychological problems such as sexual abuse can be involved as well. Pain caused by lack of lubrication or by vaginismus is not included in this ... woman wants sexual penetration. Women with this condition can still achieve ...

  12. Healthy Sexuality

    Medline Plus

    Full Text Available ... Smoking Cessation Links to Professional Societies and Organizations Home › Healthy Sexuality Sexuality is the experience and/or ... Find a Health Care Provider Back to Top Home | About Us | Reproductive Health Topics | News & Publications | Resources ...

  13. Healthy Sexuality

    Medline Plus

    Full Text Available ... body responds to sexual stimulation. During sexual arousal, blood flow increases to a woman’s genitals. Her vagina ... changes occur; a woman’s nipples become erect, her blood pressure and heart rate increase, and a “sex ...

  14. Sexual revolutions

    NARCIS (Netherlands)

    G. Hekma; A. Giami

    2014-01-01

    The sexual revolution of 1960-1980 created a major break in attitudes and practices in Western societies. It created many new freedoms for gay men, youth and women, in terms of sexual imagery, information, and rights. Leftists denounced the revolution's consumerism whilst feminists lamented its cont

  15. Brief Emotion Regulation Training Facilitates Arousal Control During Sexual Stimuli.

    Science.gov (United States)

    van Overveld, Mark; Borg, Charmaine

    2015-01-01

    Disgust, a negative emotion which evokes strong behavioral avoidance tendencies, has been associated with sexual dysfunction. Recently, it was postulated that healthy sexual functioning requires a balance between excitatory (increased sexual arousal) and inhibitory processes (lowered disgust levels). This suggests that amplification of excitatory processes (like sexual arousal) could be a valuable addition to treatments for affect-based sexual dysfunctions. The major aim of the present study was to establish whether up-regulation could effectively enhance arousal levels during sexual stimuli, and whether such a training would simultaneously reduce disgust. Students (N = 163, mean age = 20.73 years, SD = 2.35) were trained in up-regulation of affect using either a sexual arousal film (i.e., female-friendly erotic movie) or a threat arousal film clip (i.e., horror movie), while control groups viewed the films without training instructions. Following this, participants viewed and rated state emotions during a series of pictures (sexual, disgusting, or neutral). Up-regulation of mood successfully enhanced general arousal in both groups, yet these arousal levels were not paralleled by reductions in disgust. Overall, the findings indicate that emotion regulation training by maximizing positive affect and general arousal could be an effective instrument to facilitate affect-related disturbances in sexual dysfunctions. PMID:25258109

  16. Psychophysiological Reactivity in Child Sexual Abuse.

    Science.gov (United States)

    Ben-Amitay, Galit; Kimchi, Nir; Wolmer, Leo; Toren, Paz

    2016-01-01

    Sexual abuse has physiological and emotional implications. The purpose of this study is to evaluate the neurobiological sequels of childhood sexual trauma by monitoring physiological variables among sexually abused girls and women compared to controls. We assessed posttrauma and traumatic life events of 35 females sexually abused in their childhood (age range 7-51 years) and 25 control females (age range 7-54 years). Electroencephalography, frontalis electromyography, electrodermal activity, and heart rate parameters were recorded while watching sets of pictures representing neutral and trauma-suggestive stimuli. A minority of participants met the Diagnostic and Statistical Manual of Mental Disorders criteria for post-traumatic stress disorder. Abused females displayed significant elevations in heart rate, electromyography, and electroencephalography while viewing allusive stimuli and elevated heart rate while viewing neutral stimuli. The dysfunctional regulation of the physiological stress system associated with child sexual abuse may endanger the victims with various stress and anxiety disorders. PMID:26934544

  17. Sexual concerns and practices after ICD implantation

    DEFF Research Database (Denmark)

    Berg, Selina Kikkenborg; Elleman-Jensen, Line; Zwisler, Ann-Dorthe;

    2013-01-01

    given about sexual activity, (b) the areas of patient concerns related to sexual function and the ICD, and (c) changes in sexual behavior.Methods:A randomized controlled trial including 196 patients (1:1) was designed, including 12 weeks of exercise training and 1 year of psycho-educational follow......Background:Studies show that patients with implantable cardioverter defibrillators (ICD) frequently experience sexual dysfunction. These experiences are often linked to exercise intolerance, side-effects of medication, and psychological problems.Objective:To describe (a) the level of information......-up focusing on modifiable factors associated with poor outcomes, including sexual functioning. The Sex After ICD Survey was administered 6 months after the randomization as part of the planned explorative outcomes. 141 patients responded.Results:The analyses showed that 37 of the 69 (55.2%) patients...

  18. Vascular Alterations and Sexual Function in Systemic Sclerosis

    Directory of Open Access Journals (Sweden)

    Ann Julie Impens

    2010-01-01

    Full Text Available Sexual dysfunction is common in systemic sclerosis (SSc. Male erectile dysfunction (MED has been reported in around 80% of subjects and more than half of female patients fulfill criteria for diagnosis as female sexual arousal Disorder (FSAD. While some evidence supports a role for cavernosal fibrosis, abundant data suggest that MED is yet another clinical feature of SSc related to vasculopathy. The contribution of vasculopathy to the more complex issues of female sexual dysfunction is less clear. Inhibitors of Type V phosphodiesterase are effective in men with MED secondary to SSc. Limited study in women suggests inconsistent effects on behavior (frequency but not on measures related to perfusion. Sexual activity is an important component of quality of life and an important domain for the caregiver to address; it is not clear that it warrants primary consideration as a consistent measure of scleroderma-related vasculopathy.

  19. Possible ways of correction and treatment of sexual disturbances at men-liquidators of accident on Chernobyl NPP. Chapter 12

    International Nuclear Information System (INIS)

    Main aspects of sexual dysfunction treatment are discussed in the chapter. It is noted that the individual comprehensive system approach to treatment is necessary. In treatment of sexual dysfunctions it is important take into account all components of disease (neuro gumoral, mental etc)

  20. Sibling Sexual Abuse: An Empirical Analysis of Offender, Victim, and Event Characteristics in National Incident-Based Reporting System (NIBRS) Data, 2000-2007

    Science.gov (United States)

    Krienert, Jessie L.; Walsh, Jeffrey A.

    2011-01-01

    Sibling sexual abuse is identified as the most common form of familial sexual abuse. Extant literature is plagued by definitional inconsistencies, data limitations, and inadequate research methodology. Trivialized as "normal" sexual exploration, sibling sexual abuse has been linked to psychosocial/psychosexual dysfunction. Research has relied on…

  1. Sexual Problems

    Medline Plus

    Full Text Available ... and counseling may involve individual and couples sessions, cognitive behavioral therapy, and sensate focus, which are types of specific sexual exercises. Sex therapists and counselors are mental health providers ...

  2. Sexual Problems

    Medline Plus

    Full Text Available ... to a specialist trained in the diagnosis and treatment of sexual problems. This specialist may be a ... in many different ways. Often, multiple types of treatment may be required and are used together to ...

  3. Healthy Sexuality

    Medline Plus

    Full Text Available ... upbringing. Sex is an important part of your life and sexual concerns should be taken seriously. When ... Everyone can achieve the healthy and satisfying sex life that they deserve. Looking for Additional Information? Visit ...

  4. Sexual Problems

    Medline Plus

    Full Text Available ... vulvodynia. Sex is an important part of your life and sexual concerns should be taken seriously. When ... everyone can achieve the healthy and satisfying sex life that they deserve. Looking for Additional Information? Visit ...

  5. Healthy Sexuality

    Medline Plus

    Full Text Available ... about sexual function as described by Masters and Johnson in the mid-1960s. They described 4 stages, ... returns to its unstimulated state. Since Masters and Johnson, other researchers have modified the original concept with ...

  6. Sexual Problems

    Medline Plus

    Full Text Available ... may be a physician, psychologist, social worker, or physical therapist. You may also find it helpful to discuss ... enhance sexual pleasure. There are many devices that fall under this category, including vibrators, dilators, and clitoral ...

  7. Healthy Sexuality

    Medline Plus

    Full Text Available ... health to be attained and maintained, the sexual rights of all persons must be respected, protected and ... 2016 ASRM, American Society for Reproductive Medicine. All Rights Reserved. ASRM Non Discrimination Policy | ASRM Web Site ...

  8. Healthy Sexuality

    Medline Plus

    Full Text Available ... health to be attained and maintained, the sexual rights of all persons must be respected, protected and fulfilled.” The concept of “sex,” is difficult to define and varies ...

  9. Sexual Problems

    Medline Plus

    Full Text Available ... inhibitors, or SSRIs, often reduce sexual desire and response. However, some other antidepressants have been shown to ... FDA because it produced only small improvements in response rates compared with placebo and was associated with ...

  10. Sexual Problems

    Medline Plus

    Full Text Available ... and counseling may involve individual and couples sessions, cognitive behavioral therapy, and sensate focus, which are types ... training in working with people with sexual concerns. Cognitive behavioral therapy is a type of psychotherapy that ...

  11. Sexual Problems

    Medline Plus

    Full Text Available ... keeping a balanced diet, and minimizing and relieving stress. You can optimize the sexual setting by enhancing ... proposed to improve libido in women, however more studies are needed to confirm its efficacy and safety. ...

  12. Sexual Problems

    Medline Plus

    Full Text Available ... and takes into account the person’s age, physical health, and personal life circumstances. In combined arousal disorder, ... sexual exercises. Sex therapists and counselors are mental health providers who have specialized training in working with ...

  13. Sexual Problems

    Medline Plus

    Full Text Available ... sexual arousal disorder have little or no genital responsiveness to stimulation and they don’t produce adequate ... problems. This specialist may be a physician, psychologist, social worker, or physical therapist. You may also find ...

  14. Sexual Problems

    Medline Plus

    Full Text Available ... be due to many factors, including physical, psychological, medical conditions, or medications. Men with male orgasmic disorder ... very uncommon, and is usually due to a medical condition. There are 4 categories of male sexual ...

  15. Sexual Problems

    Medline Plus

    Full Text Available ... Kegel exercises, biofeedback therapy, and pelvic floor muscle rehabilitation. Kegel exercises involve contracting and relaxing the muscles ... addition to improving sexual function, pelvic floor muscle rehabilitation can improve pelvic pain and urinary incontinence. Medical ...

  16. Sexual Problems

    Medline Plus

    Full Text Available ... proposed to improve libido in women, however more studies are needed to confirm its efficacy and safety. ... shown to improve sexual desire. In a small study of nondepressed women and men with desire and ...

  17. Healthy Sexuality

    Medline Plus

    Full Text Available ... course of a lifetime. The World Health Organization has defined sexual health as “…a state of physical, ... source of immense pleasure and satisfaction. Sex also has many other positive health benefits, such as reducing ...

  18. Sexual Problems

    Medline Plus

    Full Text Available ... moisturizers, and sexual toys. Lubricants work by reducing friction between tissues. Many different types of lubricants are ... if used with latex condoms. Moisturizers also reduce friction between tissues but they are different from lubricants ...

  19. Sexual Problems

    Science.gov (United States)

    ... product's label. Return to top Loss of sexual interest Your interest in sex, also called libido, can ... Benefits - This fact sheet explains the types of employee and tax benefits that are available to adoptive ...

  20. Sexual Problems

    Medline Plus

    Full Text Available ... spasm. Vaginismus is believed to be mostly an anxiety disorder, although physical abnormalities should be checked by ... keeping a balanced diet, and minimizing and relieving stress. You can optimize the sexual setting by enhancing ...

  1. Healthy Sexuality

    Medline Plus

    Full Text Available ... 1979, desire was added to the sexual reponse model, and then response was changed to only desire, ... factors that may play a role include anxiety, depression, stress, abuse, and poor body image. Memories of ...

  2. Sexual Problems

    Medline Plus

    Full Text Available ... keeping a balanced diet, and minimizing and relieving stress. You can optimize the sexual setting by enhancing ... efficacy and safety. For men with low testosterone levels, there is some evidence that testosterone therapy may ...

  3. Healthy Sexuality

    Medline Plus

    Full Text Available ... viewing this embedded video, please click here . Transcript Sex and sexuality are important issues for many people, regardless of their age, sex, or gender. Although many people are embarrassed or ...

  4. Sexual Problems

    Medline Plus

    Full Text Available ... problems. This specialist may be a physician, psychologist, social worker, or physical therapist. You may also find ... aids include lubricants, moisturizers, and sexual toys. Lubricants work by reducing friction between tissues. Many different types ...

  5. Sexual Problems

    Medline Plus

    Full Text Available ... increase strength and tone. Biofeedback therapy involves the placement of biofeedback sensors that allow an individual to “ ... are many other herbs, supplements, and other “natural” products that are advertised to improve sexual performance or ...

  6. Sexual Problems

    Medline Plus

    Full Text Available ... this is considered within the normal range sexual function. Female dyspareunia is pain in the vaginal area ... Education is important in understanding the anatomy and physiology of sex and in having realistic expectations for ...

  7. 疏肝益阳胶囊对动脉性勃起功能障碍大鼠性功能及性腺质量的作用%Effect of Shuganyiyang Capsules on Sexual Function and Sex Gland Weight in Rats with Arteriogenic Erectile Dysfunction

    Institute of Scientific and Technical Information of China (English)

    王济; 白明华; 刘保兴; 杨寅; 杨玲玲; 王琦

    2013-01-01

    目的 观察中药疏肝益阳胶囊对动脉性勃起功能障碍(arteriogenic erectile dysfunction,AED)模型大鼠性功能及睾丸和附属性腺器官质量的改善作用.方法 选取3月龄成年雄性SD大鼠50只,采用双侧髂内动脉结扎法复制AED模型.设假手术组、模型组、西地那非组(每日10.5 mg/kg)、疏肝益阳胶囊大剂量组(每日1 g/kg)、疏肝益阳胶囊小剂量组(每日0.5 g/kg),每组10只,灌胃给药,疗程30 d.行阿朴吗啡(apomorphine,APO)试验检测性功能,取双侧睾丸及附睾、前列腺、精囊腺、球海绵体肌,称湿质量并计算质量系数.结果 APO试验显示疏肝益阳胶囊大、小剂量可显著增加AED大鼠30 min内阴茎勃起次数(P<0.01).疏肝益阳胶囊大、小剂量可显著增加AED大鼠睾丸、附睾、球海绵体肌质量系数(P<0.05).结论 疏肝益阳胶囊可明显改善AED大鼠的性功能,并可使睾丸及其附属性器官质量系数显著增加.%Objective To observe the effect of Shuganyiyang (SGYY) Capsules (for dispersing stagnated liver qi and nourishing yang) on the sexual function and the weights of testes and accessory sex glands in rats with arteriogenic erectile dysfunction (AED). Methods Fifty male Sprague-Dawley rats aged 3 months were selected in the study. Bilateral internal iliac artery ligation was used to induce a rat model of AED. The rats were randomly and equally divided into sham operation group, model group, sidenafil (10. 5 mg/kg daily) group, high-dose SGYY Capsule (1 g/kg daily) group, and low-dose SGYY Capsule (0. 5 g/kg daily) group and received their respective treatments by intragastric administration for 30 d. The sexual function of rats in each group was evaluated by apomorphine (APO) test. The bilateral testes and epididymides, prostate, seminal vesicle, and bulbocavernosus muscle of rats were collected; the wet weight of each organ was measured, and the weight coefficient was calculated. Results The APO test showed that

  8. Erectile Dysfunction in the Older Adult Male.

    Science.gov (United States)

    Mola, Joanna R

    2015-01-01

    Erectile dysfunction (ED) in the older adult male is a significant problem affecting more than 75% of men over 70 years of age in the United States. Older men have an increased likelihood of developing ED due to chronic disease, comorbid conditions, and age-related changes. Research has demonstrated that while the prevalence and severity of ED increases with age, sexual desire often remains unchanged. This article discusses the clinical picture of ED, including relevant pathophysiology, clinical presentation, and evaluation and treatment options. PMID:26197627

  9. Sexual Jealousy

    Directory of Open Access Journals (Sweden)

    David M. Buss

    2013-09-01

    Full Text Available Sexual jealousy is a basic emotion. Although it lacks a distinctive facial expression and is unlikely to solve problems of survival, it evolved because it solves adaptive problems of mating. Some adaptive functions are similar in men and women at one level of abstraction, such as warding off potential mate poachers and deterring relationship defection. Other functions are sex-differentiated, such as increasing paternity probability for men and monopolizing a mate's economic commitments for women. Dozens of studies have documented sex-differentiated design features of jealousy: The relative upset about sexual and emotional aspects of infidelity; processing speed and memorial recall of sexual and emotional infidelity cues; physiological distress to sexual and emotional infidelity cues; qualities of same-sex rivals that evoke jealousy, such as superior job prospects versus greater physical attractiveness; triggers of mate retention tactics; jealous interrogations following the discovery of infidelity; and whether an infidelity produces forgiveness or breakup. Although showing all the hallmarks of evolved functionality, sexual jealousy also leads to tremendous destruction, from humiliation to homicide. By these scientific theoretical and empirical criteria, sexual jealousy is properly considered not only "basic" but also "one of the most important emotions".

  10. Da impotência à disfunção erétil: destinos da medicalização da sexualidade From impotence to erectile dysfunction: a journey through the medicalization of sexuality

    Directory of Open Access Journals (Sweden)

    Alain Giami

    2009-01-01

    Full Text Available Este artigo retrata a história recente da transformação do conceito da impotência, como desordem psicossexual, em disfunção erétil, considerada como uma doença de etiologia principalmente orgânica. Demonstra sucessivamente como a impotência masculina constituiu uma abrangência global de todo o ciclo da resposta sexual, e ainda, uma violação da identidade e da autoimagem; como o relacionamento entre casais se transformou progressivamente em dificuldade e como a falta de um órgão claramente circunscrito pode ser o objeto de um "simples" tratamento medicamentoso. Este processo foi analisado a partir de modelo sequencial da medicalização (Conrad, que permite compreender a intervenção dos diferentes atores envolvidos (cientistas, médicos, industriais, políticos, empresários. Compreende-se, assim, como as descobertas científicas são selecionadas e desenvolvidas de acordo com seu potencial industrial e são aplicadas às pesquisas clínicas; como entidades clínicas são reconceitualizadas e medidas através de investigações epidemiológicas na população em geral e como são criados os ensaios clínicos que levam à criação de um medicamento. Em seguida, observam-se como os atores da saúde pública e os políticos intervêm para dar legitimidade ao novo problema criado. Por fim, avalia-se a possibilidade da desmedicalização de problemas com o uso não-médico do medicamento, no contexto do desenvolvimento da autoprescrição na Internet.This paper delineates the history of the recent transformation of the concept of impotence - from a psycho-social disorder to a disease with an organic etiology. Then it shows how male impotency, which globally affected the entire sexual response cycle, even acted upon self-image and the representation of the couple - progressively became a disorder as the failure of a well controlled organ liable to undergo a single medicinal treatment. This process is analyzed from the sequential model

  11. Breaking the silence: helping men with erectile dysfunction.

    Science.gov (United States)

    Peate, Ian

    2012-07-01

    Erectile dysfunction is a condition that is often under-reported. This article provides the community nurse with a brief overview of erectile dysfunction in the context of sexual health and its importance to wellbeing. The article outlines issues concerning epidemiology, the possible causes of erectile dysfunction and the impact the condition can have on the man's quality of life. Often men with erectile dysfunction report being stigmatised, feeling shame and experiencing guilt. The role of the community nurse in assessing, making a diagnosis and helping the man with the condition is described. The article emphasises the fact that in order to offer care effectively and competently the community nurse must be up to date and knowledgeable concerning the condition. PMID:22875181

  12. Spinal Cord Dysfunction (SCD)

    Data.gov (United States)

    Department of Veterans Affairs — The Spinal Cord Dysfunction (SCD) module supports the maintenance of local and national registries for the tracking of patients with spinal cord injury and disease...

  13. Diastolic dysfunction in cirrhosis

    DEFF Research Database (Denmark)

    Møller, Søren; Wiese, Signe; Halgreen, Hanne;

    2016-01-01

    Development of esophageal varices, ascites, and hepatic nephropathy is among the major complications of cirrhosis. The presence of cirrhotic cardiomyopathy, which includes a left ventricular diastolic dysfunction (DD), seems to deteriorate the course of the disease and the prognosis. Increased...

  14. Immune dysfunction in cirrhosis

    OpenAIRE

    Sipeki Nóra; Antal-Szalmás Péter (1968-) (laboratóriumi szakorvos, laboratóriumi hematológus és immunológus, klinikai farmakológus szakorvos); Lakatos Péter László; Papp Mária (1975-) (belgyógyász, gasztroenterológus)

    2014-01-01

    Innate and adaptive immune dysfunction, also referred to as cirrhosis-associated immune dysfunction syndrome, is a major component of cirrhosis, and plays a pivotal role in the pathogenesis of both the acute and chronic worsening of liver function. During the evolution of the disease, acute decompensation events associated with organ failure(s), so-called acute-on chronic liver failure, and chronic decompensation with progression of liver fibrosis and also development of disease specific comp...

  15. Diabetes Associated Male Reproductive Dysfunctions: Prevalence, Diagnosis and Risk Factors

    Directory of Open Access Journals (Sweden)

    Kamaldeep Singh

    2016-03-01

    Full Text Available Diabetes mellitus (DM is one of the most common chronic metabolic disease worldwide involving male reproductive dysfunctions (RD. Male diabetics are more prone to varieties of sexual disorders such as impotence, retrograde ejaculation, sexual drive, decreased libido, delayed sexual maturation and erectile dysfunction (ED. The incidences of impotence in diabetics are 2-5 times higher than non-diabetics. The epidemiological data revealed that 20-30% of adult diabetic men have one RD and found to be increasing with advancing of age. The prevalence rate of ejaculatory disturbance and orgasmic dysfunction were estimated in the range of 9-31% and 7-8% respectively. DM associated male RD poses major risk with advancing of age, longer duration of DM, poor glycaemic control, several medications, psychological and high consumption of alcohol. The physical factors (hormonal, vascular, neurological, alcohol and drug addiction as well as psychological factors (ignorance, negative attitude toward sex, poor self esteem marital disharmony and anxiety over sexual performance are also involved. There are no specific diagnosis available for detection of DM associated male RD but patient history, physical assessment, psychological assessment, semen analysis which include mortality, viability and morphology of semen are useful as diagnostic purpose. Recent therapeutic strategies involve in correction of physical and psychological factors.

  16. A potential mechanism underlying atypical antipsychotics-induced lipid disturbances.

    Science.gov (United States)

    Cai, H L; Tan, Q Y; Jiang, P; Dang, R L; Xue, Y; Tang, M M; Xu, P; Deng, Y; Li, H D; Yao, J K

    2015-10-20

    Previous findings suggested that a four-protein complex, including sterol-regulatory element-binding protein (SREBP), SREBP-cleavage-activating protein (SCAP), insulin-induced gene (INSIG) and progesterone receptor membrane component 1 (PGRMC1), within the endoplasmic reticulum appears to be an important regulator responsible for atypical antipsychotic drug (AAPD)-induced lipid disturbances. In the present study, effects of typical antipsychotic drug and AAPDs as well as treatment outcome of steroid antagonist mifepristone (MIF) on the PGRMC1/INSIG/SCAP/SREBP pathway were investigated in rat liver using real-time quantitative polymerase chain reaction (qPCR) and western blot analysis. In addition, serum triacylglycerol, total cholesterol, free fatty acids and various hormones including progesterone, corticosterone and insulin were measured simultaneously. Following treatment with clozapine or risperidone, both lipogenesis and cholesterogenesis were enhanced via inhibition of PGRMC1/INSIG-2 and activation of SCAP/SREBP expressions. Such metabolic disturbances, however, were not demonstrated in rats treated with aripiprazole (ARI) or haloperidol (HAL). Moreover, the add-on treatment of MIF was effective in reversing the AAPD-induced lipid disturbances by upregulating the expression of PGRMC1/INSIG-2 and subsequent downregulation of SCAP/SREBP. Taken together, our findings suggest that disturbances in lipid metabolism can occur at an early stage of AAPD treatment before the presence of weight gain. Such metabolic defects can be modified by an add-on treatment of steroid antagonist MIF enhancing the PGRMC1 pathway. Thus, it is likely that PGRMC1/INSIG-2 signaling may be a therapeutic target for AAPD-induced weight gain.

  17. Understanding Sexual Violence

    Science.gov (United States)

    Understanding Sexual Violence Fact Sheet 2014 Sexual violence refers to any sexual activity where consent is not obtained or freely given. Anyone can experience or perpetrate sexual violence. Most victims of ...

  18. Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction.

    Directory of Open Access Journals (Sweden)

    Nicoletta Cera

    Full Text Available Psychogenic erectile dysfunction (ED has been defined as the persistent inability to attain and maintain an erection sufficient to permit sexual performance. It shows a high incidence and prevalence among men, with a significant impact on the quality of life. Few neuroimaging studies have investigated the cerebral basis of erectile dysfunctions observing the role played by prefrontal, cingulate, and parietal cortices during erotic stimulation. In spite of the well-known involvement of subcortical regions such as hypothalamus and caudate nucleus in male sexual response, and the key role of nucleus accumbens in pleasure and reward, poor attention was paid to their role in male sexual dysfunction. In this study, we determined the presence of grey matter (GM atrophy patterns in subcortical structures such as amygdala, hippocampus, nucleus accumbens, caudate nucleus, putamen, pallidum, thalamus, and hypothalamus in patients with psychogenic ED and healthy men. After Rigiscan evaluation, urological, general medical, metabolic and hormonal, psychological and psychiatric assessment, 17 outpatients with psychogenic ED and 25 healthy controls were recruited for structural MRI session. Significant GM atrophy of nucleus accumbens was observed bilaterally in patients with respect to controls. Shape analysis showed that this atrophy was located in the left medial-anterior and posterior portion of accumbens. Left nucleus accumbens volumes in patients correlated with low erectile functioning as measured by IIEF-5 (International Index of Erectile Function. In addition, a GM atrophy of left hypothalamus was also observed. Our results suggest that atrophy of nucleus accumbens plays an important role in psychogenic erectile dysfunction. We believe that this change can influence the motivation-related component of sexual behavior. Our findings help to elucidate a neural basis of psychogenic erectile dysfunction.

  19. Male infertility: an obstacle to sexuality?

    Science.gov (United States)

    Bechoua, S; Hamamah, S; Scalici, E

    2016-05-01

    Interactions between infertility and sexuality are numerous and complex. Infertile men may suffer from sexual dysfunction (SD) when undergoing an assisted reproductive technology programme. We undertook a review both in French and English of the available data on male SD when being diagnosed with a fertility problem with a specific focus on azoospermic men. The review was performed over a 30-year time period using PubMed/Medline. The sexual concerns and needs of infertile/sterile men for whom potential parenting can be compromised were evaluated. When diagnosed with infertility, men usually go through a crisis that can have a deleterious effect on their sexuality with sometimes a feeling of sexual inadequacy. Infertile men will feel stigmatized because they are perceived as being deficient in a specific component of their masculinity. Hence, subsequent SD may occur that can impact the couple sexuality and the infertility management. However, little is known on how the announcement of azoospermia may affect male on a sexual and psychological point of view. The present review suggests that a global management through a healthcare network (biologist, andrologist, sexologist and psychologist) is required which will allow to consider infertility and its subsequent sexual disorders as a whole and not as dichotomized issues. PMID:27061770

  20. Sociological Theroires of and Research on Sexual Problems: A Review of the Literature

    OpenAIRE

    Kew, Melissa

    2011-01-01

    This review considers the literature on sexual problems, with a focus on the most prevalent sexual dysfunction among women – low sexual desire disorder. I first discuss the debates over the definition of Hypoactive Sexual Desire Disorder (HSDD) and then I consider the extent and nature of low sexual desire among women. Next I provide an overview of the underlying mechanisms that are said to account for HSDD. I end the review with a discussion of avenues for future work on sexual problems by s...

  1. Sexuality of child sexual abuse survivors

    OpenAIRE

    Cantón-Cortés, David

    2015-01-01

    The aim of this research was to analyse the possible differences in sexuality among female survivors of sexual abuse during childhood or adolescence and non-survivors of the same age, family structure and parental educational level. In order to assess sexual desire, sexual arousal, orgasmic ability, and negative sexual affect, the “Brief Sexual Functioning Questionnaire” (BSFQ; Meston, Rellini & Heiman 2006) was employed. An additional question was used to assess anxiety, fear, and disgust...

  2. The Synergistic (MARATHON) Effect of Combined Methamphetamine with Sexual Stimulant Drugs on Increasing the Likelihood of High-Risk Sexual Behaviors

    OpenAIRE

    Hosseinifard, Seyed Mehdi; Ahmadian, Alireza; Smaeelifar, Neda

    2014-01-01

    Background Chronic drug abuse and sexual dysfunction specifically erectile dysfunction may lead drug abusers to seek over-the-counter or non-prescription medications, out of which Sildenafil citrate, sold as the trade name of Viagra® can be considered as a prime and important treatment. Therefore, the research purpose was to draw a comparison and review the role of methamphetamine abuse and sildenafil use in increasing the likelihood of high-risk sexual behaviors (both concomitant and non-con...

  3. Erectile dysfunction and type 2 diabetes mellitus in northern Pakistan

    International Nuclear Information System (INIS)

    Objective: To determine the frequency of erectile dysfunction in married male Type-2 diabetic patients. Methods: The cross-sectional observational study was carried out at the Endocrinology, Diabetes and Metabolic Diseases Unit Hayatabad Medical Complex, Peshawar, from July 2011 to Apr 2012, comprising 217 male married Type-2 diabetic patients. Serum samples were assayed for blood glucose, lipid profile and glycated haemoglobin A1c. Body mass index and waist-to-hip ratio was calculated. Erectile dysfunction was assessed by Sexual Health Inventory for Men questionnaire. SPSS 18 was used for statistical analysis. Results: A total of 217 patients were initially interviewed. The mean age was 43.1+-8.160 years. The frequency of drectile dysfunction increased with age, duration of patients and increased body mass index. Overall, 6 (2.8%) patients had no erectile dysfunction, 37 (17.1%) had mild, 82 (37.8%) mild to moderate; 47 (21.7%) moderate; and 45 (20.7%) severe. Higher HbA1c levels and atherogenic dyslipidaemia were associated with erectile dysfunction. Conclusion: Poor glycaemic control was associated with increased erectile dysfunction risk. Duration of diabetes, older age, increased body mass index are associated with increased incidence of the condition in patients with diabetes. Intensive lifestyle changes in the beginning can add to the better management of Type-2 diabetes and prevention of erectile dysfunction. (author)

  4. Reconceptualising women’s sexual desire and arousal in DSM-5

    OpenAIRE

    Graham, Cynthia A.

    2015-01-01

    The publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 was the culmination of more than a decade of work by the APA DSM-5 task force and Work Groups. From 2007 to 2013, I served as a member of the Sexual Dysfunctions subworkgroup, part of the Sexual and Gender Identity Disorders workgroup. In the area of sexual disorders, some of the most significant changes were made in diagnostic categories for female sexual dysfunction. The DSM-IV ...

  5. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms.

    Science.gov (United States)

    DeLay, Kenneth Jackson; Nutt, Max; McVary, Kevin T

    2016-08-01

    The link between lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and sexual dysfunction is well established. Sexual dysfunction can encompass both ejaculatory dysfunction (EjD) and erectile dysfunction (ED). Ejaculatory dysfunction can consist of premature ejaculation, delayed ejaculation, retrograde ejaculation, anejaculation, decreased force of ejaculation and pain upon ejaculation. The impact of different medical and surgical therapies on ejaculatory function will be reviewed. We reviewed the various categories of LUTS treatment including the canonical epidemiology and pathophysiology as well as the surgical and medical treatments for LUTS/BPH. We note that most surgeries and several medical treatments have a certain but ill-defined negative impact on ejaculatory function. Several MISTs and selected medical therapies appear to have little impact on EjD. Both EjD and BPH are very common disorders in men under the care of an urologist. It is well documented that there is a clinical association between these two entities. Unfortunately many of the medical treatments and almost all surgical treatment impact the ejaculatory function of the patient. The surgical treatment of BPH often leads to retrograde ejaculation while medical treatment leads to anejaculation. PMID:27652217

  6. A dual physiological character for sexual function: libido and sexual pheromones.

    Science.gov (United States)

    Motofei, Ion G

    2009-12-01

    Human sexual response is a complex function involving many cerebral, spinal and peripheral aspects; the last are relatively known and benefit from good pharmacological control, as in the case of erectile dysfunction. Spinal cord sexual reflexes also have a good theoretical and experimental description. There is minimal understanding of the cerebral sexual processes (libido, sexual arousal, orgasm). The initial perspective was that the cerebral areas implied in sexuality exert descending stimulatory and inhibitory influences on spinal cord sexual centres/reflexes. This was a wrong supposition, which inhibited progress in this subject, with a considerable impact on a subject's individual and social life. A new approach to sexual function arises from the idea that simple neurological structures can support only simple functions, while a more complex function requires correspondingly complex anatomical structures. For this reason the spinal cord would not be able to realise the integration of multiple (spinal and psychosensorial) stimuli into a unique and coherent ejaculation response. Consequently, all mechanisms implied in human sexuality would be cerebral processes, ejaculation reflexes ascending in evolution to the cerebral level. This new evolutionary concept was developed after 2001 in five distinct articles on the cerebral duality of sexual arousal, sexual hormones, ejaculation and serotonergic receptors. During this period other published results suggested a possible cerebral duality for sexual pheromones and libido in humans. All these dual physiological aspects are integrated in this review into one neurophysiological model, thus trying to further develop the new concepts of sexual function and perhaps relational behaviour. In conclusion, ejaculation is a dual cerebral process with arousal sensation (hormonally modulated) and libido perception (pheromonally modulated) as the afferent part. Two neurophysiological axes could exist in both men and women. In this

  7. Agreement of Self-Reported and Genital Measures of Sexual Arousal in Men and Women: A Meta-Analysis

    NARCIS (Netherlands)

    M.L. Chivers; M.C. Seto; M.L. Lalumière; E. Laan; T. Grimbos

    2010-01-01

    The assessment of sexual arousal in men and women informs theoretical studies of human sexuality and provides a method to assess and evaluate the treatment of sexual dysfunctions and paraphilias. Understanding measures of arousal is, therefore, paramount to further theoretical and practical advances

  8. Erectile dysfunction in hemodialysis patients

    Directory of Open Access Journals (Sweden)

    Imen Gorsane

    2016-01-01

    Full Text Available Erectile dysfunction (ED is a common problem seen among patients on hemodialysis (HD, but it is still a taboo subject in our country. The attention given to this sexual problem remained low, and the prevalence of ED among these patients has not been well characterized. We carried out this study in order to determine the prevalence and severity of ED in HD patients. We conducted a descriptive cross-sectional study in our HD unit in March 2013. ED was evaluated using the International Index Erection Function. Thirty patients with a mean age of 49.1 years were eligible for this study. The main causes of chronic kidney disease were hypertension (62.5% and diabetes (41.6%. The prevalence of ED was 80%, including 33.3% severe ED. Plasma levels of gonadotropins: luteinizing hormone (LH, follicule-stimulating hormone were in the standards except for one patient who had an elevated level of LH. Prolactin was elevated in four cases. ED was present in 8.4% of patients before the discovery of renal failure and in 91.6% of patients at the beginning of dialysis. For 19 patients (79.1%, the ED had increased during the dialysis sessions. A significant number of our HD patients presented with ED of varying degrees. Nephrologists should pay attention to the problem of ED in order to improve the quality of their life.

  9. Antihypertensive medications and sexual function in women: Baseline data from the Systolic Blood Pressure Intervention Trial (SPRINT)

    Science.gov (United States)

    Thomas, Holly N.; Evans, Gregory W.; Berlowtiz, Dan R.; Chertow, Glenn M.; Conroy, Molly B.; Foy, Capri G.; Glasser, Stephen P.; Lewis, Cora E.; Riley, William T.; Russell, Laurie; Williams, Olubunmi; Hess, Rachel

    2016-01-01

    Objectives Hypertension is a risk factor for the development of cardiovascular and kidney disease, but treatment can substantially reduce risks. Many patients avoid antihypertensive medications due to fear of side effects. While associations between antihypertensives and sexual dysfunction in men have been documented, it remains unclear whether antihypertensives are associated with sexual dysfunction in women. We conducted a cross-sectional analysis of baseline data from women in the Systolic Blood Pressure Intervention Trial (SPRINT) to evaluate the relations among class of antihypertensive medication and the outcomes (a) sexual activity and (b) sexual function. Methods SPRINT enrolled individuals 50 and older with hypertension at high risk for cardiovascular disease. A subset of participants completed questionnaires regarding quality of life (QoL), including sexual function. Antihypertensive class was determined by medications taken at baseline. Results Of 690 women in the QoL subset of SPRINT, 183 (26.5%) were sexually active. There were no significant differences in sexual activity among women taking one or more antihypertensives and women not taking any. Women taking an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB) had higher odds of sexual activity [OR 1.66 (1.12-4.27), p=0.011]. Among sexually active women, the prevalence of sexual dysfunction was high (52.5%). No class of medication was associated with sexual dysfunction in the multivariable model. Conclusions ACEI/ARB use was associated with higher odds of sexual activity. While prevalence of sexual dysfunction was high, no single class of antihypertensive medication was associated with sexual dysfunction. PMID:27032074

  10. Level of Sexual Myths Level in Premature Ejaculation Cases

    Directory of Open Access Journals (Sweden)

    Mehmet Gunes

    2016-06-01

    Full Text Available Objective: The aim of this study is to determine level of belief in sexual myths in the cases of premature ejacula­tion (PE which is the most common sexual dysfunction in men. Methods: This study included 100 cases who applied Di­cle University Faculty of Medicine hospitals meet prema­ture ejaculation criteria of DSM-5 and 70 healthy controls. Sociodemographic data form, Hamilton Depression Rat­ing Scale (HDS, Hamilton Anxiety Rating Scale (HAS, Arizona Sexual Experience Scale (ASES-Men form and Sexual Myths Evaluation Form were applied to partici­pants. Results: In the study, rate of belief in sexual myths in PE cases was found significantly higher than healthy controls. In the PE cases, education time less than 10 years, the presence of comorbid sexual dysfunction were found to be statistically significant factors that increase the level of belief in sexual myths in the PE cases, HDS (p=0.0002, HAS (p=0.0001, ASES (p=0.0004 scores were statisti­cally significantly higher than the control group. In the loss of sexual desire in men with comorbid ASES (p=0.0001, with ED, ASES (p=0.001 and HDS (p=0.040 scores were found statistically significantly higher. Conclusions: Sexual information should be given in the appropriate age by educated person in educational insti­tutions.

  11. Female Sexual Function During the Menopausal Transition in a Group of Iranian Women

    Science.gov (United States)

    Eftekhar, Tahereh; Dashti, Mahboobeh; Shariat, Mamak; Haghollahi, Fedyeh; Raisi, Firoozeh; Ghahghaei-Nezamabadi, Akram

    2016-01-01

    Objective: To determine the prevalence of sexual problems in Iranian women and association of sexual dysfunction with menopausal symptoms. Materials and methods: In this cross-sectional study, 151 married women with the age of 40-60 yearsold who were referred for treatmentto Department of Gynecology in Vali-e-Asr Hospital (Tehran, Iran) from April to July 2012, were recruited. They were evaluated concerning their sexual function in the domains of desire, arousal, lubrication, orgasm, satisfaction and pain with the female sexual function index (FSFI) questionnaire.Menopause rating scale (MRS) was developed for the diagnosis and quantification of climacteric symptoms. Results: Total frequency of sexual dysfunction was 53% with the domains of lubrication, arusal and desire being commonly affected 62%, 70% and 98.5% of cases respectively. There is a relationship between severity of somatic and urogenital symptoms with sexual dysfunction (p = 0.03, p = 0.00 respectively). Conclusion: A considerable percentage of women experienced sexual dysfunctions in this period. Somatic and urogenital symptoms during the menopausal period could be a factor to maintain or intensity of sexual dysfunctions.

  12. Voiding dysfunction - A review

    Directory of Open Access Journals (Sweden)

    Sripathi V

    2005-01-01

    Full Text Available In a child who is toilet trained the sudden onset of daytime wetting with frequency or urgency is alarming to the parents. Initially this subject was subdivided into a number of descriptive clinical conditions which led to a lot of confusion in recognition and management. Subsequently, the term elimination dysfunction was coined by Stephen Koff to emphasise the association between recurrent urinary infection, wetting, constipation and bladder overactivity. From a urodynamic point of view, in voiding dysfunction, there is either detrusor overactivity during bladder filling or dyssynergic action between the detrusor and the external sphincter during voiding. Identifying a given condition as a ′filling phase dysfunction′ or ′voiding phase dysfunction′ helps to provide appropriate therapy. Objective clinical criteria should be used to define voiding dysfunction. These include bladder wall thickening, large capacity bladder and infrequent voiding, bladder trabeculation and spinning top deformity of the urethra and a clinically demonstrated Vincent′s curtsy. The recognition and treatment of constipation is central to the adequate treatment of voiding dysfunction. Transcutaneous electric nerve stimuation for the treatment of detrusor overactivity, biofeedback with uroflow EMG to correct dyssynergic voiding, and behavioral therapy all serve to correct voiding dysfunction in its early stages. In established neurogenic bladder disease the use of Botulinum Toxin A injections into the detrusor or the external sphincter may help in restoring continence especially in those refractory to drug therapy. However in those children in whom the upper tracts are threatened, augmentation of the bladder may still be needed.

  13. [Why do cardiologists disregard sexual health of their patients? A critical review].

    Science.gov (United States)

    Scardi, Sabino

    2016-05-01

    Sexual activity is an essential aspect of normal human function, well-being and quality of life. Sexual dysfunction is a common problem of increasing incidence in patients with cardiovascular disease, particularly younger and male, and continues over time in life, but these issues are not often discussed in daily practice both for a limited patient-physician relationship and clinicians' poor knowledge. Many studies suggest that the majority of patients and their partners have questions or concerns about their sexual health. Healthcare providers can help their patients if they are aware of the problem. Cardiologists need more knowledge and specific practical training in providing information on sexual concerns and sexual counseling to cardiac patients. This review aims at providing clinicians with most recent evidence about sexual dysfunction, and its management in patients with cardiac disease. Sexual couseling of cardiac patients is an important role for healthcare providers.

  14. Sexual Violence

    Centers for Disease Control (CDC) Podcasts

    2011-04-04

    This podcast discusses sexual violence - what it is, the long-term health problems it can contribute to, and tips to stop it before it begins.  Created: 4/4/2011 by National Center for Injury Prevention and Control (NCIPC).   Date Released: 4/4/2011.

  15. Sexual Problems

    Medline Plus

    Full Text Available ... as water-based, silicone-based, or oil-based products. Water-based lubricants have the advantage of being ... are many other herbs, supplements, and other “natural” products that are advertised to improve sexual performance or ...

  16. Sexual Problems

    Medline Plus

    Full Text Available ... sensate focus, which are types of specific sexual exercises. Sex therapists and counselors are mental health providers ... one’s thinking influences feelings and behavior. Sensate focus exercises are structured “touching” activities that are designed to ...

  17. Childhood sexual traumatic events and sexual life and relationship of a patient

    Directory of Open Access Journals (Sweden)

    Sobański, Jerzy A.

    2014-06-01

    Full Text Available Aim: The assessment of links between traumatic events of sexual nature recollected from the past and patients’ later functioning in sexual life and relationships. Materials and methods: Comorbidity of memories of traumatic sexual events from childhood and adolescence in patients with the features of their current partner relationships was analysed on the basis of Live Inventory completed by 2,582 women and 1,347 men, undergoing treatment between the years 1980-2002, before they were admitted to a day ward of neurotic disorder department. Results: The existence of numerous significant links was observed e.g. the information regarding incest or incest attempt experience was related with a significant risk of a sexual life assessment as completely dissatisfying in women (OR=2.71 and almost completely dissatisfying in men (OR=2.38. Sexual initiation by rape was related with women’s more frequent incidence of getting married as a result of social pressure (OR=3.77 and a feeling of hatred towards a partner (OR=5.41. Men and women who considered themselves completely sexually uneducated (before the age of 18 assessed their sexual life as completely dissatisfying (OR=2.48 and OR=2.07, which was similar to men who would get punished for masturbation or sexual plays by their guardians (OR=2.68. Conclusions: Traumatic events and circumstances relating to sexuality, indicated in the questionnaire interview, turned out to be connected with the risk of dysfunctions in a sexual life and relationship. The traumas included, among others, rape during initiation, early initiation, incest, but also unfavourable circumstances of less traumatic nature such as a lack of sexual education, punishment for masturbation, “mostly undesired initiation”. Their likely effects were rooted in relationship dysfunctions: reasons for their formation, power division, instability, problems with resolving conflicts and, most of all, sexual life dysfunctions. The results were

  18. Children sexual abuse in Poland – study of 257 sexual offenders against minors

    Directory of Open Access Journals (Sweden)

    Heitzman, Janusz

    2014-02-01

    Full Text Available Introduction. Obtaining objective data on sexual offenders against minors is difficult. In order to enhance the possibilities to prevent such crimes it is essential to determine factors that condition this kind of sexual behavior. Aim: The aim of the study was to prepare a multidimensional analysis of a profile of sexual offenders against minors. Material and method. A detailed analysis of documentation from forensic sexological, psychiatric and psychological examinations and information from the records of the proceedings concerning 257 perpetrators was performed by the authors. Information analyzed included demographic data, psychosocial background, psychosexual development, recent sexual activity, physical and mental health issues and information concerning accused sexual crime. Results. The majority of the offenders had undisturbed family relations. However, subjects with sexual preference disorders perceived their parents’ relationship as worse, reported more difficulties in educational process and in relation to teachers and peers. 5.4% of subjects experienced sexual abuse and 23.3% physical violence in their childhood. The majority reported no sexual dysfunction and had regular but rare sexual activity. 20.6% were diagnosed as having mental disorder and 36.8% were alcohol abusers. Almost 30% were under influence of alcohol or another substance during the crime. The majority had no sexual preference disorder. Definite pedophilia was found in 27% and traits of psychosexual immaturity in 23.1% of cases. There was no relationship between sexual preference disorders and psychiatric comorbidity, alcohol or substance abuse. The acts of sexual abuse comprised genital touching, vaginal or oral intercourse as well as exposing offender’s or victim’s body. These acts were typically against one child, planned, being aware of victim’s age and using physical violence. Conclusions. The data from our research should be taken into account when

  19. How Do Continence Nurses Address Sexual Function and a History of Sexual Abuse in Daily Practice? Results of a Pilot Study

    NARCIS (Netherlands)

    Bekker, Milou D.; Van Driel, Mels F.; Pelger, Rob C. M.; Nijeholt, Guus A. B. Lycklama A.; Elzevier, Henk W.

    2011-01-01

    Introduction. There is a strong association between urological complaints, sexual dysfunction, and history of sexual abuse (SA), and it is unknown whether urological continence nurses integrate this knowledge in their daily practice. Aim. To evaluate how, in their daily practice, Dutch urological co

  20. Sexual Self-Concept and General Health in Rheumatoid Arthritis Patients

    OpenAIRE

    Saadat, Seyed Hassan; Ramezani, Arash; Ahmadi, Khodabakhsh

    2015-01-01

    Background: There are several studies regarding sexual dysfunction in chronic diseases such as diabetes and renal failure; however, no significant study has been done on Iranian rheumatoid arthritis (RA) patients. Objectives: In this study, we aimed to identify and compare sexual dysfunction between RA patients and the normal population. Patients and Methods: In this case-control study, two groups of females (87 RA patients and 89 controls) were randomly selected from the rheumatology clinic ...

  1. Sexual functioning in men living with a spinal cord injury–A narrative literature review

    Directory of Open Access Journals (Sweden)

    M M Sunilkumar

    2015-01-01

    Conclusion: Spinal cord injury and sexual functioning affects a large segment of the male Indian population, yet most current research focuses on quantitative measurement with the emphasis on ejaculatory dysfunction, orgasm impairment, incontinence, and other physiological dysfunction. Further research is needed to address the subjective accounts of patients themselves with respect to the emotional and social impact of sexual disability. This would help to identify the best possible outcomes for both treatment and rehabilitation.

  2. Sexual problems in people with refractory epilepsy.

    Science.gov (United States)

    Henning, Oliver J; Nakken, Karl O; Træen, Bente; Mowinckel, Petter; Lossius, Morten

    2016-08-01

    Sexual dysfunction is an important but often neglected aspect of epilepsy. The objective of this study was to explore the prevalence and types of sexual problems in patients with epilepsy and compare the results with similar data obtained from a representative sample of the general population. At the National Centre for Epilepsy in Norway, 171 of 227 consecutive adult inpatients and outpatients with epilepsy (response rate: 75.3%) and their neurologists participated in a questionnaire study about epilepsy and sexuality. The results were compared with data available from 594 adult Norwegians who had completed the same questionnaire. Patients with epilepsy had a significantly higher prevalence of sexual problems (women: 75.3% vs. 12.0%; men: 63.3% vs. 9.6%). The most commonly reported problems (>30%) were reduced sexual desire, orgasm problems, erection problems, and vaginal dryness. The patients reported considerable dissatisfaction regarding sexual functioning. Significantly more sexual problems were found in patients of both sexes with reduced quality of life and in women with symptoms of depression. We found no significant association between sexual problems and age of epilepsy onset, type of epilepsy, or use of enzyme-inducing antiepileptic drugs. Whereas age at sexual debut did not differ between the patients with epilepsy and the general population, men with epilepsy had a lower number of partners during the last 12months, and the proportion of women with a low frequency of intercourse was higher in the group with epilepsy. In conclusion, sexual problems are significantly greater in Norwegian patients with epilepsy than in the general adult population. As no single epilepsy type or treatment could be identified as a specific predisposing factor, it seems likely that there are multiple causes underlying our results, including both organic and psychosocial factors. PMID:27371882

  3. The relationship between eating disorders and sexual trauma.

    Science.gov (United States)

    Madowitz, Jennifer; Matheson, Brittany E; Liang, June

    2015-09-01

    Research aimed at understanding the causes and comorbidities of eating disorders (ED) identifies sexual trauma as one potential pathway to the development and maintenance of eating disorders. Based on current literature, there are two main etiological pathways between sexual trauma and ED-body perceptions and psychological difficulties. However, previously published reviews on this topic are outdated and have not yielded consistent findings. Therefore, authors completed a literature review covering years 2004-2014 to examine the relationship between sexual trauma and ED according to both proposed pathway models. Authors utilized PubMed, GoogleScholar, and PsychINFO as search engines. Search terms included "sexual assault", "sexual abuse", "sexual trauma", and "rape" in conjunction with relevant ED terminology. Thirty-two studies met inclusion criteria for this review. Current data indicate an increased prevalence of sexual trauma for individuals with ED. Although limited, recent evidence suggests that sexual trauma precedes and contributes to the development of ED. Existing literature indicates that the body perceptions pathway may impact ED through body dissatisfaction, shame, sexual dysfunction, and fear of future sexual trauma. The psychological difficulties pathway indicates a link between ED and the desire to cope with the failure of the average expected environment, psychological diagnoses, the need for control, and the regulation of emotions. However, further research is needed to assess the potential causal role that sexual trauma may play in the etiology of ED. PMID:25976911

  4. Sexually transmitted organisms in sexually abused children

    OpenAIRE

    Robinson, A.; WATKEYS, J.; Ridgway, G

    1998-01-01

    OBJECTIVE—To establish the prevalence of sexually transmitted organisms and other genital organisms in potentially sexually abused children.
DESIGN—Prospective study of children attending an inner London department of community paediatrics for evaluation of possible sexual abuse.
SUBJECTS—Children under 16 referred for evaluation of possible sexual abuse.
OUTCOME MEASURES—Prevalence of sexually transmitted organisms in relation to age, symptoms, and type of abuse.
RESULTS—Sw...

  5. Nuclear medicine imaging technique in the erectile dysfunction evaluation: a mini-review

    Energy Technology Data Exchange (ETDEWEB)

    Ribeiro, Camila Godinho; Moura, Regina; Neves, Rosane de Figueiredo [Universidade do Estado do Rio de Janeiro (UERJ), RJ (Brazil). Inst. de Biologia Roberto Alcantara Gomes. Lab. de Radiofarmacia Experimental]. E-mail: cacagr@yahoo.com.br; Spinosa, Jean Pierre [Hopital de Zone, Morges (Switzerland). Dept. of Gynecology and Obstetrics; Bernardo-Filho, Mario [Instituto Nacional do Cancer, Rio de Janeiro, RJ (Brazil). Coordenadoria de Pesquisa

    2007-09-15

    Functional imaging with positron emission tomography and single photon emission computed tomography is capable of visualizing subtle changes in physiological function in vivo. Erectile dysfunction (ED) diminishes quality of life for affected men and their partners. Identification of neural substrates may provide information regarding the pathophysiology of types of sexual dysfunction originating in the brain. The aim of this work is to verify the approaches of the nuclear medicine techniques in the evaluation of the erectile function/dysfunction. A search using the words ED and nuclear medicine, ED and scintigraphy, ED and SPECT and ED and PET was done in the PubMed. The number of citations in each subject was determined. Neuroimaging techniques offer insight into brain regions involved in sexual arousal and inhibition. To tackle problems such as hyposexual disorders or ED caused by brain disorders, it is crucial to understand how the human brain controls sexual arousal and penile erection. (author)

  6. Combination therapy for erectile dysfunction: an update review

    OpenAIRE

    Dhir, Rohit R; Lin, Hao-Cheng; Canfield, Steven E.; Wang, Run

    2011-01-01

    The introduction of oral phosphodiesterase-5 inhibitors (PDE5Is) in the late 1990s and early 2000s revolutionized the field of sexual medicine and PDE5Is are currently first-line monotherapy for erectile dysfunction (ED). However, a significant proportion of patients with complex ED will be therapeutic non-responders to PDE5I monotherapy. Combination therapy has recently been adopted for more refractory cases of ED, but a critical evaluation of current combination therapies is lacking. A thor...

  7. Mitochondrial Dysfunction in Cancer

    Directory of Open Access Journals (Sweden)

    Michelle L Boland

    2013-12-01

    Full Text Available A mechanistic understanding of how mitochondrial dysfunction contributes to cell growth and tumorigenesis is emerging beyond Warburg as an area of research that is under-explored in terms of its significance for clinical management of cancer. Work discussed in this review focuses less on the Warburg effect and more on mitochondria and how dysfunctional mitochondria modulate cell cycle, gene expression, metabolism, cell viability and other more conventional aspects of cell growth and stress responses. There is increasing evidence that key oncogenes and tumor suppressors modulate mitochondrial dynamics through important signaling pathways and that mitochondrial mass and function vary between tumors and individuals but the sigificance of these events for cancer are not fully appreciated. We explore the interplay between key molecules involved in mitochondrial fission and fusion and in apoptosis, as well as in mitophagy, biogenesis and spatial dynamics and consider how these distinct mechanisms are coordinated in response to physiological stresses such as hypoxia and nutrient deprivation. Importantly, we examine how deregulation of these processes in cancer has knockon effects for cell proliferation and growth. Scientifically, there is also scope for defining what mitochondria dysfunction is and here we address the extent to which the functional consequences of such dysfunction can be determined and exploited for cancer diagnosis and treatment.

  8. Shared Parenting Dysfunction.

    Science.gov (United States)

    Turkat, Ira Daniel

    2002-01-01

    Joint custody of children is the most prevalent court ordered arrangement for families of divorce. A growing body of literature indicates that many parents engage in behaviors that are incompatible with shared parenting. This article provides specific criteria for a definition of the Shared Parenting Dysfunction. Clinical aspects of the phenomenon…

  9. Sexual and marital relationships after radiotherapy for seminoma

    International Nuclear Information System (INIS)

    Questionnaires on sexual function, marital status, and fertility were returned by 84 men who received radiotherapy for seminoma (Stage I, II, or III). The mean length of follow-up was ten years. Although 93 per cent were married, 19 per cent had low rates of sexual activity, 12 per cent reported low sexual desire, 15 per cent had erectile dysfunction, 10 per cent had difficulty reaching orgasm, and 14 per cent had premature ejaculation. The most common problems were reduced intensity of orgasm (33%) and reduced semen volume (49%). Twenty-one men remained childless, and 30 per cent of men worried at least occasionally about infertility. Thirteen children were conceived after cancer therapy. The data suggest that sexual dysfunction and infertility are important concerns for a subgroup of men treated for seminoma

  10. Sexual and marital relationships after radiotherapy for seminoma

    Energy Technology Data Exchange (ETDEWEB)

    Schover, L.R.; Gonzales, M.; von Eschenbach, A.C.

    1986-02-01

    Questionnaires on sexual function, marital status, and fertility were returned by 84 men who received radiotherapy for seminoma (Stage I, II, or III). The mean length of follow-up was ten years. Although 93 per cent were married, 19 per cent had low rates of sexual activity, 12 per cent reported low sexual desire, 15 per cent had erectile dysfunction, 10 per cent had difficulty reaching orgasm, and 14 per cent had premature ejaculation. The most common problems were reduced intensity of orgasm (33%) and reduced semen volume (49%). Twenty-one men remained childless, and 30 per cent of men worried at least occasionally about infertility. Thirteen children were conceived after cancer therapy. The data suggest that sexual dysfunction and infertility are important concerns for a subgroup of men treated for seminoma.

  11. Effects of depressive symptoms and experimentally adopted schemas on sexual arousal and affect in sexually healthy women.

    Science.gov (United States)

    Kuffel, Stephanie W; Heiman, Julia R

    2006-04-01

    The present study examined the effects of depressive mood symptoms and experimentally adopted sexual schemas on women's sexual arousal and affect. Women's vaginal response, subjective sexual arousal, and affect were measured in response to sexually explicit visual material in a laboratory setting. At baseline on a self-report measure, women with depressive mood symptoms (n = 28) reported significantly lower sexual desire than women with normal mood (n=28), but no significant differences in arousal, orgasm, satisfaction, or pain. Participants were asked to adopt both a positive and negative sexual self-schema prior to viewing erotic stimuli. Women in both mood groups demonstrated significantly greater subjective sexual arousal, vaginal response, and positive affect in the positive schema condition than in the negative schema condition when controlling for anxiety. There were no main effects for mood symptoms. These findings support an information processing conceptualization of sexual arousal and suggest that an acute dose of cognitive sexual schemas can significantly impact subsequent sexual and affective responses. Implications of findings for the assessment and treatment of sexual dysfunction are noted. PMID:16752119

  12. Sexual Jealousy

    OpenAIRE

    Buss, David M.

    2013-01-01

    Sexual jealousy is a basic emotion. Although it lacks a distinctive facial expression and is unlikely to solve problems of survival, it evolved because it solves adaptive problems of mating. Some adaptive functions are similar in men and women at one level of abstraction, such as warding off potential mate poachers and deterring relationship defection. Other functions are sex-differentiated, such as increasing paternity probability for men and monopolizing a mate's economic commitments for wo...

  13. [Adolescent sexuality].

    Science.gov (United States)

    Calero, Juan del Rey

    2010-01-01

    The social Adolescent features are insecurity, narcissism, eroticism, more impetuosity than reason. 1/3 of adolescents have risk behaviour for health. The pregnancy rate in adolescent are 9/1,000 (11,720, the abort about 50 %). The total abort (2009) were 114,480. Increase the rate of 8,4 (1990) to 14,6/ 1,000 (2009). The sexual education fails. The consulting about contraceptives get pregnancy of the OR 3,2, condom OR 2,7. The adolescent are influenced in his matter: oeer have 70-75 % of influence, mother 30-40 %, father 15 %, for yhe environment and education Cyberspace access to information: 33 % exposed to unwanted sexual materials, 1 in 7 solicited sexual online. The argument have 4 central topic: Morality and Responsibility, Desire (responsibility vs gratification), Danger (fear related to pregnancy and STD/VIH), and Victimization. The prevention of STD: so called safe sex, delayed, and abstinence, Prevention HPV vaccine. The information is not enough, are necessary personal integral formation in values as self control, abstinence, mutual respect, responsibility, reasonable decisions. PMID:21877398

  14. Cognitive dysfunction after cardiovascular surgery

    DEFF Research Database (Denmark)

    Funder, K S; Steinmetz, J; Rasmussen, L S

    2009-01-01

    This review describes the incidence, risk factors, and long-term consequences of cognitive dysfunction after cardiovascular surgery. Postoperative cognitive dysfunction (POCD) is increasingly being recognized as an important complication, especially in the elderly. A highly sensitive neuropsychol...

  15. Sexuality and Young Children.

    Science.gov (United States)

    Honig, Alice Sterling

    2000-01-01

    Describes normal aspects of sexuality during the early years, including masturbation and children's fanciful sexual ideas. Presents inappropriately mature sexual knowledge as a danger sign of abuse. Discusses whether and what teachers/caregivers should tell children about sexuality, and notes the importance of teaching staff about sexual identity…

  16. Etiological factors in female hypoactive sexual desire disorder

    OpenAIRE

    Hubin, Alexandra; De Sutter, Pascal; Reynaert, Christine

    2011-01-01

    Object : The purpose of this article is to propose a model to clinicians designed to highlight the dysfunctional elements responsible for the appearance and continuation of Hypoactive Sexual Desire Disorder. Methodology : Supported by a broad analysis of clinical and empirical accounts, we suggest a global vision whose theoretical foundations come from “sexofonctionnelle”. Results :This model underlines the multi-factor aspect of Hypoactive Sexual Desire Disorder and leads us to a didactical ...

  17. AB025. Asian men’s sexual health: Korean perspective

    OpenAIRE

    Park, Kwangsung

    2016-01-01

    Sexual function is an important component of men’s health. The prevalence of erectile dysfunction (ED) in Korea has been reported as 18–36.6% whereas Asian data showed a wide range from 2% to 88%. In 2013, the Korean Society for Sexual Medicine and Andrology (KSSMA) developed the Korean Guideline of ED. Risk factors for ED included age, diabetes, hypertension, obesity, lack of exercise, dyslipidemia, smoking, depression, lower urinary tract symptoms, and pelvic surgery. This guideline showed ...

  18. Rise of herbal and traditional medicine in erectile dysfunction management.

    Science.gov (United States)

    Ho, Christopher C K; Tan, Hui Meng

    2011-12-01

    Herbal medicine long has been used in the management of sexual dysfunction, including erectile dysfunction. Many patients have attested to the efficacy of this treatment. However, is it evidence-based medicine? Studies have been done on animal models, mainly in the laboratory. However, randomized controlled trials on humans are scarce. The only herbal medications that have been studied for erectile dysfunction are Panax ginseng, Butea superba, Epimedium herbs (icariin), Tribulus terrestris, Securidaca longipedunculata, Piper guineense, and yohimbine. Of these, only Panax ginseng, B. superb, and yohimbine have published studies done on humans. Unfortunately, these published trials on humans were not robust. Many herbal therapies appear to have potential benefits, and similarly, the health risks of various phytotherapeutic compounds need to be elucidated. Properly designed human trials should be worked out and encouraged to determine the efficacy and safety of potential phytotherapies. PMID:21948222

  19. Genetics Home Reference: surfactant dysfunction

    Science.gov (United States)

    ... and decreased surfactant function. The loss of functional surfactant raises surface tension in the alveoli, causing severe breathing problems. The combination of SP-B and SP-C dysfunction may explain why the signs and symptoms of SP-B deficiency ... dysfunction sometimes called SP-C dysfunction. These mutations ...

  20. Sexual Health in Adult Men with Spina Bifida

    Directory of Open Access Journals (Sweden)

    Gary W. Bong

    2007-01-01

    Full Text Available Medical and surgical advances in the treatment of spina bifida (SB have resulted in increasing numbers of patients reaching adulthood. As such, issues related to sexual maturity are being investigated to offer optimal healthcare to men with spina bifida. This report constitutes a review of the current literature relating to adults with spina bifida and issues of sexuality, erectile dysfunction and fertility. In general, adult males with spina bifida have normal sexual desires and an interest in addressing these issues with healthcare providers. Sexual education and access to intimacy are delayed compared to the general population. 75% of men achieve erections, but maintaining erections is a problem and some may be merely reflexive in nature. The many of these men show marked improvement with sildenafil. In SB erectile dysfunction and infertility are related to the level of neurological lesion with the best performance status in those with sacral lesions and intact reflexes. Men with lesions higher than T10 are at risk for azoospermia. There is an increased risk of neural tube defects in the children of men with spina bifida, but the current incidence with modern folic acid therapy is unknown. As the number of males with spina bifida reaching sexual maturity increases, further investigation into sexuality, sex education, intimacy, and treatments for erectile dysfunction and infertility will be needed.